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Abstract
Myxoma virus causes the lethal disease myxomatosis following infection of the European 
rabbit (Oryctolagus cuniculus), and was introduced into Australia in 1950 for the biological 
control of wild O. cuniculus populations. Shortly after its release, two, well described events 
occurred: attenuated strains of virus emerged and genetic resistance developed within the host 
rabbit populations. There have been detailed epidemiolgical and molecular studies on 
myxoma virus, but no coordinated study examining the mechanism of genetic resistance. 
This thesis provides the first detailed and coordinated study in which resistant and susceptible 
rabbits infected with virulent and naturally attenuated strains of myxoma virus are directly 
compared.
In the first part of this thesis, differences in the ability of virulent and attenuated myxoma 
virus to down regulate the immune response were examined. Populations of outbred 
laboratory rabbits were infected with the standard laboratory strain (SLS) of myxoma virus, 
which is 100% lethal, or with a naturally attenuated strain of myxoma virus, Uriarra, which 
causes myxomatosis but is lethal in less than 5% of infected rabbits. SLS but not Uriarra, 
suppressed the T-cell-mitogen induced proliferation of lymphocytes from lymph nodes of 
rabbits by 4dpi. To examine humoral immune responses, a model system of coinfections was 
studied, using a highly attenuated recombinant myxoma virus that expresses the influenza 
haemagglutinin (HA). IgG titres to HA were suppressed by coinfection of laboratory rabbits 
with either SLS or Uriarra. However, IgG titres to myxoma virus were strikingly higher in 
rabbits coinfected with SLS compared to those coinfected with Uriarra. Modulation of the 
immune response by SLS was associated with the depletion of lymphocytes from lymph 
nodes.
The next phase of this study was to determine where and when virus replication was 
controlled in infected rabbits. SLS replicated at the primary inoculation site in the skin,
XXXI
initially in MHC IT dendritic cells in the dermis, followed by replication in the epidermis. 
Virus was probably transported to the draining lymph node in these MHC IT cells. In the 
lymph node, SLS replicated to high titres, predominantly in lymphocytes and macrophages. 
Virus disseminated from here to secondary sites in the skin where it grew to high titres, and to 
other lymph nodes, the spleen and the lung. The most severe pathology occurred in the lymph 
nodes which were depleted of lymphocytes. Wild rabbits were significantly resistant to SLS. 
A major difference between wild and laboratory rabbits infected with SLS was the local 
inflammatory response in the skin and lymph nodes, which was comprised predominantly of 
mononuclear inflammatory cells in infected wild rabbits. SLS-infected laboratory rabbits had 
a polymorphonuclear inflammatory response that localised deep in the dermis, away from 
most virus replication. Control of virus replication in wild rabbits occurred at the draining 
lymph node where virus titres were 10-50 fold lower than in laboratory rabbits. However, 
titres at the skin inoculation site were similar to laboratory rabbits. Depletion of lymphocytes 
occurred but in contrast with laboratory rabbits, was restricted to the draining lymph node, 
and this lymph node became repopulated with lymphocytes around 15dpi. Uriarra grew to 
similar titres as SLS at the primary inoculation site in the skin of laboratory rabbits and in the 
draining lymph node, but virus dissemination and growth in distal tissues was reduced, and 
lymphocytes were not depleted from the lymph nodes. In both Uriarra-infected laboratory 
rabbits and SLS-infected wild rabbits, virus was cleared from the internal tissues by between 
10 and 15 days post infection and the rabbits recovered from disease.
Specific staining showed that apoptosis was a major mechanism of lymphocyte cell death in 
lymph nodes of all myxoma virus-infected rabbits. Apoptotic cells did not stain positive for 
virus. However, in SLS-infected laboratory rabbits, apoptosis was induced earlier than in the 
other rabbits, and was closely associated with virus replication.
This study has described where and in what cells myxoma virus replicates. By comparing 
resistant and susceptible rabbits it has been shown that resistance is associated with a 
lymphocyte-rich inflammatory response, control of virus replication in the draining lymph 
node and reduced replication in distal tissues. Resistance was not due to cell permissivity to 
virus infection. Therefore a model is proposed for resistance being due to the wild rabbit 
having a more effective innate and adaptive immune response to myxoma virus. This is most
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likely occurring very early in infection, possibly at the level of the initially infected dendritic 
cells and subsequently at the draining lymph node. The mechanisms of enhanced immunity 
remain to be determined and particularly the role of cytokines, NK cells and CTL responses. 
Infection of laboratory and wild rabbits with attenuated virus supports this model, which 
indicates that the attenuated virus is unable to suppress or deviate the initial immune 
response.
Chapter 1: Introduction
1. Introduction
1.1 Introduction
The release of myxoma virus into the Australian wild European rabbit (Oryctolagus 
cuniculus) population in 1950 constituted one of the greatest natural biological 
experiments of host-virus coevolution ever documented. After the release of myxoma 
virus, which was highly lethal for O. cuniculus, attenuated strains of virus emerged and 
genetic resistance developed within the host rabbit population. The original strain of 
virus that was released into the Australian field and an attenuated strain isolated from 
the field shortly afterwards are both accessible for study, as are genetically susceptible 
laboratory rabbits, and wild rabbits that have been naturally selected in the field for 
genetic resistance to myxoma virus. This gives us a unique and exciting opportunity to 
study host-virus interactions.
1.2 Myxoma virus -  classification, properties and replication
Myxoma virus is a member of the family Poxviridae, subfamily Chordopoxvirinae. Its
genus, Leporipoxvirus, comprises three closely related viruses found in Sylvilagus 
species of rabbits in the Americas, two viruses of North American squirrels (Sciurius 
sp.) and the more distantly related hare fibroma virus (in Lepus europaeus) (Table 1.1) 
(Fenner, 1994b; Fenner and Kerr, 1994). There are two major geographic types of 
myxoma virus, the South American and Californian, which show substantial differences 
in their rabbit host species (Marshall and Fenner, 1960; Marshall and Regnery, 1963; 
Marshall et al., 1963). These types also differ in the disease caused following infection 
of the European rabbit, O. cuniculus, which is not a natural host to any leporipoxvirus, 
and is susceptible to lethal infection with myxoma virus (Fenner and Ratcliffe, 1965).
By electron microscopy, myxoma vims virions are indistinguishable from those of the 
prototype poxvirus, vaccinia vims (Padgett et al., 1964) appearing oval or brick shaped 
with a biconcave nucleoprotein core and two lateral bodies surrounded by a lipoprotein 
bilayer membrane (Figure 1.1). Myxoma vims shares a common antigen with species 
of other poxvirus genera (Woodroofe and Fenner, 1962), but there is no cross-
neutralisation or cross-protection with poxviruses belonging to genera other than 
Leporipoxvirus (Woodroofe and Fenner, 1965).
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2T able l . l :T h e  natural host and types o f clinical disease produced by viruses o f  the 
genus Leporipoxvirus (family Poxviridae) in the European rabbit (Oryctolagus 
cuniculus) (modified from Fenner and Ross, 1994).
Vims Natural host Location Clinical signs in
Oryctolagus
cuniculus
Shope fibroma Sylvilagus
floridanus
eastern United States Localised, benign 
fibroma
Brazilian myxoma Sylvilagus
brasiliensis
South America generalised lethal 
disease, gross external 
signs
Californian
myxoma
Sylvilagus
bachmani
western United States generalised lethal 
disease, few external 
signs
Hare fibroma Lepus
europaeus
Europe localised, benign 
fibroma
Squirrel fibroma Sciurus
carolinensis
eastern United States localised, benign 
fibroma
W estern squirrel 
fibroma
Sciurus griseus 
griseus
western United States not determined
The poxviruses have a double stranded DNA genome which varies in size, from 130 
kbp (parapoxviruses) to about 375kbp (avipoxviruses) (Fenner and Nakano, 1988); the 
genome o f  m yxom a vims is 163kbp in length (Russell and Robbins, 1989). The two 
strands o f  DNA form telomeric structures as they are continuous, connected by hairpin 
loops, but are not completely covalently bound along the entire length (DeLange and 
McFadden, 1990). At either end o f the genome there are inverted terminal repetitions
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(ITRs), which are stretches of sequence that are identical but in opposite orientation to 
each other. The organisation of the central region of the genome is relatively conserved 
between poxviruses, encoding genes essential for viral replication and production of 
infectious progeny (Moss, 1996). The genes adjacent to and within the ITRs are less 
conserved between poxviruses, and encode proteins that determine virus virulence and 
host specificity. These genes have been termed virulence genes (McFadden, 1995).
Figure 1.1: Schematic representation of the poxvirus virion. A nucleosome with a 
core membrane associated with lateral bodies is surrounded by an internal membrane 
in which are embedded surface proteins. This form of virus is infectious and found 
intracellularly. A second form of extracellular virus particles contain a Golgi- 
derived outer envelope in which virus encoded proteins are inserted. The left hand 
side of this diagram represents the surface structure of a non-enveloped, intracellular 
particle (Fenner and Nakano, 1988).
The majority of information concerning poxvirus replication is derived from studies of 
the prototype virus, vaccinia virus. The poxviruses, including myxoma virus, replicate 
in the cytoplasm of infected cells (Beaud, 1995; Moss, 1996) (Figure 1.2). Cell entry is 
via fusion of the virus with the plasma membrane or by endocytosis, followed by the
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release of the virus core into the host cell cytoplasm (first virus uncoating). Replication 
appears to be independent of the cell nucleus and most of the protein components 
required for transcription and replication of the viral genome are encoded by the virus. 
(Beaud, 1995; Moss, 1996).
Plasma membrane
uncoating I
NUCLEUS
early gene 
expression
Golgi apparatus
uncoating II
DNA replication
intermediate and late 
gene expression
virus assemblystructural proteins 
and enzymes —
Figure 1.2: The poxvirus infection cycle in the cytoplasm of infected cells. Poxvirus 
replication occurs in the cytoplasm of infected cells, in virosomes (not pictured). 
After fusion with the plasma membrane and entry, an uncoating process releases the 
intact core and early gene expression occurs. This is followed by a second 
uncoating, DNA replication, intermediate and late gene expression and virion 
assembly. The intracellular mature virion (TMV) may acquire a double membrane 
from the Golgi apparatus. Upon release from the cell, the outer bilayer fuses with the 
plasma membrane, releasing an extracellular enveloped virus (EEV) with an internal 
membrane and an external envelope (Traktman, 1990a).
Virus replication is divided into early, intermediate and late stages. Temporal
expression of genes is regulated at the transcriptional level (Moss et al., 1991). 
Following first virus uncoating which releases the virus core, early mRNA transcription 
is initiated by the viral transcriptase. Transcription of intermediate and late genes is 
controlled by the binding of specific viral (Moss, 1996) and cellular (Rosales et al,
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51994; Zhu et al., 1998) proteins to characteristic promoter sequences. Capped and 
polyadenylated mRNAs are produced, without splicing, within minutes of viral 
infection, due to the presence of a transcription factor, capping and methylating 
enzymes and a poly(A) polymerase, all included within the core of the virion. The early 
proteins transcribed within the proteinaceous core of the infecting virion complete the 
uncoating of the core (secondary uncoating) making the viral genome accessible for 
DNA replication. These early transcripts also encode intermediate and late gene 
transcription factors and the viral DNA polymerase required for DNA replication 
(Gershon, 1998; Moss, 1996).
DNA replication, followed by intermediate gene expression, proceeds in cytoplasmic 
factories called virosomes. Poxvirus DNA replication has been suggested to proceed as 
follows. A nick is produced in the DNA at one or both telomeres which provides a free 
3’-end for priming. This is followed by an elongation of the DNA chain by the virus 
encoded DNA polymerase. This results in the formation of an inverted repeat which, 
due to complementary base pairing, folds back on itself. The leading strand synthesis of 
DNA from the inverted repeat is thought to result in the formation of concatemeric 
intermediates which are resolved into mature DNA molecules and incorporated into 
virus particles at the late stage of infection (Beaud, 1995; Moss, 1996).
Virus assembly requires the early recruitment of cellular membranes from the 
intermediate compartment, between the endoplasmic reticulum and the Golgi stack, to 
the virosomes, where the membranes are modified by the gradual incorporation of viral 
proteins (Sodeik et al., 1993). These membranes are initially crescent shaped and 
become spherical while acquiring granular material from the virosomes. The spherical 
particles are known as immature virions, which mature with the condensing of the 
nucleoprotein core to become intracellular mature virions (IMV). These particles have 
the characteristic brick morphology seen by electron microscopy and constitute the 
majority of virus particles produced in infected cells. Virions destined for extracellular 
release become wrapped by cistemae from the trans-Golgi network to form a double 
membrane (Schmelz et al., 1994), and induce actin polymerisation, forming an actin tail 
which propels them to the cell surface, and aids in proficient cell to cell spread through 
the formation of virus-tipped microvilli (Cudmore et al., 1995; Mathew et al., 1998; 
Roper et al., 1998; Wolffe et a l , 1998). Here, the outer double membrane fuses with 
the plasma membrane to release virus with an internal membrane and a Golgi-derived
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6external envelope, termed extracellular enveloped virus (EEV). IMV are released later 
by cell disruption. EEV are the minority of virions produced and are thought to be 
important in the cell to cell spread of infection (Blasco and Moss, 1992) and thus in in 
vivo dissemination (Payne, 1980). Both intracellular and extracellular enveloped 
particles have been demonstrated for myxoma virus by electron microscopy (Farrent 
and Fenner, 1953).
1.3 The evolutionary relationships between myxoma virus and the rabbit
The natural history of myxoma virus is well documented (Fenner and Ratcliffe, 1965;
Fenner and Ross, 1994). This documentation includes the natural rabbit hosts, and the 
changes in virus virulence and host genetic resistance following the introduction of 
myxoma virus into a new genus of rabbit, namely the Australian wild European rabbit. 
When considering the pathogenesis of myxoma virus infection of O. cuniculus, this 
natural history can be used as a tool to ask questions about the important driving forces 
of host-virus coevolution, and the eventual outcomes of this evolution.
1.3.1 Evolution of myxoma virus
Myxomatosis was originally described in South America as a sporadic, highly lethal 
disease of laboratory rabbits (O. cuniculus). The disease was termed ‘infectious 
myxomatosis of rabbits’ due to the production of multiple mucinous cutaneous tumors 
(Sanarelli, 1898). The aetiological agent of myxomatosis was at that time said to be a 
member of the newly defined filterable viruses, and has since been shown to be the 
poxvirus, myxoma virus (Fenner, 1953). The sporadic and lethal nature of the disease 
in O. cuniculus implied that the virus could not be maintained in the European rabbit 
population, and therefore that this animal was not the natural host of the virus. 
Laboratory experiments demonstrated that the disease was highly specific for rabbits. 
Hence, the natural reservoir of the virus was sought in wild rabbit species native to the 
regions where outbreaks of the disease in O. cuniculus occurred (Fenner and Ratcliffe, 
1965).
The natural host of the South American strain of myxoma virus was found to be the 
tropical forest rabbit (or tapeti), Sylvilagus brasiliensis (Aragao, 1943), which has a 
wide distribution in south and central America (Figure 1.3). In this rabbit species,
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7myxoma virus produces a skin tumor, or lesion, that remains localised to the inoculation 
site and acts as a source of virus for transmission (Fenner and Ratcliffe, 1965).
Figure 1.3: Map of the Americas showing the distribution of leporids significant in the 
natural history of myxomatosis (modified from Fenner, 1994c). Sylvilagus brasiliensis 
is the natural host of South American myxoma virus, S. bachmani the natural host of 
Californian myxoma virus and S. floridanus the natural host of Shope fibroma virus. 
Populations of O.cuniculus have been introduced into Chile.
Transmission of myxoma virus is mechanical (Aragao, 1943). It requires a biting 
arthropod, such as a mosquito or flea, to insert its mouthparts into the skin of a myxoma 
virus infected rabbit. Virus in the skin adheres to the mouthparts of the insect but does 
not replicate within the vector, and transmission occurs following the passive transfer of 
this virus to a susceptible rabbit while the arthropod vector feeds. The success rate of 
transmission correlates with the titre of virus in the skin of the infected rabbit (see 
section 1.5) (Day et ol., 1956; Fenner et o l , 1952; Fenner et al., 1956).
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sporadic outbreaks in domestic O. cuniculus. It was originally thought that these 
outbreaks were due to the importation of diseased laboratory rabbits from Mexico 
(Kessel et a l, 1931). It has since been demonstrated that myxoma vims is enzootic to 
the bmsh rabbit, Sylvilagus bachmani, which is distributed along the west coast of the 
United States (Figure 1.3) (Marshall and Regnery, 1960). The North American strains 
of myxoma vims are closely related, and antigenically similar, to the South American 
strains, and are known as the Californian strains. They too cause a benign skin fibroma 
which remains localised to the inoculation site following infection of Sylvilagus 
bachmani (Marshall et al., 1963). However, while the Californian strains of myxoma 
vims are highly lethal to European rabbits, the clinical disease may differ considerably 
from that caused by the South American strains (Fenner and Ratcliffe, 1965).
Both the Californian and South American strains of myxoma vims are particularly 
adapted for transmission in their respective natural hosts. Following infection of S. 
bachmani, the Californian, but not the South American, strain of myxoma vims 
multiplies in the skin to a high enough titre for mosquito transmission (Marshall and 
Regnery, 1963). Infection of other North American Sylvilagus rabbit species with 
Californian myxoma vims results in the production of skin lesions but vims replication 
is insufficient for vector transmission (Regnery and Marshall, 1971). A similar specific 
relationship exists between South American strains of myxoma vims and S. brasiliensis, 
with the South American and not the Californian strains of myxoma vims able to 
replicate to high enough titres for mosquito transmission in this host. However, South 
American myxoma vims could be transmitted from three other North American species 
of rabbit, S. auduboni, S. nuttallii and S. floridanus (Regnery and Miller, 1972).
A third leporipoxvims, Shope fibroma vims (or rabbit fibroma vims), is closely 
related to myxoma vims antigenically and genetically and is endemic to the eastern 
cottontail, Sylvilagus floridanus (Block et al., 1985; Fenner, 1965; Shope, 1932; Shope, 
1936). In its natural adult host, Shope fibroma virus causes a small fibroma at the 
inoculation site with no evidence of generalised disease (Shope, 1932). Infection of O. 
cuniculus with Shope fibroma vims also results in the production of a fibroma, but not 
a myxomatous lesion, at the primary inoculation site. Unlike myxoma virus, Shope 
fibroma virus does not disseminate from the primary lesion and is rapidly cleared by the 
host (Day et al., 1956; Fenner and Ratcliffe, 1965).
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agent
Domestic European rabbits O. cuniculus, arrived in Australia with the first fleet in 1788, 
but did not spread beyond the original settlements. Their successful colonisation of 
Australia followed the introduction of 24 wild English rabbits in 1859 at Geelong, 
Victoria, as well as later introductions at sites in South Australia. The clearance of 
property with the removal of trees, the introduction of domestic stock and the control of 
predators, all facilitated the establishment of rabbits (Myers et al., 1994). Following 
these introductions, rabbits moved across Australia at an estimated rate of 100-300 km a 
year in one of the most dramatic mammal invasions ever recorded (Figure 1.4A). The 
greater proportion of the rabbits’ present range was covered in just 60 years (Figure 
1.4B), with the population of rabbits eventually reaching an estimated 600 million 
(Rolls, 1984).
Rabbits have contributed to a loss in Australian biodiversity, with the stripping and 
killing of seedling trees and perennial shrubs, massive soil erosion and vegetational 
changes, and through direct competition for food and burrow space with native mammal 
species (Myers et al., 1994). In economic terms, rabbits are estimated to cost up to 
$300 million a year in lost agricultural production. Control methods have included 
poisoning, shooting and trapping, and the ripping and fumigation of warrens. These 
control methods alone are labour intensive, expensive, non-permanent, and are 
ineffective on a continent-wide scale.
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Figure 1.4: Spread of the rabbit over the mainland of Australia based on reports in 
newspapers and periodicals (from Stodart and Parer, 1988) (A) and map of the 
present known distribution of rabbits in mainland Australia (B) (Myers et al., 1994).
The lethality of myxoma virus in the European rabbit suggested its use as a biological 
control agent for rabbits in Australia. Several trial releases of the Standard Laboratory 
Strain (SLS), a strain derived from a Brazilian isolate (Moses) (Moses, 1911), were 
conducted in the 1930s in both Australia and Europe. However, the virus appeared to 
remain localised to the warren at which it was released and die out after a few virus 
generations (Myers, 1954). In 1950, further releases of SLS in the Murray Valley of 
Victoria were thought to have been unsuccessful, but in the summer of 1950/51, during 
which time there was an explosion of the mosquito population, myxomatosis flared up 
near one of the abandoned trial sites and spread rapidly across south-eastern Australia 
(Ratcliffe et al., 1952) (Figure 1.5). The natural spread of the virus was augmented by 
widely undertaken inoculation campaigns in the agricultural and pastoral lands of
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southern Australia so that, by 1954, myxomatosis was disseminated throughout the 
geographic range of the rabbit in Australia (Fenner and Ratcliffe, 1965). Myxomatosis 
is now an enzootic disease of the Australian wild rabbit, with epizootics developing 
periodically in association with local and seasonal vector activity (Fenner and Ross, 
1994), and the presence of susceptible rabbit kittens (Kerr and Best, 1998).
Figure 1.5: The spread of myxomatosis in Australia during the three years
following its introduction in 1950 at an experimental site in northern Victoria. The 
major spread early in 1951 (dense black) occurred along the Murray-Darling- 
Murrumbidgee river system of south eastern Australia. By 1954, myxomatosis was 
widely disseminated throughout the distribution of the rabbit due to inoculation 
campaigns and the natural spread of the virus (Fenner and Ratcliffe, 1965).
1.3.3 Emergence of attenuated strains of myxoma virus in the Australian field
The case-mortality rate of rabbits during the initial Australian epidemic of myxomatosis
in 1950/51 exceeded 99% and reduced many rabbit populations by greater than 90%.
However, following the second summer epidemic in 1951/52, there was a greater
mu
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survival rate of infected rabbits, due to emergence of attenuated strains of the virus 
(Marshall and Fenner, 1958; Myers, 1954). Changes in virus virulence were monitored 
by the inoculation of laboratory European rabbits with field isolates collected during 
sequential annual epizootics. Isolates were grouped into five levels of virulence based 
on laboratory rabbit survival times and survival rates (Fenner and Marshall, 1957) 
(Table 1.2). Grade I viruses were the most virulent, killing essentially 100% of infected 
rabbits with an average survival time of less than 13 days. Grade V viruses were the 
least virulent, killing less than 50% of infected rabbits. From the testing of field isolates 
in this manner, it became apparent that within three years of successful myxoma virus 
release, the majority of myxoma virus field isolates were of grade III virulence, killing 
70-95% of infected laboratory rabbits in 17-28 days (Marshall and Fenner, 1960) 
(Figure 1.6).
Table 1.2: Classification of strains of myxoma virus into grades of virulence based 
on mean survival time and case mortality rate of infected laboratory European 
rabbits (Fenner and Ratcliffe, 1965).
Virulence grade Mean survival time 
(days)
Estimated case-mortality rate 
(%)
I s 13 >99
n 13-16 95-99
m 17-28 70-95
IV 29-50 50-70
V - <50
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Figure 1.6: Virulence of Australian field strains recovered between 1952 and 
1981. The number of isolates tested for each period is indicated, and expressed as 
a percentage. Virulence grades are shown in Table 1.2 (from Kerr and Best, 
1998).
Transmission of myxoma virus is dependent on virus adhering to the mouthparts of 
arthropod vectors probing through the epidermis of infected rabbits and is most likely to
n
occur when the virus titre in the skin exceeds 10 pock forming units per gram of skin 
(Day et al., 1956; Fenner et a l , 1956). In an examination of the growth of viruses of 
varying virulence and their ability to be transmitted, grade I, III and IV viruses (grade II 
was not examined) replicated to sufficiently high titres in the skin to be transmissible on 
the mouthparts of mosquitoes (Fenner et a l , 1956) (Figure 1.7). In the case of grade I 
viruses, the infectious source was only available for a few days before the rabbit died 
whereas the life of the animal was prolonged during infection with grade III and IV 
viruses, thus providing a source of virus for a longer period. A highly attenuated grade 
V strain of myxoma virus, derived by serial intracerebral passage of virulent myxoma 
virus in rabbits (neuromyxoma) (Hurst, 1937b), did not multiply to high titre in the skin 
due to the ability of the host to rapidly control virus replication, and was poorly 
transmitted by mosquitoes. Thus, moderately attenuated viruses had the highest 
probability of being transmitted by arthropod vectors.
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Figure 1.7: Relationship between titre of myxoma virus in primary skin lesions in 
O. cuniculus and the potential of the lesion as a source of virus for mechanical 
transmission by mosquitoes. Rabbits infected with virus strains of all virulence 
grades except grade V were highly infectious for mosquitoes. The period of 
availability of the infectious source was short following infection with highly 
virulent strains due to the rapid death of the animal. Moderately attenuated strains 
prolonged the life of the animal and thus produced lesions that were infectious for 
longer (from Fenner et al., 1956).
1.3.4 Development of genetic resistance in the Australian wild rabbit population
Rapid selection for genetic resistance in the Australian wild rabbit population occurred
following the emergence of attenuated strains of myxoma virus in the field. 
Development of genetic resistance may have been augmented by high ambient 
temperatures and a phenomenon known as the sire effect. This has been recently 
reviewed (Kerr and Best, 1998), and is discussed briefly later in this section.
The emergence of moderately attenuated strains of myxoma virus enabled 
approximately 10% of infected rabbits to survive in the field, and thus the rapid 
selection of genetic resistance. This was demonstrated by myxoma virus challenge 
experiments on seronegative rabbits collected from a field site at Lake Urana, New 
South Wales (Marshall and Douglas, 1961; Marshall and Fenner, 1958). Rabbits were 
captured prior to the annual/spring summer epidemic of myxomatosis from 1951, and 
challenged with a grade III strain of myxoma virus (KM13). This strain caused 88% 
and 89% mortality following infection of unselected wild and laboratory rabbits 
respectively. Following the first two myxomatosis epidemics, the case mortality rate of
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rabbits from Lake Urana was unchanged. However, after the third epidemic, the 
mortality rate had dropped to 80%, and it dropped further to 50% and around 30% 
following the fourth and seventh epidemics respectively (Table 1.3). Interestingly, the 
severity of clinical symptoms in challenged rabbits was also reduced, with only 0-2% of 
rabbits said to have mild clinical symptoms after two epidemics, rising to 30% after 
seven epidemics. In the field, the animals with mild clinical symptoms are less likely to 
succumb to dietary and predatory pressures during the disease, and thus survive to pass 
on resistance genes to their offspring. Those females that recover will also provide 
maternal antibody to their offspring. There is some experimental evidence to suggest 
that this may aid survival of the young following challenge with myxoma virus (Fenner 
and Marshall, 1954).
Table 1.3: Case-mortality rates and severity of myxomatosis in groups of non- 
immune wild rabbits from Lake Urana, NSW, after successive epizootics of 
myxomatosis. Rabbits were challenged under standard laboratory conditions with 
the grade in myxoma virus, KM 13 (from Fenner and Ratcliffe, 1965).
Clinical signs in challenged rabbits (%)
Number o f Case-mortality Severe Moderate Mild
epizootics to 
which population 
had been exposed
rate (%) (including
fatal)
0 90 93 5 2
2 88 95 5 0
3 80 93 5 2
4 50 61 26 12
5 53 75 14 11
7 30 54 16 30
In the laboratory, ambient temperature affects the severity of disease (Parker and 
Thompson, 1942). High ambient temperatures increased the survival rate of rabbits 
challenged with a moderately attenuated virus KM 13 a, whereas low ambient
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temperatures decreased the survival rate (Marshall, 1959). Outbreaks of myxomatosis 
occur during the hot summer months. The high ambient temperatures at this time may 
increase the survival of rabbits infected with otherwise lethal strains of myxoma virus, 
perhaps by inhibiting virus replication (Marshall, 1959) and potentially contributing to 
selection of resistance (Kerr and Best, 1998). In support of this, seronegative rabbits 
taken from climatically hot areas of Australia were more genetically resistant to 
infection with highly vimlent grade I strains of myxoma virus than rabbits taken from 
cooler regions (in Fenner and Ross, 1994).
Another factor that may be important in the enhanced survival of wild rabbits infected 
with myxoma virus is the sire effect. In an attempt to replicate the selection for genetic 
resistance in laboratory rabbits, male laboratory rabbits were challenged with strains of 
myxoma vims that differed in vimlence. Rabbits surviving challenge were used as 
sires. Because the overall survival rate was very low and a small number of males 
could be used to impregnate a number of females, females were not challenged with 
vims. A response to selection for resistance was achieved, with an estimated 
heritability of 35-40%. The case mortality rate of the offspring was reduced from 90- 
95% in unselected rabbits to a minimum of around 80% after four generations (Sobey, 
1969). In a reinterpretation of these data, resistance to infection was attributed to the 
transmission of some unknown factor from a sire that had recovered from myxoma 
vims infection to the dam. This factor conferred a temporary resistance to myxomatosis 
on the offspring that was not associated with maternal antibody (Sobey and Conolly, 
1986; Williams and Moore, 1991). The risk of death of the progeny challenged with 
myxoma vims was reduced if kittens were bom within seven months of infection of the 
sire and if the sire and progeny were challenged with the same strain of myxoma vims. 
The enhanced survival of kittens was termed the sire effect.
In areas of annual epidemics of myxomatosis, and following the emergence of 
attenuated strains of myxoma vims, most of the kittens bom would be the progeny of 
males that had survived infection with myxoma vims. Thus, if the sire effect exists, it 
could contribute significantly to the apparent observed resistance in the field (Sobey and 
Conolly, 1986; Williams and Moore, 1991). However, analysis of this effect has been 
retrospective and the hypothesis has not been tested experimentally. If it is correct, the 
sire effect would have fundamental implications for the understanding of the biology of
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infectious disease, especially in mammals with a short generation time (Kerr and Best, 
1998).
1.4 Virus interactions with the host
The interactions of myxoma virus with the rabbit can be considered in terms of the 
rabbits’ immune response to infection and the proteins produced by myxoma virus that 
modulate this response. The outcome of the interactions between the two will 
determine the pathogenesis of disease; whether the rabbit will control virus replication 
and recover from infection, or if vims replication proceeds unchecked, resulting in the 
animal’s death. These interactions are further complicated by the level of genetic 
resistance of the rabbit. The pathogenesis of myxoma vims in the European rabbit, 
immune responses to poxvimses, immune modulation by myxoma vims and genetic 
resistance to vims infections are considered below.
1.4.1 Pathogenesis of myxoma virus in O. cuniculus
Infection of the European rabbit, O. cuniculus, with vimlent myxoma vims results in 
severe, generalised disease and death. Detailed molecular and ecological studies have 
concentrated on either the Lausanne strain (isoalated from Brazil in 1949) or the 
Standard Laboratory Strain (SLS) of South American myxoma vims, or the natural 
variants derived after establishment of myxoma vims in wild rabbit populations of 
Australia and Europe. SLS (or Moses strain) is the original strain successfully released 
in Australia in 1950 (Fenner and Ratcliffe, 1965), and the strain utilised in the current 
study. It was originally recovered from a naturally infected laboratory rabbit in Rio de 
Janeiro in 1911 (Moses, 1911), and was subsequently maintained by passage in 
laboratory rabbits.
The pathogenesis of SLS following inoculation at the skin was originally studied by 
Fenner and Woodroofe (1953) (Figure 1.8). Vims replicates at the primary inoculation
o
site in the skin to approximate titres of 10 rabbit ID50 units per gram of tissue, followed 
by replication in the regional lymph node to approximate titres of 107 rabbit ID50 units 
per gram. Rabbit ID50 is the dose of vims at which 50% of intradermally inoculated 
rabbits become infected. It is approximately equivalent to plaque forming units (pfu). 
Vims was present in the circulation after detection in the regional lymph node. This 
viraemia is associated with lymphoid cells as vims is not found free in the serum or
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associated with red blood cells (RBC) (Fenner and Woodroofe, 1953). The virus then 
replicates to high titres in the testis and in distal sites in the skin and to lower titres in 
the lung, liver and spleen.
Time after infection (days)
Inoculation s ite O 4 - -H- 4 4 4 4 4 4 4-H+ 44+f 44444-
Norm al skin O O O o + 4 + 44- 44-
Conjunctiva O O 0 ± + 4 + 444* 44444"
A nogenital
O O O o + 4 + 4+44* 4444+
Figure 1.8: The sequence of appearance and multiplication of SLS in various 
organs following intradermal inoculation. The times of appearance of clinical 
signs are indicated below the graph with an arbitrary grading of severity (± to 
I i i i  T). Normal skin refers to a portion of uninoculated skin taken from the 
equivalent site to the inoculation site, but on the opposite side of the rabbit 
(Fenner and Ratcliffe, 1965).
Clinically, virus replication at the primary inoculation site results in a lump which 
appears on the third day after infection, and increases in size reaching a maximum of 
approximately 6cm in diameter on the eighth or ninth day. The lesion is at first purple
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in colour and then becomes black in the centre. A secondary ‘rash’ which consists of 
lumps similar to the primary lesion but smaller, reaching approximately 2cm in 
diameter, appears on the sixth or seventh day. The lesions represent secondary sites of 
virus replication in the skin and are widely distributed over the body, being particularly 
obvious on the eyelids, ears and nose. The ears and eyelids become thickened, and 
there is an opalescent discharge from the eyelids which becomes copious and more 
turbid during the last two days before death. The perineum and scrotum of male rabbits 
becomes engorged through massive oedematous swelling, and respiration of rabbits 
becomes laboured (Fenner, 1994a). This is often accompanied by semipurulent nasal 
secretion due to secondary infection by Pasteurella multocida (Hobbs, 1928; Strayer et 
al., 1983a; Strayer et al., 1983b).
The cause of death of laboratory rabbits following infection with virulent myxoma virus 
is obscure. Death usually occurs within 10-12 days of infection. Hurst (1936a) 
described morbid changes in the histopathology of lymph nodes, the liver and to a lesser 
extent the lungs, through the proliferation, degeneration and necrosis of cells and blood 
vessels following infection with virulent myxoma virus. However, Mims (1964) could 
not attribute death to the growth of virus in a specific organ such as kidney, spleen, 
liver, lung or brain. Death is commonly attributed to secondary bacterial growth in the 
upper respiratory tract compromising the rabbits respiration (Hobbs, 1928; Strayer et 
al., 1983a). However, rabbits infected with highly virulent Californian strains of 
myxoma virus often die before significant bacterial growth is evident (Marshall and 
Regnery, 1960)
1.4.2 The pathogenesis of ectromelia and vaccinia viruses in infected susceptible 
mice
Ectromelia virus is a naturally occurring poxvirus, genus Orthopoxvirus, of laboratory 
mice (Fenner, 1949). The infection of mice with ectromelia virus is a potentially 
important model in the consideration of the pathogenesis of, and genetic resistance to, 
myxoma virus infection of rabbits for a number of reasons. Firstly, the virus causes a 
natural infection of laboratory mice, and wild mice are a potential natural reservoir of 
the virus (Fenner, 1949). Secondly, the model of infection is the mouse. The 
availability of murine-specific monoclonal antibodies to cytokines and cell receptors, as 
well as inbred strains of mice that are susceptible or resistant to ectromelia virus
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infection has greatly advanced the understanding of viral pathogenesis, host genetic 
resistance and host immune responses. Finally, the early events in ectromelia virus 
pathogenesis are similar to those known for myxoma virus infection of rabbits (Fenner 
and Woodroofe, 1953). Like myxoma virus, natural infection occurs at the skin, 
followed by replication at the primary inoculation site in the skin and in the regional 
lymph nodes in macrophages, endothelial cells and lymphoid cells. Primary viremia 
follows, with the infection of macrophages lining the sinusoids of the liver, replication, 
and the formation of infectious foci (Mims, 1959). The virus disseminates to secondary 
sites in the skin where it replicates and forms secondary lesions that give the name to 
the generalised infection of mousepox (Fenner, 1948a; Fenner, 1948b). However, the 
events that occur late in ectromelia virus infection of mice are different to myxoma 
virus-infection of rabbits. Ectromelia virus replication in the liver and spleen of 
infected mice is followed by extensive necrosis in these organs (Mims, 1964) that does 
not occur during myxoma vims infection of rabbits and which provides a potential 
cause of death.
Vaccinia vims is another important vims to consider in the study of myxoma vims. The 
animal model of vaccinia vims infection is again the mouse, and the importance of this 
vims both as the prototype poxvims and as a widely used vaccine has meant that the 
immune responses to vaccinia vims have been extensively studied. Infection of 
immunocompetent mice with vaccinia vims results in an acute infection, with 
replication of vims to high titres in the ovary, and to a lesser extent in the skin, lung, 
spleen and brain (Ramshaw et a l 1992). Unlike infection with ectromelia vims, 
immunocompetent mice recover from infection with vaccinia vims, and vims is cleared 
from tissues approximately 12 days after inoculation (Sharma et al., 1996).
1.4.3 Host immune responses to virus infection with particular reference to 
poxviruses
The mammalian immune response to viral infection is comprised of two interlinked 
systems, namely the innate and adaptive immune systems. Innate immune responses 
such as natural killer (NK) cells, complement and cytokines such as interferons (IFN) 
and tumor necrosis factor (TNF) occur early in infection, are antigen non-specific, and 
act to limit the spread of virus prior to the induction of an antigen specific immune
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response. The adaptive immune response involves the induction of antigen specific 
helper T-lymphocytes (CD4+) which are important in the production of effector T 
lymphocytes (CD8+, generated through a type 1 response) and antigen-specific antibody 
by B lymphocytes (generated through a type 2 response), and results in the generation 
of immunological memory (Janeway and Travers, 1994). The two systems are 
intimately linked as the innate immune response is thought crucial not only in the 
activation of the adaptive response, but in directing the immune response to a particular 
effector type (type 1 or type 2) (Medzhitov and Janeway, 1997).
The most general and simple models of type 1 or type 2 (Th I or Th2) immune responses 
are characterised by the cytokine patterns produced by CD4+ T-cells in response to 
activation (Abbas et al., 1996); TH1 CD4+ cells secrete IFN7, IL-2, IL-12 and TNFa ; 
Th2 cells secrete IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13 (Baumgarth and Kelso, 1997). 
These cytokines have both direct and indirect effects on virus replication. The type 1 
cytokine IFN7 directly suppresses vaccinia vims replication. IFN7 is also required for 
the direct anti-viral activity of CD8+ T-cells (Ruby, 1997; Ruby and Ramshaw, 1991). 
IL-2 has antiviral effects, but also acts indirectly through the attraction and stimulation 
of NK cells to produce IFN7 (Karupiah et al., 1990a; 1990b; Karupiah et al., 1993a; 
1993b; Kohonen-Corish et al., 1990). Like EFN7, TNFa  has a direct effect on vaccinia 
vims replication as its anti-viral effects are not dependant on the recruitment or 
enhancement of other cell types or responses (Sambhi et al., 1991). Both the TNF type 
I (p55) and II (p75) receptors are involved in the antiviral effects of TNFa  (Sambhi et 
al., 1991)’ although membrane-bound TNF, which has a higher affinity for TNFR2/p75, 
may be more important in immunity to poxviruses than soluble TNF (Ramshaw et al., 
1997).
In addition to the antiviral effects of the cytokines they produce, CD4+ T-cells are 
required for the generation of optimal cytotoxic T-lymphocyte (CTL) responses to viral 
infection (Mizuochi et al., 1989). In ectromelia vims-infected mice, CD8+ CTLs are 
cmcial for clearance of ectromelia vims from internal organs (Karupiah et al., 1996). 
CD4+ T cells are also thought to contribute directly to viral clearance since in CD4+ T 
cell-knock out mice, although anti-viral CD8+ CTL were generated, they were 
insufficient to clear ectromelia vims (Karupiah et al., 1996) or herpes simplex vims 
(Nash et al., 1987) from the skin. Therefore, the mechanisms of control of vims
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replication and the relative roles of CD4+ and CD8+ T-cells appear to differ at the skin 
compared to the internal organs.
The role of CD8+ T-cells in mice infected with vaccinia virus appears to be less crucial 
than during ectromelia virus infection as infection of CD8+ T-cell-deficient mice with 
high doses of vaccinia virus resulted in 100% survival (Spriggs et al., 1992a). It is 
thought that mice lacking CD8+ T cell activity may have sufficient compensatory 
mechanisms for the clearance of some non-virulent (e.g. vaccinia virus) but not highly 
virulent (e.g. ectromelia virus) infections (Raulet, 1994), such as the increased 
production of IFN7 (Karupiah et al., 1996; Ramshaw et al., 1997).
Antibody production specific to poxviruses has been demonstrated to be important in 
immunity to reinfection, and may be important in restricting virus dissemination within 
the host. However, antibody production is generally not thought to be crucial to 
recovery from infection (reviewed in Buller and Palumbo, 1991). Infection of rabbits 
with the attenuated neuromyxoma strain of myxoma virus results in the detection of 
anti-viral antibody in the serum later than after infection with highly virulent myxoma 
virus (Fenner et al., 1953; Fenner and Woodroofe, 1953), suggesting that antibody is 
not essential for controlling myxoma virus infection. However, mice with an impaired 
ability to generate antiviral antibody responses develop higher virus titres following 
infection with vaccinia virus (Ramsay et al., 1994) and can be lethally infected with 
ectromelia virus (in Ramshaw et al., 1997). Thus the generation of virus-specific 
antibody may have some role in the recovery from poxvirus infections.
1.4.4 Immune modulation by myxoma virus
Immune modulation by the large DNA viruses, including poxviruses, adenoviruses and 
herpesviruses, has been extensively and comprehensively reviewed (Buller and 
Palumbo, 1991; Cuff and Ruby, 1996; Gillet and Brun, 1996; Gooding, 1992; 
McFadden, 1995; McFadden and Graham, 1994; McFadden et al., 1995; McFadden and 
Kane, 1994; McNair and Kerr, 1992; Smith, 1993; Smith, 1994; Smith et al., 1997b; 
Spriggs, 1994; Traktman, 1990a; Turner and Moyer, 1990). Each family of viruses 
employs different strategies of host immune modulation. Poxviruses encode numerous 
proteins that function to modulate immune responses including inflammation, apoptosis 
of infected cells, fever, and potential antigen presentation/ recognition. The proteins
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known to be produced by myxoma virus are summarised in Figure 1.9 and detailed 
below.
T1*,T2*,T7*, T2*,T4,T5,
Serpl*, M11L, M11L, Serp2
IL-1 binding protein*
Downregulation 
of MHC class I, 
CD4
Inflammation 
and fever 
• chemokines 
•TNFa/ß 
•IFNy 
•EL-lß
Apoptosis of 
infected lymphocytes
; Antigen
L....... - ........... ......... ► presentation/
recognition
Virus 
specific 
CTL and 
antibody
Figure 1.9: Flow diagram of the known interactions between the anti-viral 
immune response and myxoma virus immunomodulation. At least nine myxoma 
virus produced proteins are known to specifically inhibit components of the anti-
viral immune response. * indicates proteins that are secreted from myxoma virus 
infected cells. All remaining myxoma virus immunomodulatory proteins act 
intracellularly except Ml 1L which is a transmembrane protein.
The first identified immunomodulatory protein produced by myxoma virus was M-T2. 
M-T2 is a secreted, species-specific viral homolog of the rabbit TNFa  receptor 
(Schreiber and McFadden, 1994; Upton et al., 1991), capable of binding and inhibiting 
the cytolytic activity of rabbit TNFa  and ß in vitro. M-T2 has amino acid sequence 
homology with the TNFR (tumor necrosis factor receptor) superfamily, including the 
p55 and p75 TNF receptors, Fas, CD40, CD30 and the lymphotoxin ß receptor. The N- 
terminal region of M-T2 contains four cysteine-rich domain motifs that are present in 
the ligand binding domain of TNFR superfamily members, three of which are required 
for the binding of M-T2 to rabbit TNFa . M-T2 binds rabbit TNFa  with an affinity 
similar to the mammalian TNF receptors (Schreiber and McFadden, 1994) and is
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thought to prevent TNFa  produced in response to virus infection from reaching its 
target cells, and to prevent direct cytolysis of infected cells in vivo. M-T2 deletion 
mutants of myxoma virus are attenuated in the European rabbit (Upton et al., 1991).
An intracellular form of M-T2 is also able to inhibit apoptosis of myxoma virus infected 
RL-5 cells, a rabbit CD4+ T-cell line (Macen et al., 1996b). Truncated versions of M- 
T2, that cannot bind or inhibit TNFa , are still able to inhibit apoptosis of infected T 
cells (Schreiber et al., 1997). These two functions of the protein are therefore distinct.
The M-T7 protein, the most abundantly secreted protein from myxoma virus infected 
cells, is highly homologous to the ligand binding domain of human and murine IFN7 
receptors. M-T7 binds and inhibits the activity of rabbit IFN7 in vitro (Mossman et al., 
1995a; Upton et al., 1992) and is thought to bind and sequester IFN7 in vivo, thus 
preventing it from reaching and signalling target cells. Inoculation of European rabbits 
with a recombinant myxoma virus in which the M-T7 genes have been disrupted 
(M-T7‘), results in an attenuated disease characterised by an increased inflammatory 
response at sites of infection and increased cellular activation in secondary lymphoid 
organs (Mossman et al., 1996b). Thus, M-T7 is likely to be important in the blockade 
of early inflammatory cell migration into sites of viral replication as well as interrupting 
the signalling between immune cells in secondary lymphoid organs and thus the 
generation of adaptive immune responses.
In addition to binding IFN7, M-T7 also binds chemokines, and so like M-T2, appears to 
have a dual function. Chemokines are chemotactic cytokines involved in the regulation 
of inflammatory responses to infection (Baggiolini, 1998; Schall and Bacon, 1994) and 
are thought to be important in the early inflammatory responses to viruses (Cook et al., 
1995) . Chemokines can be divided into three subfamilies, designated CXC (or a  
chemokines), CC (or ß chemokines) and C, based on the position of conserved cysteine 
residues within the polypeptide (Schall, 1994). M-T7 binds the C-terminal heparin- 
binding domain of members of all three subfamilies of chemokines in vitro (Lalani et 
al., 1997). It is postulated that M-T7 disrupts chemokine gradients and thus 
deregulates inflammatory cell migration into sites of virus infection.
M-Tl is a secreted protein, unrelated to any known receptor species, which also binds 
members of the CC and CXC chemokine subfamilies in vitro (Graham et al., 1997),
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although it only inhibits the in vitro chemotaxis of monocytes mediated by CC 
chemokines (Lalani et al., 1998). In vivo, M-Tl is thought to contribute to virus 
virulence by inhibiting leucocyte infiltration into sites of infection, although deletion of 
this gene from myxoma virus does not attenuate the disease in vivo (Lalani et al., 1998), 
and the deletion of the equivalent protein in rabbitpox virus (a derivative of vaccinia 
virus which is lethal for rabbits) did not reduce the mortality rate following infection of 
rabbits (Graham et al., 1997).
The myxoma virus M-T5 protein is an intracellular, non-membrane-associated member 
of the poxviral superfamily of designated host range proteins, which determine tissue or 
cell type specificity rather than species specificity (Mossman et al., 1996a). Infection of 
both primary lymphocytes and a rabbit CD4+ T cell line (RL5) with a myxoma virus M- 
T5’ mutant resulted in the complete shut down of both virus and host cell protein 
synthesis and the induction of apoptosis. Apoptosis did not occur following infection of 
adherent monocytes or primary fibroblast cell cultures. Infection of laboratory 
European rabbits with M-T5" resulted in an attenuated disease, with no clinical signs 
beyond the formation of a lesion at the inoculation site. It was concluded that M-T5’ 
myxoma virus was incapable of disseminating past the primary inoculation site to 
secondary sites due to a rapid apoptotic response in infected lymphocytes and an 
effective inflammatory reaction at the inoculation site (Mossman et al., 1996a).
The M-T4 protein contains a C-terminal endoplasmic reticulum (ER) retention 
sequence, -RDEL (Arg, Asp, Glut, Leu), and co-localises with calreticulin specifically 
to the ER of infected cells. M-T4 is synthesised early in infection and is necessary for 
the inhibition of apoptosis in infected lymphocytes in vitro; its disruption attenuates the 
virus in vivo (Barry et al., 1997). Similar to M-T5, M-T4 is thought to be required for 
the productive infection of lymphocytes in vivo, with its disruption resulting in the virus 
being incapable of disseminating past the site of primary inoculation to secondary sites. 
However, unlike M-T5, M-T4 does not function by preventing the arrest of viral and 
host cell protein synthesis following infection of lymphocytes (Barry et al., 1997).
Myxoma virus encodes at least two proteins belonging to the serine protease inhibitor 
(serpin) superfamily. Serine proteases regulate complex proteinase-dependent 
pathways, including the activation of cytokines during the inflammatory response to 
infection, the complement pathway (Potempa et al., 1994), and apoptosis (Sarin et al.,
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1993). Serpl is a myxoma virus encoded, glycosylated, secreted serpin that interferes 
with the early inflammatory response to virus infection and its deletion results in 
attenuation of disease in the European rabbit. (Macen et al., 1993; Upton et al., 1990). 
Further, purified Serpl is anti-inflammatory in rabbit atherosclerosis models (Lucas et 
al., 1996; Maksymowych et al., 1996). Serpl is capable of functionally inhibiting the 
human fibrinolytic enzymes plasmin, urokinase and tissue plasminogen activator in 
vitro (Lomas et al., 1993). The biological target of Serpl in rabbits is currently 
unknown.
Serp2, a second serpin encoded by myxoma virus, is an intracellular protein with 
significant homology to cowpox CrmA protein (Petit et al., 1996). CrmA inhibits 
human interleukin-lß  converting enzyme (ICE) (Komiyama et al., 1994) and is capable 
of inhibiting apoptosis by a variety of inducers (e.g. TNF, serum deprivation, Fas) 
(Gagliardini et al., 1994). Similarly, Serp2 inhibits ICE, albeit not as strongly as CrmA, 
and inhibits granzyme B (Turner and Moyer, 1998). The vaccinia virus serpin, SPI-2, 
also inhibits ICE and the induction of TNF- and Fas- mediated apoptosis of infected 
cells (Kettle et al., 1997). However, despite 93% amino acid identity between CrmA 
and rabbitpox SPI-2 and the ability of both to inhibit ICE in vitro in a similar fashion, 
the latter is not functionally equivalent to CrmA and is not as effective in inhibiting 
apoptosis o f infected cells (Macen et al., 1998). Thus, Serp2 of myxoma virus is a 
likely candidate for an inhibitor of ICE-mediated and granzyme B-mediated apoptosis 
of myxoma virus infected cells, but is not likely to be the only protein responsible for 
such inhibition in any single cell type.
The M l 1L protein is a type II transmembrane protein produced early in infection, which 
is important for the in vivo inhibition of inflammation by myxoma vims (Opgenorth et 
al., 1992, Graham, 1992 ) and the inhibition of apoptosis of infected lymphocytes
(Macen et al., 1996b). M11L does not have sequence homology with any known 
protein, or contain motifs that might enable prediction of a biochemical function, and 
the mechanisms by which it functions in either process remain to be characterised. 
Disruption of M11L results in induction o f apoptosis in infected RL-5 cells which 
significantly reduces the yield o f progeny virus compared to infection with the wild type 
virus (Macen et al., 1996b).
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The presence of multiple inhibitors of lymphocyte apoptosis suggests that inhibition of 
apoptosis in these cells during viral infection is important to virus pathogenesis and may 
involve components of more than one cell death pathway. The inhibition of apoptosis 
of infected lymphocytes by myxoma virus, either through the inhibition of CTL- 
mediated killing (Fas and granzyme B), the direct effects of TNF, or the prevention of 
the arrest of protein synthesis by the host cell, prolongs the time available for the 
production of infectious progeny (Turner and Moyer, 1998). However, the induction of 
apoptosis by virus can also be advantageous, through the spread of virus and the 
infection of phagocytic cells (McFadden and Barry, 1998) or the suppression of immune 
function. At this stage, only poxvirus-encoded inhibitors of apoptosis are known, 
although poxviral proteins which function as inducers of apoptosis may also exist (Cuff 
and Ruby, 1996; McFadden and Barry, 1998)
Myxoma virus also produces a growth factor (myxoma growth factor or MGF) that 
displays significant homology to, and is thought to mimic the activity of, epidermal 
growth factor (EGF) and transforming growth factor-01 (TGFa ) (Upton et a l , 1987)* 
Deletion of MGF results in virus attenuation in vivo (Opgenorth et al., 1992), and virus 
virulence can be restored by the insertion of either VGF (vaccinia growth factor) or rat 
TGFa ’ implying that MGF is a functional growth factor (Opgenorth et al., 1993). 
Putative biological EGF-like qualities have been demonstrated for MGF in vitro (Lin et 
al, 1991), suggesting that virus-encoded growth factors are capable of competitively 
binding cellular growth factor receptors (Strayer and Leibowitz, 1987b) such as EGF 
and inappropriately stimulating cell growth.
Myxoma virus also encodes an uncharacterised IL-lß binding protein (McFadden and 
Graham, 1994); the role it has in virus virulence in vivo has not been examined. 
However, IL-lß, and consequently the induction of fever in response to infection, has 
been shown to be inhibited by the production of a secreted IL-lß binding protein by 
particular strains of vaccinia vims in mice (Alcami and Smith, 1992; Spriggs et al., 
1992b). The inclusion of an IL-lß binding protein in vaccinia vims strains attenuates 
these viruses, presumably due to the adverse effects the induction of endogenous 
pyrogens involved in fever have on the host (Alcami and Smith, 1996).
Myxoma vims also modulates the immune response by affecting immune recognition. 
MHC class I molecules are specifically downregulated on the surface of infected cells,
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potentially inhibiting the recognition of infected cells by CTLs. This downregulation, 
which appears to be modulated by one or more late gene products, exceeds that 
achieved by complete blockage of host gene expression, and must therefore involve the 
masking or removal of preexisting MHC class I from the cell surface (Boshkov et al,
1992) . The downregulation of MHC class I on infected cells should stimulate NK cell 
activity, although the binding of IFN7 by secreted M-T7 may also downregulate NK cell 
activity. CD4 molecules are also specifically downregulated on the surface of infected 
T-lymphocytes and are degraded in lysosomal vesicles (Barry et al., 1995). This 
potentially results in the inhibition of recognition of these cells by antigen presenting 
cells (APCs) or B-cells, thus affecting activation of T-cells and potentially the 
generation of cellular and humoral immune responses.
Proteins that modulate both the innate and adaptive immune responses are encoded by 
many other poxviruses. Cowpox, ectromelia and vaccinia viruses all produce 
complement control proteins which block the activity of complement through both the 
classical and alternate pathways (Kotwal and Moss, 1988; Miller et al., 1997; Smith,
1993) . Inhibitors of apoptosis in infected cells are produced by cowpox, rabbitpox, 
vaccinia, and variola viruses (Cuff and Ruby, 1996). Orf virus encodes an IL-10 
homolog, a cytokine which has inhibitory effects both on the innate and Th I responses 
to infection (Fleming et al., 1997). Both chemokine homologs and chemokine receptor-
like proteins are produced by poxviruses, including molluscum contagiousum virus 
(Bugert et al., 1998), swinepox virus (Massung et al., 1993), capripox (Cao et al., 
1995), raccoonpox, camelpox, Shope fibroma and vaccinia viruses (Alcami et al., 
1998; Graham et al., 1997; Smith et al., 1997a) and variola and cowpox viruses (Smith 
et al., 1997a). Encoded TNF receptor homologs have been identified from vaccinia 
virus, cowpox and variola viruses (Howard et al., 1991; Hu et al., 1994; Loparev et al., 
1998; Smith et al., 1996). At least four proteins are produced by poxviruses that 
interfere with the action of EFN (Smith et al., 1998). These include soluble IFN 
receptor homologs produced by vaccinia virus, swinepox, variola, cowpox and 
ectromelia viruses (Alcami and Smith, 1995; Mossman et al., 1995b), and intracellular 
IFN inhibitors, of which two separate proteins are produced by vaccinia virus (reviewed 
in Smith et al., 1998; Smith et al., 1997). A soluble tanapox protein binds EFN7, IL-2 
and EL-5, although the gene has not been identified (Essani et al., 1994). The study of 
the proteins encoded by poxviruses is continually revealing new and novel strategies of
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virus-induced immune modulation, and further sequencing may identify additional 
proteins in myxoma virus that interfere with the immune response.
1.4.5 Immunosuppression and malignant rabbit fibroma virus
Malignant rabbit fibroma virus is a recombinant between myxoma virus and the closely 
related Shope fibroma virus. The malignant rabbit virus genome is essentially derived 
from myxoma virus, with 4kb and 7kb of Shope fibroma virus sequence inserted within 
the left and right terminus respectively (Block et al., 1985). Infection of the European 
rabbit with malignant rabbit virus results in a generalised disease characterised by the 
development of widespread lesions on the ears, face and body, and secondary bacterial 
infection of the respiratory tract, followed by death in 12-14 days (Strayer et al., 1983a). 
Infection also results in severe immunosupression as measured by the inability of 
splenocytes from infected rabbits to proliferate in response to stimulation with mitogen 
(Strayer et al., 1983b).
Malignant rabbit virus is closely related to myxoma virus and has been used to study the 
immune responses of O. cuniculus to poxvirus infection. In particular, the interactions 
between malignant rabbit virus and rabbit splenocytes have been extensively examined. 
Strayer et al (1983b) found that lymphocytes from infected rabbits at 7dpi were 
suppressed in their ability to proliferate in response to stimulation with either 
Concanavalin A (Con A) or anti-immunoglobulin (Ig). This suppression was replicated 
following the in vitro infection of lymphocytes from uninfected rabbits with virus. The 
generation of antibody to sheep red blood cells by rabbits was suppressed following 
infection with malignant rabbit virus, although antibody responses that had been 
established prior to virus infection were not affected (Strayer et al., 1983b). Despite the 
suppressed antibody responses to an unrelated antigen, rabbits developed strong 
neutralising antibody titres to malignant rabbit virus before death (Strayer and 
Leibowitz, 1987a). The ability of malignant rabbit virus-infected lymphocytes to 
produce and respond to IL-1 in vitro was unaffected, although these cells had a reduced 
capacity to produce EL-2 or respond to the exogenous addition of EL-2 despite the 
normal expression of the IL-2 receptor (Strayer et al., 1986). Lymphocytes from virus- 
infected rabbits recovered the ability to respond to mitogen by 11dpi (Strayer et al., 
1983b). Despite this recovery in immune responsiveness, malignant rabbit virus 
infected-rabbits died by two weeks post infection.
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The mechanism of malignant rabbit virus-induced immunosuppression is thought to 
result from two events. Firstly, the suppression of lymphoproliferation is thought to be 
a function of the ability of virus to replicate in lymphocytes. Shope fibroma virus is 
unable to replicate in lymphocytes (Strayer, Skaletsky, and Leibowitz, 1985). However, 
recombinant Shope fibroma virus that contained fragments of malignant rabbit virus 
DNA were capable of replicating in lymphocytes. These same viruses also induced a 
similar suppression of lymphoproliferation in response to mitogen as that induced by 
infection with malignant rabbit vims (Strayer et a l , 1990).
The second event involved in suppression of proliferative responses of lymphocytes is 
thought to be more indirect than vims replication in lymphocytes. Cell supernatants 
from splenocytes or RL-5 cells infected with ultraviolet (UV)-inactivated malignant 
rabbit vims suppressed lymphoproliferation and antibody responses of uninfected cells 
(Strayer et a l , 1988). It was proposed that a soluble factor generated from infected 
cells, termed vims induced suppressive factor or VISF, activated T-suppressor cells 
which then suppressed the ability of uninfected splenocytes to proliferate, presumably 
through cytokine production (Strayer and Dombrowski, 1988). The suppressive 
function of VISF could be reversed by mixing splenocytes or splenocyte supernatants 
taken from malignant rabbit virus-infected rabbits at 7dpi and 11dpi (Strayer and 
Leibowitz, 1986). This reversal was attributed to the generation of a second factor, 
termed anti-suppressor factor or ASF, produced by uninfected splenic T cells by 11dpi 
(Strayer and Dombrowski, 1988). ASF is postulated to restore proliferative responses 
by antagonising VISF, and provide resistance to these cells from the suppressive effects 
of VISF, thus explaining the recovery of immune function at 11dpi. However, neither 
of these factors have been purified or characterised.
Myxoma vims is commonly described as being immunosuppressive and the discovery 
of at least nine virus-encoded proteins that potentially modulate the immune response 
suggests that this is the case. However, there has been no examination of in vivo 
immune responses of laboratory rabbits following infection with myxoma vims to 
determine if a functional suppression of the cellular or humoral responses occurs.
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1.4.6 Genetic resistance to virus infections
The mechanisms for genetic resistance of a host to a virus can be manifested either at 
the cellular level, through the ability of the cell to produce infectious progeny, or at the 
level of the host immune response. Genetic resistance to flavivirus infection, for 
example, is manifested at the level of the cell. Cell cultures from mice resistant to 
flavivirus infection, both laboratory and wild, produce lower yields of virus than 
cultures from susceptible mice (Webster and Johnson, 1941) through the inhibition of 
production of progeny virion RNA (Brinton, 1981). In contrast, resistance of mice to 
influenza virus is not dependant on cell permissivity, but rather correlates with genetic 
sensitivity of cells to IFN (Haller et al., 1980).
Genetic resistance to ectromelia virus infection has been studied using inbred strains of 
mice and appears to be linked to the immune response to infection. Most strains of 
mice, such as A and A/J (both of MHC haplotype H-2a) and BALB/c and DBA (both of 
MHC haplotype H-2d), are highly susceptible to ectromelia virus infection. However, 
the mouse strains C57BL/6 (B6) and C57BL/10 (both of MHC haplotype H-2b), are 
resistant (O’Neill, 1991; Wallace et al., 1985). In susceptible mice (BALB/c), death 
occurs by 6-7 days post infection due to disseminated infection to the liver and spleen 
and consequent necrosis of these organs. In genetically resistant strains, virus spread is 
slower with lower titres of virus in the liver and spleen (Brownstein et al., 1993), 
causing minimal, non-fatal lesions (Buller and Palumbo, 1991). Resistant mice infected 
with ectromelia virus produce high levels of the type 1 cytokines, IL-2, IL-12 and 
TNFa , whereas these cytokines are produced at low levels following infection of 
susceptible mice (in Ramshaw et al., 1997). Virus specific precursor CTLs accumulate 
in the regional lymph node earlier in resistant than susceptible mice (O'Neill and 
Brenan, 1987), and strong antiviral CTL responses are generated in resistant mice which 
are delayed and weak in susceptible mice (in Ramshaw et al., 1997). However, studies 
with C57BL mice indicate that resistance is operative as indicated by controlled virus 
replication, before the generation of virus specific CTLs (O'Neill and Blanden, 1983).
Resistance to ectromelia virus infection is controlled by multiple, unlinked, autosomal 
dominant genes (Brownstein et al., 1989; Brownstein et al., 1992) that map to 
chromosomes 6 (Rmpl) (Delano and Brownstein, 1995; Wallace et a l , 1985), 2 (Rmp2) 
(Brownstein et al., 1992; Brownstein et al., 1991) and 17 (.Rmp3) (Brownstein et al., 
1991; O'Neill, 1991). Rmpl (resistance to mousepox) is a member of the NK gene
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complex, adjacent to the Prp (proline-rich protein) locus. Resistance is expressed 
through a cell with an NK cell phenotype since infection of mice bearing the Rmpl 
resistant locus but depleted of NK1.1+ cells with monoclonal antibody results in 
increased susceptibility (Delano and Brownstein, 1995). The NK gene complex in mice 
is also important in genetic resistance to cytomegalovirus (CMV) (Scalzo et al., 1992) 
suggesting that NK cell activity is important in resistance against two unrelated DNA 
viruses (Delano and Brownstein, 1995).
The development of genetic resistance of European rabbits to myxoma virus in the field 
is well documented. However, unlike ectromelia virus infection of mice, nothing is 
known about the mechanisms of genetic resistance to myxoma virus in wild rabbits.
1.5 Summary and aims of this study
The study of immunological responses of rabbits to a virus infection is difficult as there 
are no inbred lines of rabbits available. There is substantial variation between 
individuals, which increases the number of animals required to achieve statistical 
significance. Unlike the current situation for mice, there are few immunological 
reagents specific for rabbits, rendering the study of specific components of immune 
responses difficult. However, we have in Australia the rare opportunity to study the 
pathogenesis of a virus evolving in a new host. The availability of the original virus 
strain that was released into Australia and natural attenuated variants, as well as 
populations of both genetically susceptible and resistant rabbits, which have been 
selected for by natural infection with the virus, is unique. This makes the myxoma 
virus/ European rabbit model an important one for the study of host-virus interactions, 
both in terms of biological control and in terms of emerging diseases.
Since the early studies on myxoma virus in the Australian wild rabbit population 
documenting changes in viral virulence and the development of genetic resistance in the 
host population, we have a greatly increased understanding of the viral genes required 
for propagation in the host, the role individual cell subsets and cytokines have in 
recovery from poxvirus infections, and the mechanisms involved in genetic resistance to 
a natural poxvirus infection. However, we have a limited understanding of myxoma 
virus pathogenesis and what factors are important in determining whether a susceptible 
rabbit will control virus replication and survive infection with virulent or attenuated
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forms of myxomatosis. Further, nothing is known about the mechanism of genetic 
resistance to myxomatosis, and what factors are important in the control of virus 
replication by infected wild rabbits.
The experimental infection of genetically susceptible and resistant rabbits with virulent 
and attenuated strains of myxoma virus can be used to investigate important factors 
contributing to the pathogenesis of myxoma virus that have been previously obscured 
by the overwhelming lethality of the laboratory strains of myxoma virus in laboratory 
rabbits. The objective of this study is to use such experimental infections to develop a 
model of myxoma virus pathogenesis in the European rabbit and conceptualise host- 
virus coevolution by addressing the following questions. Firstly, does myxoma virus 
cause suppression of cellular and humoral immune responses in infected laboratory 
rabbits, similar to that caused following infection of rabbits with malignant rabbit virus, 
and is the ability to suppress immune responses dependent on virus virulence? This is 
addressed in Chapter 2. Secondly, where and when does control of vims replication 
occur in laboratory rabbits infected with attenuated myxoma vims, or in wild rabbits 
infected with vimlent myxoma vims (addressed in Chapter 3)? Thirdly, what cell types 
within tissues become infected with myxoma vims in laboratory and wild rabbits 
(addressed in Chapter 4)? I also examine the pathogenic mechanisms employed 
myxoma vims in the lymphoid organs of rabbits that may contribute to the death of the 
host, and how these are dependent on vims vimlence or the degree of host genetic 
resistance (Chapters 4 and 5). Finally, I investigate vims replication both in vitro and in 
vivo for the respective examination of the role of cell permissivity to vims replication in 
host resistance, and to examine the importance vims replication in dendritic cells and 
lymphocytes for vims vimlence and dissemination (Chapter 5).
Introduction
Chapter 2: Cellular and humoral 
responses to virulent and attenuated 
myxoma virus infection
2. Cellular and humoral responses to virulent and attenuated 
myxoma virus infection
2.1 Introduction
Myxoma virus encodes at least nine proteins that may function to suppress the host 
immune response. These include specific inhibitors of TNFa  and TNFß (Schreiber and 
McFadden, 1994; Upton et al., 1991), IFN7 (Mossman et al., 1995a; Upton et al., 1992) 
and chemokines (Graham et al., 1997; Lalani et al., 1997), as well as inhibitors of 
inflammation (Graham et al., 1992; Opgenorth et al., 1992) including serine proteinase 
inhibitors (Macen et al., 1993; Upton et al., 1990), and inhibitors of apoptosis in 
infected lymphocytes (Barry et al., 1997; Macen et al., 1998; Macen et al., 1996a; 
Macen et al., 1996b; Mossman et al., 1996a; Petit et al., 1996; Schreiber et al., 1997). 
The individual deletion of most of these genes results in the attenuation of the disease 
caused following infection of European rabbits. Myxoma virus also specifically 
downregulates the expression of MHC class I (Boshkov et al., 1992) and CD4 on the 
surface of infected cells (Barry et al., 1995). However, in vivo immune responses of 
European rabbits infected with myxoma virus have not been measured to determine if a 
functional suppression of the immune response occurs.
Malignant rabbit virus, a virus generated by a recombination between the closely related 
myxoma and Shope fibroma viruses, causes a generalised lethal disease in infected 
laboratory rabbits similar to that caused by infection with myxoma virus (Strayer et al., 
1983a). Also similarly to myxoma virus, malignant rabbit virus replicates in 
lymphocytes (Strayer et al., 1985), encodes inhibitors of the host immune response 
(Upton et al., 1990) and specifically downregulates MHC class I on the surface of 
infected cells (Boshkov et al., 1992). Malignant rabbit virus-infected rabbits exhibit 
decreased cellular and humoral immune functions. Suppression of splenocyte 
proliferation in response to mitogens in vitro is apparent by 7dpi, with some recovery of 
responsiveness by 11dpi (Strayer et al., 1983b). Suppression of lymphocyte 
responsiveness is associated with a reduced ability to produce and respond to IL-2 
(Strayer et al., 1986). Malignant rabbit virus-infected rabbits have a depressed ability to 
generate specific antibody to an unrelated antigen (sheep red blood cells) (Strayer et al.,
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1983b) although rabbits developed substantial neutralising antibody titres to malignant 
rabbit virus before death (Strayer and Leibowitz, 1987a).
Malignant rabbit virus-induced suppression of lymphocyte responsiveness is thought to 
be a function of the ability of the virus to replicate in lymphocytes. Shope fibroma 
virus is unable to replicate in lymphocytes (Strayer et al, 1985). Recombinants of 
Shope fibroma virus containing fragments of malignant rabbit virus DNA that confer 
the ability to replicate in lymphocytes, also induce immune suppression of infected 
rabbit lymphocytes (Strayer et al, 1990). The importance of viral replication in 
lymphocytes is thought to be two fold: direct suppression of lymphocytes (Strayer and 
Leibowitz, 1986; Strayer et al, 1985), and the induction of as yet uncharacterised 
soluble factors from infected cells that suppress the responses of uninfected cells 
(Strayer et al, 1988).
Malignant rabbit virus and Shope fibroma virus provide obvious models for 
understanding the interactions of myxoma virus with the rabbit immune response 
because of their close genetic relationship with myxoma virus. In particular, whether 
the differences in virulence between strains of myxoma virus are due to suppression of 
host immune functions in vivo. In this Chapter, the effect that two strains of myxoma 
virus had on cellular and humoral responses of infected rabbits was examined. These 
strains were the highly virulent standard laboratory strain (SLS) which causes 100% 
mortality in laboratory rabbits, and the naturally attenuated Uriarra strain of myxoma 
virus, which causes clinical myxomatosis but results in less than 5% mortality in 
infected rabbits. To examine humoral immune responses, a strong antibody response to 
an antigen must be generated in the timespan of an SLS infection. Hence, a model 
system of coinfections was studied, utilising SLS or Uriarra coinfected with an 
extremely attenuated recombinant myxoma virus (derived from Uriarra) expressing the 
influenza haemagglutinin (HA). It was already known that infection of rabbits with this 
virus provided a strong IgG response to HA by 10dpi, although preliminary results 
suggested some suppression of this response in rabbits coinfected with SLS (Kerr and 
Jackson, 1995). Lymphocyte responsiveness in vitro was examined using T and B cell 
mitogens to stimulate cells prepared from the lymph nodes or spleen of infected rabbits.
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2.2.1 Animals and viruses
2.2.1 A Rabbit care and housing
Laboratory European rabbits (Oryctolagus cuniculus) were bred in the CSIRO 
Gungahin animal house facility. Adult rabbits over four months old were individually 
housed under PC2 conditions in this facility, where the temperature and lighting regimes 
were held constant at 20°C and 12:12 hours light:dark respectively. Rabbits were fed ad 
libitum on standard rabbit pellets supplemented with cabbage leaves.
2.2.1.2 Derivation of viruses
Standard Laboratory Strain (SLS) of myxoma virus is derived from the Moses’ strain 
(Moses, 1911) and is the strain originally released in Australia. The SLS stock used in 
this study is derived from a rabbit tissue-stock freeze dried by Professor Frank Fenner in 
1953 which has subsequently been passaged twice in tissue culture (RK13 cells) and 
then twice in rabbits. The virus has Grade I virulence for laboratory rabbits with 100% 
lethality and an average survival time of <13 days (Fenner and Marshall, 1957). This 
was confirmed fox these stocks in recent retesting (Robinson et ah, submitted).
Uriarra strain of myxoma virus is derived from the plaque purified stock produced by 
Russell and Robins (1989) (Russell and Robbins, 1989) which is derived from the 
Uriarra/2/53-1 isolate (Myktowycz, 1953). It was passaged an unknown number of 
times in tissue culture (CV-1 cells) before we obtained it, and has subsequently been 
passaged twice in RK13 cells and then twice in rabbits. This virus is of Grade V 
virulence and over 95% of infected laboratory rabbits recover from infection, but all 
develop clinical myxomatosis (Fountain et al., 1997; PJ Kerr, unpublished).
UrHA is a recombinant myxoma virus of the Uriarra strain (Uriarra/2/53-1) that encodes 
the influenza haemaglutinin (HA) gene under the control of the vaccinia virus PI 1 late 
promoter (Kerr and Jackson, 1995). Virus stocks were produced in RK13 cells. This 
virus does not cause significant clinical disease in laboratory rabbits.
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2.2.13 Rabbit passage o f  virus stocks
Two adult male laboratory rabbits were infected by intradermal inoculation in the hind 
flank with 103 plaque forming units (pfu) of SLS or Uriarra strains of rabbit-passaged 
myxoma virus. At 8 (SLS) and 10 (Uriarra) days post infection (dpi), the rabbits were 
killed by barbiturate overdose and both testes removed aseptically. The two testes from 
each rabbit were washed in phosphate buffered saline (PBS; 0.14M NaCl, 0.003M KC1, 
0.003M Na2HP04, 0.003M KH2P04), the tunics removed and the remainder minced with 
scissors and passed through a 10ml syringe. The homogenised testes were placed in a 
50ml tube and approximately 10ml sterile PBS added, followed by three 5 sec bursts of 
sonication using a probe sonicator. The suspension was centrifuged at 230g for 10min 
and the supernatant removed and retained. The remaining tissue was sonicated again, 
followed by centrifugation. The supernatant was removed and combined with the 
previous supernatant. The titre of virus in the combined supernatant was determined by 
plaque assay (2.2.1.5) and 1ml stock aliquots stored at -70°C. These aliquots were 
further divided into 5OR aliquots, also stored at -70°C, that were thawed and frozen for 
use a maximum of two times before they were discarded.
2.2.1.4 VERO cell culture fo r  plaque assays
Aliquots of liquid nitrogen stored VERO cells (African green monkey kidney cell line) 
were thawed, washed once in minimal essential medium (MEM, Gibco BRL) 
supplemented with 10% newborn calf serum (CSL), 200 units/ml penicillin (Sigma), 
lOOP'g/ml streptomycin (Sigma) and 2mM L-glutamine (Sigma) (complete MEM), 
placed with medium into a T25 flask (Nunc) and allowed to grow to confluency at 37°C 
in 5% C02 in air. When confluent, cell monlayers were washed twice in PBS, washed 
twice with 0.1% trypsin in diluent (0.14M NaCl, 0.005M KCl, 0.0004M Na.HPO,, 
0.0004M KH2P 04, 0.006M NaHC03, 0.0003M ^ E D T A  pH 7.3) and left for 2min 
covered in a thin layer of 0.1% trypsin. The cells were suspended by repeated pipetting, 
placed in a T175 flask (Nunc) with complete MEM and allowed to grow to confluency 
with regular changes of complete MEM at 37°C in 5% C 02 in air. When confluent, 
cells were removed from the flask as above and placed into roller bottles (Nunc) with 
complete MEM on a rotator at 37°C, and with regular changes of complete MEM, until 
they reached confluency. Cells were then removed from the roller bottle as above and 
counted using a haemocytometer.
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2.2.1.5 Plaque assay for virus titration
VERO cells from the roller bottle cell culture were seeded into 6 well sterile plates 
(Nunc) at 0.8 x 106 cells/well in complete MEM and grown overnight at 37°C in 5% 
C02 in air to form a cell monolayer. The medium was removed leaving sufficient 
volume to just cover the monolayer. 100^1 of serial dilutions of testis preparation (see 
2.2.1.3) was added to duplicate monolayers and the plates incubated for one hour at 
37°C in 5% C02 in air, rocking every 15min, followed by addition of 3ml of complete 
MEM and incubation for 7 days. After this time, the medium was poured off and 1ml of 
10% formalin (v/v in PBS) added to each well. Plates were left for lhour, followed by 
removal of formalin and the addition of 1ml of 0.1% aqueous crystal violet (Sigma), 
which was left for a further lhour. The plates were washed in tap water, allowed to air 
dry and the number of plaques counted. Titres were expressed as plaque forming units 
(pfu)/ml of stock.
2.2.2. Infection experiments
2.2.2.1 Coinfection of laboratory rabbits with UrHA and either SLS or Uriarra
Eighteen laboratory rabbits were intradermally inoculated, in groups of three, in one 
flank with 103 pfii of the recombinant myxoma virus, UrHA. These rabbits were 
intradermally inoculated at the same time as the first inoculation in the opposite flank 
with 103 pfii of either the virulent SLS (n=6) or the attenuated Uriarra strain of myxoma 
virus (n=6) to form the UrHA/SLS and UrHA/Uriarra coinfections respectively. 
Control rabbits were inoculated with UrHA only (n=6). Clinical symptoms, rectal 
temperature and progression of the primary lesions were monitored every 24 hours. 
Every 48 hours, peripheral blood was taken from the marginal ear vein for peripheral 
white blood cell (WBC) counts (see section 2.2.2.1.1). At 10 dpi, and after a blood 
sample was taken, rabbits were killed by injection of barbiturate in the marginal ear 
vein, and the spleen and popliteal lymph node adjacent to the inoculation site of UrHA 
were aseptically excised and placed into cold Hanks balanced salt solution (HBSS; Flow 
Laboratories) supplemented with 12.5 I.U./ml heparin sodium (Fissions 
Pharmaceuticals) and kept on ice.
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2.2.2.1.1 Peripheral WBC counts
WBC from peripheral blood samples were diluted 1:10 in WBC diluting fluid (2% 
glacial acetic acid, 1% of 1% aqueous gentian violet, in ddH20), loaded into a 
haemocytometer and counted using a light microscope.
2.2.2.2 Block design experiment for measuring mitogen-induced proliferation of 
lymphocytes in vitro
Laboratory rabbits were intradermally inoculated with lOOpfu of SLS or Uriarra on the 
dorsum of the hind left foot. The relatively small dose of virus was used to mimic 
natural infection and reduce the amount of virus reaching the node due to drainage 
directly from the inoculation site. Rabbits were inoculated in groups of six, with four 
rabbits infected with virus and two inoculated with 100^1 PBS for each time point (4, 7 
and 10dpi). At any one time, six rabbits were killed in a random block design (Table 
2.1). This was the maximum number of rabbits that could be handled in one day. The 
random block design of the experiment meant that rabbits from two treatment groups 
were killed each time (for example, day 4 and day 10 post infection). In addition, a 
different combination of treatment groups was killed at each time, to randomise the 
effect that day of killing may have on the assay. Popliteal lymph nodes from both left 
and right legs (the draining and contralateral lymph nodes respectively) were removed 
and placed into HBSS supplemented with 12.5 I.U./ml heparin sodium (Fissions 
Pharmaceuticals) and kept on ice.
2.2.23 Preparation of primary cells from lymph nodes and spleen
Each spleen and lymph node was cut into small pieces with scissors and passed through 
a stainless steel mesh (50Pm) using a glass pestle and 10ml HBSS supplemented with 
heparin. The cell suspension from the spleen was passed through a second mesh (40^ 
m) to further break up cell aggregates. The resulting cell suspensions were pelleted at 
230 g for 10min at 18°C and resuspended in 5ml of shocking solution (0.0008M 
KH2P04, 0.15M NH4CI, 0.003M Na3EDTA, pH 7.2 in ddH20) for 10min at room 
temperature to lyse red blood cells (RBC). 5ml HBSS was added to the cell suspension 
and it was centrifuged again as above. The cells were washed twice with HBSS before 
resuspending in 5ml RPMI 1640 medium (GEBCO BRL) supplemented with 10% foetal 
calf serum (CSL), 200 units/ml penicillin (Sigma), 100Pg/ml streptomycin (Sigma) and
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2mM L-glutamine (Sigma) (complete RPMI). Cells were counted in WBC diluting 
fluid using a haemocytometer. Cell viability was assessed by trypan blue exclusion 
(0.2% trypan blue in ddH2Ü).
Figure 2.1: Random block design of the lymphocyte proliferation experiment. Rabbits 
were infected with either SLS or Uriarra at 4, 7 or 10 days before the day of killing. 
Rabbits were killed on six separate days (day of killing). On each of these days, three 
rabbits were killed from each of two treatment groups (a total of six rabbits/day). 
Within each treatment group, two rabbits were infected with virus and one rabbit had 
been inoculated with PBS. Rabbits infected with either Uriarra (blue) or SLS (red) were 
always killed on different days. At the end of the experiment, a total of four virus- 
infected rabbits and six PBS-inoculated rabbits had been killed at each time point of 4, 7 
and 10 dpi (days post infection), for both Uriarra and SLS infections (a grand total of 18 
rabbits per virus infection).
Day of Treatment group 1 Treatment group 2 Total number
killing (2 virus infected, 1 PBS) (2 virus infected, 1 PBS) of rabbits
1 4 dpi 7 dpi 6
2 4 dpi 10 dpi 6
3 7 dpi 10 dpi 6
4 4 dpi 7 dpi 6
5 4 dpi 10 dpi 6
6 7 dpi 10 dpi 6
2.2.2A Mitogen stimulation of primary lymphoid cells
The ability of lymphocytes to proliferate in response to mitogen stimulation was 
examined using the T-cell mitogens Concanavalin A (Con A) and phytohaemagglutinin 
(PHA) or the B-cell mitogen, lipopolysaccharide (LPS). Primary cells from lymph 
nodes or spleen were seeded into 96 well flat bottomed microtitre plates (Nunc) at 1 x 
l(f cells/well in 200|al of complete RPMI. Con A, PHA or LPS (Sigma) was added to 
triplicate cell samples, in serial two fold dilutions from 10 to 0.625jLig/ml. Cells derived 
from coinfected rabbits were stimulated with Con A only. Controls containing no 
mitogen were included. Plates were incubated for 48 hours at 37°C in an atmosphere of 
5% CO2 in air, after which 0.7p,Ci tritiated thymidine (3H-T; ICN) in complete RPMI
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was added to each well. The cells were then incubated for a further 18 hours and frozen 
at -20°C until harvested. Optimal incubation times for the maximal incorporation of 3H- 
T into DNA of proliferating cells had been previously determined (K.Saint, pers. com.). 
The plates were thawed and harvested onto printed filtermat A glass paper (Wallac Oy, 
Turku, Finland) using a Wallace Betaplate cell harvester. The filtermats were dried for 
10min at 60°C and placed into Wallace sampling bags and 10ml o f Betaplate Scint, 
scintillation fluid (Wallac Oy) added. The incorporation of 3H-T into the DNA of 
proliferating cells was counted by a 1205 Betaplate reader. The optimal mitogen 
concentrations assessed by maximum incorporation o f 3H-T into cellular DNA were 5, 5 
and lO^g/ml for Con A, PHA and LPS, respectively.
2.2.3 Preparation of influenza virus
2.2.3.1 Growth and harvest o f  influenza virus
A/PR/8/34 influenza virus was supplied by Dr. G. Laver, John Curtin School o f Medical 
Research, Australian National University at a concentration of 320 haemagglutinin 
units/ml (HAU/ml). 160 HAU influenza virus was placed into 50ml normal saline 
(0.15M) supplemented with 200 units/ml penicillin (Sigma) and lOO^g/ml streptomycin 
(Sigma). 100^1 was inoculated into the allantoic fluid o f each of 200 ten day fertilised 
eggs (Parkwood Eggs, A.C.T.). The point of entry, through the shell at the air sac, was 
sealed with wax and the eggs incubated for three days in a humidified chamber at 37°C 
with regular turning of the eggs. After this, the eggs were cut open and the allantoic 
fluid aspirated into a flask on ice. Any eggs displaying bacterial growth were discarded. 
A small amount of the fluid was kept for virus titration in a haemagglutination test 
(section 2 .233)  which at this time was 2560 HAU/ml. To concentrate the virus, 
chicken RBC (section 2.2.3.4) were added to the remainder of the fluid to make a 2% 
v/v RBC suspension that was placed on ice for 60 min, shaking every 15 min to allow 
virus to absorb to the RBC. RBC were then pelleted at 450 g  for 15 min at 0°C and the 
supernatant removed. RBC were resuspended in 50ml calcium/magnesium saline 
(0.01% CaCl2, 0.001% MgCl2 in normal saline) and incubated for 60min at 37°C with 
shaking every 15min, followed by centrifugation at 450 g  for 15min at 20°C. The 
supernatant, which now contained the virus, was removed, the haemagglutinin titre 
determined, and the virus stored at 4°C.
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2,23.2 Purification o f influenza virus
The supernatant from 2.2.3.1. was centrifuged at 22 OOO g  for 3 hours at 4°C. The 
supernatant was removed and the pellet covered with 1ml of calcium/magnesium saline 
and left overnight at 4°C to resuspend. The remaining pellet was then resuspended by 
agitation and the suspension layered above a step gradient of 10, 40 and 55% sucrose 
(w/v in ddH20). This was centrifuged at 22 000 g for 45min at 5°C in a SW28 rotor. The 
visible band of antigen (positioned a third of the way down the gradient) was collected 
and centrifuged for 3 hours at 35 000 g at 10°C and the supernatant discarded. The 
pellet was washed twice, without disruption, with saline and then resuspended in 1ml of 
saline containing 1 drop of 10% sodium azide. The final haemagglutinin titre was 
determined using the haemagglutination test and the vims stored at 4°C. This titre was 
1.6 x 108 HAU/ml.
2.2.33 Preparation of chicken RBC
Chicken blood was collected from the throats of newly slaughtered adult chickens into 
1% tri-sodium citrate in normal saline (0.15M). The citrated blood was passed through 
two layers of gauze and RBC pelleted at 450g for 15min at 0°C. RBC were washed 
twice (with centrifugation at 450 g for 15 min at 0°C) with 20ml of normal saline. The 
final pellet of RBC was covered with a thin layer of saline and stored at 4°C for up to 
seven days for use in the production of influenza vims and in the haemagglutination 
tests.
2.23.4 Haemagglutination test
The ability of antigen suspensions to agglutinate RBC was measured using the 
agglutination test. The test solution (allantoic fluid, unpurified and purified vims) was 
titrated in 2 fold serial dilutions from 1:10 in 100^1 saline in duplicate in 96-well round 
bottomed plates (Nunc). 10^L of 10% chicken RBC (v/v in saline; section 2.2.3.4) was 
added to each well, mixed thoroughly and left for 30min at room temperature. The last 
dilution at which the RBC were not agglutinated was recorded as the titre (HAU/ml).
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2.2.4.1 Enzyme linked immunosorbent assay (ELISA)
The purified influenza virus (section 2.2.4.1) was used in an ELISA (see below) such 
that a 1:100 dilution of serum from rabbits that had been previously hyperimmunised 
with UrHA gave a positive reaction of 1.0 -1.2 optical density (OD) units. This 
concentration was a 1:5000 dilution of antigen stock.
50M-L of influenza virus (section 2.2.3) or myxoma virus antigen (1:5000 or 1: 2500 
respectively in PBS) was added to all wells except the first row of 96 well flat-bottomed 
plates (Nunc) and incubated for 3 hours at 37°C. Myxoma virus antigen was prepared 
from intracellular myxoma virus (Lausanne strain) grown in tissue culture (RK13 cells). 
Virus was released from infected tissue culture cells by sonication, pelleted by 
cetrifugation through two dextran/sucrose step gradients, and stored at -20°C (Kerr, 
1997). Excess antigen was flicked out of the well and the plates washed three times 
with 5% w/v skim milk powder (Diploma) in PBS (milk/PBS). 200PL milk/PBS was 
added to all wells and the plates left overnight to block at 4°C. Rabbit sera were 
vortexed and centrifuged at 13 000 g for 5min to remove non-specific reactivity. Sera 
were diluted, in duplicate, in milk/PBS in two fold serial dilutions from 1:50 to 1:51200, 
and 50R of these dilutions added to the blocked plates after the milk/PBS had been 
flicked out of the wells. Known positive and negative samples were included as 
controls. Plates were incubated for 2 hours at 37°C and then washed four times with 
0.05% v/v Tween 20 (Sigma) in PBS (Tween/PBS). 50^1 of goat anti-rabbit IgG 
(1:4000) or anti-rabbit IgM (1:1000) conjugated with horse-radish-peroxidase (Southern 
Biotechnology) in milk/PBS was added and the plates incubated for 60min at 37°C, 
followed by six washes with Tween/PBS. lOO^L of a buffered ABTS (2,2’-Azino- 
bis(3-ethylbenzo-thiazoline-6-sulphonic acid); Sigma) solution was added to each well 
and left for 20min at room temperature. This consisted of 2ml stock ABTS (5mg/ml 
ABTS in 0.1M citrate phosphate buffer), 8ml 0.1M citrate phosphate buffer (77nM 
Na2HP04, 61mM citrate, pH 4.0 in ddH20) and 0.06% H20 2. The OD of each well was 
read at 405nm with a BIORAD 3550 microplate reader using BIORAD microplate
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manager 2.1 software. The antibody titre was read as the final dilution producing a 
positive reading at least 0.1 OD units above the OD of the 1:100 negative control.
Both the IgM and IgG ELIS As were optomised to give the highest possible signal rnoise 
ratio. IgM was difficult to detect and so a much higher background level was accepted 
to enable detection of IgM compared to IgG. Hence, the ELISA titres of specific serum 
IgM and IgG are not comparable in a quantitative sense (Kerr, 1997).
2.2.4.2 ELISPOT
Influenza virus preparation (section 2.2.3) was diluted 1:5000 in bicarbonate buffer 
(0.1M NaHC03, ImM MgCl2.6H20, pH 9.8 in ddH20) and 50^1 added to all wells of 
Millititre HA 96 well filtration plates (Millipore) with the exception of the first row, and 
incubated overnight at 4°C. The plates were then washed gently four times with PBS. 
Primary lymphoid cells from the popliteal lymph node and spleen of rabbits inoculated 
with UrHA were seeded into wells in serial two fold dilutions from 2 x 10s to 2.5 x 104 
cells/well in triplicate. A control of no cells was included. The plates were incubated 
for 6 hours at 37°C to enable cells to secrete antibody, and then washed four times with 
Tween/PBS. 100^1 of biotinylated goat anti-rabbit IgG (1:4000) or IgM (1:1000) 
(Southern Biotechnologies) in Tween/PBS was added and incubated at 4°C overnight. 
A control of no secondary antibody was included. Plates were washed four times with 
Tween/PBS followed by the addition of 100^1 of streptavidin-conjugated alkaline 
phosphatase (1:2000; Amersham Life Science), followed by incubation for 60min at 
37°C. Plates were again washed four times with Tween/PBS. 100^1 of alkaline 
phosphatase substrate was added to each well and the plates left for 20min at room 
temperature for the colour to develop. This substrate was a filtered solution consisting 
of 6mg BCEP (5-bromo-4-chloro-3 indolyl phosphate; Promega), 12mg NBT (nitro blue 
tetrazolium; Promega), dissolved in 40ml of bicarbonate buffer plus 400^1 DMF (N,N- 
dimethyl formamide; Sigma). Plates were washed with tap water and allowed to dry 
before counting spots that represented antibody secreting cells under a stereoscopic 
dissecting microscope. Results were expressed as antibody secreting cells (ASC) per 
106 lymphoid cells.
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2.2.5 Histology and immunohistochemistry
2.2.5.1 Fixed tissue sections and histology
Following autopsy, portions of lymph node and spleen were fixed in 4% buffered 
formaldehyde for 24 hours, followed by two changes in 70% ethanol, and then 
embedded in paraffin wax. Four 51% sections were cut from each tissue at intervals of 
500%  (and from either end of the spleen resulting in eight sections of spleen from each 
rabbit) and mounted on superfrost microscope slides (Menzel-Glaser). Sections were 
dewaxed in three changes of xylene for 2 min each and rehydrated through a graded 
series of ethanol (100 - 75%). Slides were then washed in tap water, stained with Gills’ 
number 3 haematoxylin for 3 min (BDH Laboratory Supplies), washed in tap water, 
blued in Scotts’ tap water substitute (20mM NaHC03, 80mM MgS04) for 1 min, stained 
with 0.025% alcoholic eosin for 2 min, differentiated in two washes of 90% ethanol and 
cleared in two changes of xylene. Sections were mounted under a coverslip with D.P.X. 
(Difco), examined by light microscopy and photographed using Fujichrome Velvia 400 
film.
2.2.5.2 Frozen tissue sections
At autopsy, blocks (10mm x 2mm) of tissue from the primary site of virus inoculation in 
the skin, the lymph node adjacent to this inoculation site and the spleen were placed in 
small cups made of foil and covered in OCT fluid (Tissue Tek). These were snap frozen 
in liquid nitrogen and stored at -70°C. Tissue sections of 4 to 7 %  thickness were cut 
from these blocks using a cryostat. The sections were placed onto superfrost slides 
(Menzel-Glaser) which had been previously coated in a 0.01% poly-L-lysine (Sigma) 
solution (v/v in ddH20) and air-dried.
2.2.5.3 Fixation o f  frozen sections
Within an hour of being cut, frozen sections were immersed in formol-calcium for 5 min 
(10% of 40% formaldehyde, 10% 1M CaCl2, 80% ddH20), dipped in cold acetone, 
immersed in chloroform/acetone (1:1) for 5min at -20°C, dipped in cold acetone and 
washed twice in PBS. Sections were then stored at -70°C.
2.2.5.4 Preparation o f  rat anti-HA polyclonal antisera
To obtain primary antibody specific for the HA antigen, one adult male Wistar rat was 
anaesthetised with halothane and inoculated on both rear flanks with 500 HAU of
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influenza virus (section 2.2.3) preparation mixed with Freunds incomplete adjuvant 
(Sigma). Three weeks later, the rat was given a booster inoculation with the same 
mixture followed by two more boosts two weeks apart. Five days following the final 
boost, the rat was anaesthetised with chloroform and exsanguinated. The blood 
obtained was centrifuged in a benchtop micro fuge at 13 000 g for 5 min and the serum 
removed and stored at -20°C. The antibody titre specific for the HA antigen was 
measured by ELISA (section 2.2.4.1).
2.2.5.5 Immunofluorescence for influenza HA or myxoma virus localisation 
Frozen tissue sections were blocked overnight at room temperature in 3% BSA (bovine
serum albumin; Sigma) in PBS and washed once with 1% BSA/PBS, followed by three 
washes with 0.01% Tween 20 in PBS. Sections were placed in a humidified container 
and covered with 100^1 of 1:50 rat anti-HA (section 2.2.5.4) or 1:200 mouse anti-
myxoma virus monoclonal antibody (clone number 3B6E4, (Fountain et al., 1997)) in 
1% BSA/PBS. Controls of pre-immune rat serum, normal mouse-ascites fluid and no 
primary antibody were included. Sections were incubated for 2 hours at 37°C and 
washed again as above. 75^1 of either mouse-absorbed anti-rat IgG (1:100) or goat anti-
mouse IgG (1:100), both conjugated to FITC (Silenus) in 1% BSA/PBS was added to 
each section. The sections were incubated in the dark for 60 min at 37°C in a 
humidified container. Sections were then washed as above and mounted with Antifade 
(Molecular Probes, Oregon, USA) under a coverslip. Sections were examined with 
either a Leitz diaplan microscope and photographed using Fujichrome 400D colour 
transparency film or with a BIORAD confocal microscope with BIORAD COMOS 
software.
2.2.6. Statistical analysis of antibody and lymphocyte proliferation responses to 
infection
Significant differences in the titres of circulating serum IgM and IgG to HA and to 
myxoma virus at 10dpi following coinfection of rabbits were determined by one tailed 
Mann-Whitney U test, with a level of significance of 0.05. Differences in the numbers 
of ASC in the spleen and lymph nodes, secreting HA-specific IgM and IgG, at 10dpi 
following coinfection of rabbits were also determined by one tailed Mann-Whitney U 
test, with a level of significance of 0.05. The correlation coefficient, r, was determined
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for comparisons of serum IgM and IgG to the number of IgM or IgG secreting cells in 
either the lymph node or spleen, or the two combined, for individual rabbits. Significant 
differences in the ability of lymphocytes from Uriarra or SLS infected rabbits to respond 
to stimulation with Con A, PHA or LPS were compared between days of infection and 
between infected and uninfected rabbits by analysis of variance (ANOVA). Multiple 
pairwise comparisons of means by Tukeys test were performed on groups of means that 
were found to be significantly different by ANOVA, to determine exactly which days 
post infection were significantly different from uninfected controls (Zar, 1984).
2.3 Results
2.3.1 Humoral immune responses following coinfection of rabbits with UrHA and 
either SLS or Uriarra
2.3.1.1 Clinical observations following coinfection o f laboratory rabbits with virulent 
and attenuated viruses
Rabbits inoculated with UrHA alone developed a lesion at the primary inoculation site. 
This lesion was first evident at 3 or 4 dpi and reached a maximum diameter of 
approximately 4 cm at 8dpi. The lesion was flat, pink and in two of six infected rabbits, 
had begun to regress at 10 dpi. Mild anogenital swelling and thickening of eyelids was 
apparent in two of six infected rabbits. All rabbits remained alert and active throughout 
the period of infection.
In rabbits coinfected with UrHA and the attenuated Uriarra strain of myxoma virus, the 
primary Uriarra lesion on the right flank was evident at 3 dpi and reached a maximum 
diameter of approximately 6cm. This lesion developed a much darker colour than the 
lesion formed at the UrHA primary lesion, which reached a maximum diameter of 5-6 
cm. Rabbits developed red eyelids, and an inflamed anogenital region by 8 to 9 dpi, 
followed by thickening of the eyelids and ears, some mucopurulent discharge from the 
nose and eyes and a depressed demeanour by 10dpi. Four animals had secondary 
lesions on the face or ears by 10dpi. All rabbits survived through to 10 dpi at which 
time they were killed by intravenous barbiturate. One rabbit did not develop a lesion at 
the Uriarra inoculation site and thus it is not certain that this rabbit was inoculated 
correctly. This rabbit has been omitted from all further results.
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In rabbits coinfected with UrHA and the virulent SLS, the primary SLS lesion was 
evident at 3 dpi and reached a maximum diameter of approximately 7cm by 10dpi. This 
lesion was hard to the touch, dark purple in colour and was often surrounded by many 
smaller lesions. The lesion formed at the inoculation site of UrHA reached a maximum 
diameter of approximately 6cm. Reddened eyelids and anogenital swelling were 
evident by 6dpi, followed by thickened ears, a mucopurulent discharge from the eyes 
and nose and laboured respiration. By 10 dpi, rabbits had developed secondary lesions 
around the nose, eyes, ears, mouth, feet, and generally over the body and had a 
depressed demeanour. All rabbits survived through to 10 dpi.
On autopsy of rabbits at 10dpi, both popliteal lymph nodes, and the spleens of animals 
coinfected with UrHA and either Uriarra or SLS were 3-4 times the size of those from 
uninfected rabbits. The popliteal lymph nodes from rabbits coinfected with SLS were 
invariably purple in colour. However, the extent of this colouration varied, 
encompassing between half and the whole of the node. Lymph nodes from rabbits 
coinfected with UrHA and Uriarra were not discoloured. At 10dpi of rabbits with 
UrHA only, the popliteal lymph node regional to the UrHA inoculation site was 2-3 
times normal size with no changes in colouration, and the spleen was up to 50% 
enlarged. The contralateral popliteal lymph node was generally not enlarged compared 
to lymph nodes from uninfected rabbits.
2.3.1.2 Febrile responses to coinfection
Rectal temperatures were measured daily during the course of infection and are 
expressed as the mean -  standard error for all rabbits on each day. The mean basal 
temperature of uninfected rabbits was 38.8 -  0.3°C (n=17). The rectal temperature of 
rabbits coinfected with either Uriarra or SLS increased from 2dpi to 5dpi, but did not 
change following infection of rabbits with UrHA alone (Figure 2.1). Elevated rectal 
temperatures were maintained from 5 to 10dpi in rabbits coinfected with UrHA/Uriarra 
(n=5), attaining a maximum of 40.4 -  0.3°C (8dpi). In rabbits coinfected with 
UrHA/SLS, rectal temperatures reached a maximum of 40.3 -  0.3°C at 8dpi, but then 
declined rapidly to 38.5 -  0.3°C (n=6) at 10dpi.
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2.3.1.3 Changes in peripheral WBC counts
Blood samples from the marginal ear vein were taken every two days over the 10 days 
of infection and peripheral WBC counted. Peripheral WBC counts did not change 
substantially following coinfection of rabbits with UrHA and Uriarra, or infection of 
rabbits with UrHA alone. In contrast, coinfection of rabbits with UrHA and SLS 
resulted in a rapid increase in peripheral WBCs from 6dpi (Figure 2.2).
40.5  -
40  -
£  39.5  -
39 "
38.5  -
- ♦ -  SLS/UrHA 
—■— Uriarra/UrHA 
— UrHA
38 -
Days post infection
Figure 2.1: Daily mean rectal temperature (°C) of laboratory rabbits coinfected with 
UrHA and SLS (n=6), UrHA and Uriarra (n=5), or infected with UrHA alone (n=6). 
Error bars have been omitted for clarity.
Cellular and humoral responses to infection
- SLS/UrHA 
—m—  Uriarra/UrHA 
— UrHA
0 2 4 6 8 10
Days post infection
Figure 2.2: Peripheral white blood cell (WBC) counts in laboratory rabbits coinfected 
with UrHA and SLS (n=6), UrHA and Uriarra (n=5), or infected with UrHA alone (n=6) 
(mean -  SE).
2.3.1.4 Measurement of circulating serum antibody at 10dpi 
2.3.1.4,1 Serum antibody specific to myxoma virus
Circulating serum IgM and IgG to myxoma virus were measured by ELISA at 10dpi in 
rabbits inoculated with UrHA, or coinfected with UrHA/Uriarra or UrHA/SLS (Figure 
2.3). Serum was titrated in duplicate in 2 fold serial dilutions, with the endpoint titre 
defined as the reciprocal of the final dilution which gave a positive reading at least 0.1 
OD units above the OD of the 1:100 negative control. Differences in titres between 
groups of rabbits were tested using a one-way Mann Whitney U test. There were no 
significant differences in circulating IgM to myxoma virus at 10dpi between any of the 
treatment groups of rabbits (Figure 2.3A). The group of rabbits coinfected with 
UrHA/SLS had significantly higher levels of serum IgG to myxoma virus at 10dpi than 
the group of rabbits inoculated with UrHA alone (P<0.05) (Figure 2.3B). There were no 
significant differences in circulating IgG to myxoma virus at 10dpi between the group 
of rabbits infected with UrHA and the group coinfected with UrHA/Uriarra.
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2.3.1.4.2 Serum antibody specific to HA
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Serum IgM and IgG to HA were measured by ELISA at 10dpi in rabbits inoculated with 
UrHA, or coinfected with UrHA/Uriarra, or UrHA/SLS (Figure 2.4, Table 2.2). Serum 
was titrated in duplicate in 2 fold serial dilutions. The endpoint titre was defined as the 
reciprocal of the final dilution giving a positive result at least 0.1 OD units above the 
OD of the 1:100 negative control. Differences in titres between groups of individual 
rabbits were tested using a one-way Mann Whitney U test. There were no significant 
differences in IgM titres between any of the groups of animals infected (Figure 2.4A). 
The group of rabbits coinfected with UrHA/SLS, and the group coinfected with 
UrHA/Uriarra, had significantly depressed levels of circulating IgG to HA at 10dpi 
compared to the group of rabbits inoculated with UrHA alone (PO.05) (Figure 2.4B).
2.3,1.5 Proportion o f  B cells secreting specific IgM  and IgG to HA at 10dpi in the 
popliteal lymph node and spleen
The proprotion of B cells secreting specific IgM or IgG to HA at 10dpi in the spleen and 
popliteal lymph node of infected rabbits was determined by ELISPOT. Differences in 
numbers of positive cells between groups were tested using a one-way Mann Whitney-U 
test (Table 2.2). The group of rabbits coinfected with UrHA/Uriarra had significantly 
lower numbers of cells secreting IgM and IgG in both the popliteal lymph node and 
spleen when compared to the group of rabbits inoculated with UrHA alone (P<0.05) 
(Figure 2.5; 2.6). The group of rabbits coinfected with UrHA/SLS also had 
significantly lower numbers of IgM and IgG secreting cells in the spleen but not the 
popliteal lymph node, compared to the group of rabbits inoculated with UrHA alone 
(Figure 2.5; 2.6). However, of the group of rabbits coinfected with SLS, one animal 
(identification number 197) produced considerably more IgM and IgG antibody 
secreting cells (ASC) in the popliteal lymph node than the other five animals in that, or 
any other, group. The omission of this animal from analysis resulted in a significant 
decrease in the number of both IgM and IgG ASC in the lymph node compared to 
animals infected with UrHA alone (Figure 2.5). There was no correlation between 
circulating serum IgM or IgG with the number of IgM or IgG ASC in the lymph node or 
spleen, or both combined, within individual rabbits (test of correlation coefficient, r).
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Figure 2.3: ELISA IgM (A) and IgG (B) to myxoma virus at 10dpi. Rabbits were 
infected with UrHA alone (n=6) and with UrHA on one flank and coinfected on the 
opposite flank with Uriarra (Ur/UrHA, n = 5) or SLS (SLS/UrHA, n = 6). Serum from 
10dpi was diluted in duplicate in 2 fold serial dilutions, where 1 = 1:50. The endpoint 
titre was defined as the final dilution which was positive at least 0.1 OD units above the 
OD of the 1:100 negative control. Each column represents the titre for an individual 
rabbit.
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Figure 2.4: ELISA IgM (A) and IgG (B) to HA at 10dpi. Rabbits were infected with 
UrHA alone (n = 6) or with UrHA on one flank and coinfected on the opposite flank 
with Uriarra (Ur/UrHA, n = 5) or SLS (SLS/UrHA, n = 6). Serum from 10dpi was 
diluted in duplicate in 2 fold serial dilutions, where 1 = 1:50. The endpoint titre was 
defined as the final dilution which was positive at least 0.1 OD units above the OD of 
the 1:100 negative control. Each column represents the titre for an individual rabbit.
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Figure 2.5: Antibody Secreting Cells (ASC) per 106 lymphoid cells from the popliteal 
lymph node of rabbits adjacent to the UrHA inoculation site, secreting specific IgM 
(A) and IgG (B) to HA at 10dpi, measured by ELISPOT. Rabbits were infected with 
UrHA on the left flank (UrHA, n = 6). Rabbits were coinfected on the right flank with 
either Uriarra (Ur/UrHA, n = 5) or SLS (SLS/UrHA, n = 6). Each column represents 
the triplicate sample from an individual rabbit (^SE). 1747 refers to the number of 
ASC for rabbit number 197 which was off the scale.
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Figure 2.6: Antibody Secreting Cells (ASC) per 106 lymphoid cells from the spleen of 
rabbits, secreting specific IgM (A) and IgG (B) to HA at 10dpi, measured by 
ELISPOT. Rabbits were infected with UrHA on the left flank (UrHA, n = 6). Rabbits 
were coinfected on the right flank with Uriarra (Ur/UrHA, n = 5) or SLS (SLS/UrHA, 
n = 6). Each column represents the triplicate sample from an individual rabbit (^SE). 
1540 refers to the number of ASC for that individual rabbit which was off the scale.
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Table 2.2: Significant differences in specific IgM or IgG responses (Mann
Whitney U test, P<0.05) to HA at 10dpi measured by ELISA or ELISPOT 
between groups of rabbits infected with Uriarra and UrHA (Ur/UrHA), SLS and 
UrHA (SLS/UrHA) or UrHA alone. (ND) no difference, (L) significantly less 
than. (*) indicates significance when rabbit 197 (identification number) was 
omitted from the analysis (see 2.3.1.4).
ELISA ELISPOT
Lymph Node Spleen
Ur/UrHA with 
respect to UrHA 
IgM ND L L
IgG L L L
SLS/UrHA with 
respect to UrHA 
IgM ND ND/L* L
IgG L ND/L* L
SLS/UrHA with 
respect to Ur/UrHA 
IgM L ND L
IgG L ND L
2.3.1.6 Expression of HA and myxoma virus antigens at 10dpi
To determine whether UrHA replication was suppressed by coinfection, EA expression
was examined in cells of the primary UrHA skin lesion, the draining lymph node and 
spleen of infected rabbits by indirect immunofluorescence. This provided an indirect 
estimate of UrHA replication. At 10dpi, HA was expressed in the lesions at the UrHA 
inoculation site in animals inoculated with UrHA alone and following both attenuated 
and virulent coinfections. The HA antigen was expressed in epidermis, apparently on 
the surface of cells (Figures 2.7A and C). There were no differences in the intensity of
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fluorescence in any of these sections suggesting that expression of HA was not reduced 
by the coinfection strategy. Myxoma virus antigen was also detected by 
immunofluorescence in the epidermis of lesions (data not shown). In the popliteal 
lymph node adjacent to the UrHA inoculations site from all infections, HA antigen was 
detected by immunofluorescence at 10dpi, on the surface of lymphocytes in the 
paracortex. The number of lymphocytes expressing HA was low, at approximately one 
to five positive cells per 60mm2 of tissue (Figures 2.7B and D). HA antigen was 
detected on the surface of lymphocytes in the spleen of only one animal.
2.3.2 Modulation of lymphocyte proliferation in response to in vitro mitogen 
stimulation
2.3.2.1 Lymphocyte proliferation assays
At 10dpi, lymphoid cell cultures from the spleen and popliteal lymph node of rabbits 
from the coinfection experiments were stimulated with the mitogen Con A for 24 hours 
and the subsequent incorporation of 3H-T into DNA measured as an index of cell 
proliferation. Figure 2.8 presents the Con A-induced proliferation response of 
lymphocytes from individual rabbits (mean of triplicate samples -  SE), and the pooled 
background level of cell proliferation without mitogen stimulation (no Con A) for all 
rabbits infected with either UrHA, UrHA/Uriarra, or UrHA/SLS, and uninfected rabbits. 
Cells from the lymph node and spleen of rabbits infected with UrHA alone (n=6) 
incorporated very high levels of 3H-T, greater than 2 x 105 cpm (counts per minute). 
Incorporation of 3H-T by lymphocytes from rabbits coinfected with UrHA/Uriarra (n=5) 
was not different to that from uninfected rabbits (n=4). Lymphocytes from rabbits 
inoculated with UrHa/SLS (n=6) did not respond to mitogenic stimulation. In each 
group of infected animals, the mean cpm from the lymph node was 1.5 to 6 fold greater 
than from the spleen.
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Figure 2.8: Con A stimulation of lymphocytes from the (A) regional lymph node and (B) 
spleen of individual rabbits infected with UrHA (n=6), UrHA and Uriarra (n=5) or UrHA 
and SLS (n=6) (mean ± SE of triplicate samples). Lymphocyte proliferation was measured 
from uninfected rabbits (n=4) as controls. Lymphocytes were stimulated with Con A, and 
the incorporation of j^HJthymidine into proliferating cells measured in counts per minute 
(CPM). Controls of lymphocytes cultured without Con A were included for each rabbit, 
and are given as the mean of all rabbits for each group of infected rabbits (mean ± SE). A 
significant decrease in lymphocyte proliferation was seen in the SLS/UrHA group 
compared to uninfected rabbits (P<0.05, Mann-Whitney U test).
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2.3.2.2 Lymphocyte proliferation responses to mitogen following single infection o f  
rabbits with SLS or Uriarra
Significant suppression of the mitogen-induced proliferation of lymphocytes from 
rabbits coinfected with SLS was shown at 10dpi in the previous experiment. However, 
this suppression was potentially complicated by the infection of rabbits with two 
viruses. To refine these measurements, mitogen-induced proliferative responses of 
lymphocytes was examined in rabbits infected with either SLS or Uriarra at 4, 7 and 
10dpi. These responses were measured from the lymph node draining the inoculation 
site of the hind foot so that the opposite popliteal lymph node could be used as a control. 
The design of these experiments was set up to take into account the variation in 
responses observed during the coinfection experiments to give statistical validity using 
an outbred population of rabbits. This variation included day to day variation in the 
proliferation assay, and the variable responses of individual rabbits as the lymphocytes 
from some normal control rabbits are not responsive to mitogen stimulation.
2.3.2.2.1 Statistical analysis of lymphocyte proliferation resp onses
To standardise variation between rabbits and between assays, rabbits were infected with
virus in a random block design, which enabled the treatment of variation at two levels or
strata; comparing the effect of day of killing, and the effect virus infection had at each
time post infection (4, 7 or 10dpi). Non-parametric analysis is often regarded as less
stringent than parametric analysis. To achieve statistical significance in a parametric
test, direct comparisons between effects of infection with virulent and attenuated
myxoma viruses were not incorporated into the experimental design. This was so that
the sample size (n) could be as large as possible to effectively determine if the
individual viruses had an effect outside the sources of variation. However, this
comparison between the effect of virulent and attenuated myxoma virus was made a
posteriori by ANOVA.
The statistical analysis used and the parameters measured are summarised in Table 2.3, 
and critical F values from ANOVA are provided in Table 2.4. One output of ANOVA 
is the least significant difference, which is the error bar displayed for Figure 2.9 to 
Figure 2.14 inclusively. The least significant difference is not a description of variation 
of the original measurements of CPM which are shown on the y-axis, but rather an
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indication of variation across the entire experiment incorporating both strata of analysis 
(day of killing and effect of virus infection) and is based on log transformed data.
Table 2.3: Statistical tests used to determine significant effects of virulent and 
attenuated myxoma virus infection on the in vitro proliferation of rabbit 
lymphocytes infected in vivo.
Statistical test Parameters measured
Two-way ANOVA • effect of day of killing
* effect of virus infection at each 
individual time post infection (4, 7 or 
10dpi)
Tukey test • multiple pairwise comparison of means
to determine which time points are 
significantly different from uninfected 
controls
Multi-variate ANOVA • comparison of significant effects
between virulent and attenuated myxoma 
virus infection
2.3.2.2.2 Proliferative responses of lymphocytes from rabbits infected with Uriarra or 
SLS
Con A-induced proliferation of lymphocytes from the draining lymph node of rabbits 
infected with SLS was significantly suppressed at 4dpi and 10dpi, but not at 7dpi 
compared to that of uninfected rabbits (Figure 2.9 A). Proliferation of lymphocytes, in 
response to Con A, from the contralateral lymph node was suppressed at 7dpi, but not at 
4dpi or 10dpi, compared to that from uninfected rabbits (Figure 2.9 B). PHA-induced 
proliferation of lymphocytes from the draining lymph node of rabbits infected with SLS 
was significantly suppressed at 4dpi and 10dpi, but not at 7dpi. At 7dpi, PHA-induced 
lymphocyte proliferation from these rabbits was significantly greater than at 4dpi 
(Figure 2.10 A). Proliferation of lymphocytes in response to PHA stimulation from the 
contralateral lymph node was significantly decreased at all time points of 4, 7 and 10dpi 
compared to that from uninfected rabbits (PO.05) (Figure 2.10 B).
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Lymphocytes from the draining or contralateral lymph nodes of SLS infected rabbits 
responded to stimulation with LPS at the same level as those from uninfected rabbits at 
all time points post infection (Figure 2.11).
Following infection of laboratory rabbits with Uriarra, lymphocytes harvested from the 
lymph nodes at 4, 7 or 10 dpi had no significant decrease in the incorporation of 3H-T 
following Con A (Figure 2.12) or PHA stimulation (Figure 2.13) compared to 
lymphocytes from nodes of uninfected rabbits.
Following LPS stimulation of lymphocytes from Uriarra infected rabbits, there was no 
significant difference in the incorporation of 3H-T into DNA of cells from the draining 
or contralateral lymph nodes compared to that of stimulated lymphocytes from the 
nodes of uninfected rabbits. At 10dpi, there was a trend towards an increased level of 
proliferation, although this was not significantly greater than that from uninfected 
rabbits at a probability level of 0.05 (Figure 2.14).
The effect of infection of rabbits with SLS on Con A- and PHA-induced proliferation of 
lymphocytes from both the draining and contralateral lymph node was significantly 
different from infection with Uriarra (P<0.05) (Table 2.4). There was no significant 
difference in LPS-induced proliferation of lymphocytes between rabbits infected with 
SLS or Uriarra.
Table 2.4: Obtained F values following statistical analysis by ANOVA of
mitogen-stimulated proliferation of lymphocytes from the draining and 
contralateral lymph nodes of laboratory rabbits. An asterix indicates a significant 
value at a probability level of 0.05. The critical F value (F 005 (1)314) was 3.34.
Con A PHA LPS
SLS Uriarra SLS Uriarra SLS Uriarra
Draining 
lymph node
8.186* 2.264 15.447* 2.99 1.447 3.105
Contralateral 
lymph node
5.458* 3.735* 9.845* 2.62 0.529 3.22
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Figure 2.9: Con A stimulation of lymphocytes from the (A) draining and (B)
contralateral popliteal lymph nodes of laboratory rabbits infected with SLS. Four SLS 
infected rabbits were killed at each of 4, 7 and 10dpi, the lymphocytes from lymph 
nodes stimulated with Con A, and the incorporation of [3H]thymidine into proliferating 
cells measured in counts per minute (CPM). Control rabbits were injected with PBS, 
with two rabbits killed at each time point, and the data pooled. A significant decrease in 
lymphocyte proliferation compared to uninfected rabbits is indicated (at P<0.05). Error 
bar represents the least significant difference derived from ANOVA.
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Figure 2.10: PHA stimulation of lymphocytes from the (A) draining and (B)
contralateral popliteal lymph nodes of laboratory rabbits infected with SLS. Four SLS 
infected rabbits were killed at each of 4, 7 and 10dpi, the lymphocytes from lymph 
nodes stimulated with PHA, and the incorporation of [3H]thymidine into proliferating 
cells measured in counts per minute (CPM). Control rabbits were injected with PBS, 
with two rabbits killed at each time point, and the data pooled. A significant decrease in 
lymphocyte proliferation compared to uninfected rabbits is indicated (at P<0.05). Error 
bar represents the least significant difference derived from ANOVA.
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Figure 2.11: LPS stimulation of lymphocytes from the (A) draining and (B)
contralateral popliteal lymph nodes of laboratory rabbits infected with SLS. Four SLS 
infected rabbits were killed at each of 4, 7 and 10dpi, the lymphocytes from lymph 
nodes stimulated with LPS, and the incorporation of [3H]thymidine into proliferating 
cells measured in counts per minute (CPM). Control rabbits were injected with PBS, 
with two rabbits killed at each time point, and the data pooled. Error bar represents the 
least significant difference derived from ANOVA.
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Figure 2.12: Con A stimulation of lymphocytes from the (A) draining and (B)
contralateral popliteal lymph nodes of laboratory rabbits infected with Uriarra. Four 
Uriarra infected rabbits were killed at each of 4, 7 and 10dpi, the lymphocytes from 
lymph nodes stimulated with Con A, and the incorporation of ['HJthymidine into 
proliferating cells measured in counts per minute (CPM). Control rabbits were injected 
with PBS, with two rabbits killed at each time point, and the data pooled. Error bar 
represents the least significant difference derived from ANOVA.
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Figure 2.13: PHA stimulation of lymphocytes from the (A) draining and (B)
contralateral popliteal lymph nodes of laboratory rabbits infected with Uriarra. Four 
Uriarra infected rabbits were killed at each of 4, 7 and 10dpi, the lymphocytes from 
lymph nodes stimulated with PHA, and the incorporation of [3H] thymidine into 
proliferating cells measured in counts per minute (CPM). Control rabbits were injected 
with PBS, with two rabbits killed at each time point, and the data pooled. Error bar 
represents the least significant difference derived from ANOVA.
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Figure 2.14: LPS stimulation of lymphocytes from the (A) draining and (B)
contralateral popliteal lymph nodes of laboratory rabbits infected with Uriarra. Four 
Uriarra infected rabbits were killed at each of 4, 7 and 10dpi, the lymphocytes from 
lymph nodes stimulated with LPS, and the incorporation of [3H]thymidine into 
proliferating cells measured in counts per minute (CPM). Control rabbits were injected 
with PBS, with two rabbits killed at each time point, and the data pooled. Error bar 
represents the least significant difference derived from ANOVA.
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2.3.2.3 Histological observations of the spleen and popliteal lymph node
At 10dpi, lymph nodes from rabbits infected with UrHA alone or coinfected with 
UrHA/Uriarra, showed both B- and T-cell dependent areas densely populated with 
lymphocytes and pronounced germinal centre formation, indicative of a functioning 
immune response. Lymph nodes contained few neutrophils (Figure 2.15 A). In 
contrast, lymph nodes from laboratory rabbits coinfected with SLS were extensively 
depleted of lymphocytes. However, even at this advanced stage of disease, parts of the 
lymph node from SLS coinfected rabbits appeared relatively normal with some B- and 
T-dependent areas being well populated with lymphocytes. More specifically, losses of 
lymphocytes were consistently evident at the periphery of the nodes between the 
germinal centres. The germinal centres themselves also had obvious losses of 
lymphocytes, predominantly from the outer edges of the germinal centre and the side 
opposite the subcapsular sinus. Within germinal centres, high numbers of nuclear 
fragments were present. In addition, lymph nodes from SLS coinfected rabbits 
contained large numbers of neutrophils distributed throughout the nodes, particularly in 
areas of extensive lymphocyte depletion (Figure 2.15 B)
The histology of the spleen from rabbits spleens from UrHA infected, or UrHA/Uriarra 
coinfected, rabbits contained well defined germinal centres (Figure 2.15 C). The spleen 
from rabbits coinfected with UrHA/SLS at 10dpi did not appear markedly different to 
that from uninfected rabbits. There was little evidence of loss of lymphocytes from the 
white pulp. However, there was also little evidence of the expansion of lymphocyte 
populations or the extensive development of germinal centres in these spleens (Figure 
2.15 D).
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The suppression of cellular and humoral immune responses has been examined 
extensively following infection of laboratory rabbits with two viruses that are closely 
related to myxoma vims, namely malignant rabbit vims and Shope fibroma vims 
(Strayer, 1992). The study described in this Chapter aimed to determine if suppression 
of immune functions could be demonstrated following infection of rabbits with myxoma 
vims, and if such suppression was a function of vimlence. To achieve this, two strains 
of myxoma vims were used; the highly vimlent SLS and the naturally attenuated 
Uriarra, both of which cause clinical myxomatosis in rabbits, but only SLS is uniformly 
lethal (Fenner and Marshall, 1957; Fountain et al., 1997). The main findings were that 
firstly, mitogen induced proliferation of T-lymphocytes from rabbits infected with 
vimlent vims was suppressed. Infection of rabbits with vimlent myxoma vims also 
resulted in a rapid decline in rectal temperature from 8dpi, a rapid increase in peripheral 
WBC counts from 6dpi, a lack of germinal centre formation in lymph nodes and the 
spleen, and the extensive depletion of lymphocytes from lymph nodes by 10dpi. These 
responses to infection were all functions of vims vimlence, as they were not observed 
following infection of rabbits with attenuated myxoma vims. Humoral responses were 
also affected by infection with myxoma vims. IgG fibres to a coexpressed antigen 
(influenza HA) were suppressed in rabbits coinfected with either SLS or Uriarra. 
However, IgG titres to myxoma vims were strikingly higher in rabbits coinfected with 
SLS compared to Uriarra.
Vimlent myxoma vims suppressed the in vitro proliferative responses of T-cells from 
lymph nodes of infected rabbits to stimulation with either Con A and PHA. In the 
draining lymph node, significant suppression was measured at 4dpi, well before the 
development of clinical illness. There was some recovery at 7dpi but suppression was 
significant again at 10dpi. Suppression at 10dpi was associated with pathological 
changes in lymph nodes, including the loss of lymphocytes and the infiltration of large 
numbers of inflammatory cells. Suppression of T-cell proliferation in vitro was also 
observed in cells from the contralateral lymph node of SLS-infected rabbits at 7dpi. In a 
separate series of experiments, suppression was observed in cells from the popliteal 
lymph node and spleen of rabbits coinfected with UrHA and SLS at 10dpi (the only 
timepoint examined). In contrast, infection of rabbits with the attenuated Uriarra strain
Cellular and humoral responses to infection
70
of myxoma vims did not cause significant suppression of mitogen-induced T-cell 
proliferation at any time post infection, and did not cause pathological changes in the 
lymph nodes at 10dpi. This suggests that these responses are functions of vims 
virulence.
Strayer et al. (1983) showed that suppression of Con A- and anti-immunoglobulin- 
driven proliferation of lymphocytes from the spleen of rabbits infected with malignant 
rabbit vims was first apparent at 7dpi, with partial recovery of proliferation at 11dpi 
(Strayer et al., 1983b). The experiments are not directly comparable with mine as 
myxoma vims is likely to reach the draining lymph node earlier than the spleen. The 
more direct comparison between the results of Strayer et al. and those presented here 
may be the contralateral lymph node where suppression was observed at 7dpi, with 
some recovery at 10dpi.
Two mechanisms of suppression of lymphocyte function have been proposed for 
malignant rabbit vims. These are the direct replication of vims in lymphocytes (Strayer 
and Leibowitz, 1986; Strayer et al., 1985) and the virus-induced production of soluble 
suppressive factor(s) by infected lymphocytes (Strayer et al., 1988). The close genetic 
relatedness between malignant rabbit vims and myxoma virus suggests that mechanisms 
of suppression induced by myxoma vims may be similar. At this stage, the viral 
proteins responsible for this suppression have not been clearly identified for malignant 
rabbit vims. However, transformation of Shope fibroma virus with fragments of 
malignant rabbit vims DNA have led to the implication of a putative viral transcription 
factor in virus-induced effects on lymphocytes (Strayer and Mathew, 1993). Myxoma 
virus-induced suppression of lymphocyte responsiveness was clearly a function of 
virulence, however, there is no indication that Uriarra replicates less efficiently in lymph 
nodes compared to SLS (Fenner and Ratcliffe, 1965). In other experiments in our 
laboratory, the generation of suppressive factors by lymphocytes infected with myxoma 
vims in vitro could not be demonstrated (Cartledge, 1995).
Suppression of ConA induced T-cell proliferation may operate through the inhibition of 
crosslinking of cell surface antigens. Myxoma virus specifically downregulates CD4 
(Barry et al., 1995) and MHC class I (Boshkov et al., 1992) surface antigens of infected 
cells, and such downregulation of these and other surface molecules could reduce the
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number of surface antigens available for Con A-induced crosslinking. However, 
malignant rabbit virus infection of lymphocytes does not alter Con A-binding or Con A- 
stimulated capping (Strayer et al., 1983b), although this virus also downregulates MHC 
class I surface antigens (Boshkov et al, 1992). An alternative explanation is that viral 
infection of rabbits may result in lymphocyte anergy due to the partial activation of T- 
cells in the absence of costimulatory signals such as IL-2. Malignant rabbit virus- 
infected lymphocytes are defective in the production of, and the ability to respond to, 
IL-2 (Strayer et al, 1986), the main T-cell growth factor induced in Con A-induced T- 
cell proliferation.
Further insights into possible mechanisms of virus-induced suppression of lymphocyte 
proliferation can be drawn from other systems of virus infection. Measles virus 
infection of peripheral blood lymphocytes in vitro causes suppression of lectin-induced 
proliferation of uninfected lymphocytes through contact between uninfected- and 
infected-cells. This required cell surface expression of both the F and H measles virus 
glycoproteins by infected cells (Schlender et a l, 1996). This contact appears 
independent of the production of soluble suppressive factors, and results in partial 
activation of cells followed by cell cycle arrest with a reduced capacity of uninfected 
lymphocytes to release or respond to IL-2 (Schnorr et al., 1997). A second strategy of 
virus-induced immune suppression is the production of immunomodulatory proteins. 
African swine fever virus (ASFV) encodes a protein, A238L, that inhibits activation of 
both nuclear factor kappa B (NF-KB) (Powell et al, 1996) and nuclear factor of 
activated T cells (NFAT) (Miskin, 1998), and hence the gene transcription of host-cell 
immunoregulatory proteins. Such a protein has not been demonstrated for myxoma 
virus or malignant rabbit virus, although both viruses produce proteins that function to 
modulate the host immune response (McFadden, 1995).
As well as suppression of T-cell responsiveness, coinfection of rabbits with SLS 
resulted in suppression of IgG titres to an unrelated antigen (HA) expressed by the 
recombinant UrHA myxoma virus. Paradoxically, this was accompanied by the 
development of greater anti-myxoma virus IgG titres compared to coinfection with 
Uriarra. Although the experimental systems are quite different, similar results follow 
the infection of rabbits with malignant rabbit virus, which suppressed the generation of
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specific antibody responses to an unrelated antigen (SRBC) inoculated at 4dpi, although 
rabbits developed substantial virus-neutralising antibody titres before death (Strayer and 
Leibowitz, 1987a). Serum antibody is normally regarded as having little role in 
recovery from poxvirus infections. Strayer and Leibowitz (1987a) have suggested that 
antibody may be involved in clearance of malignant rabbit virus from the spleen by 
opsonisation and phagocytosis. However, these rabbits die despite the high neutralising 
titres. The fact that rabbits infected with virulent myxoma vims developed high anti-
viral serum IgG titres by 10dpi suggests that the production of anti-viral antibody has 
little positive effect on the outcome of myxoma vims infection.
The mechanism of myxoma vims-induced modulation of antibody responses is unclear. 
HA-specific antibody production may be suppressed if, during coinfection of rabbits, 
growth of vimlent myxoma vims is more efficient than that of attenuated vims and 
suppresses the growth of UrHA and thus the expression of HA. This was not supported 
by immunofluorescence specific for the HA antigen, as HA was expressed on the 
surface of epidermal cells in the primary UrHA lesion at 10dpi with either the vimlent 
or attenuated coinfections. HA antigen was also present on the surface of lymphocytes 
in the draining lymph node following coinfection with SLS, showing that UrHA did 
reach the draining lymph node during this coinfection; it was also associated with 
lymphocytes of the spleen.
If direct suppression of HA antigen production is not the cause of decreased antibody 
production, then it is possible that T-cell responses are critical. The specific production 
of serum IgG to HA is reduced by infection with vimlent myxoma vims which may 
suggest that T-cells involved in isotype switching of antibody are not effective (Spriggs 
et a i, 1992a). In support of this, germinal centre development in the lymphoid organs 
of rabbits infected with vimlent myxoma vims is inhibited. Germinal centres are the 
principal sites of isotype switching and affinity maturation of antibody and their 
development requires a ß T-cell help (Liu and Arpin, 1997). As already discussed, T- 
cell proliferation in vitro is suppressed by myxoma vimlent myxoma vims infection in 
vivo.
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In the face of the suppressed IgG response to HA, the increased production of IgG 
specific for myxoma virus appears paradoxical. Increased anti-viral IgG may be the 
result of a downregulation of TH1 T cell responses by virulent myxoma virus, and a 
consequent upregulation of TH2 T cell responses. This would result in upregulation of 
humoral immune responses and a downregulation of CTL responses, which are known 
to be critical in the control of many poxvirus infections (Buller and Palumbo, 1991; 
Karupiah et al., 1996). Indeed, myxoma virus is known to produce specific proteins 
that bind and inhibit TH1 associated cytokines, particularly IFN7 (Mossman et al., 
1995a; Upton et al., 1992).
It is possible that the humoral response in coinfections represents a form of antigenic 
competition. However, a conventional mechanism for this during myxoma virus 
coinfection is unclear. Antigenic competition is described as the inhibition of the 
humoral immune response to one antigen by the introduction of a second antigen or 
determinant that is thought to compete for recognition by T-cell receptors (Guery et al., 
1993; Lakey et al., 1986; Taussig, 1973). The conditions under which antigenic 
competition is most pronounced are when the antigens are structurally similar, the 
antigen to which the response is suppressed is introduced one to seven days after the 
first antigen, the dosage of the first antigen is greater than the second and the antigens 
are introduced into the same site (Adorini and Nagy, 1990; Babbitt et al., 1986; Pross 
and Eidinger, 1974). A particular example is the antibody responses to bacterial pili 
subtypes administered as vaccines (Hunt et al., 1995). The conditions described are not 
very similar to those in this experiment although the coinfection experiments may 
provide suitable conditions for antigenic competition through the inoculation of rabbits 
with replicating viruses that specifically disseminate to sites of antibody production 
(lymph nodes and spleen).
A third explanation for the alteration of humoral immune responses by virulent myxoma 
virus is through the generation of T-cell independent (TI) antibody responses. Viruses 
with highly repetitive epitopes, such as those of the glycoprotein of vesicular stomatitis 
vims (VSV), can extensively crosslink B-cell receptors. This results in in the a P T cell- 
independent activation of B-cells and the production of virus-specific IgM and IgG 
(Bachmann and Zinkemagel, 1996; 1997) in the absence of germinal centre formation
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(Maloy et al., 1998). Polyomavirus infection of T-cell-deficient mice induced TI 
isotype switching from IgM to IgG, also without the formation of germinal centres in 
lymph nodes (Szomolanyi-Tsuda et al., 1998). Interestingly, the co-administration of 
live virus and repetitive virus like-particles (VPLs) resulted in IgG production specific 
for the virus but not the VLPs, indicating that live virus was required to elicit the 
response (Szomolanyi-Tsuda et al., 1998). Myxoma virus-specific IgG production may 
be a TI event, with a higher local concentration of antigen due to the potential greater 
growth of virulent myxoma virus resulting in greater IgG production (Szomolanyi- 
Tsuda et al., 1998). In contrast, HA-specific IgG production may require the help of T- 
cells. It is possible that the suppressed T-cell responses in rabbits infected with virulent 
myxoma virus favours this outcome. TI antibody production does not occur in mice 
infected with vaccinia virus (Bachmann and Zinkemagel, 1996). However, myxoma 
virus is more lethal to rabbits than vaccinia virus is to mice and the regulation of 
immune responses to infection may differ substantially between both rabbits and mice, 
and between the different viruses.
The suppression of T-cell responsiveness, lymphocytotoxicity in vivo and generation of 
high anti-viral antibody titres by virulent myxoma virus in contrast to attenuated 
myxoma virus appear to be critical to the outcome of infection. Laboratory rabbits 
infected with SLS die within 10-14 dpi whereas laboratory rabbits infected with Uriarra 
develop severe clinical disease but survive infection. Previous experimental data 
(Fenner and Ratcliffe, 1965) suggests little difference in titres of SLS or Uriarra in 
draining lymph nodes. However, the results in this Chapter suggest a critical difference 
at this level. It is likely that interactions between rabbit lymphocytes and myxoma virus 
in vitro will strongly resemble the paradigms described for malignant rabbit virus in 
vitro. However, these events have not been examined in detail for myxoma virus in 
vivo. In particular, histological observations showed extensive lymphocytotoxicity in 
vivo for myxoma virus (although not for malignant rabbit virus) but the virus does not 
appear lymphocytoxic in vitro (Barry et al., 1997; Macen et al., 1998; Macen et al., 
1996a; Macen et al., 1996b; Mossman et al., 1996a; Petit et al., 1996; Strayer et al., 
1985). In the succeeding Chapters, the replication of SLS and Uriarra in vivo and the 
cells infected will be investigated. The results obtained with virulent versus attenuated 
infection of laboratory rabbits with no resistance to myxoma vims suggest that infection 
of resistant rabbits may mimic that of laboratory rabbits infected with attenuated vims.
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These relationships between laboratory and wild rabbits infected with virulent or 
attenuated myxoma vims will be explored.
Cellular and humoral responses to infection
Chapter 3: Replication and control of
myxoma virus in European rabbits
3. Replication and control of myxoma virus in European rabbits
3.1 Introduction
In the years following the introduction of myxoma virus into the Australian wild rabbit 
population, two closely linked events were described. Firstly, the predominant strains of 
virus in the field were less virulent than the originally introduced SLS, with most field 
strains isolated being of the attenuated grade El or IV phenotype. This was due to the more 
efficient transmission of attenuated virus strains. The emergence of attenuated field strains 
of myxoma virus, which allowed the survival of over 10% of infected rabbits in the field, 
was probably directly responsible for the rapid selection for rabbits genetically resistant to 
myxomatosis (Marshall and Fenner, 1958). While a considerable amount of molecular 
analysis has been performed on myxoma virus, very little has been done concerning the 
differences between the pathogenesis of virulent and attenuated strains of virus, and there is 
nothing known of the mechanism of resistance of wild rabbits to myxomatosis.
In Chapter 2 it was shown that the ability of rabbits to mount a cellular response, indicated 
by T-cell mitogen responses in vitro, at least partially determined the outcome of infection. 
However, rabbits infected with SLS developed a strong humoral immune response to the 
virulent virus that was associated with lethal disease. These results indicated that early 
events in the immune response were important in determining the outcome of infection, but 
did not show how these events were related to virus growth and dissemination within the 
rabbit. The differences in T-cell responses from the draining lymph node and the pathology 
of the lymph nodes suggested that lymphoid tissue was critical in control of virus infection. 
In addition, the response of wild rabbits with a degree of genetic resistance to infection was 
not examined and in particular, whether resistant rabbits respond to infection with virulent 
virus in the same manner as laboratory rabbits respond to infection with attenuated virus 
was not explored.
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The basic pathogenesis of virulent myxoma virus was described for laboratory rabbits 
infected with SLS by Fenner and Woodroofe (1953). Following intradermal inoculation, 
myxoma virus initially replicated in the skin at the primary inoculation site and in the 
lymph node draining the inoculation site. Virus titres reached greater than 107 fD50 per 
gram in both of these tissues. Virus was not found free in the blood, but was detected in 
blood leucocytes from 3dpi. These are presumed to be critical for systemic spread of 
myxoma virus. Virus was also present in the spleen and lung but did not generally reach 
high titres in these tissues. Virus was first detected in an uninoculated skin site situated 
opposite to the inoculation site at 3dpi, and reached approximately 107 fD50 per gram by 
8dpi. Small, reddened swellings, or secondary lesions, in uninoculated skin were evident 
from 6dpi. Virus titre increased steadily in all affected organs during infection until a day 
or so before death when they generally declined (Fenner and Woodroofe, 1953). As 
laboratory rabbits do not recover from this infection, there have been no studies of viral 
clearance and the recovery of the rabbit. Only limited studies have been done on the 
pathogenesis of attenuated field strains of myxoma virus (Fenner et al., 1956; Fenner and 
Ratcliffe, 1965). These have predominantly focussed on the relationship between virus titre 
in the skin and virus transmission by mosquitoes, and have not examined the details of 
virus replication over time in different tissues, nor have they examined control and 
clearance of the virus (with the exception of a detailed study of the testis (Fountain et al., 
1997).
The skin is a critical tissue in myxoma virus pathogenesis, both at the inoculation site and 
at sites where secondary lesions form. The latter are particularly important sources of virus 
for transmission by mosquitoes (Fenner and Woodroofe, 1953). Lymphoid tissues, 
particularly lymph nodes, are important sites of virus replication and the initiation of 
viremia and systemic dissemination. However, it is unclear how virus replication in these 
and other tissues such as the lung, liver and/or testis, affects the outcome of infection 
(Mims, 1964). More specifically, the relative importance of individual tissues over time in 
the control of attenuated infection is not known. Similarly, nothing is known concerning 
the pathogenesis of strains of myxoma virus in wild rabbits, and which tissues are involved 
in controlling infection of wild rabbits with a virulent virus that would be lethal in
Replication and control of myxoma virus
78
laboratory rabbits.
Chapter 2 demonstrated that key differences between Uriarra and SLS occurred in the 
lymphoid tissue. These were the depletion of lymphocytes and the early suppression of 
lymphocyte responses. In this Chapter, I examine tissue responses in rabbits infected with 
attenuated or virulent vims, and compare these in laboratory rabbits which have not been 
selected for resistance with infection of wild Australian rabbits that have been subjected to 
nearly 50 years of selection. This gives the additional opportunity to re-examine WBC 
counts, and temperature and humoral responses reported in Chapter 2. This was done 
during time course experiments designed to measure vims titres in the key tissues of skin 
(at the inoculation site and elsewhere), lymph nodes (draining and contralateral), spleen, 
lung and peripheral WBC.
In developing the protocols for this study, two sets of preliminary experiments were done. 
Firstly, two sites in the skin were explored as primary inoculation sites; the thigh and the 
dorsum of the hind foot. It was necessary to identify the lymph nodes that predominantly 
drained these sites so that early interactions between the lymph nodes and vims could be 
properly examined. In particular we wanted to have a single draining lymph node so that 
the stages of vims dissemination could be accurately defined. Initial experiments indicated 
that the thigh could be used as an inoculation site. However, the vims titres at the putative 
draining lymph node were not commensurate with this being the sole draining node. 
Therefore these experiments were repeated using the foot inoculation site. The initial set of 
data is presented as well as the definitive set from the foot inoculation experiments. 
Secondly, following infection of rabbits, vims titre was to be determined in the skin. Small 
skin samples are difficult to homogenise and therefore the use of collagenase was 
investigated to assist in release of vims from the skin. A preliminary experiment was 
conducted to determine if this method could be used, and the optimal conditions for tissue 
digestion, by measuring the effect that enzyme concentration and incubation time had on 
tissue degradation and the viability of vims.
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3.2 Materials and Methods
3.2.1 Indian ink localisation of draining lymph nodes
To determine which lymph node drained the inoculation site, 500^1 of Indian ink was 
inoculated intradermally in both upper thighs or the dorsum of both feet of three laboratory 
rabbits (a total of six rabbits). At 24 hours post inoculation the rabbits were killed by an 
intravenous injection of barbiturate and the popliteal, inguinal and prefemoral lymph nodes 
excised, sliced open and examined for the presence of ink by visual observation.
3.2.2 Infection of laboratory and wild rabbits with SLS or Uriarra
Male laboratory rabbits (O. cuniculus) greater than four months of age, were inoculated
intradermally with 100 pfu of either SLS or Uriarra (virus stocks prepared as in sections
2.2.1.2 and 2.2.1.3) in the left hind thigh or the dorsum of the left hind foot. At 2, 4, 6, 8 
and 10 dpi, two rabbits inoculated with SLS and two inoculated with Uriarra in the thigh 
were killed by intravenous injection of barbiturate (a total of 10 rabbits infected with each 
virus). At 2, 4, 6 and 10 dpi, two pairs of rabbits inoculated in the dorsum of the left hind 
foot with SLS or Uriarra were killed. In addition, at 15 and 20 dpi, two rabbits inoculated 
in the hind foot with Uriarra were killed (a total of 8 rabbits infected with SLS and 12 
rabbits infected with Uriarra). Rabbits had been randomly allocated to these harvest time 
points at the time of inoculation.
In a second experiment, male wild rabbits (O. cuniculus) bred in the Gungahlin animal- 
house and greater than four months of age were inoculated intradermally with 100 pfu of 
either SLS or Uriarra in the dorsum of the left hind foot. At 2 and 4 dpi, two rabbits 
infected with each virus were killed by intravenous injection of barbiturate. At 6, 10, 15 
and 20dpi, three rabbits infected with each virus were killed (a total of 16 rabbits infected 
with each virus).
3.2.3 Tissue collection and monitoring of clinical signs
The tissues collected from these rabbits comprise the majority of material used in time- 
course experiments in this and subsequent chapters (Figure 3.1). These tissues were the 
skin at the primary inoculation site (primary lesion), the popliteal lymph node adjacent to
Replication and control of myxoma virus
80
the inoculation site (the draining lymph node), the popliteal lymph node in the leg opposite 
the inoculation site (the contralateral lymph node), spleen, lung, and a distal skin site. The 
distal skin was an uninoculated piece of skin taken from the opposite hind foot to the 
primary lesion. Approximately 25ml o f peripheral blood was taken by cardiac puncture 
into a heparinised syringe (50 units/ml heparin in ddH20 ; Sigma) immediately before 
killing each rabbit. Clinical signs of disease and rectal temperatures were recorded daily. 
Blood samples from the marginal ear vein were taken every 48 hours for peripheral and 
differential WBC counts.
Draining 
lymph node
Contralateral 
lymph node
■Primary lesionDistal skin
Figure 3.1: Schematic view of a rabbit at autopsy showing the tissues collected to examine 
virus growth. Rabbits were inoculated on the dorsum o f the left hind foot with myxoma 
virus. Rabbits were killed at various times post infection and the following tissues 
collected: the inoculation site in the skin or primary lesion formed at this site, the draining 
and contralateral lymph nodes, spleen, lung and an uninoculated site o f skin on the right 
hind foot (distal skin). 25ml of peripheral blood was also collected by heart puncture at the 
time o f death. These tissues comprise the majority o f material used in the time course 
experiments o f this and subsequent chapters.
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3.2.4 Ficoll-paque preparation of peripheral blood mononuclear cells
Peripheral anti-coagulated blood collected as described in section 3.2.3 was centrifuged at
500g for 20min at 18°C. The buffy coat of WBC was removed and mixed with an equal 
volume of PBS. Serum was also removed from the centrifuged blood sample and stored at 
-20°C for later assay for serum and neutralising antibody by ELISA and plaque-reduction 
neutralisation assay, respectively. 4ml of the diluted buffy coat in PBS was carefully 
layered over 3ml of Ficoll-Paque (Ficoll 400; Pharmacia) in a 10ml centrifuge tube. This 
was centrifuged at 400g for 20min at 18°C. The layer of mononuclear cells at the 
PBS/Ficoll-interface was removed using a Pasteur pipette. The remaining supernatant was 
discarded. The pelleted RBC/granulocytes were resuspended in shocking solution to lyse 
RBC as described for the preparation of lymphocyte samples from rabbit spleens (section 
2.2.23). The mononuclear cell and granulocyte preparations were washed twice by 
resuspending complete MEM and centrifuging at 250 g for 10min at 18°C, followed by 
resuspension in 1ml complete RPMI. These two WBC fractions were stored at -70°C for 
plaque assay on Vero cell monolayers.
3.2.5 Peripheral and differential WBC counts
Peripheral blood was taken from the marginal ear vein of rabbits every 48 hours over the 
course of infection. Peripheral white blood cell (WBC) counts were made in as in section 
2.2.2.1.1. Cell viability was separately assessed by trypan blue exclusion (0.2% trypan blue 
in ddH20). For differential WBC counts, a drop of blood taken from the marginal ear vein 
of rabbits was placed on a superfrost microscope slide. A second slide held at a 45° angle 
was used to draw the blood into a thin smear. This was allowed to air dry for 15min. 
Smears were covered with 1ml of Wright stain (CSL Diagnostics) for 30sec followed by the 
addition of 1ml of PBS. Slides were left for lmin before being washed with ddH20  and 
then running tap water. Smears were allowed to air dry and mounted under a coverslip with 
D.P.X (Difco).
3.2.6 Preparation of tissue samples for plaque assay
Throughout these procedures, all samples were kept on ice unless otherwise stated. Lymph 
nodes, spleen, lung, were trimmed to remove fat, weighed, chopped with scissors or a
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scalpel blade, and homogenised using a small pestle in a 1.5ml plastic tube. Tissue 
homogenates were suspended in complete MEM to give a 10% or 25% weight/volume 
(w/v) suspension. Suspensions were sonicated in three 5 sec cycles using a probe sonicator, 
and freeze-thawed twice. These samples were plaque assayed on Vero cell monolayers 
(section 3.2.7).
Counted WBC suspensions made from peripheral blood (section 3.2.4) were briefly 
sonicated, in two 5 sec cycles, before plaque assay on Vero cell monolayers. Preparations 
of mononuclear cells and granulocytes were assayed separately, although the results were 
pooled for each individual rabbit. Cell suspensions were assayed undiluted, at the highest 
possible volume of stock preparation. Hence, for a sample containing a total of 2 x 108 
cells in 1ml volume, a total of 8 x 107 or 400^1 was assayed on duplicate Vero cell 
monolayers.
Skin samples were treated with collagenase to facilitate homogenisation and release of 
vims. To determine optimal collagenase concentration, preliminary experiments on skin 
from uninfected rabbits spiked with vims of known titre were performed. Two 
concentrations of SLS, 1 x 103 pfu/ml and 1 x 106 pfu/ml, were mixed with either 
0.1mg/ml, lmg/ml or Omg/ml collagenase D (Boehringer Mannheim), with or without an 
uninfected block of chopped and homogenised rabbit skin piece of 1cm x 0.5cm. 
Collagenase D (catalogue number 1088 858) was chosen as it had the lowest trypsin 
activity (<0.1 U/mg) of the available collagenase preparations. Replicates of each treatment 
were incubated for 30min, 60min, or 90min at 37°C with regular agitation. Samples were 
then plaque assayed to determine if collagenase treatment or incubation time at 37°C 
reduced vims titre. Near to maximum vims titres were recovered regardless of treatment 
although treatment of tissues with 0. lmg/ml collagenase resulted in slightly better recovery 
of vims than lmg/ml (see section 3.3.1 for results of trials).
Hence, blocks of skin sample, 1cm x 0.5cm, carefully removed from equivalent areas of 
primary lesion and distal skin and shaved of hair, were washed in PBS, chopped with a 
scalpel blade, weighed and homogenised. Skin samples were then suspended in 1 ml of
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O.lmg/ml collagenase D and placed at 37°C for 90min, with agitation every 15min, 
followed by three cycles of sonication. These samples were adjusted to a standard w/v of 
10% or 25% in complete MEM and plaque assayed on Vero cell monolayers (section 
3.2.7).
3.2.7 Plaque assay of rabbit tissues and WBC samples
Plaque assays of virus were performed on Vero cell monolayers as described in section 
2.2.1.5.
3.2.8 Measurements of antibody production following infection 
3.2.8.1 Detection of anti-myxoma virus IgM and IgG
Serum samples were assayed by ELISA for myxoma virus-specific IgM and IgG, as 
described in section 2.2.4.1.
3.2.8.2 Plaque reduction neutralisation assay
Vero cells were seeded into 6 well sterile plates (Nunc) at 0.8 x 106 cells/well in complete 
MEM and grown overnight at 37°C in 5% C 02 in air to form a cell monolayer. The serum 
samples were incubated in a 56°C waterbath for 30min prior to assay to inactivate 
complement. Pre-immune and hyper-immune rabbit serum were included as negative and 
positive controls respectively. Dilutions of heat inactivated serum in complete MEM were 
mixed with an equal volume (150^1) of myxoma virus, strain SLS, to give a final virus titre 
of 1.5 x 103 pfu/ml and final serum dilutions of 1:5, 1:10, 1:15, 1:30, 1:50, 1:80, 1:100, 
1:150, 1:200, 1:300, 1:500, 1:1000, 1:2000, 1:3000, 1:4000, 1:5000, 1:6000, 1:7000, 
1:10000. Virus/serum samples were incubated for 60min in a 37°C waterbath, with a brief 
vortex every 20 min. Medium was removed from the cell monolayers leaving sufficient 
volume to cover the monolayer, and 100^1 of each dilution was added in duplicate to 
separate monolayers. The plates were incubated for 60 min at 37°C in 5% C 02 in air, 
rocking every 15 min, followed by replacement of complete MEM and incubation for 7 
days. Plaques were visualised as described in section 2.2.1.5 and counted. The neutralising 
titre was the lowest dilution (averaged over the duplicate samples) at which myxoma virus
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plaque formation was reduced by 50% or greater.
3.3 Results
Several experiments were performed to develop the protocols used in this study. These are 
described here prior to the detailed presentation of the time course of rabbit infections and 
virus replication.
3.3.1 Recovery of virus following collagenase D treatment
The effect of collagenase D (0, 0.1 or 1.0 mg/ml), incubation time at 37°C (30, 60 or 90 
min) and presence or absence of skin tissue on the recovery of myxoma virus (103 or 106 
pfu) from a myxoma virus suspension of known titre was determined by plaque assay 
(Table 3.1). None of the treatments affected virus titres greatly. However, 0.1 mg/ml 
collagenase resulted in slightly better recovery of virus than 1 mg/ml. This may be 
attributable to less trypsin present in the total sample. There was a trend towards a greater 
reduction in virus titre following treatment with collagenase when the original virus titre 
was 103 pfu compared to 106 pfu. However, the standard deviation in this assay is equal to 
the square root of the number of plaques counted, which was approximately 100. Thus the 
standard variation is around 10%, indicating that there is no difference between treatment of 
103 pfu or 106 pfu with collagenase. Incubation time at 0.1 mg/ml of enzyme did not affect 
virus titre, although the longer the skin was incubated with enzyme, the better the tissue 
degradation. Hence, 0.1 mg/ml collagenase D and 90 min incubation time was chosen to 
provide maximum breakdown of skin samples.
3.3.2 Localisation of lymph nodes that drain the primary inoculation site
To identify lymph nodes that drained the inoculation sites, Indian ink was inoculated into
the mid-thigh of laboratory rabbits, and the presence of ink in lymph nodes examined after 
8 and 24 hours. In all rabbits, the popliteal lymph node was most heavily coloured with ink 
such that it was obvious within the fat behind the knee without slicing the node open. In 2 
of 6 inoculations, the prefemoral lymph node, also positioned in the leg, was coloured with 
ink but not as intensely as the popliteal lymph node. Also in 2 of 6 cases, the inguinal
Replication and control of myxoma virus
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lymph node was lightly discoloured with ink which was observed only after slicing the 
node open. It was concluded that the mid-thigh inoculation site was drained primarily by 
the popliteal lymph node adjacent to the inoculation site, with a small amount of drainage 
occurring to the prefemoral and inguinal lymph nodes.
Table 3.1: Recovery of virus following collagenase D treatment. Myxoma virus (103 
or 106pfu) was incubated in the presence or absence of a rabbit skin sample at different 
concentrations of collagenase D and for different incubation times. Samples were then 
titred by plaque assay and titres recorded as the mean of duplicate samples.
Collagenase D concentration
Original virus titre, 
incubation time
no enzyme 0.1 mg/ml 1 mg/ml
Without rabbit 103 pfu, 30 min 1.02 x 103 0.95 x 103 0.87 x 103
skin sample
103 pfu, 60 min 0.96 x 103 1.12 x 103 0.99 x 103
103 pfu, 90 min 1.13 x 103 1.03 x 103 0.82 x 103
106 pfu, 30 min 1.28 x 106 1.33 x 106 0.77 x 106
106 pfu, 60 min 1.23 x 106 1.04 x 106 0.78 x 106
106 pfu, 90 min 0.97 x 106 1.07 x 106 0.7 x 106
With rabbit skin 103 pfu, 30 min 0.92 x 103 0.91 x 103 0.87 x 103
sample
103 pfu, 60 min 1.1 x 103 0.95 x 103 0.91 x 103
103 pfu, 90 min 1.01 x 103 0.98 x 103 0.78 x 10s
106 pfu, 30 min 1.24 x 106 1.16 x 106 0.96 x 106
106 pfu, 60 min 1.12 x 106 1.32 x 10" 0.88 x 106
106 pfu, 90 min 1.03 x 106 1.03 x 106 0.89 x 106
3.3.3 Titres of myxoma virus in laboratory rabbits following virus inoculation in the 
thigh
To compare the pathogenesis of SLS and Uriarra, lOOpfu of each virus was inoculated 
intradermally into the left hind thigh of laboratory rabbits. Virus titres were determined in
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the popliteal lymph node regional to the inoculation site, the contralateral popliteal lymph 
node, spleen and peripheral blood at 2, 4, 6, 8 and 10dpi (Table 3.2). SLS was first present 
in the spleen of one animal, and in the spleen, popliteal and contralateral lymph nodes of 
the second rabbit at 4dpi. SLS replicated to relatively low titres in the spleen, reaching a 
maximum of 4.5 x 105 pfii/g in one rabbit at 10dpi. Maximum virus titres in all tissues 
examined following SLS infection occurred from 6dpi. There was no difference in the titre 
of virus between the draining and contralateral lymph nodes. Virus was present in the 
blood of rabbits infected with SLS earlier, and reached a higher level, than during Uriarra 
infection. Uriarra was first present in the spleen of one rabbit at 4dpi. Uriarra also 
replicated to relatively low titres in the spleen, reaching a maximum of 7.6 x 103 pfii/g in 
one rabbit at 10dpi. Maximum titres in the draining and contralateral lymph nodes, spleen 
and peripheral blood following Uriarra infection occurred from 6dpi. From this time, virus 
titres were generally higher in SLS infected rabbits than in rabbits infected with Uriarra.
The virus titres of SLS in the draining lymph node following inoculation of rabbits in the 
thigh were lower and were detected later than those obtained by Fenner and Woodroofe 
(1953). Based on these studies, it was also unexpected to first detect virus in the lymph 
node and the spleen simultaneously. This suggested that virus was not draining principally 
to the popliteal lymph node. Therefore, the inoculation site in the thigh did not provide an 
optimal experimental system to examine virus dissemination. Although localisation of 
draining lymph nodes by Indian ink inoculations in the skin demonstrated that the popliteal 
lymph node predominantly drained the inoculation site, it was necessary to resolve the 
differences between these results and those of Fenner and Woodroofe (1953). In order to 
select a better inoculation site, Indian ink was inoculated intradermally into the dorsum of 
the hind foot of three rabbits and the lymph nodes subsequently examined for the presence 
of ink at 24 hours. After 5 of the 6 inoculations, the popliteal lymph node was the only 
regional lymph node that was coloured by ink. In the sixth case, the inguinal lymph node 
was lightly discoloured with ink, as observed after slicing the node open. The popliteal 
lymph node thus was the predominant lymph node draining the lower leg inoculation site.
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To confirm this result, myxoma virus was inoculated into the dorsum of a hind foot to 
determine if utilising an inoculation site that was more exclusively drained by the popliteal 
lymph node would change the kinetics of virus replication in the lymph nodes and spleen. 
Two rabbits inoculated with SLS or Uriarra were killed at 2 and 4 dpi. The virus titres 
obtained from the popliteal lymph nodes and spleen of these rabbits were similar to those 
obtained by Fenner and Woodroofe (1953) with SLS at these time points. Hence, this work 
was repeated with rabbits infected in the hind foot with SLS or Uriarra as described in 3.2 
and the results presented below.
Table 3.3: Time of onset of clinical symptoms in wild and laboratory rabbits 
following hind foot inoculation of 100 pfu of SLS or Uriarra.
Laboratory rabbits W ild rabbits
D ays
post
infection
SLS Uriarra SLS Uriarra
2 - pink inoculation site - no clinical signs - pink inoculation site - no clin ical signs
3 - pink inoculation site
4 - pink inoculation site
5 - anogenital 
inflam m ation
- inflam ed conjunctiva
6 - anogenital 
inflam m ation and 
scrotal oedem a
- inflam ed  
conjunctiva and 
watery discharge
- secondary lesion  
form ation
- anogenital 
inflamm ation and 
scrotal oedem a
- inflamed  
conjunctiva and 
watery discharge
- thickened eyelids
7 - difficulty breathing - anogenital 
inflam m ation and 
scrotal oedem a
- secondary lesions
- inflam ed  
conjunctiva
Replication and control of myxoma virus
Table 3.3 continued: Time of onset of clinical symptoms in wild and laboratory 
rabbits following hind foot inoculation of 100 pfu of SLS or Uriarra.
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L aborato ry  rabbits W ild  rabbits
D ays
po st
in fec tion
SLS U riarra SLS U riarra
9 - secondary  lesion 
form ation
- d ifficu lty  brea th ing  
in  1 o f  9 rabb its
10 - m u copu ru len t 
d ischarge
- depressed  
d em eanou r
- ex tensive  anogen ita l 
odem a
-R A B B IT S  K IL L E D
- m ucopu ru len t 
d ischarge
- d ifficu lty  brea th ing  
and  depressed  
dem eanour
- ex tensive anogenita l 
odem a
- m u copu ru len t 
d ischarge
- dep ressed  d em eanou r
- anogen ita l odem a
- secondary  lesion  
fo rm ation
- w ate ry  con junctival 
d ischarge
12 -reg ression  o f  lesions 
- d ifficu lty  b rea th ing  
in m ost rabb its
15 - secondaries over 
bo d y
- reduc tion  o f  
anogen ita l sw elling
- reduced  
m ucopu ru len t 
d ischarge
- reg ression  o f  lesions
17 - reg ression  o f  lesions
3.3.4 Clinical symptoms and gross pathology following intradermal inoculation of 
myxoma virus in the dorsum of the hind foot
Clinical symptoms are described below for rabbits inoculated in the hind foot and 
summarised at the end of the descriptions in Table 3.3 for SLS and Uriarra infected 
laboratory and wild rabbits. Clinical signs did not differ in laboratory rabbits between thigh 
and foot inoculations, nor did they differ from those described in Chapter 2. However in 
Chapter 2, autopsies were only performed at 10dpi.
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3.3.4.1 SLS infection of laboratory rabbits
At 2dpi, the primary inoculation site in the skin was pink. On autopsy, the draining lymph 
node was slightly enlarged, but all other tissues appeared normal. At 4dpi, the inoculation 
site was thickened and pink. The draining lymph node was approximately 75% enlarged in 
size (approximately 0.75cm high, 1.5cm long), and the distal skin sample was visibly 
thickened. At 5dpi, the primary lesion was approximately 1cm in diameter. At 6dpi, this 
had increased to approximately 2cm in diameter (Figure 3.2). Clinical signs other than at 
the primary inoculation site developed between 4 and 6dpi. At 6dpi, the anogenital area 
was inflamed. The conjunctivae were red and swollen and there was a clear, watery 
discharge from the eyes. The base of the ears were thickened and hot to the touch. 
Secondary lesions in the skin were evident over most of the body, including the distal skin 
site. These were small, round, red and raised areas of the skin that were first apparent at 
approximately 4mm in diameter. On autopsy at 6dpi, the draining lymph nodes were 
enlarged to four times normal size and were purple in colour. The contralateral lymph 
nodes were up to three times normal size and the spleens were swollen to approximately 
twice normal size. The livers appeared mottled on the uncut surface, although the lungs 
and kidneys were normal. By 7dpi, rabbits had impaired respiration and a clear, watery 
discharge from the eyes and nose. Clinical signs continued to develop in severity and by 
10dpi, the primary lesion was up to 7 x 4 cm (length x breadth) and 2cm high, purple in 
colour, and hard to the touch (Figure 3.3). Secondary lesions, approximately 0.75cm in 
diameter, were evident around the nose and mouth, and over the eyelids and ears, and 
approximately 1cm in diameter on the feet and chest of the animals.
The anogenital region and scrotum were swollen and oedematomous and there was a thick, 
opaque mucopurulent discharge from the eyes (which were closed) and nose (Figure 3.3). 
Both the draining and contralateral lymph nodes were 3-4 times normal size; the spleens 
were approximately three times normal size. The livers appeared mottled and were fragile 
(tearing easily when handled); the lungs appeared normal. The cortex of the kidneys of one 
of two rabbits was pale. Rabbits had a depressed demeanour. The study of SLS-infected 
laboratory rabbits was not continued beyond 10dpi as the rabbits were very ill and, based on 
previous studies, rabbits would have invariably died in the following one to two days if not
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Figure 3.2: Laboratory rabbit infected with SLS at 6 dpi. This rabbit has a protuberant 
primary lesion (arrow, A). The skin around the face and ears is red, and is thickened 
over the eyelids. There is a clear, watery discharge from the eyes (B).

Figure 3.3: Laboratory rabbit infected with SLS at 10 dpi. This rabbit has a 
protuberant primary lesion (A), swollen anogenital region (B) and the skin over the 
face and ears is thickened. There are several secondary lesions around the nose 
(closed arrow, C). In this figure, the base of the ears is thickened (open arrow), the 
eyes are shut due to swelling o f the eyelids and an opaque mucopurulent discharge.
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killed at this time (Fenner and Ratcliffe, 1965; Robinson et al., submitted).
3.3.4.2 Uriarra infection of laboratory rabbits
Rabbits autopsied at 2dpi with Uriarra appeared normal. The first clinical signs of 
myxomatosis following infection of laboratory rabbits with Uriarra were observed at 3dpi 
when the primary inoculation site was pink and slightly raised. By 4dpi, this had swollen to 
approximately 1cm in diameter. On autopsy at 4dpi, the draining lymph node was 
approximately 1.5 times normal size, but other tissues appeared normal. At 6dpi, the 
primary lesion was up to 3cm in diameter. The eyelids of the rabbits were thickened and 
red with a limited, clear discharge from 2 of 8 infected rabbits. Half of the infected rabbits 
showed slight anogenital swelling and scrotal oedema. On autopsy at 6dpi, the draining 
lymph nodes were 3-4 times normal size and purple, and the contralateral lymph nodes 
were 1.5-2 times normal size. By 9dpi, secondary lesions of approximately 0.5cm in 
diameter were evident around the eyes, and the ears were thickened and hot to the touch. 
At 10dpi, all six rabbits had extensive scrotal oedema and anogenital inflammation. 
Secondary lesions were obvious on the eyelids and ears with some mucopurulent discharge 
from the eyes and nose. The primary lesion was up to 6cm in diameter, but remained light 
in colour (Figure 3.4). Respiration was impaired and rabbits had a depressed demeanour. 
On autopsy, the draining and contralateral lymph nodes and the spleens were all 3-4 times 
normal size. The livers, lungs and kidneys were normal. By 14dpi, the testes were 
palpably shrunken although scrotal oedema remained extensive. At 15dpi, secondary 
lesions were present over the nose, feet and body (Figure 3.5). The primary lesions were 
circumferenced by a dark ring, had darkened in colour and were shrunken in the centre.
Although both draining and contralateral lymph nodes were enlarged, there was no 
evidence of haemorrhage in the nodes. The lungs and kidney were normal, but the livers 
were mottled and fragile. The spleens were 3-4 times normal size. By 17dpi, a scab had 
begun to form over the primary lesion of both remaining rabbits. When these rabbits were 
autopsied at 20dpi, the spleens were approximately twice normal size and the lymph nodes 
approximately three times normal size. The livers were mottled but the lungs appeared 
normal. By this time, an extensive scab had formed over the primary lesions. No deaths
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Figure 3.4: Laboratory rabbit infected with Uriarra at 10 dpi. This rabbit has a 
protuberant lesion at the primary inoculation site (arrow, A). The anogenital region 
is swollen (B). The eyelids are thickened and there is a clear, watery discharge from 
the eyes (C).

Figure 3.5: Laboratory rabbit infected with Uriarra at 15 dpi. This rabbits has a swollen 
anogenital region and scrotal odema (A) and discharge from the conjunctiva of the eyes, 
thickened eyelids and the formation of red swellings or small secondary lesions on the 
face (arrow) (B).
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occurred apart from those planned up to 20 days of infection with Uriarra when the final 
rabbits were killed, and based on previous experience, most rabbits would have recovered 
completely if allowed (Fountain et al., 1997).
3.3.4.3 SLS infection of wild rabbits
At 2dpi with SLS, the primary inoculation site in wild rabbits was pink. On autopsy, the 
draining lymph node of 1 of 2 rabbits was light purple in colour, although it was not 
enlarged. The draining lymph node of the other rabbit, and other tissues of both rabbits, 
were normal. By 4dpi, the primary lesions were slightly raised and 0.5cm in diameter 
(Figure 3.6). At autopsy, the draining lymph nodes were approximately twice normal size 
and purple in colour, but other tissues were normal. By 5dpi, the primary lesions were 
approximately 1cm in diameter and the anogenital regions and eyes of 3 of 12 infected 
rabbits were reddened. At 6dpi, the primary lesions were flat and approximately 3 x 1.5 cm 
(length x breadth) in size. All of the rabbits had red and visibly thickened eyelids. On 
autopsy, the draining lymph node was 2-3 times normal size and approximately half of the 
node was purple in colour, appearing haemorrhagic. The spleen was up to twice normal 
size, the liver was slightly congested and fragile while the lungs were normal. By 7dpi, the 
anogenital regions of most rabbits were inflamed. The primary lesions had developed a 
purple centre and small secondary lesions, approximately 3-4mm in diameter, were evident 
on the eyelids of 7 of 9 rabbits. One of these rabbits had a clear, watery discharge from 
both eyes. By 8dpi, secondary lesions (approximately 0.5cm in diameter) were evident 
over the eyes, ears feet and body of all rabbits. The primary lesions were no longer flat, 
being approximately 1.5cm high and purple in colour. By 9dpi, the primary lesion was 2.5- 
3cm high with blood breaking through the surface. One of nine rabbits had laboured 
breathing. By 10dpi, all rabbits had a discharge, which ranged from clear and watery to 
opaque and thick in consistency, from the nose and eyes, and anogenital odema was 
extensive (Figure 3.7). The primary lesions were dark purple in colour and rabbits had a 
depressed demeanour. On autopsy at this time, the draining lymph nodes were grossly 
enlarged, 4-5 times normal size, and purple in colour. The contralateral lymph nodes were 
approximately 1.5 times normal size. The spleens were swollen, up to three times normal 
size. Both the liver and lungs appeared mottled and congested, with livers being fragile to
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Figure 3.6: Wild rabbit infected with SLS at 4 dpi. This rabbit has a small pink 
primary lesion (arrow, A). The anogenital region (B) and face and ears (C) have no 
clinical signs of myxomatosis.
A
Figure 3.7: Wild rabbit infected with SLS at 10 dpi. This rabbit has a protuberant 
primary lesion (A), an inflamed anogenital region (B) and reddened, distorted eyelids, 
with some clear, watery discharge from the eyes (C).
A*2«i
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touch. The one rabbit that was experiencing difficulty breathing on day 9 and 10 died 
during that night. This rabbit had the most extensive primary and secondary lesions of all 
SLS infected animals. On autopsy, the lungs of this rabbit were congested and filled with 
blood, although other tissues appeared similar to those of rabbits killed at 10dpi. By 12dpi, 
weeping and scabbing was evident over the primary and secondary lesions. However, all 5 
remaining rabbits were experiencing difficulty breathing, possibly due to obstruction of the 
nasal passages by the mucopurulent discharge. By 15dpi (Figure 3.8), respiration had 
improved in all rabbits. Scrotal oedema was limited and anogenital swelling was reduced 
compared to 10dpi. Rabbits had lost considerable body condition by 15dpi, although on 
autopsy, the stomachs of rabbits were half-full to full. Granulomas were apparent in the 
epididymis of 1 of 3 rabbits autopsied. The lungs of these rabbits were normal although the 
livers appeared engorged. The draining lymph nodes were up to 3 times normal size, the 
spleens were about twice normal size, while the contralateral lymph nodes remained at 
approximately 1.5 times normal size. At 20dpi, primary and secondary lesions were 
scabbed over and there was no mucopurulent discharge from the eyes or nose (Figure 3.9). 
On autopsy, both the draining and contralateral lymph nodes were enlarged but there was 
no evidence of haemorrhage within these tissues. Both the lungs and livers were normal. 
The testes were considerably shrunken with granulomas on the epididymides of 2 of 3 
animals.
33.4.4 Uriarra infection of wild rabbits
The first clinical signs of myxomatosis following infection of wild rabbits with Uriarra 
were observed at 4dpi when the inoculation site was raised and pink. There were no signs 
of abnormalities in tissues from rabbits autopsied at 2dpi or at 4dpi. By 6dpi, the primary 
lesions were flat, pink and up to 3cm in diameter. On autopsy, the draining lymph nodes 
were approximately twice normal size, but all other tissues were normal. By 7dpi, one 
rabbit had red, visibly thickened eyelids. By 10dpi (Figure 3.10), 2 of 9 rabbits had a clear, 
watery discharge from the conjunctiva, although their eyelids were only slightly swollen 
and there was no mucopurulent discharge. One rabbit had a secondary lesion on the eyelid. 
Seven of 9 rabbits had mild anogenital swelling and scrotal odema. The primary lesions 
had reached approximately 4 x 2.5 cm (length x breadth), and were raised and red. On
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Figure 3.8: Wild rabbit infected with SLS at 15 dpi. This rabbit has a protuberant 
primary lesion (arrow, A), and an inflamed anogenital region (B). The eyelids show 
limited swelling and redness although mucopurulent conjunctival discharge is evident 
(C). Extensive, rash-like secondary lesions have developed over the back (D)

Figure 3.9: Wild rabbit infected with SLS at 20 dpi. The primary lesion o f this 
rabbit is scabbing over (A), as are the anogenital region (B) and the small secondary 
lesions on the eyelids (C).

Figure 3.10: Wild rabbit infected with Uriarra. At 10dpi, rabbits have a small 
primary lesion (A) but no thickening or reddening of the eyelids (B). At 20 dpi, the 
primary lesion has begun to scab over (C). The face and ears of this rabbit remained 
free of secondary lesions and discharge (D).
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autopsy, the draining lymph node was 3-4 times normal size but did not appear discoloured 
or haemorrhagic. The spleens were swollen to approximately twice normal size. The 
contralateral lymph nodes were not enlarged. By 12dpi, another one of the remaining six 
rabbits had developed a small secondary lesion on the eyelid. By 15dpi, the primary lesions 
had a dark and sunken centre, often with a dark ring at the lesion circumference. 
Anogenital swelling had increased from 10dpi in all infected rabbits, but was at no time 
considered severe. On autopsy, the draining lymph nodes were approximately twice normal 
size while the contralateral lymph nodes varied between normal to three times normal size. 
By 20dpi, the primary lesions and small secondary lesions on eyelids had formed scabs and 
had begun to regress (Figure 3.10). The anogenital swelling and scrotal oedema were mild 
and reduced compared to 15dpi. Both draining and contralateral lymph nodes were 
approximately twice normal size with no evidence of haemorrhage. The spleens were twice 
normal size. Wild rabbits infected with Uriarra remained relatively bright, did not suffer 
from obvious loss of body condition and apart from the small secondary lesions on the 
eyelids, did not develop discrete secondary lesions on the body. The lungs, livers and 
kidneys appeared normal at all times.
3.3.5 Titres of virulent and attenuated myxoma virus in laboratory and wild rabbits 
following virus inoculation in the hind foot
Virus titres in rabbit tissues following inoculation of lOOpfu of either SLS or Uriarra in the 
hind foot were measured by plaque assay. The lowest limit of detection for this assay was 
50 pfu/g tissue or 0.1 pfu/106 peripheral WBC. However, this represented two plaques for a 
sample, and such low titres should thus be interpreted as a positive indication of virus 
present rather than as an absolute measure of virus titre.
3.3.5.1 Titres of myxoma virus in the skin at the primary inoculation site
In laboratory rabbits inoculated with either SLS or Uriarra, virus was present at 2dpi
between approximately 50 pfu/g and 1.2 x 105 pfu/g (Figure 3.11 A). Maximum SLS titres 
occurred at 4, 6 and 10dpi, with 4 of 6 laboratory rabbits having SLS titres greater than 108 
pfu/g skin. At 4dpi, the Uriarra titre was greater than 107 pfu/g in 1 of 2 laboratory rabbits,
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and in both rabbits killed at 6dpi. Maximum titres of both SLS and Uriarra occurred at 4, 6 
and 10dpi, ranging from 1.9 x 108 to 1.0 x 109 pfu/g. At 15 and 20dpi, titre of Uriarra was 
below 107 pfu/g. During the first 10 days of infection, virus titres per gram of tissue of 
Uriarra were not different from those of SLS at the primary inoculation site in laboratory 
rabbits, although the size of the lesion was generally smaller (see section 3.3.3).
In wild rabbits at 2dpi, titres of both SLS and Uriarra ranged between 9.5 x 103 and 1.1 x 
106 pfu/g (Figure 3.1 IB). At 4dpi, the titre of both Uriarra and SLS was greater than 107 
pfu/g in 1 of 2 wild rabbits. At 6dpi, maximum titres of SLS, greater than 108 pfu/g, were 
reached in all three infected wild rabbits. Similarly to SLS infections, maximum titre of 
Uriarra, greater than or equal to 108 pfu/g, occurred at 6dpi in all three wild rabbits. At 10 
and 20dpi, the titre of both Uriarra and SLS was between 2.0 x 106 and 1.2 x 108pfu/g, but 
were slightly lower, between 3.8 x 104 and 3.7 x 106 pfu/g, at 15dpi. There was no 
difference between virus titre of SLS and Uriarra at the primary inoculation site in wild 
rabbits, although Uriarra infection resulted in the formation of a smaller primary lesion than 
SLS.
3.3.5.2 Titres of myxoma virus in the draining and contralateral lymph nodes
There was no difference between titres of Uriarra and SLS (102-104 pfu/g) at 2dpi in the
draining lymph node of laboratory rabbits (Figure 3.12A). SLS reached maximum titres, 
greater than 107 pfu/g, at 4, 6 and 10dpi, in 5 of 6 laboratory rabbits. Similarly, Uriarra also 
had maximum titres at 4, 6 and 10dpi; these ranged from 1.1 x 104 to 8.7 x 106 pfu/g. At 15 
and 20dpi, Uriarra was not present in the draining lymph node of laboratory rabbits infected 
with Uriarra.
SLS was present in the draining popliteal lymph node of 1 of 2 wild rabbits at 2dpi (Figure 
3.12B). At 4dpi, SLS was present in the draining lymph node of both wild rabbits. The 
highest titres reached were 1.6 x 104 to 5.0 x 10s pfu/g at 4 and 6dpi. From 6 to 20dpi, there 
was a steady decline in titre of SLS with virus detectable in the draining lymph node of 2 of 
3 rabbits at 15dpi and of 1 of 3 wild rabbits at 20dpi. In each case, titres were less than 104 
pfu/g. Following inoculation of Uriarra into wild rabbits, virus was not present in the
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Figure 3.11: Myxoma virus titres (plaque forming units/gram tissue) at the primary 
inoculation site following intradermal inoculation of SLS or Uriarra in (A) laboratory and 
(B) wild European rabbits. Each point represents an individual rabbit. Two laboratory 
rabbits infected with SLS or Uriarra were killed at 2, 4, 6 and 10dpi. Two laboratory 
rabbits infected with Uriarra were killed at 15 and 20dpi. Two wild rabbits infected with 
SLS or Uriarra were killed at 2 and 4dpi. Three wild rabbits infected with SLS or 
Uriarra were killed at 6, 10, 15 and 20dpi (except for 15dpi with SLS, when one rabbit
had previously died). (-----) virus titre required in skin for transmission (Fenner et a l.,
1956).
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Figure 3.12: Myxoma virus titres (plaque forming units/gram tissue) in the draining 
lymph nodes of laboratory (A) and wild (B) rabbits infected with SLS or Uriarra. Each 
point represents an individual rabbit. Two laboratory rabbits infected with SLS or 
Uriarra were killed at 2, 4, 6 and 10dpi. Two laboratory rabbits infected with Uriarra 
were killed at 15 and 20dpi. Two wild rabbits infected with SLS or Uriarra were killed 
at 2 and 4dpi. Three wild rabbits infected with SLS or Uriarra were killed at 6, 10, 15 
and 20dpi (except for 15dpi with SLS, when one rabbit had previously died).
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Figure 3.13: Myxoma virus titres (plaque forming units/gram tissue) in the contralateral 
lymph nodes of laboratory (A) and wild (B) rabbits infected with SLS or Uriarra. Each 
point represents an individual rabbit. Two laboratory rabbits infected with SLS or 
Uriarra were killed at 2, 4, 6 and 10dpi. Two laboratory rabbits infected with Uriarra 
were killed at 15 and 20dpi. Two wild rabbits infected with SLS or Uriarra were killed 
at 2 and 4dpi. Three wild rabbits infected with SLS or Uriarra were killed at 6, 10, 15 
and 20dpi (except for 15dpi with SLS, when one rabbit had previously died).
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Figure 3.14: Myxoma virus titres (plaque forming units/gram tissue) in the spleen 
following intradermal inoculation of SLS or Uriarra in (A) laboratory and (B) wild 
European rabbits. Each point represents an individual rabbit. Two laboratory rabbits 
infected with SLS or Uriarra were killed at 2, 4, 6 and 10dpi. Two laboratory rabbits 
infected with Uriarra were killed at 15 and 20dpi. Two wild rabbits infected with SLS or 
Uriarra were killed at 2 and 4dpi. Three wild rabbits infected with SLS or Uriarra were 
killed at 6, 10, 15 and 20dpi (except for 15dpi with SLS, when one rabbit had previously 
died).
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Figure 3.15: SLS and Uriarra virus titres (plaque forming units/ 106 white blood cells) 
in the peripheral blood o f infected laboratory rabbits. Each point represents an individual 
rabbit. Two laboratory rabbits infected with SLS or Uriarra were killed at 2, 4, 6 and 
10dpi. Two laboratory rabbits infected with Uriarra were killed at 15 and 20dpi.
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Figure 3.16: Myxoma virus titres (plaque forming units/gram tissue) in the lung 
following intradermal inoculation of SLS or Uriarra in (A) laboratory and (B) wild 
European rabbits. Each point represents an individual rabbit. Two laboratory rabbits 
infected with SLS or Uriarra were killed at 2, 4, 6 and 10dpi. Two laboratory rabbits 
infected with Uriarra were killed at 15 and 20dpi. Two wild rabbits infected with SLS or 
Uriarra were killed at 2 and 4dpi. Three wild rabbits infected with SLS or Uriarra were 
killed at 6, 10, 15 and 20dpi (except for 15dpi with SLS, when one rabbit had previously 
died).
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assay at any time.
3.3.5.5 Titres o f  myxoma virus in the distal skin
Virus titre was measured at an uninoculated skin site on the opposite side of the body to the 
inoculation site (termed distal skin) (Figure 3.17A). In laboratory rabbits inoculated with 
SLS, virus was first detected in distal skin at 4dpi. Maximum titres were reached at 6 and 
10dpi, at which times the titre was greater than 107 pfu/g. In laboratory rabbits inoculated 
with Uriarra, virus was present at 6dpi, but not at 2 or 4dpi. Maximum titres of Uriarra 
were present at 6 and 10dpi, but were only 5.0 x 102 and 1.3 x 104pfu/g; at 10dpi, virus was 
present in the distal skin of only 1 of 2 laboratory rabbits. At 15 and 20dpi, 1.3 x 102 to 1.3 
x 103pfu/g of Uriarra was present in 3 of 4 laboratory rabbits. Discrete secondary lesions 
were not observed at the distal skin site from laboratory rabbits infected with Uriarra, but 
were observed at this site in one rabbit killed at 6 dpi and both rabbits killed at 10 dpi with 
SLS.
At the distal skin site of wild rabbits, SLS was present at 4 dpi in both rabbits, but not at 
2dpi (Figure 3.17B). SLS was present in skin from this area for the 20 days of infection at 
titres generally between 103 and 105pfu/g, except for two rabbits, one with a virus titre of 
1.3 x 102 pfu/g at 4dpi, and one with a titre greater than 107pfu/g at 15dpi. The latter wild 
rabbit had a secondary lesion at the distal skin site. Uriarra was not detected in the distal 
skin of wild rabbits until 15 dpi, when it was present in 1 of 3 rabbits (3.3 x 103 pfu/g). At 
20 dpi, Uriarra was present in the distal skin of 1 of 3 wild rabbits (2.0 x 102 pfu/g). 
Discrete secondary lesions were not observed at the distal skin site from wild rabbits 
infected with Uriarra, but were observed in 2 of 9 wild rabbits killed at or after 10 days of 
infection with SLS, including the rabbit with a virus titre of greater than 107 pfu/g at this 
site.
3.3.6 Humoral immunity to myxoma virus infection
The production of circulating serum antibody specific for myxoma virus was measured in 
serum samples taken when the infected rabbits were killed. Circulating serum IgM and IgG 
were measured by ELISA. Neutralising antibody was measured by plaque reduction 
neutralisation assay.
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Figure 3.17: Myxoma virus titres (plaque forming units/gram tissue) at the distal skin 
following intradermal inoculation of SLS or Uriarra in (A) laboratory and (B) wild 
European rabbits. Each point represents an individual rabbit. Two laboratory rabbits 
infected with SLS or Uriarra were killed at 2, 4, 6 and 10dpi. Two laboratory rabbits 
infected with Uriarra were killed at 15 and 20dpi. Two wild rabbits infected with SLS or 
Uriarra were killed at 2 and 4dpi. Three wild rabbits infected with SLS or Uriarra were 
killed at 6, 10, 15 and 20dpi (except for 15dpi with SLS, when one rabbit had previously 
died). (-----) virus titre required in skin for transmission (Fenner et al., 1956).
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IgM was not present in sera at 2dpi. A low titre of IgM (50-100) was present in several 
laboratory rabbits infected with SLS or Uriarra at 4 and 6dpi (Table 3.4). IgG was not 
present in laboratory rabbits infected with SLS or Uriarra at 2, 4 or 6dpi, but was present at 
10dpi. At 10dpi, there was no significant difference in ELISA IgM or IgG titres between 
viruses. However, titres were not substantially higher in the two SLS-infected laboratory 
rabbits compared to the Uriarra-infected laboratory rabbits. Neutralising antibody was first 
present in both rabbits infected with SLS or Uriarra at 10dpi, but was higher in SLS- 
infected rabbits. Uriarra-infected laboratory rabbits developed high neutralising antibody 
titres by 15 and 20dpi.
There were dramatic differences in the development of both IgG and neutralising antibody 
to myxoma virus in wild rabbits (Table 3.5). IgG was first present at 6dpi in 1 of 3 SLS- 
infected wild rabbits, but was not present in Uriarra-infected wild rabbits. By 10dpi, IgG 
titres in SLS-infected wild rabbits were substantially higher than in Uriarra-infected wild 
rabbits, and remained higher at 15 and 20dpi. Similarly, neutralising antibody was first 
present at 6dpi of wild rabbits with SLS, but were not present in Uriarra-infected rabbits at 
6dpi. At 10 and 15 dpi, SLS-infected wild rabbits had considerably greater neutralising 
antibody titres than Uriarra-infected rabbits. At 20dpi, neutralising antibody titres were 
similar in SLS- and Uriarra-infected wild rabbits.
3.3.7 Febrile responses to infection
Rectal temperatures were measured daily during the course of infection, and are shown in 
Figure 3.18A expressed as the mean of all rabbits on each day. Basal temperature of both 
laboratory and wild rabbits ranged between 38.0 and 39.6°C, with a mean of 38.8°C -  0.6 (-  
standard error). The rectal temperature of laboratory rabbits infected with either Uriarra or 
SLS increased from 2dpi to 5dpi (Figure 3.18A). Elevated rectal temperatures were 
maintained from 5 to 20dpi with Uriarra, attaining a maximum of 40.6°C -  0.6 (9dpi). 
However, after attaining a maximum of 40.3°C -  0.4 at 8dpi, temperatures rapidly declined 
at 9 and 10dpi in laboratory rabbits infected with SLS to a mean of 38.9°C.
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The rectal temperatures of wild rabbits infected with either Uriarra or SLS increased from 
2dpi to 5dpi (Figure 3.18B). Elevated rectal temperatures were maintained from 5 to 20dpi 
in wild rabbits infected with SLS, with a maximum of 40.6°C -  0.3 at 7dpi. Wild rabbits 
infected with Uriarra maintained elevated rectal temperatures from 5 to 14dpi (maximum of 
39.9°C -  0.3 at 4dpi), after which time there was a steady decline.
Table 3.4: Neutralising and ELISA antibody following Uriarra and SLS infection of 
laboratory rabbits. Neutralising antibody (N) was measured by plaque reduction 
neutralisation assay and indicates the reciprocal serum dilution at which 50% or 
greater of myxoma virus plaque formation was neutralised. To determine ELISA 
IgM and IgG, serum was titrated in duplicate in two fold serial dilutions. The 
endpoint titre was defined as the final dilution 0.1 OD units above the OD of the 
1:100 negative control.
Day Rabbit
Uriarra 
N IgM IgG Rabbit
SLS
N IgM IgG
2 2160 - - - 984 - - -
749 - - - 989 - - -
4 936 - _ 987 - - -
975 - 50 - 982 - 50 -
6 167 _ 50 _ 269 - . -
156 - 50 - 272 - 100 -
10 160 15 50 200 165 300 400 800
158 50 400 400 179 300 200 400
15 169 4000 3200 3200
217 2000 3200 6400
20 163 3000 1600 3200
207 3000 1600 3200
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Table 3.5: Neutralising and ELISA antibody following Uriarra and SLS infection of 
wild European rabbits. Neutralising antibody (N) was measured by plaque reduction 
assay and indicates the reciprocal serum dilution at which 50% or greater of myxoma 
virus plaque formation was neutralised. To determine ELISA IgM and IgG, serum 
was titrated in duplicate in two fold serial dilutions. The endpoint titre was defined 
as the final dilution 0.1 OD units above the OD of the 1:100 negative control.
Day Rabbit
Uriarra 
N IgM IgG Rabbit
SLS
N IgM IgG
2 298 - - - 193 - - -
r .
428 - - - 501 - - -
4 426 _ . . 188 - _
427 - 50 - 194 - - -
6 401 . _ - 190 300 50 200
402 - 50 - 189 150 50 -
429 - 50 - 505 5 50 -
10 343 80 800 50 250 3000 1600 1600
344 50 400 - 504 2000 800 3200
403 30 400 100 508 300 400 3200
15 768 50 400 800 498 3000 800 25600
473 30 200 3200 506 500 800 25600
467 50 200 6400 502 died
20 466 2000 200 12800 500 2000 400 51200
502 300 100 1600 499 3000 800 51200
324 6000 100 25600 860 6000 800 51200
3.3.8 Haematology
Blood samples from the marginal ear vein were taken and peripheral WBC counted and 
differential blood cell counts made every two days over the period of infection.
3.3.8.1 Changes in peripheral WBC counts
Peripheral WBC counts did not change over the 20 days of infection of laboratory rabbits 
with Uriarra or wild rabbits with either Uriarra or SLS. SLS infection of laboratory rabbits 
resulted in a rapid increase in peripheral WBCs from 6dpi to approximately three-fold 
greater than that of other infections by 10dpi (Figure 3.19).
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Figure 3.18: Daily mean rectal temperature (°C) of laboratory (A) and wild (B) 
rabbits infected with SLS or Uriarra. A change in the number of rabbits (N) infected 
with each virus at each time post infection is indicated below the graph.
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SLS domestic 
UR domestic 
SLS wild 
UR wild
Days post infection
N laboratory
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N wild
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Figure 3.19: Peripheral white blood cell (WBC) counts in laboratory and wild rabbits 
infected with SLS or Uriarra (mean ± SE of all rabbits for each time except where n=2 [for 
SLS-infected laboratory rabbits from 7dpi, and Uriarra-infected laboratory rabbits from 
16dpi]. The bars then indicate a range about the mean). A change in the number of 
laboratory or wild rabbits (N) infected with each virus at each time post infection is 
indicated below the graph.
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Figure 3.20: Differential WBC counts following infection of O. cuniculus with myxoma 
virus. The percent number of monocytes (A), eosinophils (B) and basophils (C) were 
determined from blood samples taken from laboratory and wild rabbits infected with SLS 
or Uriarra (mean -  SE of all rabbits for each time except where n=2 [for SLS-infected 
laboratory rabbits from 7dpi, and Uriarra-infected laboratory rabbits from 16dpi]. The bars 
then indicate a range about the mean). Changes in the number of rabbits (N) infected with 
each virus at each time point after infection are indicated below.
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33.8.2 Differential WBC counts
Percent changes in numbers of basophils, eosinophils, mononuclear cells, lymphocytes and 
neutrophils in peripheral blood smears were monitored over the course of infection with 
myxoma virus. Laboratory rabbits infected with Uriarra, or laboratory and wild rabbits 
infected with Uriarra, did not demonstrate any changes in relative cell numbers (Figure 
3.20, Figure 3.21). The percent cell numbers of basophils and monocytes in laboratory 
rabbits inoculated with SLS did not change over 10 days of infection, although there was a 
slight decrease in the percent number of eosinophils present at 10dpi (Figure 3.20). There 
was a large increase in the percent of neutrophils in the peripheral blood from 6 dpi which 
was concomitant with a decrease in the percent of lymphocytes present (Figure 3.21). The 
change in the proportion of lymphocytes in blood smears was not due to a change in the 
number of lymphocytes counted in a sample, but due to the increase in neutrophils, 
resulting in proportionally less lymphocytes in a sample.
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Figure 3.21: Differential WBC counts of peripheral blood samples following infection of 
O. cuniculus with myxoma virus. The percent number of neutrophils (A) and lymphocytes 
(B) were determined from blood samples taken from laboratory and wild rabbits infected 
with SLS or Uriarra (mean ± SE of all rabbits for each time except where n=2. The bars 
then indicate a range about the mean). Changes in number of rabbits infected with each 
virus at each time point are the same as indicated for Figure 3.19.
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3.4 Discussion
The study described in this Chapter examined virus titres in tissues from laboratory and 
wild rabbits infected with SLS or Uriarra, to investigate when and in which tissues control 
of virus replication occurs. This study also examined the rectal temperature, peripheral 
WBC and antibody responses of wild and laboratory rabbits infected with SLS and Uriarra 
which confirmed the results obtained in Chapter 2, and extended these for wild rabbits. 
Differences between individual rabbits in each group were observed, especially following 
infection of rabbits with attenuated myxoma virus. This is unavoidable in outbred 
populations and especially as only two or three animals could be used at each time point. 
However, the investigation of virus titres at up to six time points, and in four groups of 
infected rabbits, made the results very clear. These are discussed below for each set of 
infected rabbits.
The first samples in which virus titres were measured were collected at 2dpi. At this time 
in laboratory rabbits, SLS was present only in the primary' inoculation site and draining 
lymph node. However by 4dpi, rabbits had a generalised infection, with SLS present in the 
contralateral lymph node, spleen, WBC and distal skin. Rectal temperature increased 
between 2 and 5dpi, and a discrete primary lesion formed over this time at the inoculation 
site, but rabbits were not showing any other clinical signs of myxomatosis. These 
commenced at 6dpi, when rabbits had inflammation of both the anogenital region and 
conjunctivae. Secondary lesions are an obvious clinical feature of virus generalisation and 
were present over the face and body of SLS-infected laboratory rabbits from 6dpi. Clinical 
signs of myxomatosis progressed in severity, such that rabbits were having difficulty 
breathing because of mucopurulent discharge from the nose due to secondary bacterial 
infection of the upper respiratory tract, and hence experiments were not continued beyond 
10dpi. Virus titres in the tissues had peaked at 6dpi, and were similar at 10dpi. Virus titres 
and clinical signs were consistent with the pathogenesis described by Fenner and 
Woodroofe (1953) in which virus spread from the primary inoculation site to the draining 
lymph node, where monocytes/lymphocytes became infected, which subsequently 
disseminated virus to other tissues. It is not possible to examine the clearance of virus and
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recovery of rabbits, as SLS infection of laboratory rabbits is uniformly lethal (Fenner and 
Ratcliffe, 1965).
Infection of laboratory rabbits with the attenuated Uriarra strain of myxoma virus had a 
similar pattern to SLS, with virus replication in the skin and draining lymph node by 2dpi. 
Uriarra was disseminating by 4dpi as it was present in the spleen. However, a generalised 
infection of the contralateral lymph node, spleen, lung, distal skin and in WBC was not 
present until 6dpi. Similarly to SLS-infected laboratory rabbits, the rectal temperatures of 
Uriarra-infected rabbits became elevated between 2 and 5dpi, and the first clinical changes 
in eyelids and anogenital regions were observed at 6dpi. However, inflammation of these 
areas was milder and progressed more slowly than in SLS-infected laboratory rabbits. 
Secondary lesions were not observed over the face until 9dpi, indicating that the 
generalisation of Uriarra infection in laboratory rabbits was slower than in SLS-infected 
laboratory rabbits. There was little difference in Uriarra titres between 6 and 10dpi, with 
both peak titres and peak temperatures measured during this time. In general, Uriarra was 
present at lower titres than SLS. This was more obvious in distal tissues, particularly the 
lung and skin. Severity of clinical symptoms peaked between days 12 and 13. By 15dpi, 
the reduction in severity of clinical myxomatosis was associated with clearance of virus 
from many tissues; a reduction in virus titre in the primary inoculation site at 15dpi 
presaged the beginnings of resolution of the primary lesion observed at 17dpi.
SLS infection of wild rabbits is not an inconsequential disease. These rabbits became 
significantly ill, but as with Uriarra infection of laboratory rabbits, were able to control 
virus infection and mostly survive the disease. At 2dpi of wild rabbits with SLS, only one 
of two rabbits had virus in the draining lymph node, although both had titres in the skin 
comparable to laboratory rabbits infected with SLS. At 4 and 6dpi, virus was present in 
the draining lymph node of all infected wild rabbits but at titres considerably less than in 
laboratory rabbits, and virus persisted in this tissue throughout the 20 days of infection. 
Virus was present in the spleen of one wild rabbit at 4dpi and in the distal skin of both, 
indicating that dissemination was occurring by this time, but it was not present in the lymph 
node draining the distal skin at 4dpi. Moreover, SLS was only detected in peripheral WBC
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from one wild rabbit. By 6dpi, SLS was present in the contralateral lymph node of two of 
three wild rabbits, but at all subsequent time points, there was at least one rabbit in which 
virus was not detectable in this tissue. In the lung, virus was present in only one of three 
rabbits at each of 6 and 10dpi at titres around 102 to 103 pfu/g. Similarly to laboratory 
rabbits infected with SLS, changes in the anogenital region and eyelids were first observed 
at 6dpi and rectal temperatures increased between 2 and 5dpi. Clinical signs progressed 
rapidly and peaked around 12dpi, but progression appeared a day or so behind in 
comparison with laboratory rabbits. Another difference was in the secondary lesions of 
SLS-infected wild rabbits which were small and retained discrete margins, unlike the 
indefinite and merged secondary lesions on the eyelids and ears of laboratory rabbits. 
Unlike laboratory rabbits infected with Uriarra, some wild rabbits cleared SLS completely 
in the draining lymph node and spleen by 15dpi, although there was usually one rabbit 
which still had virus in this tissue, and all rabbits had SLS present in the distal skin but at 
relatively low titres.
Wild rabbits infected with Uriarra showed only mild clinical signs of myxomatosis, which 
were limited to the primary inoculation site and occasional mild anogenital swelling. 
Secondary lesions did not form in the majority of infected wild rabbits, and while 
temperatures were elevated, the average temperature did not reach 40°C. Virus titres in the 
skin were similar to the other infections, but virus was not present in the draining lymph 
node until 4dpi. At 10dpi, Uriarra was present in the draining lymph node of one of three 
rabbits but was not detected after 10dpi. Despite the lack of secondary skin lesions, 
systemic dissemination of Uriarra was occurring in wild rabbits as virus was present in the 
spleen at 6dpi, and low virus titres were present in the contralateral lymph node from 6dpi. 
Uriarra was not detected in peripheral WBC. Uriarra was detected in the distal skin of only 
one of three wild rabbits at each of 15 and 20dpi, at 102 to 103 pfu/g, indicating that it did 
reach the skin but appeared unable to replicate to high titres. In contrast to SLS infection, 
Uriarra was cleared from both lymph nodes between 10 and 15 days of infection. This is 
similar to what occurred in Uriarra-infected laboratory rabbits although infected laboratory 
rabbits had much more severe clinical signs.
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Despite the differences in clinical signs and outcomes of infection, there was little 
difference between virus titres in the primary inoculation site in any of the treatments. 
However, there were clear differences in timing of dissemination and in titres reached in 
both the draining lymph node and distal tissues in laboratory rabbits infected with 
attenuated virus and in rabbits with a degree of genetic resistance. These differences in 
timing of dissemination were correlated with slower development of clinical signs. Despite 
dissemination being apparently delayed, virus does reach distal tissues but replicates to 
lower titres, indicating that replication is being constrained. It is not clear whether the 
delay in dissemination is due to the less efficient replication in the draining lymph node. In 
Uriarra-infected laboratory rabbits, titres in the draining lymph node and timing of virus 
dissemination to distal tissues were similar to those infected with SLS. However, 
replication in the distal tissues was limited. In contrast, SLS infected wild rabbits had 
lower virus titres in the draining lymph node, dissemination was somewhat slower, and the 
titres in the distal tissues were reduced. Thus it appears that in wild rabbits, there is a 
distinct constraint of virus replication in the draining lymph node, which was not present in 
laboratory rabbits, as well as a constraint of virus replication in distal tissues, which was 
observed in Uriarra-infected laboratory rabbits. The subsequent clearance of virus from 
internal organs and resolution of clinical signs were closely linked. However, virus 
persisted at the primary inoculation site in all rabbits for the 20 days of the experiment 
despite the rapid recovery of wild rabbits and the beginnings of resolution of the primary 
lesion.
Critical events in control of virus infection appear to be mediated very early in infection. I 
have shown in Chapter 2 that the ability of lymphocytes from the draining lymph node of 
SLS-infected laboratory rabbits to respond to mitogenic stimulation is suppressed by 4dpi, 
and this may be critical in allowing the overwhelming infection that occurs both in this 
node and in distal tissues. Myxoma virus encodes proteins that are expected to suppress 
mediators of the anti-viral immune response, including TNFa /ß and IFN7 ^Mossman et al., 
1995a; Schreiber and McFadden, 1994; Schreiber et al., 1997; Upton et al., 1991; Upton et 
al., 1992), and this suggests that wild rabbits are more effective at combating these viral 
proteins and mounting an effective immune response. My data indicate that this occurs
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within the first four days of infection, and so most likely reflects a more effective innate 
immune response of wild rabbits, particularly in the draining lymph node. The stimulation 
of a strong and appropriate innate immune response is more likely to enable an effective 
cell-mediated immune response, with the appropriate balance of TH1 and TH2 responses, to 
allow rabbits to control virus replication and survive infection (Fearon and Locksley, 1996; 
Kos and Engleman, 1996).
In another poxvirus system, resistance to ectromelia virus infection by inbred strains of 
mice is manifested by reduced virus replication in the spleen and liver following 
intravenous inoculation (Brownstein et al., 1993). This constraint of virus replication is 
evident early in infection, before the generation of virus-specific CTL (O'Neill and 
Blanden, 1983). Resistance to ectromelia virus has been mapped to loci from the NK gene 
complex, and involves NK cells (Delano and Brownstein, 1995; Jacoby et al., 1989) as well 
as interferons (Jacoby et al., 1989), especially interferon-Y (Karupiah et al., 1993a), as 
blocking the activity of NK cells or interferon- or -Y abrogates resistance. In addition, 
mice that are resistant to ectromelia virus infection produce higher levels of TH1 associated 
cytokines (Ramshaw et al., 1997), and develop earlier and stronger virus-specific CTL 
responses (O'Neill and Brenan, 1987) compared to susceptible mice. Based on the 
similarities in the early control of replication, it is possible that similar mechanisms of 
control are involved in the resistance of wild rabbits to myxoma virus infection, but which 
are more important remains to be examined.
The greater antibody titres produced by SLS-infected compared to Uriarra-infected 
laboratory rabbits in Chapter 2 led to the suggestion that production of high titres of virus 
specific antibody in laboratory rabbits may indicate a poor prognosis. However, wild 
rabbits infected with SLS, and which it is presumed would have survived infection post 20 
days, produced high titres of anti-viral antibody from 10dpi compared to rabbits infected 
with Uriarra. Whether this antibody has a role in control of virulent myxoma virus 
infection is unclear. The data from studies with vaccinia virus in mice suggest that 
antibody may have a role in controlling poxvirus infections. Infection of IL-6 knockout 
mice, which have a reduced capacity to produce antibody in response to infection, results in
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higher titres of virus in the ovary compared to infection of wild-type mice (Ramsay et al., 
1994). In particular, neutralising antibody may be important in controlling spread of virus 
from cell-to-cell by preventing the release of extracellular enveloped virus (EEV) from the 
surface of infected cells (Vanderplasschen et al., 1997). The early dissemination of SLS 
may thus be important in determining the outcome of infection, with the early and high 
production of neutralising antibody by wild rabbits reducing virus dissemination or 
replication in particular tissues.
Despite the involvement of respiratory difficulties in the clinical pathogenesis of myxoma 
virus infection of both laboratory and wild rabbits, gross pathology of the lung was rarely 
observed, and virus did not replicate to high titres in the lung. This is supported by Hurst 
(1937a) who found no clear correlation of clinical signs (difficulty breathing) with lung 
histopathology. Respiratory distress may thus be attributable to pathology of the upper 
respiratory tract. This was demonstrated in laboratory rabbits inoculated with malignant 
rabbit virus (Strayer et al., 1983a) which developed secondary bacterial infection with 
Pasteurella multocida of the conjunctiva and nasal mucosa, but not of the lungs or trachea.
An interesting and unexpected finding in this Chapter concerns the comparison of virus 
growth in the skin with the internal tissues. Virus titres at the primary inoculation site 
remained high over the course of infection of laboratory rabbits with Uriarra, or of wild 
rabbits with SLS or Uriarra, while virus was cleared from the internal tissues of most 
rabbits by 15 or 20dpi. It has been suggested that different immune response mechanisms 
are employed in the control of replication of ectromelia and herpes simplex viruses in the 
skin compared to the internal organs of mice (Karupiah et al., 1996; Nash et al., 1987). 
During infection with these viruses, specific CD8+ T-cells are critical in the control of virus 
replication in internal tissues. However in the skin, CD8+ T-cells were not sufficient for 
control of virus replication and CD4+ T-cells were required for virus clearance in a role 
which was independent of their provision of help to CD8+ T-cells. This suggests that CD4+ 
T-cells have an active role in the elimination of virus in the skin, perhaps through the 
production of cytokines. It was speculated that IFN7 production by CD4+ T-cells may be 
important in controlling virus replication in the skin. Indeed, IFN7 is critical in the control
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of ectromelia virus infection, but this is not the mechanism of T-cell mediated virus 
clearance. Inhibition of the function of IFN^’ and to a lesser extent IFNß’ in mice 
exacerbated titres of ectromelia virus in internal tissues but had no effect on virus titres in 
the skin, again suggesting that control of virus infection in the skin and internal tissues may 
operate through different mechanisms (Karupiah et al., 1993a). However, the relative roles 
of individual components of the rabbit immune response such as IFN or CD4 ' and CD8" T- 
cell subsets, to myxoma virus infection of laboratory and wild rabbits are unknown. In the 
case of myxoma virus, virus-encoded mediators of the immune and inflammatory responses 
have evolved to allow the virus to persist in the skin of the natural host where as far as it 
known, systemic dissemination does not occur (Marshall et al., 1963). If virus replicating 
in the skin of these animals reaches the draining lymph node, which is perhaps likely in 
antigen presenting cells (dendritic cells and/or macrophages), it must not replicate 
efficiently at this site. This supports the possibility of different control mechanisms of 
myxoma virus replication in the skin and lymph node. However, the failure of myxoma 
virus to disseminate past the skin in its natural host may be a result of differential 
permissivity of cells in the skin compared to the lymph nodes to myxoma virus replication.
In studies of virus pathogenesis, it is important to know when and in which tissues virus is 
replicating. It is also important to know what is happening at the cellular level within 
individual tissues, such as which cell types are involved in virus replication. The skin and 
lymph nodes are important sites of myxoma virus replication in both laboratory and wild 
rabbits, infected with either virulent or attenuated virus. However, it is not known which 
cells become infected with myxoma virus following inoculation into the skin, how virus is 
transported from the skin to the draining lymph node, where virus replicates within lymph 
nodes, and how these may differ between virulent and attenuated myxoma virus, and 
between infected resistant and susceptible rabbits. To address these questions, the 
histopathogenesis and cellular localisation of virulent and attenuated myxoma virus in the 
skin and lymphoid tissues of infected laboratory and wild rabbits are examined in Chapter 
4.
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Chapter 4: Virus localisation and 
histopathology in the skin, lymph nodes
and spleen
4. Virus localisation and histopathology in the skin, lymph 
nodes and spleen
4.1 Introduction
In Chapter 3, the titres of virulent and attenuated myxoma virus in individual tissues 
from infected laboratory and wild rabbits were determined. The determination of virus 
titres in these animals yields information of where the virus is replicating, but not what 
cells become infected, what pathology is being caused in the tissue, and how this differs 
between infection of laboratory and wild rabbits with virulent or attenuated myxoma 
virus. To examine these factors of myxoma virus pathogenesis, it is necessary to 
examine the histopathology and virus localisation within individual tissues from 
infected rabbits. The histopathology of tissues from laboratory rabbits infected with 
virulent myxoma virus has been described for advanced stages of myxomatosis (Rivers, 
1930; Hurst, 1937a). These studies examined the skin, lymph nodes, spleen, lung, liver, 
kidney, testis and brain of infected rabbits, and highlighted myxomatosis as a 
proliferative and degenerative disease, predominantly affecting the epidermis and 
vascular-endothelium of the skin, and cells of the reticular and vascular systems in the 
lymph nodes and spleen. The pathology of myxomatosis was also characterised by the 
appearance of large, stellate cells called myxoma cells in the dermis of the skin, lymph 
nodes and spleen (Hurst, 1937a). Hurst (1937a) hypothesised that myxoma virus 
replicates in vascular endothelial cells causing them to proliferate, bud off and migrate 
into the tissue as myxoma cells. However, the cellular localisation of myxoma virus in 
the blood vessels of various tissues has not been examined to investigate this further. 
The pathological changes in tissues from laboratory rabbits infected with the attenuated 
neuromyxoma strain of myxoma virus have also been described (Hurst, 1937b). 
However, Hurst (1937b) concluded that the disease caused by this virus was possibly 
not true myxomatosis as myxoma cells were not observed in tissues from infected 
rabbits.
Previous pathological studies have been limited. Firstly, studies of the cellular 
localisation of virus within individual tissues has not been published in any detail 
(Mims, 1964; Strayer and Sell, 1983), and studies of tissue histopathology have not 
considered the localisation of virus in their interpretation, or the titres of virus within the 
same tissues. Secondly, the study of attenuated myxoma virus did not involve a
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naturally attenuated strain of myxoma virus. In addition, there has been no study to 
investigate differences in the histopathology and/or cellular localisation of virulent 
myxoma virus in rabbits that have a degree of genetic resistance compared to 
susceptible rabbits. Finally, the study of virulent and attenuated myxoma virus has not 
been brought together in one group of rabbits and has not been described in a detailed 
time course study.
The study in this Chapter examined the pathology caused by virulent or attenuated 
myxoma virus, and the cellular localisation of virus, in the primary lesion, distal skin, 
draining and contralateral lymph nodes and the spleen o f both laboratory and wild 
rabbits. The tissues investigated were portions of the same tissues in which virus titres 
were determined in Chapter 3, from wild rabbits, and from laboratory rabbits inoculated 
in both the thigh and the dorsum of the hind foot. Changes in the expression of selected 
cell markers (MHC class II, MHC class I, M- chain of immunoglobulin on B-cells, CD43, 
CD45) in lymph nodes, and of MHC class II in the skin, were determined by 
immunolocalisation. The visualisation of this specific staining, particularly for myxoma 
virus, and the corresponding histopathological changes within individual tissues of 
laboratory and wild rabbits was utilised to addresses the following questions relating to 
myxoma virus pathogenesis: what cell types are infected following inoculation of 
myxoma virus into the skin; what is the likely mode of transport of virus from the skin 
to the draining lymph node; what cell types are infected in the lymph nodes and spleen 
and what changes in cell populations occurs in the lymph nodes of laboratory rabbits; 
what immunopathologic mechanisms may occur in the lymphoid tissue; what is the 
extent of involvement of the spleen in virus replication and pathogenesis; where and 
when control of virus replication occurs and what key factors o f myxoma virus 
pathogenesis differ between virulent and attenuated myxoma virus infection o f either 
laboratory or wild rabbits?
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4.2 Materials and Methods
4.2.1 Infection of rabbits and tissue collection
The tissues examined for histopathology and immunolocalisaton were the primary 
inoculation site in the skin, distal skin, draining lymph node, contralateral lymph node, 
and spleen, and were portions of the tissues taken from myxoma virus-infected rabbits 
in section 3.2.3. These tissues were from laboratory rabbits that had been inoculated 
either in the thigh or foot and killed at 2, 4, 6 and 10dpi with lOOpfu SLS, or at 2, 4, 6, 
10, 15 and 20dpi with lOOpfu of Uriarra. Tissues from the additional time point of 8dpi 
were available from laboratory rabbits that had been inoculated with either SLS or 
Uriarra in the thigh. Tissues were collected from wild rabbits inoculated in the hind 
foot with lOOpfu of either SLS or Uriarra and killed at 2, 4, 6, 10, 15 and 20dpi. The 
numbers of rabbits killed at each time point are shown in Table 4.1. Portions of all 
tissues were taken for both fixed and frozen sections. In addition, two laboratory and 
two wild rabbits were infected with lOOpfu of either SLS or Uriarra in the dorsum of 
both hind feet and killed at 12 and 24 hours post infection (hpi). The inoculation site, 
which had been carefully shaven of hair and marked on the skin, and the draining lymph 
node were removed for frozen tissue sections only (see section 4.2.2.2).
4.2.2 Histology and immunohistochemistry
4.2.2.1 Histology
At autopsy, portions of tissue were fixed in 4% buffered formaldehyde and embedded in 
paraffin wax and processed as described in section 2.2.5.1.
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Table 4.1: The number of laboratory and wild rabbits infected with SLS or Uriarra that 
were killed at each time post infection and their tissues examined by histology and 
immunofluorescence for myxoma virus and MHC II positive cells. An asterix (*) 
indicates the time points at which two laboratory rabbits were killed following 
inoculation in the hind foot and two rabbits were killed that had been inoculated in the 
thigh. (#) indicates where the two rabbits killed following inoculation in the thigh. All 
wild rabbits were inoculated in the hind foot, (hpi) hours post infection, (dpi) days post 
infection.
Time post 
infection
Laboratory rabbits 
Uriarra SLS
Wild rabbits 
Uriarra SLS
1 2  hpi 2 2 2 2
24 hpi 2 2 2 2
2  dpi 4  * 4 * 2 2
4 dpi 4 * 4 * 2 2
6  pdi 4 * 4 * 3 3
8  dpi 2 # 2 # 3 3
1 0  dpi 4 * 4 * 3 3
15 dpi 2 - 3 3
2 0  dpi 2 - 3 3
4.2.2.2 Sectioning of the primary inoculation site and draining lymph node from 12 
and 24 hpi
Following intradermal inoculation of myxoma virus into the dorsum of the hind feet, the 
point of penetration through the skin and the margins of the skin that had become raised 
following injection of virus inoculum, were marked. At 12 or 24 hpi, rabbits were 
killed and this entire area of skin, and the draining popliteal lymph node removed. The 
skin was divided into thirds; the middle third containing the needlestick point, and the 
first and third portions containing the remaining skin that had been marked. The 
draining lymph node was trimmed of fat and cut in halves lengthwise along the dorsum. 
All portions of tissue were placed in individual small foil cups, covered in OTC 
embedding fluid (Tissue Tek), snap frozen in liquid nitrogen and stored at -70°C. The 
entire tissue blocks were sectioned on a cryostat; sequential tissue sections (serial 
sections) of 4-l^m were placed onto superfrost slides (Menzel-Glaser) which had been 
previously coated in a 0.01% poly-L-lysine (Sigma) solution (v/v in ddFLO) and air- 
dried. Sections were labeled, and fixed as described in section 2.2.5.3 for the
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identification of specific antigens by immunohistochemistry.
At all other time points, blocks (10mm x 2mm) of tissue from the primary site of virus 
inoculation, the skin site distal to the inoculation site, the draining and contralateral 
lymph nodes, and the spleen were placed in individual small cups made of foil and 
covered in O.C.T. embedding fluid. These were treated as described above for the early 
time points, although the sectioning regime was different. Ten serial sections were 
made and placed onto slides. The tissue was sectioned through a further lOO^m and the 
sections discarded, ten more serial sections were made and retained, a further lOO^m of 
tissue was sectioned through and discarded, and ten more serial sections made and 
retained. The serial sections were placed on slides and fixed as above.
4.2.2.3 Primary and secondary monoclonal antibodies
The mouse monoclonal antibodies used to detect specific rabbit cell antigens were 
supplied by Serotec (Raleigh, North Carolina, US), and used at a 1:10 dilution. These 
were: anti-CD43 (LI 1/135) which has high affinity for T-cells, and low affinity for 
monocytes and macrophages (Wilkinson et al., 1992); anti-Ig^ (NRBM) which 
recognises the Fc chain of IgM expressed on the surface of B-cells; anti-CD45 
(LI2/201) (Jackson et al., 1983) which recognises the leucocyte common antigen and 
hence is a pan leucocyte marker; MHC class I (73-2), MHC class II RLA-DQ (2C4) 
(Lobel and Knight, 1984). To detect SLS or Uriarra, the mouse anti-myxoma virus 
monoclonal antibody (3B6E4) was used at a 1:200 dilution. By western blot, 3B6E4 
recognises a late protein of the virus core. It is cross-reactive for the North and South 
American strains of myxoma virus as well as Shope fibroma virus, but is not cross-
reactive with the Orthopoxvirus, vaccinia virus. In myxoma virus-infected tissue 
culture cells, the monoclonal antibody recognises virus in the cytoplasm, as discrete 
virus factories early in infection and in the entire cytoplasm late in infection (P.J. Kerr, 
unpublished).
Secondary antibodies used were FITC-conjugated goat anti-mouse Ig (Boehringer 
Mannheim; 1:50), Rhodamine-conjugated goat anti-mouse Ig (Boehringer Mannheim, 
1:10), biotin-conjugated sheep anti-mouse Ig (Boehringer Mannheim; 2Pg/ml or 1:500), 
and unconjugated sheep anti-mouse Ig (Silenus; 1:50).
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4.2.2.4 Single stained immunofluorescence for myxoma virus
Frozen tissue sections were stained for myxoma virus as described in section 2.2.5.5.
4.2.2.5 Alkaline phosphatase single staining for cell markers
Frozen sections of lymph nodes and spleen from uninfected and myxoma virus-infected 
rabbits were blocked overnight at 4°C in 5% skim milk powder (Diploma) in lx Tris 
Buffered Saline (TBS; lOmM TrisHCl, 0.15M NaCl, pH 8.0) and then washed four 
times in TBS. 50R of the primary antibody LI 1/135, NRBM, L12/201, 73-2 or 2C4 
was added, ensuring complete coverage of each section, and sections were incubated for 
2 hours at 37°C. The primary and secondary antibodies and the streptavidin enzyme 
conjugate were all diluted in 1% milk/TBS. Sections were washed four times in TBS 
and lOO^l of secondary antibody applied (sheep anti-mouse Ig conjugated with biotin). 
Sections were incubated for 2 hours at 37°C and washed four times in TBS. 100^1 of 
streptavidin conjugated alkaline phosphatase (Amersham Life Science) at 1:150 was 
added and incubated for lhour at 37°C, followed by four washes with TBS. The 
binding of specific antibody was visualised by development with fast red. One fast red 
tablet (Boehringer Mannheim) was dissolved in 2ml 0.1M Tris HC1, pH 8.2, filtered and 
100^1 added to each section, which were left at room temperature for 5min before 
rinsing with ddH2Ü. The fast red substrate was used in preference to BCIP/NBT due to 
the resulting red product which was readily counterstained with haematoxylin. Sections 
were immersed in Gills Number 3 haematoxylin for 20 seconds, rinsed in water, 
immersed in Scotts tap water substitute for 20 seconds, rinsed in water and finally 
coverslipped using Girrs’ aqueous mounting agent, Aquamount improved (BDH 
Laboratory Supplies).
4.2.2.6 Double immunofluorescence staining for myxoma virus and MHC II
Fixed frozen tissue sections of lymph node and skin were blocked in 3% BSA in PBS 
overnight at 4°C, followed by four washes in PBS. 50^L of 2C4, 1:10 in 1% BSA/PBS, 
was added to each section, followed by incubation for 2 hours at 37°C. Sections were 
washed as above and 100^1 of goat anti-mouse conjugated to FITC (1:50 in 
1%BSA/PBS) added and sections incubated for a further 1 hour at 37°C. FITC was 
utilised first as it is a smaller molecule than rhodamine. From this point, all steps were
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completed in a box covered in foil to limit light penetration. Slides were washed and 
100^1 of 1:50 sheep anti-mouse Ig in 1% BSA/PBS added to each section. Slides were 
incubated for 1 hour at 37°C, washed and the second primary antibody added. This 
antibody was mouse anti-myxoma virus monoclonal (3B6E4) diluted 1:200 in 
1%BSA/PBS. Slides were incubated for 1 hour at 37°C, washed and 50^1 of 1:10 sheep 
anti-mouse Ig conjugated to rhodamine (section 4.2.2.3) added to each section, followed 
by a further lhour incubation at 37°C. Sections were washed and mounted with 
coverslips using Antifade. Control sections for this procedure included staining of 
tissue sections from uninfected rabbits and the use of normal mouse ascites fluid in 
place of either primary antibody. For each section that was stained for both myxoma 
virus and MHC class II, the section that was cut from the block immediately before and 
after it was stained for either myxoma virus or MHC class II, but not both.
4.3 Results
The following is a description of the cellular localisation of myxoma virus within the 
skin at the primary inoculation site, the distal skin, the draining and contralateral lymph 
nodes and the spleen, from both wild and laboratory rabbits infected with either SLS or 
Uriarra. It also includes a description of the histopathology of myxoma virus within 
these tissues, and a description of changes in the presence of cells staining positive for 
selected cell markers. Tissue sections were examined for every rabbit from each time 
point, including from laboratory rabbits inoculated both in the dorsum of the hind foot 
and in the thigh. For each rabbit killed (Table 4.1), at least three sections were 
examined from every tissue for each of histology, immunofluorescent staining for 
myxoma virus, and for MHC class II. The immunolocalisation of all other specific cell 
markers was performed on tissue sections from laboratory rabbits only.
Histopathological changes in the skin, the lymph nodes and the spleen of laboratory 
rabbits late in infection with SLS were not markedly different from those described by 
Hurst (1937a). However, the descriptions by Hurst (1937a) did not examine many time 
points early in infection or describe the cellular localisation of virus. Hence, the 
following is a description of the time course of infection and highlights the differences 
in virus localisation and pathology following infection of laboratory and wild rabbits 
with either SLS or Uriarra.
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4.3.1 The primary inoculation site
4.3.1.1 Un infected skin
Skin was taken from the dorsum of the hind feet of uninfected rabbits, and from the 
primary lesion and uninoculated distal skin site of myxoma virus infected rabbits. 
Uninfected skin is shown in Figure 4.1. Rabbit skin consisted of a thin epidermis and 
the dermis, with a number of large hair follicles (Figure 4.1 A). The epidermis (Figure 
4.IB) consisted of a single layer of cuboidal cells with oval nuclei, the stratum basale, 
which was overlaid by layers of progressively flattened cells (the stratum spinosum). 
The next cell layer, the stratum granulosum, consisted of cells containing keratohyaline 
granules, but was not always obvious in the thin skin located over the foot. The 
outermost layer consisted of flattened dead cells, the stratum comeum, from which 
desquamating keratin was usually observed.
The dermis (Figure 4.1C) consisted of connective tissue of collagen and elastic fibres, 
as well as many fat cells and blood vessels (Figure 4. ID). There were a number of cell 
types represented in the dermis that could be identified by their nuclear morphology 
including lymphocytes, mast cells, macrophages, and fibroblasts. The most common of 
these were lymphocytes and fibroblasts (Figures 4.1 B and D). Bundles of superficial 
striated muscle layers were located immediately below the dermis.
When uninfected skin sections were stained for MHC class II by immunofluorescence 
(Figure 4.2), positive staining cells localised to areas directly under or at the 
epidermal/dermal junction, around the margins of hair follicles or directly outside blood 
vessels (Figure 4.2A). These cells were elongated, with a long cellular process ( 3 0 ^  
long) extending from one or both ends of the nucleated body (approximately 30^m 
across) (Figure 4.2B). Deeper in the dermis, the majority of MHC class II positive cells 
present (at approximately 18 cells/mm ) had the morphology of a nucleated body with 
multiple dendritic processes (Figure 4.2C). Other MHC class II positive staining 
cellular bodies did not have clear morphologies and were likely to be the cellular 
processes and portions of similar cells that had been sectioned through.
4.3.1.2 Histopathological changes, cellular localisation of myxoma virus and MHC 
class IIpositive cells in the skin at the primary lesion of rabbits
Changes in the skin at the primary inoculation site following infection of rabbits with
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Figure 4.1: Skin from the dorsum of the hind foot of an uninfected laboratory rabbit 
showing the structure and visible cell types. (A) The epidermis and dermis which contains 
hair follicles. (B) The epidermis of uninfected rabbit skin. (C) The dermis of uninfected 
rabbit skin. (D) Blood vessels in the epidermis showing the single layer of flattened 
endothelial cells. E, epidermis; HF, hair follicles; SB, stratum basale; SC, stratum 
comeum; K, keratin; L, lymphocyte; F, fibroblast; VE, vessel endothelium. Bars represent 
lOOum.

Figure 4.2: Typical MHC class II staining by immunofluorescence in the skin of an
uninfected rabbit. (A) Distribution of MHC class II positive cells in skin. MHC class IF 
cells localised to the epidermal/dermal junction and surrounding blood vessels in the 
dermis. Bar represents 200p.m. (B) Morphology of MHC class II positive cells at the 
epidermis/dermis junction. Bar represents 25pm. (C) Morphology of MHC class II 
positive cells in the dermis. Bar represents 10pm. E, epidermis; D, dermis, arrows indicate 
blood vessels.
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myxoma virus occurred particularly in the stratum basale of the epidermis, the 
endothelial cells of blood vessels and the connective tissue in the dermis, and in the 
infiltration of inflammatory cells into the dermis (Table 4.2). The changes in the 
epidermis and dermis are described below. The changes in the endothelial cells in the 
blood vessels are described separately. The changes in MHC class II positive cells, and 
the cells that became infected with myxoma virus in the skin, are also described below.
Table 4.2: MHC class II staining, myxoma virus localisation and histopathology in the 
primary inoculation site in the skin following intradermal inoculation of laboratory or 
wild rabbits with either SLS or Uriarra.
SLS Uriarra
Laboratory Wild Laboratory Wild
TWELVE HOURS POST INFECTION
M H C  class II F ibroblast-like 
cells and  dendritic  
cells o f  ep iderm is/ 
derm is ju n c tio n  
and derm is
F ibroblast-like 
cells and dendritic 
cells o f  ep iderm is/ 
derm is ju n c tio n  
and derm is
F ib rob last like 
cells and  dendritic  
cells o f  ep iderm is/ 
derm is ju n c tio n  
and derm is
F ib rob last-like  
cells and  dendritic  
cells o f  ep iderm is/ 
derm is ju n c tio n  
and  derm is
V iru s localisation N o t p resen t N o t p resen t N o t p resen t N o t p resen t
TWENTY-FOUR HOURS POST INFECTION
M H C  class II F ib rob last-like F ibrob last-like F ib rob last-like F ib rob last-like
cells and  dendritic cells and  dendritic cells and  dendritic cells and  dendritic
cells o f  derm is cells o f  derm is cells o f  derm is cells o f  derm is
V iru s localisation D endritic  cells in D endritic  cells in D endritic  cells in D endritic  ce lls in
the derm is the derm is the derm is the derm is
TWO DAYS POST INFECTION
M H C  class II F ib rob lasts and F ibroblasts and F ib rob lasts and F ib rob lasts and
dendritic  cells o f dendritic  cells o f dendritic  cells o f dendritic  ce lls  o f
derm is derm is derm is derm is
V iru s localisation F ib rob lasts and F ibrob lasts and F ib rob lasts and F ib rob lasts and
dendritic  cells o f dendritic  cells o f dendritic  cells o f dendritic  ce lls o f
derm is derm is derm is derm is
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T able 4.2 continued: • » i •
S L S U r ia r r a
L a b o r a to r y W ild L a b o r a to r y W ild
F O U R  D A Y S  P O S T  IN F E C T IO N
MHC class II Fibroblasts and Fibroblasts and Fibroblasts and Fibroblasts and
dendritic cells 'Of dendritic cells of dendritic cells of dendritic cells of
dermis dermis dermis dermis
Virus localisation Fibroblasts and Fibroblasts and Fibroblasts and Fibroblasts and
dendritic cells of dendritic cells of dendritic cells of dendritic cells of
dermis dermis dermis dermis
Epidermis Intracellular 
edema, cell 
proliferation
Intracellular edema Intracellular edema No change
Inflammation Mononuclear cell Mononuclear cell Mononuclear cell Mononuclear cell
infiltrate into infiltrate infiltrate infiltrate
lower dermis throughout dermis throughout dermis throughout dermis
Blood vessels Swollen
endothelium
No change No change No change
S IX  D A Y S  P O S T  IN F E C T IO N
MHC class II Round cells Round cells Round cells Round cells
without dendrites without dendrites without dendrites without dendrites
in dermis, few in dermis, few in dermis, few in dermis, few
dendritic cells dendritic cells dendritic cells dendritic cells
Virus localisation Epidermis and Epidermis and Epidermis and Epidermis and
external root external root external root external root
sheath; round cells sheath; round cells sheath; round cells sheath; round cells
in dermis; large, in dermis in dermis in dermis
rectangular cells
proximal to dermal
blood vessels
Epidermis Intracellular Intracellular Intracellular Intracellular
edema, cell edema, cell edema, cell edema, cell
proliferation and proliferation proliferation proliferation
degradation, vims
inclusion bodies
Inflammation Neutrophillic Mononuclear cell Mononuclear cell Mononuclear cell
infiltrate infiltrate infiltrate infiltrate
predominantly in throughout dermis throughout dermis throughout dermis
lower dermis
Blood vessels Swelling and Swelling of Swelling of No change
proliferation of endothelial cells endothelial cells
endothelial cells
Stellate myxoma Present Absent Absent Absent
cells
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T able 4.2 continued:
S L S U r ia r r a
L a b o r a to r y W ild L a b o r a to r y W ild
T E N  D A Y S  P O S T  IN F E C T IO N
V irus localisation E piderm is and E piderm is and E piderm is and E piderm is and
external root ex ternal root ex ternal roo t ex ternal roo t
sheath; large, 
rec tangu la r cells 
p rox im al to derm al 
b lood  vessels
sheath; sheath; sheath;
E piderm is N ecro tic , re ticu lar In tracellu lar In trace llu lar In trace llu lar
degradation edem a, cell edem a, cell edem a, cell
(vesic le p ro lifera tion  and p ro lifera tion  and p ro life ra tion  and
form ation), v im s degradation , v im s degradation , v im s degradation , v im s
inclusion  bodies inclusion  bodies inc lusion  bod ies inc lusion  bod ies
In flam m ation N eu troph illic M ononuclear cell M assive M ononuc lea r cell
in filtra te infiltra te m ononuclear cell in filtra te
p redom inan tly  in th roughou t derm is infiltra te th roughou t derm is
low er derm is th roughou t derm is
B lood  vessels E ndo thelia l cell Sw elling  o f S w elling  o f S w elling  o f
p ro lifera tion  and 
necrosis
endo thelia l cells endo thelia l cells endo thelia l cells
S tellate m yxom a P resen t th roughou t P resen t in deep P resen t in  deep A bsen t
cells derm is derm is derm is
F IF T E E N  D A Y S  P O S T  IN F E C T IO N
V im s localisation - S tratum  basale  and S tra tum  basale  and S tra tum  basale  and
external root ex ternal roo t ex ternal roo t
sheath sheath sheath
E p iderm is - N ecro tic, re ticu lar N ecro tic , re ticu la r N ecro tic , re ticu la r
degradation , scab degradation , scab degradation , scab
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4.3.1.2.1 The dermis and epidermis of the primary lesion
Virus was detected by immunofluorescence in the dermis at the primary inoculation site 
of both laboratory and wild rabbits infected with either SLS or Uriarra at 24 hpi, but 
was not observed at 12hpi. At 24hpi, myxoma virus was present in two cell types. The 
first was a flattened, elongated cell located in the upper dermis, often proximal to the 
epidermis/dermis junction. These cells resembled fibroblasts. Figure 4.3 A and C are 
histological sections showing the architecture of the skin and the cell types that myxoma 
virus localised to (Figures 4.3 B and D). The second cell type was also located in the 
upper dermis, approximately 130 to 300 Ihn below the epidermis (Figure 4.4A), and had 
prominent dendritic cell processes. In Figure 4.4A, there is some autofluorescence 
associated with keratin in hair follicles. However, this was obviously different from the 
specific fluorescence obtained by the specific binding of the monoclonal antibody. To 
examine if cells containing virus costained for MHC class II, sections of 4 to 7 o f t  were 
cut sequentially from blocks of tissue (serial sections). One of the sections in a series 
was stained for myxoma virus, another for MHC class II, and another section was 
double stained for both antigens. The staining of serial sections in such a manner 
ensures that the same population of cells, and often the same cell, is being examined in 
each section. It is also an effective way to work up the protocols for double staining of 
sections to ensure that the monoclonal antibodies are binding antigens specifically, 
particularly when the monoclonal antibodies are raised in the same species. Both of the 
cell types described above that contained virus also stained positive for MHC class II in 
serial sections (Figure 4.4B) or in double stained sections (Figures 4.4 C and D). These 
cells were probably both dendritic cells.
By 2 and 4dpi with either SLS or Uriarra, the dermis of the primary lesion of all 
laboratory and wild rabbits examined contained many cells that stained positive for 
virus antigen, with little difference observed between the two time points, or between 
treatment groups. Figure 4.5 shows a typical example of the staining of virus in the 
cells of the dermis of SLS-infected laboratory and wild rabbits at 4dpi (Figures 4.5 A 
and C), and the histology of the skin at the primary inoculation site at the same time 
(Figures 4.5 B and D). There is little difference between the number or distribution of 
virus-positive cells. There was an increase in the number of elongated fibroblast-like 
cells in the upper dermis at 4dpi of both laboratory and wild rabbits infected with SLS 
or Uriarra. At this time, inflammatory mononuclear cells had infiltrated into the dermis 
of the primary inoculation site of all infected rabbits. However, in SLS-infected rabbits,
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Figure 4.3: The histology of the primary inoculation site and immunofluorescent
immunolocalisation of myxoma virus at 24 hpi of SLS-infected laboratory rabbits. (A) 
Histological section of the skin at 24 hpi. The cell type that myxoma virus commonly 
localised to at this time is indicated by an arrow. Bar represents 90(Lim. (B) Myxoma virus 
positive cell at the epidermal/dermal junction of the skin, similar to the cell indicated in (A) 
Bar represents 30 pm. (C) Histological section of the skin at 24 hpi indicating fibroblast-
like cells in the dermis (arrows). Bar represents 90 pm. (D) Myxoma virus positive 
fibroblast-like cell in the dermis at 24hpi. Bar represents 10pm. E, epidermis; D, dermis.

Figure 4.4: Immunofluorescent staining for myxoma virus and MHC class II in the 
primary inoculation site at 24hpi. (A) Skin showing myxoma virus positive cells with 
dendritic processes in the dermis. Bar represents 225pm. (B) Serial section, taken 7pm 
from (A) showing MHC class II staining of cells in the dermis that have a dendritic 
morphology. Bar represents 225 pm. In tissue sections A and B, the keratin in hair follicles 
is visible due to autofluorescence. Tissue sections were also double stained for myxoma 
virus and MHC class II. (C) Myxoma virus staining. Bar represents 10pm. (D) MHC class 
II staining of the same cell as in C. Bar represents 10pm. E, epidermis; D, dermis; HF, 
hair follicle.

Figure 4.5: Virus localisation by immunofluorescence and the histology of the skin at the 
primary inoculation site of SLS-infected laboratory and wild rabbits at 4dpi. (A) Myxoma 
virus positive cells in the dermis of SLS-infected laboratory rabbits at 4dpi. Virus positive 
cells were not present in the epidermis at this time. Bar represents 150pm. (B) The 
histology of the skin of an SLS-infected laboratory rabbit at 4dpi. Bar represents 100pm. 
(C) Myxoma virus positive cells in the dermis of SLS-infected wild rabbits at 4dpi. Virus 
positive cells were not present in the epidermis at this time. Bar represents 150pm (D) The 
histology of the skin of an SLS-infected wild rabbit at 4dpi. Bar represents 100pm. E, 
epidermis; D, dermis.
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these cells were not in the very upper epidermis, close to the epidermal/dermal junction 
as they were in other infections. In addition, as shown in Figure 4.6, round cells of 
approximately 10 Mm in diameter, with a large round nucleus that occupied most of the ^ 
cell and a thin cytoplasm, stained positive for myxoma virus in dermis from SLS- 
infected wild rabbits (Figure 4.6 A and B), but not in SLS-infected laboratory rabbits 
(Figure 4.6 C and D). These cells were probably inflammatory lymphocytes.
In sections stained for MHC class II expression, the number of MHC class II positive 
cells in the upper dermis at the inoculation site had increased substantially from 24hpi in 
both SLS- and Uriarra-infected laboratory and wild rabbits (an example is shown in 
Figure 4.7A; compare with Figure 4.5A), although due to the extent of processes of 
these cells, they were difficult to quantify. In sections double stained for virus and 
MHC class II (Figure 4.7B), myxoma virus localised to the cytoplasm of these cells, 
which had a maximum diameter across the main body containing the nucleus of 15Mm, 
with two to three dendrites that also stained positive for virus (Figure 4.7C and D). By 
4dpi of laboratory rabbits with SLS, the spaces between the connective tissue of the 
dermis of infected rabbits had increased, perhaps indicating some edema. Fibrin had 
been deposited in localised areas of the dermis.
From 6dpi of laboratory or wild rabbits with SLS or Uriarra, only a small number of 
cells in the dermis with a dendritic morphology stained positive for myxoma virus or 
MHC class II (Figure 4.8A). In SLS-infected laboratory rabbits, myxoma virus 
localised to the endothelium of some blood vessels and virus-positive cells were 
clustered around these blood vessels (Figure 4.8B). The endothelial cells of these 
vessels were always swollen and had increased in number (see section 4.3.1.2.2). 
Endothelial cells did not stain positive for MHC class II, and were not observed positive 
for virus in the primary lesion from Uriarra-infected laboratory rabbits, or in wild 
rabbits infected with either SLS or Uriarra. Other dermal cells that did costain for MHC 
class II and myxoma virus in both laboratory and wild rabbits infected with SLS or 
Uriarra, were round, approximately 10Mm in diameter with no discemable nuclear 
morphology (Figure 4.8C). However at 6dpi, most of the virus was associated with the 
epidermis and the epithelial cells of the external root sheath in hair follicles.
Figure 4.9 shows a typical example of myxoma virus localisation and the architecture of 
the epidermis and hair follicles at 6dpi of laboratory rabbits infected with SLS. Virus
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Figure 4.6: Immunofluorescent localisation of myxoma virus in the dermis of the primary 
inoculation site of SLS-infected laboratory and wild rabbits at 4dpi. (A) Myxoma virus 
positive cells in the dermis of SLS-infected wild rabbits. Bar represents 100pm. (B) 
Myxoma virus positive cells in the dermis of SLS-infected wild rabbits at higher 
magnification showing infected lymphocytes. Bar represents 15pm. (C) Myxoma virus 
positive cells in the dermis of SLS-infected laboratory rabbits. Bar represents 100pm. (D) 
Myxoma virus positive cells in the dermis of SLS-infected laboratory rabbits at higher 
magnification showing infected dendritic cells. Bar represents 15pm.

Figure 4.7: Skin sections from the primary inoculation site o f SLS-infected laboratory 
rabbits at 4dpi and double stained by immunofluorescence for MHC class II and myxoma 
virus. (A) MHC class II positive staining o f dendritic cells in the dermis. Bar represents 
160pm. (B) Double stained section showing myxoma virus (green) and MHC class II (red) 
in the dermis. The colocalisation of both myxoma virus and MHC class II in the same cells 
gives yellow. Bar represents 80pm. (C) Colocalisation (shown in yellow) o f myxoma virus 
(green) and MHC class II (red) in a dermal dendritic cell. Bar represents 10pm. (D) The 
staining of the two antigens shown in (C) has been digitally split using BIORAD software 
to show the individual staining of myxoma virus (green) in the cytoplasm of infected cells, 
and MHC class II (red) on the surface of infected cells. Bar represents 10pm.

Figure 4.8: MHC class II and myxoma virus staining in the dermis at the primary 
inoculation site of SLS-infected laboratory rabbits at 6dpi. (A) MHC class II positive cells 
in the dermis of the inoculation site. Bar represents 200pm. (B) Myxoma virus positive 
cells in the blood vessel endothelium and in the dermis immediately surrounding these 
vessels. Bar represents 8pm. (C) Myxoma virus positive cells in the dermis at 6dpi. Bar 
represents 5pm. E, epidermis; D, dermis; VE, vessel endothelium.

Figure 4.9: Histopathology and virus immunolocalisation in the epidermis and hair
follicles at the primary inoculation site of SLS-infected laboratory rabbits at 6dpi. (A) 
Histopathology of the epidermis. (B) Myxoma virus staining in the epidermis. (C) 
Histopathology of the hair follicle. (D) Myxoma virus staining in the hair follicle. E, 
epidermis; D, dermis; HF, hair follicle. Bars represent 150pm.
A
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replication in the epidermis was associated with a number of cellular changes, 
particularly in the cells of the stratum basale (Figure 4.10A). There was an increase in 
the number of cuboidal cells in the lower epidermis, although mitotic figures were not 
observed at any time post infection. The obvious thickening of the epidermis by 6dpi, 
and the loss of flattened cells of the upper epidermis could be due either to cell 
proliferation or differentiation. The elongation and swelling of cells and the cell 
nucleus indicated pathological changes in epidermal cells. The cytoplasm of these cells 
became foamy, indicating intracellular edema or hydropic degeneration, and appeared to 
be compartmentalised to one end of the cell. The nucleus was located at the opposite 
end of the cell to the cytoplasmic material, and stained heavily at the periphery, 
indicating marginalisation of nuclear chromatin. The centre of the nucleus appeared 
either vesicular or contained blocks of dark staining chromatin. In the most severely 
affected areas of the epidermis, both the nuclear and cellular membranes were poorly 
defined, indicating degradation and necrosis of cells. At this stage, the cytoplasm of 
many of the epidermal cells was no longer obvious and round or semi-lunar shaped 
granules were present at the opposite end of the cell to the nucleus. Others of these 
cells, some of which did not have a nucleus (which may be an artifact of sectioning of 
the tissue), contained acidophilic inclusion bodies at one end of the cell (Figure 4.1 OB). 
Virus antigen was present at all layers throughout the epidermis in which these changes 
were observed, with no difference between SLS- or Uriarra-infected laboratory and wild 
rabbits.
Although the pathology described above was similar for both SLS- and Uriarra-infected 
laboratory and wild rabbits, differences were observed in the timing and the extent of 
the changes (Figure 4.11). At 6dpi of laboratory rabbits with SLS (Figure 4.11 A), the 
changes and necrosis of cells in the epidermis were more extensive than following 
infection with Uriarra at the same time (Figure 4.1 IB). The cells of the stratum basale 
had increased in number and size over more diffuse areas, and cell layers of the 
epidermis appeared more disrupted. It was not until 8dpi of laboratory rabbits 
inoculated with Uriarra in the thigh, that cells were necrotic, with the nucleus located at 
one end of the cell, the nuclear membrane was poorly defined and the cytoplasm was 
foamy. Infection of wild rabbits with SLS or Uriarra induced the same changes in the 
epidermis of the primary lesion as observed in laboratory rabbits, but the timing of these 
changes closely followed those in Uriarra-infected laboratory rabbits.
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Figure 4.10: Pathological changes in the skin at the primary inoculation site of myxoma 
virus-infected rabbits at 6dpi. (A) The pathological changes in the epidermis are indicated 
with numbers. (1) swelling of cells of the stratum basale, (2) cellular elongation, (3) 
increase in the number of cuboidal cells in the stratum basale and the appearance of a 
foamy cytoplasm, and (4) marginalisation of nuclear chromatin, and presence of viral 
inclusion bodies within the cytoplasm. At 6dpi, the dermis and the cells within the dermis 
appeared relatively normal. Bar represents 50pm. (B) Cytoplasmic viral inclusion bodies 
in the epidermis. Bar represents 15pm. BV, blood vessel; F, fibroblast; IB, inclusion body; 
L, lymphocyte.

Figure 4.11: Histopathology of the skin at the primary inoculation site of SLS and Uriarra- 
infected laboratory rabbits at 10dpi. (A) SLS-infected laboratory rabbit. (B) Uriarra 
infected-laboratory rabbit. (C) SLS-infected laboratory rabbit. (D) Uriarra-infected 
laboratory rabbit. E, epidermis; HF, hair follicle; LB, inclusion body; nf, nuclear fragments; 
P, plasma cell; L, lymphocyte. Bars represent 150pm.
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Figure 4.11 also depicts the differences in the distribution and composition of 
inflammatory cell infiltrate into the primary lesion of SLS (Figure 4.11 A and C) and 
Uriarra-infected rabbits at 6dpi (Figure 4.11 B and D). The dermis of the primary 
inoculation site from laboratory rabbits infected with Uriarra, or wild rabbits infected 
with either Uriarra or SLS, contained large numbers of mononuclear cells; 
macrophages, small lymphocytes and some plasma cells. These inflammatory cells 
were concentrated in the upper dermis, with aggregates of cells at the epidermis/dermis 
junction, directly below areas of epidermis with the changes associated with cell 
proliferation and pathology described above (Figure 4.1 ID). These changes were 
always associated with staining for myxoma virus by immunofluorescence. The influx 
of inflammatory cells into the dermis of infected wild rabbits was similar in 
composition to Uriarra-infected laboratory rabbits but always involved more cells. In 
contrast, inflammatory cells in the dermis of SLS-infected laboratory rabbits were 
predominantly neutrophils, which often appeared karyorrhectic or apoptotic, although 
lymphocytes and macrophages were also present. Similarly to 4dpi, inflammatory cells 
were less concentrated in the upper dermis of SLS-infected laboratory rabbits compared 
to Uriarra-infected laboratory rabbits, or to wild rabbits infected with either SLS or 
Uriarra, and were instead aggregated in the deep dermis, proximal to, and throughout, 
the superficial muscle layer (Figure 4.12). The muscle layer itself appeared shrunken 
and less organised in SLS-infected laboratory rabbits (Figure 4.12A) compared to 
rabbits infected with Uriarra (Figure 4.12B). In both SLS- and Uriarra-infected 
laboratory rabbits, myxoma virus was present in cells throughout the superficial muscle 
layer at the primary inoculation site (Figure 4.12 C). Myxoma virus was not observed 
at the superficial muscle layer of infected wild rabbits.
At 10dpi of laboratory or wild rabbits with either SLS or Uriarra (Figure 4.13), virtually 
all of the epidermis across the primary lesion stained positive for virus. Histologically, 
the epidermis of SLS-infected laboratory rabbits showed a marked progression of the 
changes described at 6dpi (Figure 4.13A). The stratum spinosum was loose and 
disorganised and contained large, fluid filled vesicles. These vesicles often contained 
polymorphonuclear leucocytes. The nucleus of many epidermal cells was semi-lunar 
shaped, shrunken and/or pyknotic, and appeared to be joined to the cell membrane by 
strands of remnant cytoplasm. Viral inclusion bodies were prominent in many 
epidermal cells. In Uriarra-infected laboratory rabbits (Figure 4.13B), and in wild 
rabbits infected with SLS at 10dpi, the epidermis of the primary inoculation site
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Figure 4.12: Histopathology and virus localisation at the superficial muscle layer of the 
primary inoculation site of SLS and Uriarra-infected laboratory rabbits at 10dpi. (A) 
Histopathology of skin from an SLS-infected laboratory rabbit. (B) Histopathology of skin 
from a Uriarra infected-laboratory rabbit. Note the shrunken appearance of muscle in SLS- 
infected skin and the numerous inflammatory cells deep in the dermis compared to that in 
skin from Uriarra-infected laboratory rabbits. (C) Myxoma virus immunolocalisation in 
cells proximal to the superficial muscle layer of an SLS-infected laboratory rabbit. D, 
dermis; SM, superficial muscle. Bars represent lOOum.

Figure 4.13: Histopathology and virus localisation in the epidermis of the primary 
inoculation site of SLS and Uriarra-infected laboratory rabbits at 10dpi. (A) 
Histopathology of skin from an SLS-infected laboratory rabbit. (B) Histopathology of skin 
from a Uriarra-infected laboratory rabbit. (C) Myxoma virus immunolocalisation in the 
epidermis of an SLS-infected laboratory rabbit. E, epidermis; D, dermis. Bars represent 
100pm.
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resembled that described at 6dpi for SLS-infected laboratory rabbits. Cells of most of 
the stratum basale showed changes associated with cell proliferation and pathology, and 
cells in the upper epidermis contained inclusion bodies.
Figure 4.14 shows differences between infections in the dermis of the primary 
inoculation site. These were the inflammatory responses and the organisation of the 
connective tissue. In SLS-infected laboratory rabbits (Figure 4.14A), the upper dermis 
contained nuclear fragments and cellular debris. Similarly to earlier time points in 
infection, inflammatory cells were concentrated deep in the dermis. The concentration 
of dermal collagen fibres was generally reduced compared to uninfected skin, especially 
directly under the epidermis and proximal to the superficial muscle layer. Collagen 
fibres that were present were of a disorganised appearance with either fibrin or large 
spaces between fibres and dermal fibroblasts were enlarged. In Uriarra-infected 
laboratory rabbits (Figure 4.14B), and wild rabbits infected with SLS (Figure 4.14C) or 
Uriarra, the upper dermis contained numerous lymphocytes and some monocytes. 
Spaces in the connective tissue of the dermis were larger than in the dermis from 
uninfected rabbits, however, pathologic changes did not progress much further, with the 
collagen fibres remaining well organised. The deposition of fibrin was much less 
extensive than following SLS infection of laboratory rabbits, and fibroblasts were of 
normal size.
From 15dpi of laboratory rabbits with Uriarra (Figure 4.15A) or of wild rabbits with 
SLS (Figure 4.15B), areas of the primary lesion had scab material consisting mainly of 
damaged epidermis and inflammatory cells. Many small, dark staining nuclear 
fragments of inflammatory cells were in the upper dermis proximal to the 
epidermis/dermis junction. Virus antigen was present in the epidermis of the primary 
skin lesion, but the numbers of infected cells were considerably less than at earlier time 
points. The strongest fluorescence was in the stratum basale of the epidermis, and in the 
epithelial cells of the external root sheath of hair follicles (Figure 4.15C). From 15dpi, 
mitotic figures were occasionally observed in the cells of the stratum basale. Long, thin 
fibroblast-like cells extended from underneath the stratum basale, and were positioned 
under the necrotic tissue The pathology of the epidermis at 15dpi in these rabbits was 
similar to those described at 10dpi in SLS-infected laboratory rabbits; the stratum basale 
was up to three layers thick, many cells appeared necrotic and large vesicles had formed 
in the epidermis of the primary lesions.
Virus localisation and histopathology
Figure 4.14: Histopathology of the dermis at the primary inoculation site of myxoma virus- 
infected rabbits at 10dpi. (A) SLS-infected laboratory rabbit. (B) Uriarra-infected 
laboratory rabbit. (C) SLS-infected wild rabbit, nf, nuclear fragment; F, fibroblast; BV, 
bloodvessel. Bars represent 100pm.
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Figure 4.15: Histopathology and virus localisation in the epidermis of the primary 
inoculation site of Uriarra-infected laboratory rabbits and SLS-infected wild rabbits at 
15dpi. (A) Histopathology o f skin from a Uriarra-infected laboratory rabbit. The stratum 
basale is indicated with an arrow. (B) Histopathology of skin from an SLS-infected wild 
rabbit. The stratum basale is indicated with an arrow. (C) Myxoma virus localisation in 
the stratum basale in the epidermis of a infected laboratory rabbit. Immunolocalisation was 
performed on frozen tissue sections and some o f the epidermis has been tom away in the 
sectioning process. E, epidermis. Bars represent lOOjim.
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By 20dpi, thick scab material overlaid the lesion of Uriarra-infected laboratory rabbits 
(Figure 4.16A) or of SLS-infected wild rabbits (Figure 4.16B). Similarly to 15dpi, virus 
was present in cells of the stratum basale of the epidermis, and in the epithelial cells of 
the external root sheath of hair follicles, but was not observed in the dermis (Figure 
4.16C). Massive aggregations of inflammatory cells, mainly lymphocytes, were located 
at the margins of the scab material and extending down into the dermis and throughout 
the deep dermis. This was observed particularly in infected wild rabbits. The number 
of nuclear fragments and inflammatory cells, and the amount of cellular debris, in the 
dermis proximal to the dermis/epidermis junction and in the centre of the primary lesion 
was decreased compared to 15dpi. The density and organisation of collagen fibres had 
increased throughout the dermis, especially surrounding blood vessels, and coincided 
with a greater number of fibroblasts in the dermis. The amorphous fibrin material was 
condensed. Extravasated RBCs were located throughout the dermis.
4.3. i .2.2 The endothelial cells of small blood vessels and the appearance of
myxoma cells in the dermis
The endothelial wall of capillaries consists of a single layer of cells (Figure 4.17A). At 
4dpi of laboratory rabbits with SLS, the endothelium of some capillaries and venules in 
the dermis appeared swollen, as cells were enlarged and both the nuclear and cellular 
membranes appeared distended (Figure 4.17B). Changes in the endothelium of these 
vessels, but not the larger arterioles, were extensive by 6dpi, especially of the vessels in 
the deep dermis proximal to the superficial muscle layer (Figure 4.17C). Endothelial 
cells were enlarged, and the nucleus was pale staining except at the periphery, and 
appeared slightly vacuolated. The number of cells in the endothelium had increased by 
6 and 10dpi (Figure 4.17D). This increase in cells was particularly obvious in 
capillaries. The vessel type could still be determined despite the increase in cell number 
and swelling of cells, by the size of the vessel lumen and the extent of the elastic tissue 
associated with the vessel. Cells which resembled those described as myxoma cells by 
Hurst (1937a) were present by 6dpi proximal to blood vessels that contained abnormal 
endothelial cells. Myxoma cells were typically large, polygonal or stellate shaped cells 
with large, pale staining, hypertrophic nuclei (Figure 4.17E). Myxoma cells did not 
stain positive for MHC class II. Endothelial cells of capillaries did not stain positive for 
MHC class II and rarely stained positive for myxoma virus. By 10dpi, many of the 
blood vessels were surrounded by extravasated RBCs and the endothelial cells appeared 
necrotic. Myxoma cells were highly stellate in shape, and the nuclear membrane in
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Figure 4.16: Histopathology and virus localisation in the epidermis of the primary 
inoculation site of Uriarra-infected laboratory rabbits and SLS-infected wild rabbits at 
20dpi. (A) Histopathology of skin from a Uriarra-infected laboratory rabbit. (B) 
Histopathology of skin from an SLS-infected wild rabbit. (C) Myxoma virus localisation 
in the stratum basale in the epidermis and the hair follicle of a infected laboratory rabbit. E, 
epidermis; D dermis; HF, hair follicle. Bars represent 100pm.

Figure 4.17: Changes in the endothelium of blood vessels and the appearance of myxoma 
calls in SLS and Uriarra infected laboratory rabbits. (A) Capillary from an uninfected 
rabbit. (B) Capillary from an SLS-infected rabbit at 4dpi. (C) Capillary from an SLS- 
infected rabbit at 6dpi. (D) Capillary from an SLS-infected rabbit at 10dpi. . (E) Stellate 
myxoma cell. (F) Capillary from a Uriarra-infected rabbit at 10dpi. Arrows indicate the 
blood vessel endothelium. Bars represent 30pm.
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many cells was poorly defined, indicating that these cells were also necrotic. These 
myxoma cells were often surrounded by aggregates of neutrophils.
At 6dpi of laboratory rabbits with Uriarra, or of wild rabbits infected with SLS, 
endothelial cells of capillaries and venules were swollen. This swelling was also 
evident at 10dpi (Figure 4.17F), but in general, no further changes in the blood vessels 
were observed. Myxoma virus antigen was not detected in the blood vessel 
endothelium. Large, stellate myxoma cells were not prominent in the dermis at any 
time post infection of laboratory or wild rabbits infected with Uriarra. However, 
myxoma cells were occasionally observed from 10dpi in the deep dermis of Uriarra- 
infected laboratory rabbits. Stellate myxoma cells were also rare in the dermis of wild 
rabbits infected with SLS.
4.3.2 The distal skin
Skin was removed from the dorsum of the opposite hind foot (distal skin) to the primary 
inoculation site in myxoma virus-infected rabbits. The pathologic changes in the distal 
skin closely resembled their counterparts at the primary inoculation site and are 
described below.
In SLS-infected laboratory rabbits virus was first present in the dermis of the distal skin 
in MHC class II positive dendritic cells, in one of two rabbits at 4dpi, but was not 
present at 2dpi. These dendritic cells had increased in number at 4dpi compared to the 
numbers present in uninfected skin samples. By 6dpi, myxoma virus was present in 
dermal dendritic cells in both SLS-infected laboratory rabbits that had been inoculated 
in the hind foot. This was associated with the infiltration of mononuclear cells, 
predominantly lymphocytes, into the deep dermis, and the swelling of endothelial cells 
of some capillaries. In localised areas of the epidermis, cells of the stratum basale were 
swollen, with both the nuclear and cellular membranes distended, and had increased in 
number (Figure 4.18A).
By 10dpi of laboratory rabbits with SLS, virus was present in the epidermis of distal 
skin, with few virus-positive cells in the dermis. The pathological changes in the 
epidermis of the distal skin resembled that described for the primary inoculation site of 
SLS-infected laboratory rabbits at 6dpi; the cytoplasm of nucleated cells was vesicular,
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and virus inclusion bodies were present in some cells. Inflammatory cells, 
predominantly neutrophils, remained localised to the deep dermis. Endothelial cells of 
dermal capillaries had increased in number and small stellate myxoma cells were 
present. Myxoma cells in the distal skin samples did not stain positive for myxoma 
virus.
Virus was first present in the distal skin of Uriarra-infected laboratory rabbits and SLS- 
infected wild rabbits at 6dpi and 4dpi respectively. Similarly to SLS-infected wild 
rabbits, myxoma virus-infected cells were dendritic cells that costained positive for 
MHC class II. However, cells positive for virus were distributed in the upper dermis 
and proximal to blood vessels and did not have the uniform distribution throughout the 
dermis that was observed in the primary inoculation site of the same rabbits or either 
skin site from SLS-infected laboratory rabbits. In addition, the number of MHC class II 
positive dendritic cells had increased in the dermis of Uriarra-infected laboratory rabbits 
and SLS-infected wild rabbits by 6dpi, but not to the extent observed in SLS-infected 
laboratory rabbits. However, the most striking difference between these rabbits and 
laboratory rabbits infected with SLS was the early infiltration of mononuclear cells 
throughout the dermis from 4dpi and particularly at 10dpi. At 6dpi of laboratory rabbits 
with SLS, inflammatory cells in the upper dermis were predominantly neutrophils and 
included lymphocytes (Figure 4.18A). The inflammatory response in the distal skin of 
wild rabbits infected with SLS was monocytic (Figure 4.18B). Lymphocytes and 
macrophages were particularly prominent proximal to small blood vessels and at the 
epidermis/dermis junction of the distal skin by 4dpi, before virus was present in the 
epidermis. This was in contrast to the primary inoculation site, where inflammatory 
cells were present at this junction at the same time as myxoma virus. This early 
infiltration of mononuclear cells was most prominent in SLS-infected wild rabbits 
(Figure 4.18B).
At 10dpi in SLS-infected wild rabbits and in Uriarra-infected laboratory rabbits, virus 
generally remained localised to the dermis of distal skin. Spread of virus from the 
dermis to the epidermis was observed in one SLS-infected wild rabbit only. The 
inflammatory response in the distal skin was distributed extensively throughout the 
dermis of SLS-infected wild rabbits and Uriarra-infected laboratory rabbits although 
generally involved more cells in infected wild rabbits.
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Figure 4.18: Histopathology of the distal skin from SLS-infected laboratory and wild 
rabbits at 6dpi. (A) SLS-infected laboratory rabbit. (B) SLS-infected wild rabbit. E, 
epidermis; L, lymphocyte; M, monocyte, N, neutrophil. Bars represent 100pm.
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At 15dpi, one of two SLS-infected wild rabbits had a secondary lesion at the distal skin 
site and virus was present in the epidermis from both SLS-infected wild rabbits. 
However, virus did not infect the epidermis of the entire tissue section. Instead, virus 
localised to short stretches, up to 30 cells of the stratum basale in length (Figure 4.19). 
Cellular changes associated with virus replication in the epidermis were similar to those 
in the primary lesion at 6dpi for these rabbits. In the dermis, endothelial cells of blood 
vessels were swollen with distended cellular and nuclear membranes, but generally had 
not increased in number and myxoma cells were not observed. Virus was not present in 
the epidermis of distal skin in Uriarra-infected laboratory rabbits or Uriarra-infected 
wild rabbits.
Figure 4.19: Myxoma virus localisation in the dermis and epidermis of distal skin 
from an SLS-infected wild rabbit at 15dpi. E, epidermis; D, dermis. Bar represents 
150pm.
By 20dpi, virus was present in the distal skin in the stratum basale of the epidermis and 
in the external root sheath of some hair follicles in two of three SLS-infected wild 
rabbits. This was similar to virus localisation in the skin of the primary lesion at the 
same time. Virus was not present in the distal skin of the third SLS-infected wild 
rabbit. Similarly, virus was not present in the epidermis of laboratory or wild rabbits
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infected with Uriarra. In all rabbits, the dermis contained numerous mononuclear 
inflammatory cells, particularly concentrated at the epidermis/dermis junction and in the 
deep dermis.
4.3.3 The draining and contralateral lymph nodes 
4.3.3.1 Uninfected lymph n odes
The anatomy of the popliteal lymph node from an uninfected rabbit is depicted 
schematically in Figure 4.20. and in micrographs in Figure 4.21. The lymph node is 
surrounded by a capsule, into which the afferent lymphatics enter and bathe the cortex 
via the subcapsular sinus. Fibrous radial bands called trabeculae extend into the node 
from the lymph node capsule, and in many species, divide the main body of the node, 
the diffuse cortex, into lobules (Figure 4.20). These bands did extend through the cortex 
of rabbit lymph nodes, but did not divide it into obvious lobules (Figure 4.21 A and B). 
The structural network of the lymph node consists of reticular cells and fibres, although 
these are not readily observed in lymph nodes from uninfected rabbits by light 
microscopy and staining with haematoxylin and eosin. Lymph nodes are generally 
located in fatty tissue within the animal, and a network of adipose tissue surrounds the 
outside of the lymph node in section.
A histological section of a lymph node can be divided into two general zones; the cortex 
and the medulla. The cortex consists of two areas, namely the T cell-dependent 
paracortex in which B cell-dependent germinal centres form in response to antigenic 
stimulation (Figure 4.21 A). The cortex contains high endothelial venules (HEV) which 
are bordered by cortical sinuses (Gretz et al., 1997); the entire structure constitutes the 
paracortical cord (Kelly, 1975). The medulla is constituted with cords of reticular cells 
that are lined with macrophages and immediately surrounded by sinuses. The lymph 
drains into the medullary sinuses. Efferent lymphatics arise in the hilus from these 
sinuses.
The diffuse cortex of lymph nodes from uninfected rabbits contained lymphocytes, 
macrophages (Figure 4.21C) and plasma cells. Neutrophils were rarely present in 
lymph nodes from uninfected rabbits. In the cortex of uninfected lymph nodes, both 
germinal centres and clusters of small lymphocytes called follicles were present. Care 
must be taken as to the interpretation of these clusters as follicles or as a section taken
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through one edge of a germinal centre. Similar to other species such as mouse or 
human (Liu and Arpin, 1997), germinal centres in rabbit lymph nodes had a number of 
zones, the dark zone containing centroblasts, the light zone containing centrocytes and 
follicular dendritic cells, and the mantle zone containing small, newly differentiated 
lymphocytes. Cells undergoing mitotic division or with fragmented nuclei were 
occasionally observed in the light and mantle zones (Figure 4.2ID). Plasma cells were 
present in the paracortex below germinal centres, in the subcapsular sinus and amongst 
the medullary cords.
Afferent lymphatics
Cortex
Medullary sinuses
(.ymphoid follicle
Follicle with germinal centre
Capsule Trabecula
Efferent lymphatic
Medullary cord
Subcapsular sinus
Figure 4.20: Schematic drawing of a lymph node showing its strucure. The node is 
encapsulated by dense connective tissue (capsule). Lymph drains into the node via the 
afferent lymphatics, through the subcapsular sinus and the medullary sinuses to the 
efferent lymphatics (modified from Wheater et al., 1987).
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Figure 4.21: Popliteal lymph node from an uninfected rabbit. (A) The cortex of a rabbit 
lymph node showing the T-cell-dependent paracortex and a B cell-dependent germinal 
centre. (B) The cortex of a rabbit lymph node in which the T-cell-dependent paracortex 
and a B cell-dependent follicle are indicated. (C) Paracortex of a lymph node from an 
uninfected rabbit, in which lymphocytes, macrophages and a blood vessel are indicated. 
(D) The light zone of a germinal centre showing lymphocytes, a cell in mitotic division 
(arrow) and an apoptotic cell containing nuclear fragments. A, apoptotic cell; BV, blood 
vessel; GC, germinal centre; F, follicle; PC, paracortex; M, macrophage. Bar represents 
100 pm.
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4.3.3.2 Virus antigen, histopathological changes and immunohistochemical staining 
in the draining and contralateral lymph nodes of rabbits infected with 
myxoma virus
Changes in the lymph nodes following infection of rabbits with myxoma virus occurred 
particularly in the paracortex and germinal centres. These included a general depletion 
of lymphocytes, the proliferation and degeneration of reticular and endothelial cells, and 
an influx of inflammatory cells into the nodes. These changes are described in detail 
below (and summarised in Table 4.3), as well as the cellular localisation of myxoma 
virus and changes in cell populations detected by immunohistochemistry.
Table 4.3: Myxoma virus localisation and histopathology of lymph nodes from
laboratory or wild rabbits infected with either SLS or Uriarra. Virus was not present in 
the draining lymph node at 12 hours post infection.
Laboratory_____  _____________________ Wild
SLS Uriarra SLS Uriarra
24 HOURS POST INFECTION
V iru s  a n tig e n M o n o n u c le a r  ce lls M o n o n u c le a r  c e lls M o n o n u c le a r  ce lls N o t p re s e n t
in  p a ra c o r te x in  p a ra c o r te x in  p a ra c o r te x
TWO DAYS POST INFECTION
V iru s  a n t ig e n C o n tin u o u s  lin e s C o n tin u o u s  lin e s C o n tin u o u s  lin e s C o n tin u o u s  lin e s
sp a n n in g  th e sp a n n in g  th e s p a n n in g  th e s p a n n in g  th e
p a ra c o r te x ; p a ra c o r te x ; p a ra c o r te x ; p a ra c o r te x
ly m p h o c y te s ly m p h o c y te s ly m p h o c y te s
FOUR DAYS POST INFECTION
V iru s  a n t ig e n L y m p h o c y te s  an d L y m p h o c y te s  a n d L y m p h o c y te s  a n d V im s  n o t  o b se rv e d
m a c ro p h a g e s  in m a c ro p h a g e s  in m a c ro p h a g e s  in in  d ra in in g  o r
p a ra c o r te x  o f p a ra c o r te x  o f p a ra c o r te x  o f c o n tra la te ra l
d ra in in g  an d d ra in in g  ly m p h d ra in in g  an d ly m p h  n o d e s
c o n tra la te ra l n o d e c o n tra la te ra l
ly m p h  n o d e s , ly m p h  n o d e s ,
ly m p h  n o d e ly m p h  n o d e
c a p su le c a p su le
P a ra c o r te x In te r fo ll ic u la r H y p e rp la s ia  o f In te r fo ll ic u la r H y p e rp la s ia  o f
h y p o p la s ia  o f ly m p h o c y te s  in h y p o p la s ia  o f ly m p h o c y te s  in
ly m p h o c y te s  in p a ra c o r te x  o f ly m p h o c y te s  in p a ra c o r te x  o f
d ra in in g  ly m p h d ra in in g  an d d ra in in g  ly m p h d ra in in g  ly m p h
n o d e c o n tra la te ra l 
ly m p h  n o d e s
n o d e n o d e
G e rm in a l c e n tre s N o  in c re a se  in H y p e rp la s ia  o f L im ite d H y p e rp la s ia  o f
s ize , d e f in i t io n  o r ly m p h o c y te s  a n d h y p e rp la s ia ly m p h o c y te s
n u m b e r in c re a se  in  n u m b e r  
o f  g e rm in a l c e n tre s
B lo o d  v e s se ls S w e llin g  o f N o  c h a n g e S w e llin g  o f N o  c h a n g e
e n d o th e lia l  ce lls  in e n d o th e lia l  c e lls  in
th e  d ra in in g  ly m p h th e  d ra in in g  ly m p h
n o d e n o d e
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Table 4.3 continued:
Laboratory Wild
SLS Uriarra SLS Uriarra
SIX DAYS POST INFECTION
Virus antigen Lymphocytes and Lymphocytes and Lymphocytes and Not present
macrophages in macrophages in macrophages in
paracortex of paracortex of paracortex of
draining and draining and draining and
contralateral lymph contralateral lymph contralateral lymph
nodes, lymph node node nodes, lymph node
capsule capsule
Paracortex Extensive depletion Hyperplasia of Extensive depletion Hyperplasia of
of lymphocytes lymphocytes of lymphocytes lymphocytes
from both draining from draining but
and contralateral not contralateral
lymph nodes lymph nodes
Germinal centres Extensive depletion Hyperplasia of Extensive depletion Hyperplasia of
of lymphocytes lymphocytes of lymphocytes lymphocytes
from both draining from draining but
and contralateral not contralateral
lymph nodes,
neutrophil
infiltration
lymph nodes
Blood vessels Swelling and Swelling of Swelling of Swelling of
increase in number endothelial cells in endothelial cells in endothelial cells in
of endothelial cells the draining lymph the draining lymph the draining lymph
in draining and 
contralateral lymph 
nodes
node node node
Stellate myxoma 
cells
Present Absent Absent Absent
T E N  D A Y S  P O S T  IN F E C T IO N
Virus antigen Reticular or Lymphocytes and Lymphocytes in Lymphocytes in
myxoma cells macrophages in paracortex of paracortex of
associated with paracortex of draining and draining and
degenerating draining and contralateral lymph contralateral lymph
germinal centres in contralateral lymph nodes, lymph node nodes
draining and 
contralateral lymph 
nodes
node capsule
Paracortex/ Extensive Mild depletion of Highly variable No further changes
germinal centres infiltration of lymphocytes from between rabbits -
neutrophils and interfollicular and ranging between
reticular cell mantle zones of extensive depletion
proliferation in draining and and reticular cell
draining and contralateral lymph proliferation to
contralateral lymph nodes relatively heathy.
nodes Some infiltration of 
neutrophils
Blood vessels Swelling and Swelling of Swelling of Swelling of
increase in number endothelial cells in endothelial cells in endothelial cells in
of endothelial cells the draining lymph the draining lymph the draining lymph
in blood vessel 
walls of draining 
and contralateral 
lymph nodes
node node node
Stellate myxoma Present in draining Absent Present in draining Absent
cells and contralateral 
lymph nodes
lymph nodes
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T a b le  4 .3  c o n tin u ed :
L a b o r a to r y W ild
S L S U r ia r r a S L S U r ia r r a
F IF T E E N  D A Y S  P O S T  IN F E C T IO N
V irus an tigen
.'•rr>
P resen t in a few  
lym phocy tes in 
paraco rtex  o f  
d rain ing  lym ph 
node
N o t p resen t N o t p resen t
P aracortex / 
germ inal cen tres
N o  further changes R epopu la tion  o f  
d rain ing  lym ph 
node w ith  sm all 
lym phocy tes in 
paraco rtex  and 
hyperp lasia  o f  
lym phocy tes in 
germ inal centre
N o  fu rther changes
B lood  vessels " Sw ollen
endo thelium
S w ollen
endo thelium
N o  change
S tellate m yxom a 
cells
A bsen t A bsen t
T W E N T Y  D A Y S  P O S T  IN F E C T IO N
A bsen t
V irus an tigen N o t presen t C on tinuous lines 
o f  an tigen  in the 
p araco rtex  o f  
d rain ing  lym ph 
node b u t no t 
associa ted  w ith  
lym phocy tes
N o t p resen t
P araco rtex / 
germ inal cen tres
N o  further changes N o fu rther changes N o  fu rther changes
B lood  vessels R educed  sw elling  
o f  endo thelium
R educed  sw elling  
o f  endo thelium
N o  change
S tellate m yxom a 
cells
" A bsen t A bsen t A bsen t
4.3.3.2.1 Twenty-four hpi, two and four days post infection of laboratory and wild 
rabbits with myxoma virus.
The earliest detection of myxoma virus was at 24 hpi in the paracortex of the draining 
lymph node of laboratory rabbits infected with SLS or Uriarra, or wild rabbits infected 
with SLS (Figure 4.22). Cells infected with myxoma virus at this time were 
mononuclear cells; small cells which had short processes at opposite ends to each other 
(Figure 4.22A) and slightly larger cells that possessed two slender dendritic processes 
(Figure 4.22B). Cells infected with myxoma virus were always located close to each 
other. Virus was not detected until 2dpi in the draining lymph node of wild rabbits 
infected with Uriarra.
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Figure 4.22: Myxoma virus infected cells in the paracortex of the draining lymph 
node at 24hpi. These cells were not characterised further than their morphology. (A) 
Small, mononuclear cell, approximately 6pm in diameter, with short processes at 
opposite ends to each other. Bar represents 3 pm. (B) Larger mononuclear cell with 
long, slender dendritic processes (arrow). Bar represents 8pm.
By 2dpi, virus was localised in cells directly under the capsule of the draining lymph 
node (Figure 4.23A), and spanning the paracortex as continuous lines (Figure 4.23B), 
with no difference observed between wild or laboratory rabbits infected with Uriarra or 
SLS. The lines of virus antigen varied in the intensity of fluorescence. It was not clear 
if lines of antigen of low intensity represented virus aggregates that were not cell- 
associated or infected cell debris, that was draining directly into the lymph nodes from 
the primary inoculation site in the skin. The lines of virus antigen of high staining 
intensity were associated with the cytoplasm of lymphocytes in both the draining and 
contralateral lymph nodes of infected rabbits (Figure 4.23C) and hence are likely to 
depict early replication of virus within the draining lymph node. Virus was also present 
in separate cells that were not associated with the continuous lines of virus in the cortex 
of lymph nodes (Figure 4.23D), or in clusters of two to five cells adjacent to each other. 
These cells resembled lymphocytes as they had a single round nucleus and a narrow 
cytoplasm.
At 4dpi of laboratory rabbits with either SLS or Uriarra, virus was present in 
lymphocytes and was evenly distributed throughout the diffuse cortex of lymph nodes 
draining the inoculation site (Figure 4.24 A and B). This infection of T-cell-dependent 
areas at 4dpi was more extensive in popliteal lymph nodes from rabbits that had been
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Figure 4.23: Myxoma virus localisation in the draining lymph node of an SLS-infected 
laboratory rabbit at 2dpi. (A) Myxoma virus staining cells of the outer lymph node cortex, 
directly under the lymph node capsule. Bar represents 25pm. (B) Myxoma virus infection 
of continuous lines of cells that spanned the paracortex. Bar represents 100pm. (C) High 
magnification of (B) showing myxoma virus localisation in the cytoplasm of infected cells. 
Bar represents 25 pm. (D) Myxoma virus-infected lymphocyte in the cortex of the draining 
lymph node. Bar represents 15pm. C, capsule.

Figure 4.24: Myxoma virus localisation in the draining and contralateral lymph nodes of 
an SLS and Uriarra-infected laboratory rabbits at 4dpi. (A) Draining lymph node of an 
SLS-infected laboratory rabbit. Bar represents 300pm. (B) Draining lymph node of a 
Uriarra-infected laboratory rabbit. Bar represents 150pm. (C) Contralateral lymph node of 
an SLS-infected laboratory rabbit. Bar represents 300pm. (D) Contralateral lymph node of 
a Uriarra-infected laboratory rabbit. Bar represents 150pm. (E) Myxoma virus-infected 
lymphocyte in the paracortex. Bar represents 10pm. (F) Myxoma virus-infected
macrophage-like cell in the paracortex. Bar represents 10pm. GC, germinal centre; P, 
paracortex.
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inoculated in the foot compared to that of rabbits that had been inoculated in the thigh, 
and was more extensive in SLS-infected laboratory rabbits. Virus was not associated 
with germinal centres in the draining lymph node of laboratory rabbits infected with 
either SLS or Uriarra. However, in the contralateral lymph node of infected rabbits 
(Figures 4.24 C and D), virus had infected lymphocytes (Figure 4.24E) in both the 
diffuse cortex and in the newly forming mantle zones of germinal centres, particularly 
in the contralateral lymph nodes of infected laboratory rabbits. Virus had also infected 
large mononuclear cells that resembled macrophages in the paracortex in both the 
draining and contralateral lymph nodes (Figure 4.24F). Infection of the T-cell- 
dependent zones in the contralateral lymph nodes was less extensive than the draining 
lymph node, particularly in Uriarra-infected rabbits. From 4dpi, cells within the wall of 
the lymph node capsule from SLS, but not Uriarra, infected laboratory rabbits stained 
positive for virus antigen (Figure 4.25A). These cells were elongated, approximately 
90pm across, with a large central nucleus (Figure 4.25B).
Figure 4.25: Localisation of SLS in the draining lymph node of a laboratory rabbit 
at 4dpi. (A) SLS localisation in cells of the lymph node capsule. Bar represents 
100pm. (B) Higher magnification of (A) showing localisation of SLS in the 
cytoplasm of an infected cell. Bar represents 15pm. Arrow indicates the cell shown 
at higher magnification in (B). C, capsule.
In wild rabbits infected with SLS at 4dpi, virus was present in lymphocytes in the 
diffuse cortex of the draining lymph node, but less cells were infected than in the
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draining lymph node of SLS-infected laboratory rabbits at the same time. In the 
contralateral lymph node, SLS was present in lymphocytes in the cortex of one of two 
infected rabbits. Uriarra was not present in the draining or contralateral lymph nodes of 
wild rabbits at 4dpi.
The earliest striking difference between the draining lymph nodes from myxoma virus- 
infected rabbits was the number of primary follicles and germinal centres at 4dpi. In 
SLS-infected rabbits, these numbered up to eight per tissue section (Figures 4.26 A and 
B show the range of follicle development), whereas there were up to 40 in Uriarra- 
infected rabbits (Figure 4.26C). The number of follicles and germinal centres was 
generally greater in SLS-infected wild rabbits compared to laboratory rabbits, but was 
never as great as in the lymph nodes of Uriarra-infected rabbits. In the tissue sections 
from two of four laboratory rabbits infected with SLS at 4dpi, there were no germinal 
centres present in the draining or contralateral lymph nodes, although there were 
numerous follicles in the very outer cortex. In SLS-infected wild rabbits, germinal 
centre formation was limited in the draining lymph node (Figure 4.27A), but in the 
contralateral lymph node, was more comparable to that of Uriarra-infected laboratory 
rabbits (Figure 4.27B). In some follicles from SLS-infected laboratory or wild rabbits, 
there was an increase in the area represented by the light zone but with no concomitant 
increase in the area of the mantle zone. However, in lymph nodes from Uriarra-infected 
rabbits, there were more cells in mitotic division in the mantle zones of germinal centres 
indicating that cell division was occurring following infection of rabbits. There was also 
an increased number of cells with apoptotic nuclei. Apoptotic cells had small, globular, 
dark staining fragments instead of a single nucleus. In the lymph nodes from these 
rabbits, there was also a general increase in the number of small lymphocytes in the 
paracortex compared to uninfected lymph nodes.
In addition to the development of germinal centres, differences in lymph nodes between 
laboratory or wild rabbits infected with either virulent or attenuated myxoma virus were 
observed in the paracortex. Endothelial cells of capillaries and venules within the 
paracortex of lymph nodes from SLS-infected laboratory rabbits were swollen by 4dpi, 
and in some vessels, had increased in number. Neutrophils were present within the 
lumen of blood vessels in both the draining and contralateral lymph nodes at 2 and 4dpi 
with SLS, but were not present outside the blood vessels (Figure 4.28A). The nucleus 
of lymphocytes proximal to blood vessels containing neutrophils contained dark-
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Figure 4.26: Histopathology of the draining lymph node of SLS or Uriarra-infected
laboratory rabbits at 4dpi. (A) Lymph node from one SLS-infected laboratory rabbit that 
contains follicles in the cortex, but no germinal centres. (B) Lymph node from the other 
SLS-infected laboratory rabbit which contains several germinal centres in the cortex at 
4dpi. (C) Lymph node from a Uriarra-infected laboratory rabbit which has numerous, well 
defined germinal centres in the outer cortex and throughout the paracortex. Bars represent 
100pm. F, follicle; GC, germinal centre; PC, paracortex.
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staining blocks of chromatin or were apoptotic. In SLS-infected wild rabbits or in 
Uriarra-infected wild or laboratory rabbits, blood vessel endothelia were similar to those 
in the lymph nodes of uninfected rabbits, and neutrophils were not routinely observed in 
the blood vessel lumen (Figure 4.28B). However, on autopsy at 2dpi, the draining 
lymph node from one SLS-infected wild rabbit was purple in colour and contained a 
large aggregation of neutrophils associated with extravasated RBC in a localised area of 
the subcapsular sinus and cortex. There were numerous nuclear fragments in this area. 
The contralateral lymph node of the same rabbit appeared normal, with no neutrophils 
in the lumen of blood vessels.
By 4dpi, there was depletion of lymphocytes from both the draining and contralateral 
lymph nodes of SLS-infected laboratory rabbits (Figure 4.29 A and B). The decrease in 
the number of lymphocytes was in the cortex, directly under the subcapsular sinus and 
in the interfollicular regions, and was associated with the deposition of fibrin. Some 
lymphocytes in the interfollicular zones stained darker at the periphery of the nucleus 
and in dark blocks in the centre of the nucleus, indicating condensation and 
marginalisation of chromatin. The nucleus of lymphocytes present in the blood vessel 
lumen also stained heavily at the periphery. In SLS-infected wild rabbits, depletion of 
lymphocytes had occurred by 4dpi from the interfollicular zones of draining lymph 
nodes, similar to that described for SLS-infected laboratory rabbits, but the contralateral 
lymph nodes were normal. The diffuse cortex of both draining and contralateral lymph 
nodes of Uriarra-infected laboratory or wild rabbits was well populated with 
lymphocytes and macrophages, with no evidence of cell depletion by 4dpi (Figures 4.29 
C and D).
4.3.3.2.2 Six days post infection of laboratory and wild rabbits with SLS or Uriarra
At 6dpi of laboratory or wild rabbits with either SLS or Uriarra, virus had infected 
mononuclear cells resembling lymphocytes and macrophages in both the draining and 
contralateral lymph nodes. In all rabbits inoculated with myxoma virus, infected cells 
were evenly distributed throughout t^e much of the diffuse cortex of both draining and 
contralateral lymph nodes (Figure 4.30A) and in the mantle zones of germinal centres. 
However, in SLS-infected wild rabbits (Figures 4.30 B and C), or Uriarra-infected 
laboratory rabbits (Figures 4.30 D and E), some areas of the cortex had very few cells 
infected with virus. In the draining lymph node, lymphocytes within both the paracortex
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Figure 4.27: Histopathology of the draining and contralateral lymph nodes from an SLS- 
infected wild rabbit at 4dpi. (A) Draining lymph node from one SLS-infected wild rabbit 
that contains a follicle and a small germinal centre in the cortex. (B) The contralateral 
lymph node from the same SLS-infected wild rabbit as (A) which has several germinal 
centres in the cortex at 4dpi. Bars represent lOOpm. F, follicle; GC, germinal centre; PC, 
paracortex.
B
Figure 4.28: Histopathology of in the draining lymph node of SLS or Uriarra-infected 
laboratory rabbits at 4dpi. (A) Blood vessel in the lymph node paracortex from an SLS- 
infected laboratory rabbit. Note the number of neutrophils within the vessel lumen and the 
cell with an apoptotic nucleus near the blood vessel. (B) Blood vessel in the lymph node 
paracortex from a Uriarra-infected laboratory rabbit. The lumen of this blood vessel 
contains lymphocytes and a single neutrophil. Bars represent 25 pm. A, apoptotic cell; L, 
lymphocyte; N, neutrophil.
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Figure 4.29: Histopathology of the draining lymph node of SLS or Uriarra-infected
laboratory rabbits at 4dpi. (A) Lymph node from an SLS-infected laboratory rabbit. 
Lymphocytes have been depleted from the interfollicular zones. (B) Higher magnification 
of an interfollicular zone in the draining lymph node from an SLS-infected laboratory 
rabbit. (C) Lymph node from a Uriarra-infected laboratory rabbit. (D) Higher magnification 
of an interfollicular zone in the draining lymph node from a Uriarra-infected laboratory 
rabbit. Bars represent 100pm. C, capsule; IF, interfollicular zone; GC, germinal centre; L, 
lymphocyte; M, macrophage; PC, paracortex.

Figure 4.30: Myxoma virus localisation in the draining lymph nodes of myxoma virus- 
infected laboratory and wild rabbits at 6dpi. (A) Draining lymph node from an SLS- 
infected laboratory rabbit. Bar represents 200pm. (B) Draining lymph node from an SLS- 
infected wild rabbit. Bar represents 200pm. (C) A different region of the draining lymph 
node from the same SLS-infected wild rabbit as (B). Bar represents 200pm. (D) Draining 
lymph node from a Uriarra-infected laboratory rabbit. Bar represents 200pm. (E) A 
different region of the draining lymph node from the same Uriaira-infected laboratory 
rabbit as (D). Bar represents 200pm. P, paracortex.
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and mantle zones were infected (Figure 4.31 A). In the contralateral lymph nodes, 
infection of lymphocytes of the mantle zones of germinal centres occurred without 
extensive infection of surrounding T-dependent areas (Figure 4.3IB). Also in the 
contralateral lymph nodes, WBC contained in the lumen of blood vessels were positive 
for myxoma virus (Figure 4.31 C). These cells included lymphocytes, some of which 
were positioned between the endothelial cells of the vessel (Figure 4.3ID) and hence 
were possibly migrating across the vessel wall. Mononuclear cells distinguished by a 
horseshoe shaped nucleus in the subcapsular sinus of contralateral lymph nodes stained 
positive for myxoma virus (Figure 4.3IE). In both draining and contralateral lymph 
nodes, areas of the paracortex often remained relatively virus free with only one or two 
positive lymphocytes even when other areas contained high numbers of infected cells. 
Virus was not detected by immunofluoresence in the draining or contralateral lymph 
nodes of wild rabbits infected with Uriarra at 6dpi.
The differences in virus localisation between groups of myxoma virus-infected rabbits 
at 6dpi were mainly observed in the cell types infected. Similarly to 4dpi, SLS infected 
cells of the lymph node capsule in both laboratory and wild rabbits, but not in rabbits 
infected with Uriarra. In SLS-infected laboratory rabbits, areas of the paracortex 
containing high numbers of infected lymphocytes also had large cells that stained 
intensely for virus antigen. These large cells were located immediately surrounding 
blood vessels, although the endothelial cells of the vessel wall remained uninfected. 
These cells resembled myxoma cells, but were rectangular rather than stellate in shape, 
and were not infected following SLS infection of wild rabbits, or Uriarra infection of 
either laboratory or wild rabbits. In SLS-infected wild rabbits only, virus antigen was 
often present in the cytoplasm of lymphocytes in limited areas of the cytoplasm rather 
than as a generalised staining of the cytoplasm. These resembled virus factories in the 
cytoplasm and may indicate that virus replication is limited in primary cells from wild 
rabbits.
At 6dpi of both SLS-infected laboratory and wild rabbits, pathological changes were 
most extensive in the germinal centres and the paracortex of draining lymph nodes and 
were associated with the depletion of lymphocytes from these areas. In germinal 
centres, the depletion of lymphocytes resulted in poor definition of the light and dark 
zones. Similarly to 4dpi, depletion of lymphocytes had occurred in the interfollicular 
areas and extending into the paracortex, which contained increased numbers of swollen
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Figure 4.31: Myxoma virus localisation in the draining and contralateral lymph nodes of 
SLS-infected laboratory rabbits at 6dpi. (A) Draining lymph node from an SLS-infected 
laboratory rabbit. Bar represents 200pm. (B) Contralateral lymph node from the same 
SLS-infected laboratory rabbit as (A). Bar represents 200pm. (C) Contralateral lymph node 
from an SLS-infected laboratory rabbit. Myxoma virus was present in white blood cells 
within the lumen of a blood vessel (solid arrow indicates the blood vessel). Bar represents 
100pm. (D) Contralateral lymph node from an SLS-infected laboratory rabbit. Myxoma 
virus was present in white blood cells located within the lumen and between endothelial 
cells of the blood vessel (open arrow indicates the connective tissue of the blood vessel). 
Bar represents 30pm. (E) Myxoma virus localisation in the cytoplasm of cells within the 
lymph node subcapsular sinus. These cells include a mononuclear cell with a horseshoe-
shaped nucleus (slender arrow). Bar represents 20pm. C, capsule; GC, germinal centre; Lu, 
lumen of blood vessel; P, paracortex.
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reticular cells and neutrophils as well as fibrin deposits. However, areas of the 
paracortex more central in the node, towards the medulla, remained populated with 
lymphocytes.
Other changes in the draining lymph nodes of SLS-infected laboratory or wild rabbits 
included the presence of high numbers of neutrophils in the subcapsular sinus and 
throughout the adipose tissue, but only low numbers were present in the body of the 
node. Similarly to 4dpi of laboratory rabbits with SLS, the endothelial cells of SLS- 
infected laboratory and wild rabbits were swollen and in some vessels, had increased in 
number. Large, rectangular cells that resembled myxoma cells were present in areas of 
the lymph node depleted of lymphocytes, especially proximal to damaged blood vessels. 
However, stellate myxoma cells were present in the lymph nodes of SLS-infected 
laboratory rabbits only.
Despite the similarities in the pathology of the draining lymph node from SLS-infected 
laboratory and wild rabbits at 6dpi, the contralateral lymph nodes from the two groups 
of infected rabbits were quite different. The pathology of the contralateral lymph node 
from SLS-infected laboratory rabbits resembled that described above for the draining 
lymph node, except that the infiltration of neutrophils into the subcapsular sinus and 
mterfollicular regions appeared greater in contralateral lymph nodes. However, the 
contralateral lymph nodes from wild rabbits infected with SLS were not depleted of 
lymphocytes, and instead resembled the contralateral lymph nodes from Uriarra- 
infected laboratory rabbits, described below.
At 6dpi of laboratory and wild rabbits with Uriarra, the paracortex of the draining and 
contralateral lymph nodes was densely populated with large and small lymphocytes and 
often appeared punctuated with other, larger mononuclear cells resembling 
macrophages. Germinal centres were generally large and well defined within the cortex 
of lymph nodes, and contained macrophages which had phagocytosed numerous dark 
staining nuclear fragments. However, in one laboratory rabbit there was a much more 
limited response as shown by underdeveloped germinal centres with no obvious 
hyperplasia of small lymphocytes within the paracortex. This lymph node contained the 
most amount of virus by immunofluorescence and by plaque assay, of any rabbit at 
6dpi. In the paracortex of lymph nodes from Uriarra-infected rabbits, there was some 
swelling of the reticular and endothelial cells, however, changes in blood vessels and
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reticular cells in lymph nodes were never as severe as those infected with SLS. In 
contrast to SLS-infection at the same time, the subcapsular sinus and adipose tissue 
contained more mononuclear cells than neutrophils.
Following inoculation of laboratory rabbits with Uriarra in the thigh, lymphocytes were 
depleted from the interfollicular areas of both the left and right popliteal lymph nodes 
by 8dpi. This depletion was mild, giving the impression of a general reduction in the 
number of lymphocytes rather than a devastation of cells, and had not progressed further 
in lymph nodes from rabbits inoculated in the thigh and killed at 10dpi.
; i -  r -
4.3.3.2.3 Ten days post infection of laboratory and wild rabbits with myxoma virus
By 10dpi of laboratory rabbits with SLS, virus was present in both the draining and 
contralateral lymph nodes in a circular distribution in germinal centres that had been 
depleted of lymphocytes (Figure 4.32A). Cells containing virus antigen were not 
lymphocytes, but rather were large ( 2 0 - 2 5 in diameter) with no discernible nuclear 
morphology (Figure 4.32B). It is probable that these cells were proliferated reticular 
cells or possible myxoma cells as these were the predominant cell type observed by 
haematoxylin and eosin staining of the same lymph nodes. Throughout the course of 
infection, SLS was rarely associated with cells in the medulla, except in one laboratory 
rabbit at 10dpi, when virus localised to lymphocytes in this area. In SLS-infected wild 
rabbits, virus was present in lymphocytes of the paracortex of both the draining and 
contralateral lymph nodes, regardless of the extent of lymphocyte depletion. However, 
the number of virus-positive cells was considerably less than at 6dpi.
At 10dpi, the distribution of virus in the draining and contralateral lymph nodes of one 
of two laboratory rabbits infected with Uriarra in the hind foot resembled that at 6dpi. 
Virus was present in lymphocytes in an even distribution throughout the paracortex, but 
was not closely associated with germinal centres. In the other rabbit, tissue sections 
contained only one to two positive lymphocytes in the paracortex. Following infection 
of wild rabbits with Uriarra, 10dpi was the only time point besides 2dpi when virus was 
observed in lymph nodes. At this time, virus was present in the cytoplasm of a small 
number of lymphocytes within the paracortex of both the draining and contralateral 
lymph nodes.
Virus localisation and histopathology
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Figure 4.32: Myxoma virus localisation in the draining lymph node of an SLS- 
infected laboratory rabbit at 10dpi. (A) Myxoma virus localised to cells in a circular 
distribution within the remnants of germinal centres. Bar represents Draining lymph 
node from an SLS-infected laboratory rabbit. Bar represents 300pm. (B) Higher 
magnification of (A) showing the morphology of cells containing myxoma virus. 
The identity of these cells is unknown. Bar represents 15pm.
At 10dpi of laboratory rabbits with SLS, the pathological changes in the lymph nodes 
involved half to all of the node and while some areas were completely devoid of 
lymphocytes, others appeared well populated. Lymph nodes were always affected from 
the periphery inwards, with marked increases in the number of reticular cells spreading 
inwards along the trabeculae of the node towards the medulla (Figure 4.33A). In 
laboratory rabbits, these changes did not differ markedly between the draining and 
contralateral lymph nodes. By 10dpi, neutrophils had infiltrated extensively into areas
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Figure 4.33: Histopathology of the draining lymph node of SLS-infected laboratory
rabbits at 10dpi. (A) Trabeculum which is thickened and contains increased numbers of 
swollen reticular cells compared to that in lymph nodes from uninfected rabbits. Bar 
represents 100pm. (B) The diffuse cortex of a draining lymph node that has been depleted 
of lymphocytes. The continuous line of dark staining cells are predominantly neutrophils. 
Bar represents 100pm. (C) High magnification of the paracortex of an SLS-infected 
draining lymph node showing a stellate myxoma cell, some intact lymphocytes and cellular 
debris. Bar represents 50pm. (D) Germinal centres from SLS-infected lymph nodes
sometimes appeared with dark central zones and a lighter outer zone. Bar represents 
100pm. L, lymphocyte; MC, myxoma cell.
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from which lymphocytes were completely absent, and were often observed in clusters 
surrounding myxoma cells, or in rings one or two cells deep surrounding germinal 
centres that had been completely destroyed (Figure 4.33B). Extracellular fibrin was 
observed between myxoma cells, enlarged reticular cells and macrophages (Figure 
4.33C). Some germinal centres contained macrophages and lymphocytes within the 
light zones although lymphocytes had disappeared from the light zones. These 
macrophages were full of nuclear fragments and cellular debris. The germinal centres 
thus appeared as though they had been inverted, with a very light staining area in the 
mantle zone surrounding a dark staining area in the light zone (Figure 4.33D).
At 10dpi with Uriarra, both the germinal centres and paracortex were richly populated 
with lymphocytes and macrophages with the occasional mitotic figure observed in these 
areas. Some depletion of lymphocytes had occurred in the interfollicular areas, which 
contained macrophages rather than myxoma cells, but there was limited neutrophil 
infiltration into lymph nodes. The adipose tissue surrounding the lymph node was filled 
with small lymphocytes. Lymphocytes with morphological characteristics of cells 
undergoing apoptosis were present in the paracortex of lymph nodes. These cells 
ranged from having marginalised chromatin within the nucleus, to being shrunken with 
a fragmented nucleus. At 10dpi of laboratory rabbits with Uriarra, plasma cells were 
present in the medullary cords and the paracortex of nodes. Some germinal centres 
appeared to either have shrunken in size compared to 6dpi through a depletion of 
lymphocytes from areas of the marginal zone closest to the lymph node capsule or, in 
fewer cases, to have not developed during earlier days of infection.
At 10dpi with SLS, the histopathology of lymph nodes from wild rabbits varied greatly 
(Figure 4.34). In one draining and two contralateral lymph nodes all from separate 
rabbits killed at 10dpi, the lymph nodes appeared relatively healthy. These lymph 
nodes contained many nuclear fragments in the paracortex although this area remained 
generally well populated, with limited evidence of increased numbers of swollen 
reticular cells or the infiltration of neutrophils, despite the presence of neutrophils in the 
subcapsular sinus of lymph nodes and throughout the adipose tissue surrounding the 
node. Large clusters of small lymphocytes were in areas where germinal centres would 
be expected to have formed. However, these aggregations of cells were not defined into 
dark, light and mantle zones. In the two other draining lymph nodes and one 
contralateral lymph node from SLS-infected wild rabbits, the nodes contained large
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Figure 4.34: Histopathology of lymph nodes from SLS-infected wild rabbits at 10dpi. (A) 
Draining lymph node from an SLS-infected wild rabbit showing extensive depletion of 
lymphocytes throughout. (B) Higher magnification of (A) showing some intact 
lymphocytes and cellular debris in the form of nuclear fragments. (C) A second area of the 
same draining lymph node as shown in (A). This area contains clusters of lymphocytes in 
the outer cortex and is well populated with lymphocytes in the paracortex. (D) Higher 
magnification of (C) showing numerous intact lymphocytes. Bars represent 100pm. L, 
lymphocyte; nf, nuclear fragments; P, paracortex.
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areas from which lymphocytes were completely depleted (Figure 4.34A) and where 
there were large numbers of swollen reticular cells (Figure 4.34B). However, these 
areas were localised within lymph nodes, with other areas of the paracortex remaining 
relatively unaffected and well populated with lymphocytes (Figures 4.34 C and D). 
Other pathological changes, such as the presence of large myxoma cells, deposition of 
extracellular fibrin, neutrophil infiltration into the lymph node and adipose tissue, were 
more extensive than those observed following infection of laboratory rabbits with 
Uriarra, and resembled the changes following infection of laboratory rabbits with SLS 
described at 6dpi.
4.3.3.2.4 Fifteen days post infection of laboratory and wild rabbits with myxoma virus
Uriarra was not detected in lymph nodes from Uriarra-infected laboratory rabbits at 
15dpi. Histologically, the paracortex was well populated with large and small 
lymphocytes and macrophages although areas of lymphocyte depletion were evident. 
However these were constrained to the interfollicular zones of the cortex of draining 
lymph nodes. Germinal centres were numerous and well defined. In general, the lymph 
nodes contained numerous nuclear fragments and some neutrophils had infiltrated into 
the nodes from the subcapsular sinus. The leucocytes in the lumen of blood vessels 
were predominantly lymphocytes. Some extravasated RBCs were present in the 
paracortex around these vessels.
Virus was not detected by immunofluorescence in the lymph nodes of SLS- or Uriarra- 
infected wild rabbits at 15dpi. The paracortex of both draining and contralateral lymph 
nodes SLS-infected wild rabbits resembled that described for the healthy areas of lymph 
nodes that remained at 10dpi; it was well populated with large and small lymphocytes 
and macrophages. The formation of new germinal centres, consisting of large light 
zones and relatively small mantle zones, was apparent in some lymph nodes of SLS- 
infected wild rabbits and plasma cells were observed in the paracortex. Neutrophils 
were observed in areas of lymph node where lymphocytes remained scarce, or at the 
edge of areas that were repopulated with lymphocytes. However, the number and 
distribution of neutrophils was never as extensive as in the lymph nodes from SLS- 
infected laboratory rabbits, and neutrophils were not present in areas containing 
numerous lymphocytes. The lumens of blood vessels and the adipose tissue were filled 
with small lymphocytes.
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4.3.3.2.5 Twenty days post infection of laboratory and wild rabbits with myxoma virus
At 20dpi of wild rabbits with SLS, virus antigen was detected in the draining lymph 
nodes as faintly staining, continuous lines of antigen spanning the paracortex. Similarly 
to very early in infection, this antigen appeared outside cells. Virus was not detected in 
the contralateral lymph nodes of infected rabbits. The draining lymph nodes that had 
previously been depleted of lymphocytes were now populated with small lymphocytes 
and macrophages and newly forming, well defined germinal centres were present. 
Thick, eosin-staining, fibres were present in localised areas of the paracortex of the 
draining lymph nodes, and to a lesser extent in the contralateral lymph nodes.
Virus was not detected in the draining or contralateral lymph nodes of Uriarra-infected 
rabbits at 20dpi. Histologically, these lymph nodes were not distinguishable from those 
described at 15dpi.
4.3.3.3 Changes in lymphocyte populations in the lymph nodes of myxoma virus- 
infected laboratory rabbits determined by immunohistochemistry
The draining and contralateral lymph nodes of laboratory rabbits inoculated in the thigh 
with either SLS or Uriarra were stained for cell surface expression of MHC class I, 
MHC class II, CD43, CD45 or Ig-M-. This staining does not indicate the definitive 
timing of changes in these cell populations as it was performed on tissues obtained 
following thigh and not foot inoculations. Hence, the staining of lymph node cell 
populations was compared between tissues from rabbits killed at 6 and 10dpi with those 
from uninfected rabbits as an indication of which populations were affected.
CD43 was strongly expressed by leucocytes in the T-cell-dependent areas of uninfected 
lymph nodes (Figure 4.35A). The intensity of CD43 staining in the paracortex of 
Uriarra-infected laboratory rabbits was reduced at 10dpi compared to that from 
uninfected rabbits (Figure 4.35B). By 6dpi with SLS, the number of CD43+ cells in the 
interfollicular zones was reduced and CD43+ cells of the paracortex stained with a 
reduced intensity. By 10dpi with SLS, localised areas of the paracortex contained 
CD43+ cells, although most of the paracortex contained greatly reduced numbers of 
positive cells (Figure 4.35C). This was due to a generalised depletion of cells from 
these areas by 10dpi.
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Figure 4.35: Immunolocalisation of cells expressing CD43 in the lymph nodes of
laboratory rabbits. The binding of anti-CD43 was detected using an alkaline phosphatase- 
conjugated secondary antibody and fast red as a substrate. The presence of CD43 is shown 
in red. (A) Lymph node from an uninfected rabbit. CD43 was strongly expressed on 
leucocytes in the paracortex. (B) Lymph node from a Uriarra-infected rabbit at 10dpi. The 
intensity of CD43 staining in the paracortex of Uriarra-infected laboratory rabbits is 
reduced compared to uninfected rabbits. (C) Lymph node from an SLS-infected laboratory 
rabbit. The loss of CD43-specific staining in lymph nodes was associated with the 
depletion of lymphocytes. Bars represent 100pm. F, follicle; GC, germinal centre; P, 
paracortex; arrow head indicates the remnants of a germinal centre.
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Leucocytes in the T-cell-dependent areas of uninfected lymph nodes (Figure 4.36A) 
generally expressed CD45. The number and staining intensity of CD45+ cells was 
reduced following ten days of infection with either Uriarra or SLS. However, this 
staining intensity did not differ substantially between infections (Figures 4.36 B and C).
MHC class I was expressed on cells throughout the T-cell and B-cell dependent areas of 
uninfected lymph nodes (Figure 4.37A). Staining for MHC class I in lymph nodes 
differed from CD43 as it stained the light zones of germinal centres, which CD43 did 
not. The distribution of MHC class I+ cells in lymph nodes from Uriarra-infected 
laboratory rabbits at 10dpi was similar to that of uninfected lymph nodes although some 
areas stained with greater intensity (Figure 4.37B). It was not determined if this was 
due to an upregulation of MHC class I surface expression, or due to an increase in the 
number of MHC class I+ cells. The distribution of cells expressing MHC class I in SLS- 
infected lymph nodes by 10dpi was reduced compared to nodes from uninfected rabbits 
or from rabbits infected with Uriarra, and were often clustered together in the localised 
areas of the paracortex that contained numerous lymphocytes (Figure 4.37C). Areas of 
the paracortex that were depleted of lymphocytes contained low numbers of cells 
expressing MHC class I.
MHC class II positive cells were distributed throughout entire lymph nodes from 
uninfected rabbits, as well as rabbits infected with either SLS or Uriarra. However, at 
10dpi of Uriarra infected rabbits, the intensity of staining in the light zone of germinal 
centres increased compared to in that of uninfected lymph nodes. This increased 
staining intensity occurred in the light zones of two germinal centres from the 
contralateral lymph nodes of SLS-infected laboratory rabbits at 6dpi, but was not 
present in the lymph nodes at 10dpi (data not shown).
In lymph nodes from uninfected rabbits, Ig-F1 was expressed throughout the cytoplasm 
of plasma cells, and on the surface of some lymphocytes (B-lymphocytes) and cells of 
the light zone of germinal centres, most probably indicating antibody on the surface of 
dendritic cells. In uninfected lymph nodes, plasma cells localised throughout the 
paracortex, in the mantle zone of germinal centres located most central to the node 
(Figure 4.38A) and in the medullary cords. Staining for this marker yielded the greatest 
amount of background staining in the tissue, particularly after infection of rabbits with 
myxoma virus, which may correspond to the detection of secreted antibody in the lymph
Virus localisation and histopathology
Figure 4.36: Immunolocalisation of cells expressing CD45 in the lymph nodes of
laboratory rabbits. The binding of anti-CD45 was detected using an alkaline phosphatase- 
conjugated secondary antibody and fast red as a substrate. The presence of CD45 is shown 
in red. (A) Lymph node from an uninfected rabbit. CD45 was expressed on leucocytes in 
the paracortex. (B) Lymph node from a Uriarra-infected rabbit at 10dpi. (C) Lymph node 
from an SLS-infected laboratory rabbit. CD45-specific staining is reduced in lymph nodes 
from both Uriarra and SLS-infected laboratory rabbits. Bars represent 100pm. P, 
paracortex.

Figure 4.37: Immunolocalisation of cells expressing MHC class I in the lymph nodes of 
laboratory rabbits. The binding of anti-MHC class I was detected using an alkaline 
phosphatase-conjugated secondary antibody and fast red as a substrate. The presence of 
MHC class I is shown in red. (A) Lymph node from an uninfected rabbit. MHC class I 
was expressed throughout the paracortex and germinal centres. (B) Lymph node from a 
Uriarra-infected rabbit at 10dpi. The staining intensity of MHC class I increased following 
infection of laboratory rabbits with Uriarra. (C) Lymph node from an SLS-infected 
laboratory rabbit. The distribution of MHC class I-positive cells thoughout the paracortex 
was reduced compared to that in (A) or (B). Bars represent 100jam. GC, germinal centre; 
P, paracortex.
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and serum. The distribution of Ig-f1 + cells in the lymph nodes from Uriarra-infected 
laboratory rabbits was similar to that of uninfected lymph nodes. However, the number 
of Ig-^1 + cells was usually less (Figure 4.38B). Similarly, in SLS-infected laboratory 
rabbits at 6dpi, the number of Ig-^ + cells in the paracortex or associated with B-cell 
dependent areas of lymph nodes was reduced compared to lymph nodes from uninfected 
rabbits. However, by 10dpi, diffuse areas of the paracortex contained numerous Ig-P + 
cells (Figure 4.38C). These cells were distributed evenly throughout the paracortex and 
were not proximal to germinal centres.
4.3.4 The spleen
4.3.4.1 Uninfected spleen
The spleen from uninfected rabbits consisted of two general areas, the red and white 
pulp (Figure 4.39). The red pulp contained primarily RBCs, lymphocytes, granulocytes 
and plasma cells. The white pulp was lymphoid tissue and formed nodules surrounding 
branches of the splenic artery and vein (or periarteriolar lymphoid sheath; PALS). 
Many small follicles, and occasional gemiinal centres that had formed around a central 
arteriole, were observed within these nodules. The marginal zone surrounded the white 
pulp and was filled with large lymphocytes. The spleen pulp is surrounded by a capsule 
of dense connective tissue from which trabeculae projected into the pulp (Figure 
4.39A). The capsule, trabeculae, accompanying reticular fibres and blood vessels 
constituted the connective architecture of the spleen.
4.3.4.2 Virus antigen and histopathological changes
The histopathology of the spleen can be considered using rabbits inoculated in either the 
foot or the thigh as both the timing of virus dissemination and virus growth in this tissue 
was similar for the two groups. Changes in the spleen following infection of rabbits 
with myxoma virus resembled, but were not as severe as, those described in the lymph 
nodes, and were the most variable of all the tissues described. These changes were 
apparent in the both the red and white pulp and included a general depletion of 
lymphocytes, the proliferation and degeneration of reticular and endothelial cells, and a
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Figure 4.38: Immunolocalisation of cells expressing Ig-p in the lymph nodes of laboratory 
rabbits. The binding of anti-Ig-p was detected using an alkaline phosphatase-conjugated 
secondary antibody and fast red as a substrate. The presence of Ig-p is shown in red. (A) 
Lymph node from an uninfected rabbit. Ig-p was strongly expressed on cells associated 
with germinal centres. (B) Lymph node from a Uriarra-infected rabbit at 10dpi. The 
distribution of Ig-p-positive cells throughout the paracortex and associated with germinal 
centres in the lymph nodes of these rabbits was similar to uninfected rabbits although the 
number of positive cells was generally less. (C) Lymph node from an SLS-infected 
laboratory rabbit. Ig-p-positive cells were distributed throughout the lymph node 
paracortex and were not associated with well defined germinal centres. Bars represent 
100pm. GC, germinal centre; P, paracortex.

Figure 4.39: Histology of the spleen from an uninfected laboratory rabbit. (A) The spleen 
is divided into two main areas, the red pulp and the white pulp (lymphoid tissue). A nodule 
of white pulp is seen here in cross-section. The spleen is surrounded by the capsule 
(connective tissue). (B) The white pulp surrounds splenic arteries and in longitudinal 
section, appears as a sheath rather than as nodules. Bars represent 100pm. C, capsule; 
PALS, periarteriolar lymphoid sheath; RP, red pulp; WP, white pulp.
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limited influx of inflammatory cells. The enlargement of the spleen in SLS-infected
laboratory rabbits described in Chapter 3 (see section 3.3.4.1) was probably due to the 
engorgement of the spleen with blood. Virus antigen was detected in the spleen
following infection of laboratory rabbits at 6dpi with SLS (Figure 4.40A) and Uriarra
o\
(Figure 4.40B). In both cases, virus localised to the cytoplasm Jymphocytes within the 
white pulp. However, the number of infected cells detected was low. Virus was also 
present in clusters of mononuclear cells in the white pulp of SLS but not Uriarra- 
infected laboratory rabbits. Some of these cells were approximately lö^hn in diameter 
and resembled macrophages (Figure 4.40C). Virus antigen was not detected in the 
spleen of wild rabbits infected with either Uriarra or SLS at any time. The 
histopathological changes in the spleen are described in sequence below.
4.3.4.2.1 Four days post infection of laboratory and wild rabbits with myxoma virus
Obvious changes in the spleens from laboratory rabbits infected with SLS were first 
observed at 4dpi in one of four infected rabbits (Figure 4.41 A). This rabbit had the 
highest virus titre in the spleen of the four infected rabbits. Changes included a 
moderate hyperplasia of lymphocytes resulting in an increased area of the spleen 
occupied by the white pulp. The number of germinal centres had increased, and these 
contained an increased number of cells with apoptotic nuclei or with mitotic figures, 
particularly in the light zones. The reticular cells of the capsule appeared swollen, with 
foamy nuclei. There was an increase in the number of neutrophils in the red pulp 
directly under the capsule. Localised areas of the red pulp also contained swollen 
reticular cells that were proximal to areas of deposition of scanty extracellular fibrinous 
material. The spleens of the remaining three of the four infected rabbits examined 
showed few changes, and contained many small germinal centres with well defined 
zones in which numerous cells were undergoing mitotic division.
Changes were also observed in the spleen of Uriarra infected laboratory rabbits at 4dpi 
(Figure 4.4IB). These included a moderate hyperplasia of lymphocytes in the white 
pulp, with cellular activity evident in newly forming germinal centres (nuclear 
fragments of apoptotic bodies and cells with mitotic figures) resulting in a general 
increase in the number of small lymphocytes within mantle zones. There was an 
increase in the numbers of neutrophils present in the red pulp, and the deposition of 
fibrinous material in small areas of red pulp.
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Figure 4.40: Myxoma virus localisation in the spleen of laboratory rabbits at 6dpi. (A) 
Spleen from an SLS-infected laboratory rabbit. (B) Spleen from a Uriarra-infected 
laboratory rabbit. In both (A) and (B), virus was present in the cytoplasm of a small 
number of lymphocytes in the white pulp. Bars represent 170pm. (C) SLS also infected 
clusters of cells in the white pulp, including macrophage-like cells. Bar represents 20pm. 
RP, red pulp; WP, white pulp. Thin arrows indicate myxoma virus-infected lymphocytes, 
green arrow heads indicate cell nuclei in clusters of virus-infected cells.

Figure 4.41: Histopathology of the spleen from laboratory rabbits at 4dpi (A) Spleen from 
an SLS-infected laboratory rabbit. There was a moderate hyperplasia of lymphocytes 
associated with germinal centres in the white pulp of this rabbit. (B) Spleen from a Uriarra- 
infected laboratory rabbit. The spleen of this rabbit had large, well defined germinal 
centres. Bars represent 100p.m. GC, germinal centre.
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4.3.4.2.2 Six days post infection of laboratory and wild rabbits with myxoma virus
At 6dpi of both laboratory and wild rabbits with SLS, the red pulp stained very heavily 
red due to an engorgement of the spleen with RBCs (Figure 4.42A). There was a 
reduced density of lymphocytes in the red pulp, which may have been due to a depletion 
of these cells, or to the increased space between them resulting from the increase in 
RBCs. The cytoplasm of a number of macrophages in the red pulp contained RBCs, 3-5 
neutrophils and/or a number of small, dark staining nuclear fragments. Neutrophils 
were observed directly under the capsule and infiltrating into the red pulp but not in the 
white pulp. There was a mild hyperplasia of small lymphocytes in the white pulp but no 
formation of germinal centres. Localised groups of lymphocytes within the white pulp 
had karryorhetic nuclei which stained darkly at the periphery.
At 6dpi of laboratory rabbits with Uriarra (Figure 4.42B), the spleen from one of four 
rabbits showed the severest changes observed at any time after infection with either SLS 
or Uriarra. These included a general reduction of small lymphocytes from the white 
pulp such that much of the white pulp resembled marginal zone. In the red pulp 
adjacent to the white pulp, there was an increase in the number of neutrophils and 
nuclear fragments present, an increase in the deposition of extracellular foamy material 
and the proliferation of reticulum cells. However, the spleens from the remaining three 
animals and wild rabbits infected with Uriarra at 6dpi, showed a moderate number of 
small lymphocytes present within the zones of germinal centres, although these zones 
were not sharply defined (Figure 4.42C). These spleens contained small, localised areas 
in which there were apoptotic bodies and neutrophils, and contained many macrophages 
with cytoplasms full of these cells and cell fragments.
4.3.4.2.3 Ten days post infection of laboratory and wild rabbits with myxoma virus
By 10dpi of laboratory rabbits with SLS, the spleen was engorged with RBCs. The 
cellular membranes of RBCs were not well defined and hence the cells appeared 
liquefied. Lymphocytes had been depleted from the white pulp such that the red and 
white pulps were not well defined (Figure 4.43A) and the majority of white pulp 
resembled marginal zone (Figure 4.43B). Polymorphonuclear cells were present in the 
red pulp at the edge of, and infiltrating into, marginal zones. The reticular cells in these 
areas were swollen, had a foamy cytoplasm and had increased in number, with the
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Figure 4.42: Histopathology of the spleen from rabbits at 6dpi with myxoma virus. (A) 
Spleen from an SLS-infected laboratory rabbit. The dark staining of the white pulp was 
due to the engorgement of the spleen with red blood cells. Note that besides the dense 
staining of red blood cells, the white pulp is not well defined. (B) Spleen from a Uriarra- 
infected laboratory rabbit. The spleen of this rabbit had the most severe pathology of the 
all Uriarra-infected laboratory rabbits. The white pulp was engorged with red blood cells, 
and was poorly defined. (C) Spleen from a second Uriarra-infected laboratory rabbit. The 
spleen of this rabbit had large, well defined germinal centres. Bars represent 100pm. GC, 
germinal centre, RP, red pulp; WP, white pulp.
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Figure 4.43: Histopathology of the spleen from rabbits at 10dpi with myxoma virus. (A) 
and (B) Spleens from SLS-infected laboratory rabbits. The red and white pulp are poorly 
defined. This was due to the depletion of lymphocytes from both areas. (C) Spleen from 
an SLS-infected wild rabbit containing a large germinal centre. (D) The spleen of a Uriarra- 
infected laboratory rabbit. The red and white pulps are well defined and there was no 
evidence of lymphocyte depletion from these areas. Bars represent 100pm. GC, germinal 
centre, RP, red pulp; WP, white pulp.
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spaces between cells expanded and taking on a vesicular appearance. These changes in 
reticular cells were also evident directly under the capsule in the red pulp. Localised 
areas of the capsule and trabeculae were thickened; the cells of the latter had increased 
in number and were swollen. The endothelial cells of small blood vessels were also 
swollen, with the cellular and nuclear membranes distended. Amongst the reticular 
fibres, there were a number of different cell types. Many large cells with a pale staining 
hypertrophic nucleus and a foamy cytoplasm were present in these areas. These cells 
resembled the myxoma cells described in the lymph nodes of SLS infected laboratory 
rabbits, but did not appear as stellate in shape. Other cells of the reticulum were 
phagocytic, containing nuclear fragments or neutrophils within their cytoplasm. A third 
cell type within the reticulum was giant cells that had 2-3 large nuclei.
In wild rabbits infected with SLS at 10dpi, some depletion of lymphocytes was 
observed from the white pulp and neutrophils had infiltrated into the red pulp of the 
spleen. However, the red and white pulp were well defined and germinal centres were 
prominent (Figure 4.43C). By 10dpi, the spleens from Uriarra-infected laboratory 
rabbits contained multiple large germinal centres, with no evidence of lymphocyte 
depletion from the white pulp (Figure 4.43D).
4.3.4.2.4 Fifteen and twenty days post infection of laboratory and wild rabbits with 
myxoma virus.
At 15dpi of wild rabbits with SLS, blood vessels were surrounded by cuffs of 
lymphocytes and at 15 and 20dpi, there was a general increase in small lymphocytes in 
the white pulp and the formation of well defined germinal centres compared to 10dpi 
(Figure 4.44A). At 20dpi, thick strands of eosin-staining connective tissue, resembling 
hyaline tissue, were present in between the mantle zones of germinal centres and the 
marginal zone (Figure 4.44B). At 15dpi and 20dpi of laboratory rabbits with Uriarra, a 
general expansion of the splenic area occupied by white pulp was evident containing 
many small lymphocytes, small follicles and well defined germinal centres (Figure 
4.44C).
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Figure 4.44: Histopathology of the spleen from rabbits at 15 and 20dpi with myxoma 
virus. (A) Spleen from an SLS-infected wild rabbit at 15dpi. The white pulp was densely 
populated with small lymphocytes. (B) Spleen from an SLS-infected wild rabbit at 20dpi. 
The white pulp contained thick strands of eosin-staining connective tissue in between the 
mantle zones of germinal centres and the marginal zone. (C) Spleen from a Uriarra- 
infected laboratory rabbit at 15dpi showing well defined areas of red and white pulp. Bars 
represent 100|Lim. GC, germinal centre; RP, red pup; WP, white pulp.
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4.4 Discussion
To further investigate the pathogenesis of virulent and attenuated strains of myxoma 
virus in infected laboratory and wild rabbits, the histopathology and cellular localisation 
of virus was examined in the principal target organs, the skin and lymphoid tissues. The 
portions of tissue used in this study were from the same tissues for which virus titres 
were determined in Chapter 3. Hence, for each individual rabbit killed at each time 
point post infection, we know which tissues the virus is replicating in, how much virus 
is present, what cells the virus is replicating in and what pathological changes have 
occurred. Furthermore, we can investigate between-virus differences by examining how 
each rabbit handles a virulent or an attenuated strain of virus when the differences 
observed depend on the virulence of the virus. In the same manner, between-rabbit 
differences can be examined where differences between the response of laboratory and 
wild rabbits to SLS or Uriarra infection depends on the evolved genetic resistance of the 
rabbit. The key aspects of virus pathogenesis derived from these results are discussed 
below for each set of infected rabbits.
Following intradermal inoculation of SLS into the hind foot of laboratory rabbits, virus 
was present at 24 hpi MHC II positive dendritic cells in the dermis. SLS was also 
present at 24hpi in the paracortex of the draining lymph node, in lymphocytes and large 
mononuclear, MHC II positive cells. This suggests that the early transport of virus from 
the primary inoculation site in the skin to the draining lymph node is likely to occur in 
infected MHC II positive dendritic cells. Virus that is not within cells may also drain 
from the skin to the draining lymph node either as free virus or associated with cell 
debris. This would be difficult to visualise in tissue sections by immunofluorescence, 
although weak staining of viral antigen that was not cell-associated was observed by 
2dpi in continuous lines in the periphery of the lymph node cortex and spanning the 
paracortex. Whether this consists of infectious virus has not been determined. 
However, similar continuous lines of virus that localised to the cytoplasm of 
lymphocytes were observed early in infection. This could indicate that lymphocytes in 
the paracortex are being infected by cell-free virus draining through the subcapsular 
sinus.
At 2 and 4dpi, when the titre of virus in the skin was increasing, the dermis at the 
primary inoculation site contained numerous SLS-infected MHC II positive cells. At
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4dpi in the lymph node draining the inoculation site in the foot, SLS had infected 
lymphocytes in the T-cell dependent paracortex, but had infected few lymphocytes 
associated with follicles or germinal centres. This generalised infection of lymphocytes 
in the paracortex of the popliteal lymph node was not observed until 6dpi following 
inoculation into the thigh. This indicates that the hind foot inoculation site was indeed 
the better site of the two for the early examination of myxoma virus interactions with 
the lymph nodes.
SLS was visualised in the contralateral lymph node of infected laboratory rabbits by 
4dpi, and similarly to the draining lymph node, was replicating in lymphocytes of the 
paracortex. Infection of both the draining and contralateral lymph nodes in laboratory 
rabbits resulted in a lack of germinal centre development and the depletion of 
lymphocytes from nodes, first observed as a reduced number of lymphocytes at the 
periphery of the cortex by 4dpi. Depletion of lymphocytes from lymph nodes and the 
associated pathologic changes were consistent with the descriptions of Hurst (1937a) for 
infection of laboratory rabbits with SLS. This depletion progressed directionally 
inwards towards the centre of the node, involving both T- and B-cell populations. In 
areas depleted of lymphocytes, the reticular cells and the endothelial cells of small 
blood vessels were swollen and had increased in number, and neutrophils and large 
stellate myxoma cells were abundant. Despite the extensive depletion of lymphocytes, 
in which myxoma virus replicates, from both the draining and contralateral lymph nodes 
from 6dpi, the titres of SLS in these tissues were high. At this time, virus replication 
was predominantly in clusters of abnormally large reticular cells situated near remnants 
of germinal centres, and in cells of the lymph node capsule. Some depletion of 
lymphocytes also occurred in the spleen of SLS-infected laboratory rabbits, despite the 
moderate titres of virus in the spleen and the observation of virus antigen in only a small 
number of cells.
By 4dpi, SLS was present in the distal skin of infected laboratory rabbits. Similar to 
infection of skin at the primary inoculation site, SLS was first observed in MHC II 
positive cells in the dermis. At 6 and 10dpi, when SLS titres in the primary lesion and 
distal skin were the highest, the majority of virus was in the epidermis of the skin at 
both sites. Large numbers of inflammatory cells, predominantly neutrophils, had 
infiltrated the lower dermis at these sites, but did not traffic to the upper dermis 
proximal to the epidermis where virus replication was concentrated. Pathological
Virus localisation and histopathology
157
changes had occurred in the endothelial cells of dermal blood vessels and myxoma cells 
were abundant in the dermis, but virus antigen was visualised only very rarely in either. 
This observation does not support the suggestion of Hurst (1937a) that virus replication 
in the endothelium was responsible for pathology observed in the blood vessel walls and 
budding of myxoma cells from the endothelium.
Uriarra replication in the skin of laboratory rabbits was similar to that described for 
SLS-infected laboratory rabbits. These observations are consistent with the titres of 
SLS and Uriarra in the skin, which were similar to each other over the first ten days of 
infection. However, in contrast to SLS-infected primary lesions, inflammatory cells in 
the dermis of Uriarra-infected primary lesions were predominantly lymphocytes and 
trafficked throughout the dermis, aggregating at the dermal/epidermal junction. 
Changes in the cells of the epidermal stratum basale associated with virus replication 
were similar to SLS-infected laboratory rabbits, but their progression was generally 
delayed. Initial changes in the endothelium of dermal blood vessels of Uriarra-infected 
laboratory rabbits were also similar to SLS-infected laboratory rabbits, but did not 
progress as rapidly or severely, and myxoma cells were not a prominent cell type in the 
dermis of Uriarra-infected rabbits. In addition, Uriarra was first detected in the distal 
skin of laboratory rabbits at 6dpi, by immunofluorescence and plaque assay, which was 
delayed compared to laboratory rabbits infected with SLS. By 15 and 20dpi with 
Uriarra, virus replication was restricted to localised areas of the stratum basale in both 
the primary inoculation and distal skin sites.
The draining lymph node of laboratory rabbits infected with Uriarra was similar to that 
of SLS in the first six days of infection with virus, localising to the cytoplasm of 
infected lymphocytes and macrophages in the lymph node paracortex. However Uriarra 
was not present in reticular cells or cells of the lymph node capsule and by 10dpi, was 
present only in low numbers of lymphocytes. Uriarra was first visualised in the 
contralateral lymph node at 4dpi, with a similar distribution of replication to the 
draining lymph node, although fewer lymphocytes were infected and greater expanses 
of lymph node tissue remained virus-free. Mild depletion of lymphocytes in the 
draining lymph node occurred in the first six days of infection, particularly in the 
interfollicular regions. However, unlike SLS infection, numerous germinal centres had 
developed in lymph nodes by this time and infection was not associated with the 
infiltration of masses of neutrophils into the node, or with the extensive proliferation of
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reticular cells. Lymphocyte depletion did not occur in the contralateral lymph node or 
the spleen of infected rabbits. Despite the high numbers of follicles, the number of Ig- 
cells in the lymph nodes was smaller in Uriarra-infected rabbits than in SLS-infected 
rabbits. In addition, the production of neutralising antibody and virus-specific IgG 
measured in Chapters 2 and 3 was slower in Uriarra-infected laboratory rabbits. Uriarra 
was cleared from the lymph nodes of laboratory rabbits by 15dpi as it was not detected 
by immunofluorescence or plaque assay at 15 or 20dpi.
The cellular localisation of SLS and Uriarra in the primary inoculation site of wild 
rabbits, and the pathological changes associated with virus replication, were similar to 
that of Uriarra-infected laboratory rabbits over the 20 days of the experiment. However, 
wild rabbits had a greater influx of inflammatory lymphocytes into the dermis of the 
primary lesion than any myxoma virus-infected laboratory rabbit. In particular, 
lymphocytes were densely aggregated at the margins of the lesion by 15dpi. Virus was 
present at 15 and 20dpi in mitotically active cells of the stratum basale directly 
underlying areas of damaged epidermis, and in the sheaths of hair follicles, but was not 
observed outside the perimeter formed by the dense aggregates of inflammatory cells. 
The mononuclear infiltrate into the dermis of wild rabbits infected with myxoma virus, 
and in particular those infected with SLS, involved more cells and was distributed 
throughout more of the dermis, proximal to virus replication, than in infected laboratory 
rabbits. This was also the case in the distal skin site of wild rabbits, in which SLS was 
first detected at 4dpi and Uriarra at 15dpi. The inflammatory response to myxoma virus 
infection in wild rabbits may thus be important in the local control of virus spread in the 
skin, and the restriction of the size of the primary lesion.
SLS had drained to the popliteal lymph node from the primary inoculation site of wild 
rabbits by 24 hours post infection. However, the appearance of Uriarra was delayed, as 
the first observation of virus in the draining lymph node was at 2dpi. Similarly to SLS- 
infection of laboratory rabbits, SLS infected the lymphocytes in the paracortex of the 
draining lymph node and cells of the lymph node capsule, and caused extensive 
depletion of lymphocytes from this node. However, the titres of virus in the draining 
lymph node of SLS-infected wild rabbits indicated that this tissue was involved in 
control of virus replication by resistant rabbits. Consistent with this, depletion of 
lymphocytes generally remained restricted to localised areas within lymph nodes. This 
lymphocyte depletion was associated with proliferation of reticular cells, but not with
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severe changes in the endothelium of blood vessels, the extensive infiltration of 
neutrophils, or the appearance of myxoma cells in the tissue. More importantly, this 
depletion of lymphocytes did not occur in the contralateral lymph node of SLS-infected 
wild rabbits and although virus reached the contralateral lymph node, virus replication 
within this node was shown by plaque assay and immunofluorescence to be reduced 
compared to that in infected laboratory rabbits. By 15dpi, regions of the draining lymph 
node paracortex that contained high numbers of abnormally large reticular cells, a 
pathological change that was associated with the depletion of lymphocytes, appeared 
repopulated with small lymphocytes, and germinal centres had developed, implying 
immune activation within the nodes.
4.4.1 How does resistance operate?
By examining virulent and attenuated myxoma virus, where differences in pathogenesis 
are attributable to the virulence of the virus, and myxoma virus-infected laboratory and 
wild rabbits, where differences in response to infection are attributable to the evolved 
genetic resistance of the rabbit, we can gain clear insights into how resistance of the 
host operates.
4.4.1.1 The inflammatory response to infection with myxoma virus
Both virulent and attenuated myxoma virus targeted the skin and lymph nodes as major 
sites of replication in both laboratory and wild rabbits. However, the inflammatory 
response to virus replication in these tissues was markedly different between SLS- 
infected laboratory rabbits, and Uriarra-infected laboratory rabbits or SLS-infected wild 
rabbits. In the Leporid species of the Americas in which myxoma virus evolved, virus 
replicates in the skin at the primary inoculation site but apparently does not disseminate 
to secondary skin sites. Hence, virus replication and persistence in the primary 
inoculation site is crucial for transmission. Not surprisingly, myxoma virus has evolved 
proteins that bind and inhibit the action of pro-inflammatory cytokines such as TNF, 
interferons and chemokines, and are thought to disrupt local cytokine gradients to 
suppress the mobilisation of an effective inflammatory response to infection in vivo 
(Graham et al., 1997; Graham et al., 1992; Lalani et al., 1997; Lalani et al., 1998; 
Macen et al., 1993; McFadden and Barry, 1998; McFadden et al., 1997; Mossman et
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al, 1995a; Opgenorth et al., 1992; Schreiber and McFadden, 1994; Upton et al., 1992).
In all rabbits infected with myxoma virus, the inflammatory response in the skin was 
induced by 4dpi. However, in SLS-infected laboratory rabbits, this response consisted 
predominantly of neutrophils deep in the skin, away from the sites of virus replication in 
the upper dermis and epidermis. This was in contrast to the inflammatory response of 
Uriarra-infected laboratory rabbits, or of wild rabbits infected with either SLS or 
Uriarra, in which lymphocytes predominated in the inflammatory response and were 
mainly in tissue proximal to virus replication. One of the most important families of 
cytokines involved in the orchestration of the inflammatory response are chemokines. 
The T1 protein encoded by myxoma virus is secreted from infected cells and binds 
chemokines from both the CC- and CXC-subfamilies (Graham et al., 1997). T1 
specifically inhibits the CC-mediated chemotaxis of monocytes in vitro but does not 
inhibit CXC-mediated chemotaxis of neutrophils (Lalani et al., 1998). The inhibition of 
the infiltration of mononuclear cells but not neutrophils is consistent with the 
histopathology of the primary inoculation site of the skin of SLS-infected laboratory 
rabbits. CC-chemokines are involved in the attraction of T- and B- lymphocytes, NK 
cells and dendritic cells into the site of infection (Luster, 1998). The differences in 
inflammatory responses suggests that Uriarra does not modulate the inflammatory 
response of infected rabbits in the same way as SLS, and that the wild rabbit is able to 
overcome at least some SLS-induced modulation of inflammatory responses.
The inflammatory response to myxoma virus at the primary inoculation site of SLS- 
infected wild rabbits was not sufficient to prevent and control virus replication in the 
skin or prevent the dissemination of virus to the draining lymph node. However, the 
spread of myxoma virus to the draining lymph node and other distal tissues in wild 
rabbits was not associated with efficient virus replication in these tissues or the death of 
the infected host. The control of virus replication that was observed by both 
immunofluorescence and plaque assay compared to laboratory rabbits is likely to 
involve both the innate and adaptive immune responses, as has been shown for the 
poxvirus, ectromelia virus (Karupiah et al., 1993a; 1993b; O'Neill and Blanden, 1983; 
Delano and Brownstein, 1995; Karupiah et al., 1996; Ramshaw et al., 1997). In 
Chapter 2, the responses of lymphocytes from lymph nodes of SLS-infected laboratory 
rabbits to stimulation with T-cell mitogens were suppressed by 4dpi, which suggests 
that SLS is capable of supressing T-cell function in vivo. These cells are critical in
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developing an effective adaptive immune response. The modulation of the 
inflammatory response generated in the skin by myxoma virus, the early suppression of 
T-cell responses in the draining lymph node and the ability of wild rabbits to overcome 
SLS-induced immune modulation are potentially linked. The major target of early virus 
replication following infection of either laboratory or wild rabbits was dendritic cells in 
the skin. These cells are crucial in the activation of T-cells and the development of the 
adaptive immune response, and thus are a potential link between inflammation, immune 
suppression and host resistance.
4.4.1.2 Role of dendritic cells in myxoma virus pathogenesis and host resistance.
From the descriptions of myxoma virus pathogenesis above, it is likely that dendritic 
cells in the skin are important in the transport of virus from the primary inoculation site 
in the skin to the draining lymph node. Dendritic cells have been implicated in this role 
following flavivirus infection of mice (Johnston et al., 1996), and pulmonary 
macrophages have been shown to transport the ectromelia virus to draining lymph node 
from the lung following infection of mice with aerosol (Rivers, 1930). However, this is 
the first demonstration of the potential importance of dendritic cells in myxoma virus 
infection of rabbits.
Dendritic cells in the dermis of the primary inoculation site in the skin and mononuclear 
cells in the paracortex of the draining lymph node were infected by myxoma virus at 24 
hpi in laboratory rabbits infected with SLS or Uriarra, and in wild rabbits infected with 
SLS. This suggests that genetic resistance is not predominantly mediated by a block in 
the initial replication of virus in dendritic cells. Similarly virus attenuation did not 
affect replication in dendritic cells, but it did stimulate an entirely different 
inflammatory response. Interestingly, in wild rabbits infected with attenuated myxoma 
virus, the transport of virus from the skin to the draining lymph node was delayed 
compared to all other infections. This suggests that the role of dendritic cells in 
myxoma virus pathogenesis may be different depending on the virulence of the virus 
and the resistance of the host, but that these differences are difficult to measure using 
the relatively insensitive techniques of immunolocalisation or plaque assay unless host 
resistance and virus attenuation are combined. It is thus likely that skin dendritic cells 
have a role in virus replication and transport. It is also interesting to speculate that 
suppression of the inflammatory response may be a direct effect of SLS on dendritic 
cells in laboratory rabbits.
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Intradermal inoculation of mice with vaccinia virus resulted in an increased number of 
Langerhans cells (skin dendritic cells). This increase was greater in mice infected with 
a virulent strain of virus than in mice infected with an avirulent strain (Sprecher and 
Becker, 1987). One interpretation of this is that infection with virulent virus results in 
an increase in these cells in the skin by the host to combat infection. The virulent virus 
evokes a stronger response, which may be a response by the host to perceived danger. 
An alternative interpretation is that the virus upregulates dendritic cells in the skin as 
target cells and that virulent virus is able to deviate the immune response elicited by 
infected dendritic cells to the hosts detriment. The local depletion of Langerhans cells 
by steroid treatment enhanced the lethality of virulent but not avirulent vaccinia virus 
(Becker and Sprecher, 1989), which supports the former interpretation. However, the 
actual mechanism of myxoma virus pathogenesis may lie in between these 
interpretations as infection of rabbits with myxoma virus is more lethal than vaccinia 
virus-infection of mice. The host may upregulate the number of dendritic cells in the 
skin in response to myxoma virus infection, and this upregulation may be greater in 
response to infection with virulent virus. Both virulent and attenuated viruses replicate 
in these cells, but the virulent virus is able to modulate their response to a greater extent 
than the attenuated virus. Following contact with antigen in the skin, Langerhans cells 
migrate to lymph nodes where they are thought to have a pivotal role in the activation of 
lymphocytes (Banchereau and Steinman, 1998). The infection of these cells, and the 
early interactions between infected cells and T-lymphocytes in the draining lymph node, 
is thus potentially important in the early activation of T-cell dependent responses of 
infected rabbits.
4.4.2 Replication of myxoma virus in lymphocytes
Replication of myxoma virus in lymph nodes occurred predominantly in lymphocytes of 
the T-cell dependent paracortex. In vitro, myxoma virus infects 100% of RL5 cells, a 
rabbit CD4+ T cell line (Cartledge, 1995). These results suggest that T-cells are a major 
target of virus replication in the lymph nodes. Early virus replication in lymph node 
was visualised as continuous lines of virus-infected cells spanning the paracortex and in 
groups of lymphocytes immediately adjacent to each other. It is possible that infection 
of lymphocytes in the nodes requires cell-to-cell contact, and may imply a role for 
extracellular enveloped virus (EEV) budding from the surface of infected cells to infect 
adjacent cells, which has been demonstrated as important in the dissemination of
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vaccinia virus between cells (Payne, 1980; Vanderplasschen et a l , 1997). Lymphocyte 
depletion was an important aspect of pathology of the lymphoid tissue in both 
laboratory and wild rabbits infected with SLS. Lymphocyte depletion will almost 
certainly affect local immune responses to infection, and virus replication in T-cells is 
likely to be critical in the depletion of lymphocytes following infection with myxoma 
virus, and in suppressed T-cell responses observed in SLS-infected laboratory rabbits.
In vitro, replication of virulent myxoma virus in lymphocytes does not cause cell death 
(Macen et al., 1996b; Strayer et al., 1985). At least four proteins encoded by myxoma 
virus are known to inhibit apoptosis of infected lymphocytes (Barry et al., 1997; Macen 
et al., 1996b; Mossman et al., 1996a; Schreiber et al., 1997). Deletion of any one of 
these proteins induces apoptosis in infected lymphocytes. As Uriarra replicates to 
similar titres to SLS in RL-5 cells and does not induce apoptosis, all of these proteins 
are obviously functioning (P.J. Kerr, unpublished). However, it is not known if 
lymphocyte depletion and/or immune suppression are direct consequences of virus 
replication in lymphocytes in vivo, or if indirect mechanisms of cell death are operating. 
Although both SLS and Uriarra induced depletion of lymphocytes from the lymph 
nodes, laboratory rabbits infected with Uriarra and wild rabbits infected with SLS were 
able to restrict the loss of lymphocytes in the draining lymph node and control the 
depletion in the contralateral lymph node. In both cases this was associated with control 
of virus replication.
Following replication of myxoma virus in the draining lymph node, systemic 
dissemination of myxoma virus occurs in infected peripheral WBC (Fenner and 
Woodroofe, 1953). This implies that initiation of virus replication in distal tissues 
occurs following the migration of infected WBC into tissues. Alternatively, it has been 
suggested that virus growth across the endothelium may be important for virus invasion 
of immune privileged sites, such as the central nervous system (CNS) and the testis into 
which diapedisis, and thus invasion by infected leucocytes, may be limited (Mims, 
1964). Hurst (1937a) speculated that virulent myxoma virus replicated in the 
endothelial cells of blood vessels. However, virus antigen was rarely observed in 
endothelial cells of blood vessels in the skin and lymph nodes, although massive 
proliferation of endothelial and reticular cells occurred following infection of laboratory 
rabbits with SLS. This was consistent with the descriptions of Hurst (1937). Hence, the
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main mode of myxoma virus dissemination throughout the rabbit is likely to be in 
infected leucocytes.
Myxoma virus infected small numbers of lymphocytes in the spleen of rabbits which 
correlates with the lower virus titres recorded in this organ compared to the skin and 
lymph nodes. However, infection of laboratory rabbits with SLS resulted in a lack of 
germinal centre formation in the spleen as well as some depletion of lymphocytes and 
the swelling and increase in number of reticular cells. The pathology in the spleen of 
laboratory rabbits when SLS titres were relatively low may indicate a generalised 
systemic suppression of the host immune response. However, the spleen does not 
appear to be a major site of SLS replication or virus-induced pathology. This is similar 
to the descriptions of myxoma virus-induced pathology in the spleen by Hurst (1937a) 
and to malignant rabbit virus-infection of rabbits (Strayer and Sell, 1983), but is in 
contrast to ectromelia virus infection of mice. Ectromelia virus growth and the resulting 
necrosis of the spleen is an important aspect of disease and death (Mims, 1964).
4.4.3 Myxoma virus replication and transmission
At 15 and 20dpi of laboratory rabbits with Uriarra or wild rabbits with SLS, virus was 
present in the basal cells of the epidermis in the primary lesion. The histology of the 
skin at this time suggests continued proliferation and renewal of the basal cells of the 
epidermis. Hence, this is a likely site of continued virus replication in the skin and of 
continued virus drainage into the lymph nodes. The amount of virus antigen in the 
epidermis in the skin at 15dpi was considerably less than at 10dpi, although the virus 
titres were similar at these two time points, at approximately 106 - 107 pfu/g. This may 
be attributable to the presence of infective cell-free virus in the tissue that does not stain 
well by immunofluorescence. However, when considering transmission of virus from 
the primary lesion, the scab material formed over the lesion at this stage will prevent the 
probing of mosquito vectors at the primary lesion, with transmission of virus relying on 
the presence of less advanced secondary lesions on eyelids (Day et al., 1956). In 
Uriarra-infected laboratory rabbits, secondary lesions had not scabbed over at this time 
and may be a continued source of infective virus for mosquitoes. In SLS-infected wild 
rabbits, scabbing of secondary lesions was rapid, suggesting that these rabbits would be 
poor transmitters of SLS in the field.
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The early pathological changes and localisation of myxoma virus in the skin and 
draining lymph nodes are similar in both laboratory and wild rabbits infected with either 
SLS or Uriarra. However, as shown by both virus localisation and virus titres, 
laboratory rabbits infected with Uriarra and wild rabbits infected with SLS were able to 
control replication of virus in the draining lymph node and limit subsequent virus 
dissemination, replication and pathology in distal tissues. It was suggested that the 
early inflammatory response together with NK cells and the subsequent adaptive 
immune response to infection is important in determining the outcome of infection in 
rabbits with a degree of genetic resistance. However, the permissivity of primary cells 
from laboratory and wild rabbits to virus replication may also be involved. The ability 
of myxoma virus to replicate in lymphocytes, and deplete them from the draining lymph 
node may contribute to the overwhelming of the immune response. As discussed 
previously, the in vitro replication of myxoma virus in lymphocytes does not cause cell 
death, and a number of proteins produced by myxoma virus function to inhibit apoptosis 
of infected cells in vitro. The histopathology of the lymph node suggests that both 
apoptosis and necrosis are major mechanisms of cell destruction. It is thus not clear to 
what extent the depletion of lymphocytes can be attributed to apoptosis, how this may 
differ between virulent and attenuated myxoma virus, or how the depletion of 
lymphocytes may relate to suppression of the immune response in laboratory rabbits. In 
addition, there is limited information on the role of viral anti-apoptosis proteins in virus 
virulence, replication and dissemination. These questions concerning cell permissivity 
and cell death following infection of rabbits with myxoma virus are addressed in 
Chapter 5.
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Chapter 5: Mechanisms of host genetic 
resistance and myxoma virus pathogenesis
_____
5. Mechanisms of host genetic resistance and myxoma virus 
pathogenesis
5.1 Introduction
The growth of myxoma virus in rabbits is characterised by replication at the primary 
inoculation site in the skin, followed by transport to and replication in the draining 
lymph node. Virus disseminates from here to distal tissues, including other lymph 
nodes and the spleen, and to secondary sites in the skin where it grows to high titres. 
Laboratory rabbits infected with virulent SLS die at 10 to 12 days post infection. The 
most severe pathology is in the lymph nodes which are depleted of lymphocytes. 
Infection of laboratory rabbits with the attenuated Uriarra strain of myxoma virus results 
in the growth of virus to similar titres as SLS in the primary inoculation site and the 
draining lymph node, but virus dissemination to and growth in distal tissues is reduced, 
and lymphocytes are not depleted from the lymph nodes. SLS-infection of wild rabbits 
results in similar virus titres in the primary inoculation site, but SLS titres in the 
draining lymph node of wild rabbits are less than in laboratory rabbits. Depletion of 
lymphocytes occurs but is restricted to the draining lymph node, and lymph nodes 
become repopulated with lymphocytes around 15dpi. In both Uriarra-infected 
laboratory rabbits and SLS-infected wild rabbits, virus is cleared from the internal 
tissues by between 10 and 15 days post infection and the rabbits recover from disease. 
From these depictions of myxoma virus pathogenesis, obvious important factors of 
virulence and host resistance are the ability of virus to replicate in the draining lymph 
node, cause lymphocyte depletion and disseminate to distal tissues, and in the ability of 
the host to control virus replication, dissemination and tissue pathology.
The results presented in this thesis suggest that wild rabbits have an enhanced immune 
response to SLS and that this controls viral replication. However, resistance to viral 
infection could also be mediated at the level of the cell. The innate and heritable 
resistance of inbred strains of mice to flavivirus infection is mediated by cell 
permissivity, which restricts virus replication and the production of infectious progeny 
(reviewed in Shellam et al., 1998). Such restricted permissivity of cells from wild 
rabbits to myxoma virus infection could result in reduced virus titres, reduced virus- 
induced pathology and more efficient virus clearance. A comparison of the growth of 
virulent myxoma virus in primary cells from laboratory and wild rabbits has not
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Histopathology of lymph nodes from myxoma virus-infected rabbits in Chapter 4 
indicated that both necrosis and apoptosis of cells were occurring and associated with 
lymphocyte depletion. Other viruses induce cell death by apoptosis both in cultured 
cells, for example influenza virus (Price et al., 1997), and in vivo, for example African 
swine fever virus causes apoptosis of lymphocytes in the lymphoid tissue of infected 
pigs (Summerfield et al., 1998). In the case of some infections, such as HIV infection 
of humans, depletion of lymphocytes by apoptosis is associated with immune 
suppression (Finkel et al., 1995). Myxoma virus encodes at least four genes which have 
been shown to inhibit the apoptosis of infected lymphocytes in vitro, and these cells are 
not killed by infection (Barry et al., 1997; Macen et al., 1996b; Mossman et al., 1996a; 
Schreiber et al., 1997). However, the consequences of replication in vivo may be quite 
different as indicated by the histological results presented in Chapter 4. In addition, a 
fifth myxoma virus anti-apoptotic gene Serp2, does not function as an inhibitor of 
apoptosis in vitro, but is reported to inhibit apoptosis of lymphocytes in vivo (Messud- 
Petit et al., 1998). Therefore the induction of apoptosis was examined in lymph nodes 
and spleen from infected rabbits to determine if this was a major cause of cell death and 
whether apoptosis was occurring in virus-infected cells.
Lymphocytes have been postulated as a major cell type in which myxoma virus 
disseminates within the infected rabbit (Fenner and Woodroofe, 1953). As already 
discussed, myxoma virus replicates well in lymphocytes in vitro and there are at least 
four genes which are critical for this replication. These are Ml 1L, M-T2, M-T4 and M- 
T5 (Barry et al., 1997; Macen et al., 1996b; Mossman et al., 1996a; Schreiber et al., 
1997). Single gene knockout mutants for these genes are at least partially defective in 
replication in lymphocytes, induce apoptosis in infected lymphocytes in vitro and are 
highly attenuated in vivo (Table 5.1). However, the M-T5 knockout virus replicates in 
primary macrophage/monocytes, but is reported not to disseminate beyond the site of 
inoculation (Mossman et al., 1996a). My observations indicate that MHC II positive 
dendritic cells are sites of primary replication and are probably involved in 
dissemination to the draining lymph node. If virus could not replicate in these cells, it 
might be expected to be less able to suppress an inflammatory response in the skin as 
has been reported for the single-gene knockout viruses for M11L, MT-5 and MT-4 
(Barry et al., 1997; Graham et al., 1992; Mossman et al., 1996a; Opgenorth et al.,
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1992). It may also be important that virus-infected dendritic cells are the first cells to 
reach the draining lymph node as these may influence subsequent events in the draining 
lymph node. In addition, since the knockout viruses for Ml 1L, MT-2, MT-4 and MT-5 
cannot replicate productively in lymphocytes in vitro, there should be limited replication 
of these viruses in the draining lymph node and very limited systemic dissemination 
unless other mechanisms of virus spread are operating. Therefore these viruses have 
been used not to examine apoptosis or virulence, but to begin to explore the roles of 
these genes in replication in dendritic cells and lymphocytes in vivo and in 
dissemination in vivo.
______________________________________________________________________________________168
Table 5.1: Replication of myxoma virus gene-deletion mutants, vMyxiacT2\ 
vMyxlacT4', vMyxlacT5' or vMyxlacMl 1L\ in primary lymphocytes and RL-5 
cells
M yxom a virus 
gene deletion  
mutant
A poptosis o f  
infected  
lym phocytes 
in vitro?
Productive in 
vitro
replication in 
RL-5 ce lls ?
Productive in 
vitro  replication  
in primary 
lym phocytes ?
Attenuated 
in vivo?
References
vM yxlacT2' Y es N o Unknown Y es M acen et al., 
1996b; 
Schreiber et 
al., 1997
vM yxlacT4' Y es Reduced Unknown but 
induces 
apoptosis
Y es Barry et al., 
1997
vM yxlacT5' Y es Reduced Unknown but 
induces 
apoptosis
Y es M ossm an et 
al., 1996a
vM yxlacM l 1L' Y es N o Productive 
infection in 
m itogen- 
stimulated 
cultures only
Y es Opgenorth et 
al., 1992; 
M acen et al., 
1996a
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5.2.1 In vitro infection of primary cell culture from laboratory and wild rabbits
To examine the permissivity of primary cells to SLS infection, primary lymphoid cells 
from the lymph nodes and spleen and fibroblasts from the tunics of the testes were made 
from each of three uninfected laboratory and three uninfected wild, male rabbits. These 
cells were infected with SLS and the virus titre as well as the proportion of infected 
cells determined at 24, 48 and 72 hours post infection.
5.2.1.1 Preparation ofprimary lymphoid cells from lymph nodes and spleen
The popliteal lymph nodes and the spleen were excised aseptically from each rabbit and 
placed into HBSS on ice. Primary lymphoid cells were obtained as described in section 
2 .2 .2 .3 .
5.2.1.2 Preparation ofprimary fibroblast cell cultures
The scrotum of each rabbit was incised and the testes removed aseptically into a petri 
dish on ice. The testes were washed in sterile PBS and the tunics removed using sterile 
forceps and scissors. The tunics were cut with a scalpel blade into 1mm2 pieces, placed 
into T25 flasks (six pieces per flask, six flasks per rabbit), and each piece covered with a 
drop of complete MEM supplemented with 20% fetal bovine serum (FBS). The tissue 
explants were incubated for 24 hours at 37°C in 5% CO2 in air, followed by the addition 
of fresh medium. When fibroblasts surrounding the tissue explant were confluent, the 
explants were gently dislodged and discarded. Fibroblast monolayers were washed 
twice with PBS, twice with 0.1% trypsin in diluent (section 2.2.1.4) and left for 2 min 
covered in a thin layer o f 0.1% trypsin. Fibroblasts were gently removed from the flask 
and re-seeded into T25 flasks. Complete MEM containing 10% FBS was added and 
cells were grown to confluency. When confluent, fibroblast monolayers were washed 
twice with PBS and removed from the flask using 0.1% trypsin as above. Fibroblasts 
from each individual rabbit were pooled and pelleted by centrifugation (230g for 5min 
at 18°C). The supernatant was removed and cells were resuspended in 6ml o f 10% 
DMSO in FBS (filtered). 1ml aliquots in cryotubes (Nunc) of the cell suspension were 
placed in the centre o f a large, cottonwool-filled container and frozen overnight at
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-70°C, before being stored in liquid nitrogen.
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5.2.1.3 Infection o f  primary cells
Primary cells from the lymph nodes or spleen were counted and 1 x 107 cells in 3ml of 
compete medium placed in 10ml tubes. Myxoma virus (SLS) was added at a MOI of 3, 
to ensure at least 95% of primary cells were infected. Virus and cells were mixed, 
followed by an hour incubation at 37°C in a waterbath, shaking every 10 min. The cells 
were centrifuged at 230g for 10min, the supernatant removed and the cells were 
resuspended in 12ml fresh medium. The cells were centrifuged as above, the 
supemantant removed and the cells resuspended at 1 x 106 cells/ml. 1ml aliquots of 
cells were seeded into wells of a sterile, 24 well plates (Nunc) and cultured for 24, 48 
and 72 hours at 37°C in 5% CO2 in air. At each harvest point, the cells were gently 
resuspended using a pasteur piptette and wells were checked by microscopy to ensure 
that all cells were removed. Cells were placed in a 1.5ml tube and stored at -70°C until 
virus titre could be determined by plaque assay.
Aliquots of primary fibroblasts were thawed, washed once in complete MEM, placed 
with complete MEM into a T25 flask, and allowed to grow to confluency at 37°C in 5% 
CO2 in air. When confluent, cells were washed twice with PBS, washed twice with 
0.1% trypsin in diluent and left for 2min covered in a thin layer of 0.1% trypsin. The 
cells were resuspended using a pasteur pipette, and the cells were counted using a 
haemocytometer. 2 x 105 cells in 1ml of complete medium were seeded into each well 
of sterile 24 well plates, and allowed to grow to confluency overnight. The estimated 
number of cells per confluent monolayer was 2 x(l08 cells. SLS was added at a MOI of 
3 in 75 Pi complete medium, and allowed to absorb for an hour with rocking every 
10min. The medium was aspirated from the cells, which were then washed by two 
changes of fresh complete MEM. 1ml of complete MEM was added and the SLS- 
infected cells cultured for 24, 48 or 72 hours at 37°C in 5% CO2 in air. At each time 
point, medium was removed from the fibroblasts, and 75^1 SSC (0.15M NaCl, 0.015M 
C6H5Na3 0 7 , pH 7.0) added. Cells were left for 2min and removed from the wells using 
a pasteur piptette. Wells were checked by microscopy to ensure that all cells had been 
removed. Cells were placed in a 1.5ml tube and stored at -70°C until virus titre could 
be determined by plaque assay.
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5.2.1.4 Immunofluorescence assay for myxoma virus in SLS-infected primary cell 
cultures
At 24, 48 and 72 hours post infection, SLS-infected lymphoid cells were harvested by 
repeated pipetting and placed into a 1.5ml tube. These cells were fixed briefly in 
acetone:methanol (1:1), washed twice in PBS and centrifuged onto poly-L-lysine coated 
slides using a cytospin (Shandon Cytospin 2). Cells were then blocked in 3% BSA/PBS 
at room temperature for 60 min, followed by a further two washes in PBS. Slides were 
placed in a humidified container and 100^1 of primary mouse anti-myxoma virus 
monoclonal antibody (clone number 3B6E4), 1:200 in 1% BSA/PBS was added. Slides 
were incubated for 2 hours at 37°C, followed by two washes in PBS. Sections were 
then incubated in the dark for 60min at 37°C with 75^1 of 1:100 goat anti-mouse IgG 
conjugated to FITC (Boehringer Mannheim) in 1% BSA/PBS in a humidified container. 
Sections were washed as above and mounted with Antifade under a coverslip, and 
viewed using confocal microscopy.
Primary fibroblasts were grown on glass coverslips placed in the bottom of 24 well 
plates and cells were infected with SLS as described in section 5.2.1.3. At 24, 48 and 
72 hours post infection, infected-fibroblasts were fixed for 5min at 4°C with 
acetone:methanol (1:1), washed twice with PBS and blocked in 3% BSA/PBS at room 
temperature for 60 min, followed by a further two washes in PBS. Cells were stained 
for myxoma virus using the 3B6E4 monoclonal antibody as described above. After the 
final wash with PBS, the coverslips were removed from the 24 well plates and inverted 
onto glass slides using Antifade as a mounting medium, and viewed using confocal 
microscopy.
5.2.1.5 Vero cell culture and plaque assay for virus titration
Primary cells infected with SLS were harvested and virus titre determined by plaque 
assay on monolayers of Vero cells. Vero cell culture conditions and plaque assay are 
described in sections 2.2.1.4 and 2.2.1.5, respectively.
5.2.2 Detection of apoptotic cells in vivo
The number and distribution of apoptotic cells were examined in paraffin embedded 
tissue sections of the popliteal lymph nodes and spleens taken from laboratory and wild
Mechanisms of pathogenesis and genetic resistance
rabbits infected with either SLS or Uriarra in Chapter 3. These tissues are the same 
tissues for which virus localisation and histopathology were described in Chapter 4 and 
the numbers of rabbits infected with each virus and killed at each time point are shown 
in Table 4.1.
5.2.2.1 Terminal deoxy-UTP nick end labelling of tissue sections
Tissues were fixed in 10% formaldehyde, paraffin embedded within 24 hours of 
fixation, and sectioned onto 0.1% poly-L-lysine coated slides. Sections were dewaxed 
by passing them through the following alcohol series to water: three changes of xylene 
( l x  10min, 2 x 1  min), three changes of 100% ethanol (3 x 2min), 95% ethanol ( l x  
2min), 75% ethanol (1 x 2min), 50% ethanol (1 x 2min), ddH2Ü. Sections were soaked 
in 2x SSC for 20min at 80°C, soaked in ddH20  for 10min at room temperature and 
immersed in prewarmed 0.1M Tris/EDTA at 42°C for 2min. Sections were placed into 
a humidified container and covered with lOOPl o f 0.1mg/ml proteinase K in Tris/EDTA 
for 10min at 37°C, followed by a rinse in ddH20 . Sections were blocked in 1% BSA in 
PBS for 5min at room temperature, and then permeablised for 2min at 4°C in 0.1% 
sodium citrate with 1:1000 Triton X-100 (Sigma) followed by two immediate washes 
with PBS. Sections were returned to the humidified container, covered with 50^1 of the 
reaction mix and incubated for lhour at 37°C. Per tissue section, the reaction mix 
consisted of 31 Pi ddH20 , 10Pl 5x TdT (terminal transferase) buffer (1M potassium 
cacodylate, 125mM Tris-HCl, 1.25 mg/ml BSA, pH 6.6; Boehringer Mannheim), 2Pl 
25mM CoCl2 (Boehringer Mannheim), 3Pl ImM dATP (Boehringer Mannheim), 3Pl 
1:100 FITC conjugated dUTP (ImM; Boehringer Mannheim) and lPl TdT enzyme (25 
x 103 units/ml; Boehringer Mannheim). The reaction mix without enzyme was added to 
lymph node sections as a negative control. Tissue sections o f ovary and liver were 
included as positive and negative controls respectively. The reaction was terminated by 
the addition of 50Pl 0.05M EDTA. Coverslips were mounted with Antifade and 
sections viewed by confocal fluorescent microscopy.
To quantitate the number of apoptotic cells in each tissue section, a grid (1000 Pm2) was 
superimposed over the field of view and the number o f TUNEL+ cells counted. 
Counting of cells was segregated into the different zones o f lymphoid tissue (paracortex 
and germinal centres for the lymph nodes and red and white pulp for the spleen). Up to 
20 individual units of the grid were counted for each microspcope field of view at low 
magnification (lOx). If a unit o f the grid in which cells were counted overlaid more
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than one zone of lymphoid tissue, the proportion of the field occupied by that zone was 
estimated and the number of cells adjusted accordingly. Four microscope fields of view 
were used for each section of lymph node tissue, and five fields were used for each 
section of spleen tissue. Three different sections were used from each tissue from each 
rabbit (see Table 4.1 for the number of rabbits at each time point). The number of 
TUNEL+ cells were expressed as the mean -  standard error, and included all counts for 
a group of infected rabbits killed at the same time point.
5.2.2.2 Staining of sections for myxoma virus and TUNEL+ cells using double 
labeling and serial sections.
To examine if apoptosis occurred in virus-infected cells, double staining for myxoma 
virus and apoptotic cells was performed on frozen tissue sections of lymph nodes that 
had been made and fixed as described in sections 2.2.5.2 and 2.2.5.3. These tissues 
were stained for myxoma virus by immunofluorescence as described in section 2.2.5.5 
with the exception that sections were labeled using a sheep anti-mouse secondary 
antibody conjugated to rhodamine (Boehringer Mannheim; at a dilution of 1:10 in 1% 
BSA/PBS) rather than conjugated to FITC. Frozen tissue sections were then stained 
using the TUNEL reaction described in section 5.2.2.1 with the following exceptions. 
Sections were not treated with 2xSSC at 80°C, digested with proteinase K or 
permeablised with sodium citrate/Triton-X as sections were permeablised during the 
fixative process by acetone.
To confirm that neither positive signal for virus or TUNEL+ cells was being lost during 
double labeling, serial frozen sections were made of lymph nodes and spleen. 
Sequential sections were either stained for myxoma virus or using the TUNEL reaction. 
This indicated that the number of virus-infected cells was reduced in double stained 
tissue sections and sometimes the number or staining intensity of TUNEL+ cells was 
also reduced. Hence, serial sections were routinely used in the examination of virus 
localisation and apoptotic cells in tissue sections and it is the results generated from 
these tissue sections presented in 5.3.2.
5.2.3 Infection of laboratory rabbits with vMyxlac+, vMyxlacMl 1L', 
vMyxlacT2', vMyxlacT4'or vMyxlacT5‘
The myxoma virus gene-deletion mutants, vMyxlacMl 1L" (Graham et al., 1992), 
vMyxlacT2* (Macen et al., 1996b; Schreiber et a l , 1997), vMyxlacT4' (Barry et al.,
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1997) or vMyxlacT5' (Mossman et al., 1996a) and a control virus with vMyxlac+ 
(Macen et al., 1993) were kindly supplied by Professor Grant McFadden, John P. 
Robarts Research Institute and Department of Microbiology and Immunology, 
University of Western Ontario, Canada. In each case, the gene of interest has been 
insertionally inactivated by the E. coli lacZ gene. vMyxlac+ has lacZ inserted 
intergenically. All viruses are derived from the highly virulent Lausanne strain (Brazil 
campinas 1949). The titre of virus stocks was determined by plaque assay on Vero cells 
(section 2.2.1.5). Nine laboratory rabbits were inoculated intradermally with lOOOpfii 
of each virus in the dorsum of the left hind foot. Three rabbits were killed by 
intravenous injection of barbituate at each of 24 and 48hpi and 6dpi. The skin at the 
primary inoculation site, and the draining and contralateral popliteal lymph nodes were 
removed. Tissues taken at 24 and 48hpi were processed for frozen tissue sections 
(section 4.2.2.2) and stained for virus by immunofluorescence (section 2.2.5.5). Tissues 
taken at 6dpi were processed for the titration of virus by plaque assay (section 2.2.1.5).
5.3 Results
5.3.1 Growth of myxoma virus in primary cells from laboratory and wild rabbits.
To determine whether host resistance to myxoma virus infection was associated with
resistance to virus replication within cells, primary cultures of lymphoid cells from the 
lymph nodes and spleen, and of fibroblasts from the tunics of the testes, were made 
from each of three wild and three laboratory rabbits. Lymphoid cell suspensions and 
fibroblast cell monolayers were infected with SLS at a MOI of 3 which should ensure 
infection of 95% of cells, and cultured for 24, 48 and 72 hours. By 24hpi, SLS had 
replicated to similar titres in cells from the lymph node of either laboratory or wild 
rabbits, at mean titres of 3.9 x 105 and 3.3 x 105 respectively (Figure 5.1). These titres 
did not change substantially at 48 and 72 hpi. SLS grew to similar titres in primary 
mononuclear cells from the spleen of both laboratory and wild rabbits at 24, 48 and 72 
hpi (Figure 5.2). By 24hpi, SLS had replicated to titres of 1.6 x 105 and 3.1 x 105 in 
fibroblasts from the testes of either laboratory or wild rabbits, respectively (Figure 5.3). 
At 48 and 72 hpi, titres of SLS in primary fibroblasts were also similar between cultures 
from laboratory and wild rabbits.
SLS-infected primary cells were stained by immunofluorescence for myxoma virus. By 
24 hpi, approximately 50% of primary cells from either the lymph nodes (Figure 5.4 A)
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or spleen (Figure 5.4 B) of laboratory rabbits were infected with myxoma virus. By 48 
and 72 hpi, there was no increase in the proportion of infected cells, with approximately 
50% of cultured cells containing virus. Similarly, myxoma virus infected 
approximately 50% of primary cells cultured from the lymph nodes and spleens of wild 
rabbits at 24 (Figure 5.4 C and D), 48 or 72 hpi. Cell suspensions made from the spleen 
were often clumped together. The counts of myxoma virus-positive cells indicated that 
approximately 50% of cells in a sample were infected, although this is not clear from 
the subsample depicted in Figure 5.4D. By 24hpi, SLS had infected 95 to 100% of 
primary fibroblasts cultured from the testis of either laboratory or wild rabbits (data not 
shown).
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Figure 5.1: SLS titre following infection of primary lymphocytes from lymph nodes of 
laboratory and wild rabbits. Primary cells were cultured from each of three laboratory 
and three wild rabbits and infected with SLS at a moi of 3. Triplicate samples of 
infected cells were cultured for 24, 48 or 72 hours, and the virus titre determined by 
plaque assay (±SE between rabbits).
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Figure 5.2: SLS titre following infection of primary lymphocytes from spleens of
laboratory and wild rabbits. Primary cells were cultured from each of three laboratory 
and three wild rabbits and infected with SLS at a moi of 3. Triplicate samples of 
infected cells were cultured for 24, 48 or 72 hours, and the virus titre determined by 
plaque assay (±SE between rabbits).
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Figure 5.3: SLS titre following infection of primary fibroblasts from testes of
laboratory and wild rabbits. Primary cells were cultured from each of three laboratory 
and three wild rabbits and infected with SLS at a moi of 3. Infected cells were cultured 
for 24, 48 or 72 hours, and the virus titre determined by plaque assay (±SE between 
rabbits).
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Figure 5.4: Primary lymphocytes from the lymph nodes and spleen of rabbits infected 
with SLS in vitro. Lymphocytes were infected with SLS at a moi of 3, cultured for 24 
hours and stained for myxoma virus. (A) lymph node lymphocytes from a laboratory 
rabbit, (B) splenic lymphocytes from a laboratory rabbit, (C) lymph node lymphocytes 
from a wild rabbit, (D) splenic lymphocytes from a wild rabbit. In each case, 
approximately 50% of cells were positive for myxoma virus, except in (D), which is an 
artifact of cell distribution on the slide rather than the number of virus-positive 
splenocytes.

5.3.2 Cell death in lymph nodes due to apoptosis
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Changes in the number and distribution of cells with apoptotic nuclei in the lymph 
nodes and spleens following infection of laboratory or wild rabbits with SLS or Uriarra 
were examined by TUNEL reaction in fixed tissue sections. Tissue sections from ovary 
and liver were included as positive and negative controls respectively (Figure 5.5). The 
distribution of cells with apoptotic nuclei in the lymph nodes of uninfected rabbits and 
the changes following infection are described below.
5.3.2.1 Lymph nodes from uninfected rabbits
The lymph nodes from 11 uninfected laboratory rabbits were labelled by the TUNEL 
reaction to determine the distribution of apoptotic cells in uninfected lymph nodes 
(Figure 5.6A). Apoptotic cells were often clustered in a group of 3-15 cells in the centre 
of dark zones or at the edge of light zones in germinal centres (Figure 5.6B). Some 
germinal centres were surrounded by a ring of apoptotic cells, or had 3-10 apoptotic 
cells at the border of germinal centres and the paracortex. Apoptotic cells in the 
paracortex of uninfected lymph nodes were evenly distributed at a density of 2.3 -  1.1 
cells/lOOlfrn2 (Figure 5.6C). Fluorescence was usually only observed in intact cells, 
with apoptotic bodies rarely observed.
5.3.2.2 Changes in the number and distribution of apoptotic cells in draining and
contralateral lymph nodes following the infection of laboratory or wild rabbits 
with either SLS or Uriarra
The density of apoptotic cells in the paracortex of draining lymph nodes is shown in 
Figure 5.7. This indicates that SLS-infection of laboratory rabbits resulted in an 
increase in the number of cells with apoptotic nuclei in the draining lymph node by 
4dpi. Apoptotic cells were a prominent feature in the lymph nodes from 6dpi in all 
other rabbits. By 10dpi when most other infections had high numbers of apoptotic cells 
in the paracortex, the draining lymph nodes from SLS-infected laboratory rabbits had 
low numbers. This was associated with depletion of lymphocytes from the lymph 
nodes. Changes in the density of apoptotic cells in the contralateral lymph node were 
similar to the draining lymph node and are shown in Figure 5.7B.
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Figure 5.5: Tissue sections of rabbit ovary (A) and liver (B) stained with the
TUNEL reaction. Cells of the ovary granulosum have a high rate of apoptosis, and 
thus this tissue was used as a positive control for the TUNEL reaction. Apoptosis is 
not a major mechanism of cell turn over in the liver, and thus this tissue was used 
routinely as a negative control for this assay. Bar represents 400pm.
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Figure 5.6: TUNEL+ cells in the popliteal lymph nodes from uninfected rabbits. 
(A) TUNEL+ cells in the paracortex and follicles. Note the even distribution of 
TUNEL+ cells in the paracortex and in small clusters associated with follicles of 
uninfected lymph nodes. Bar represents 300pm. (B) TUNEL+ cells in germinal 
centres. Bar represents 150pm. (C) TUNEL+cells in the paracortex. Bar 
represents 150pm. P, paracortex; F, follicles; GC, germinal centres.
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Figure 5.7: Numbers of TUNEL+ cells in the paracortex of (A) draining and (B) 
contralateral lymph nodes from SLS and Uriarra infected laboratory and wild rabbits 
(cells/100pm2 ± SE). Using fixed tissue sections, the nucleus of cells containing 
fragmented DNA was labeled using the TUNEL reaction. A grid was superimposed 
over the field of view (4 fields were used per section, three tissue sections per tissue, see 
Table 4.1 for the number of rabbits at each time point) and up to 20 individual units of 
the grid counted. The SE is calculated for all tissue sections from all rabbits.
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In addition to changes in the density of apoptotic cells, the distribution of TUNEL+ cells 
in the lymph nodes of myxoma virus-infected rabbits also differed between infections. 
These differences in distribution were particularly associated with the paracortex and 
germinal centres of lymph nodes, and are described below. Using serial sections, lymph 
node tissues from infected rabbits were stained for cells with apoptotic nuclei By 
TUNEL reaction. Sequential tissue sections of 4^m thickness were stained for myxoma 
virus. The results are described below.
5.3.2.3 Changes in the distribution of apoptotic cells and localisation of myxoma 
virus
5.3.2.3.1 The paracortex
In SLS-infected laboratory rabbits, apoptotic cells were first seen in the paracortex 
immediately under the subcapsular sinus, over the cortex and extending down between 
follicles and germinal centres (Figure 5.8A). This was observed in both the draining 
and contralateral lymph nodes at 4dpi, although many areas of the paracortex were 
normal (Figure 5.8B). In other cases, a continuous line of positive cells, seen as a band 
of positive cells approximately 400Mm across, or as a line one to two cells deep, 
spanned the paracortex directly under the follicles (Figure 5.8C and D). These lines of 
TUNEL+ cells were usually associated with continuous lines of myxoma virus-infected 
lymphocytes, but cells staining positive for myxoma virus generally did not have 
apoptotic nuclei. This is shown in Figure 5.9 in serial sections with the TUNEL+ cells 
shown in Figure 5.9A and virus localisation in a second but sequential tissue section 
shown in Figure 5.9B. At 4dpi of laboratory rabbits with SLS, high numbers of 
apoptotic cells in the cortex of the lymph nodes was associated with the presence of 
virus-infected lymphocytes. However, apoptotic cells were not infected with SLS 
(Figure 5.10). Although myxoma virus was present in the lymph nodes of Uriarra- 
infected laboratory rabbits, and SLS- or Uriarra-infected wild rabbits at the same time, 
the distribution of apoptotic cells in the paracortex of Uriarra-infected laboratory rabbits 
was similar to that in lymph nodes from uninfected rabbits.
Apoptotic cells became evenly distributed throughout large areas of the cortex and 
paracortex of the draining and contralateral lymph nodes of all infected rabbits by 6dpi 
(Figure 5.11 A and B). There was an even distribution of myxoma virus-infected 
lymphocytes in the paracortex from all infected rabbits (an example is shown in Figure 
5.11C) except Uriarra-infected wild rabbits. WBC contained within the lumen of blood
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vessels also stained positive by the TUNEL reaction in all infected rabbits (Figure 
5.12A). Endothelial cells did not have apoptotic nuclei. In draining lymph nodes from 
SLS-infected laboratory rabbits but not from other rabbits, there was an increase in the 
number of cells containing nuclei that stained intensely positive immediately 
surrounding the blood vessels (Figure 5.12B) and trabeculae (Figure 5.12C) of the 
diffuse cortex.
182
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Figure 5.8: TUNEL+ cells in the paracortex of the draining lymph node of SLS- 
infected laboratory rabbits at 4dpi. (A) TUNEL+ apoptotic cells in the paracortex 
immediately under the subcapsular sinus, over the cortex and extending down 
between follicles and germinal centres. Bar represents 150lhn. (B) Diffuse cortex 
in another area of the same lymph node as (A). Bar represents 150Mm. (C).
Continuous band of TUNEL+ cells spanning the paracortex. Bar represents lOOlhn. 
(D) Continuous band of TUNEL+ cells spanning the paracortex. Bar represents 
lOOlhn. (GC) germinal centre.
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Figure 5.9: Serial sections of lymph nodes from an SLS-infected laboratory 
rabbit at 4dpi stained by TUNEL reaction or by immunofluorescence for 
myxoma virus. (A) Myxoma virus positive lymphocytes in the paracortex. (B) 
Serial section taken 4pm from (A) showing the TUNEL+ cells spanning the 
paracortex. TUNEL+ cells were adjacent to myxoma virus infected lymphocytes. 
Bars represent 100pm.
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Figure 5.10: Serial sections of a lymph node from an SLS-infected laboratory 
rabbit at 4dpi. (A) TUNEL+ cells in the cortex and throughout a follicle. (B) 
Localisation of SLS . F, follicle. Bars represent 100pm.
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Figure 5.11: TUNEL+ cells and myxoma virus positive cells in the paracortex of 
draining lymph nodes at 6dpi. (A) TUNEL+ cells in the lymph node paracortex from 
an SLS-infected laboratory rabbit. (B) TUNEL+ cells in the lymph node paracortex 
from an SLS-infected wild rabbit. (C) Myxoma virus staining in the lymph node 
paracortex from an SLS-infected laboratory rabbit. Bars represent 150|iim.
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Figure 5.12: TUNEL+ cells associated with blood vessels and connective structures 
in the paracortex of lymph nodes at 6dpi. (A) TUNEL+ WBC in the lumen (arrow) 
of a blood vessel from an SLS-infected laboratory rabbit. Bar represents 100(im. 
(B) TUNEL+ cells surrounding blood vessels in the lymph node paracortex from an 
SLS-infected laboratory rabbit. Bar represents 100p.m. (C) TUNEL+ cells
surrounding the trabeculus in the lymph node paracortex from an SLS-infected 
laboratory rabbit. Bar represents 200p.m. BV, blood vessel; P, paracortex; T, 
trabeculus.
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The number and staining intensity of apoptotic cells in the cortex and paracortex of 
most draining and contralateral lymph node sections taken from SLS-infected rabbits at 
10dpi were generally reduced compared to 6dpi. This reduction was associated with the 
depletion of lymphocytes from the lymph nodes. In contrast, the paracortex of lymph 
nodes from Uriarra-infected laboratory rabbits, or from wild rabbits infected with either 
SLS or Uriarra, contained evenly distributed TUNEL+ cells at medium to high densities 
(Figure 5.13 A), similar to that at 6dpi, even when virus was not present in serial 
sections (Figure 5.13B). This general distribution of cells with apoptotic nuclei was 
maintained in the diffuse cortex of lymph nodes from Uriarra-infected laboratory 
rabbits, or from wild rabbits infected with either SLS or Uriarra, over the 20 days of 
infection, although virus was not detected by immunofluorescence in lymph nodes from 
15 and 20dpi.
5.3.2.3.2 Germinal Centres
Changes in the distribution of TUNEL+ cells and myxoma virus-infected lymphocytes 
associated with germinal centres in lymph nodes were substantially different between 
infections. In Uriarra-infected laboratory rabbits (Figure 5.14A) and in wild rabbits 
infected with either SLS (Figure 5.14B) or Uriarra, the number of apoptotic cells in the 
newly forming germinal centres of the draining lymph node increased slightly at 4dpi, 
and was substantial by 6dpi. This increase was most obvious in the dark zones of 
germinal centres and throughout the side of the mantle zone closest to the lymph node 
paracortex. Myxoma virus was present in lymphocytes in the paracortex of these 
rabbits, but was not associated with germinal centres. By 10dpi of these rabbits, large 
macrophage-like (approximately 3$fAm across) were present in the light zone of many 
germinal centres in both the draining and contralateral lymph nodes. These cells 
contained 10-20 apoptotic bodies within their cytoplasm (Figure 5.14C). In SLS- 
infected wild rabbits, myxoma virus localised to the mantle zones of some germinal 
centres by 6dpi. TUNEL+ cells were distributed evenly over the entire area of these 
germinal making distinct zones difficult to define. The generalised distribution of 
TUNEL+ cells over germinal centres was not observed in the lymph nodes from Uriarra- 
infected laboratory rabbits.
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Figure 5.13: TUNEL staining and virus localisation in serial sections of lymph node 
from a Uriarra-infected laboratory rabbit at 6dpi. (A) TUNEL+ cells were distributed 
throughout the paracortex and inner mantle zone of germinal centres. (B) Myxoma virus 
localisation in a serial section taken 4jim from (A). The germinal centre indicated (GC) 
is the same one in each case. Bars represent 200jim. P, paracortex.
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Figure 5.14: TUNEL+ staining of germinal centres in draining lymph nodes from 
myxoma virus-infected rabbits. (A) Uriarra-infected laboratory rabbit at 6dpi. Bar 
represents 100pm. (B) SLS-infected wild rabbit at 6dpi. Bar represents 100pm. (C) 
Macrophage-like cells containing TUNEL+ apoptotic bodies within the cytoplasm. 
These were present in the light zones of germinal centres from 10dpi of Uriarra-infected 
laboratory rabbits or SLS-infected wild rabbits. Bar represents 35pm. P, paracortex; 
GC, germial centre.
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In SLS-infected laboratory rabbits, myxoma virus localised in lymphocytes of the 
mantle zones of some germinal centres by 4dpi, and there was an increase in TUNEL+ 
cells in germinal centres by 6dpi. Both the virus localisation and the distribution of 
apoptotic cells were highly variable. In some germinal centres, the distribution of 
TUNEL+ cells was clustered in the dark or inner mantle zones (Figure 5.15A). SLS was 
not present in the mantle zones of these germinal centres. In other germinal centres that 
did contain SLS, TUNEL+ cells were distributed throughout most of the germinal centre 
(Figure 5.15B) or contained large numbers of rounded fluorescent particles of two 
general sizes. The first and smallest were distributed throughout the dark and light 
zones of the germinal centres and were likely to be nuclear fragments corresponding to 
apoptotic bodies. The second, larger particles were distributed throughout the mantle 
zone of germinal centres and were the size of intact cells with apoptotic nuclei (Figure 
5.15C). Germinal centres containing numerous nuclear fragments were never present in 
Uriarra-infected laboratory rabbits and was observed only at 20dpi in one SLS-infected 
wild rabbit.
The number of TUNEL+ cells in the germinal centres of lymph nodes from SLS- 
infected laboratory rabbits declined at 10dpi (Figure 5.15D), but was generally 
maintained over the course of infection in Uriarra-infected laboratory rabbits or in wild 
rabbits infected with either SLS or Uriarra.
As has been discussed, SLS localised to the mantle zones of germinal centres in both the 
draining and contralateral lymph nodes of laboratory rabbits by 4dpi (Chapter 4). This 
was associated with an increase in the number of TUNEL+ cells. However, in serial 
sections taken at 4f1m intervals, cells within germinal centres that had apoptotic nuclei 
did not stain positive for myxoma virus. Two examples of TUNEL staining and 
myxoma virus localisation in germinal centres from the lymph nodes of SLS-infected 
rabbits are shown in Figure 5.16.
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Figure 5.15: TUNEL staining in germinal centres from the draining lymph nodes of 
SLS-infected laboratory rabbits. (A) Germinal centre at 6dpi. TUNEL+ cells are present 
in the dark zone or in the area of the mantle zone closest to germinal centres from the 
paracortex. (B) Germinal centres from the same draining lymph node shown in (A). 
TUNEL+ cells are evenly distributed over the germinal centres. (C) Germinal centre at 
6dpi containing TUNEL+ fragments of two sizes; small apoptotic bodies (open long 
arrow) and larger, intact lymphocytes (open short arrows). (D) Remnants of a draining 
lymph node germinal centre at 10dpi containing few TUNEL+ cells. The closed arrow 
indicates the edge of the remnant centre. GC, germinal centre; P, paracortex. Bars 
represent 150jLtm.
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Figure 5.16: TUNEL staining (left hand side) and myxoma virus localisation (right 
hand side) in two germinal centres from SLS-infected laboratory rabbits. TUNEL+ cells 
were clustered in the middle of the germinal centres whereas myxoma virus-infected 
cells were present in the mantle zones. In addition, more cells were apoptotic than were 
infected with virus.
TUNEL MV
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5.3.3 Cell death in the spleen due to apoptosis
5.3.3.1 Spleens from uninfected rabbits
Uninfected spleens contained low densities of TUNEL+ lymphocytes throughout the 
white pulp at 1.7 -  1.0 cells/1 OOlfrn2 and many clusters of positive staining mononuclear 
cells in the red pulp (Figure 5.17A). These cells in the red pulp were of two types. The 
first were macrophages as they were large, and contained numerous TUNEL+ nuclear 
fragments within their cytoplasm, although the cell nucleus was not positive (Figure 
5.17B). The nucleus o f the other mononuclear cell type stained positive by TUNEL. 
These were probably lymphocytes and were present in the red pulp at 2.6 - 1 . 2  
cells/1 OOlV.
5.3.3.2 Changes in the number and distribution of apoptotic cells in the spleen 
following the infection of laboratory or wild rabbits with either SLS or 
Uriarra
In general, the changes in the number of TUNEL+ cells in the red and white pulp of the 
spleen (Figure 5.18 A and B) were small compared to the lymph nodes. However, SLS 
infection of laboratory rabbits was clearly different from Uriarra-infected laboratory 
rabbits or SLS-infected wild rabbits. The two prominent differences shown by TUNEL 
staining were seen at 10dpi. The first o f these was a decrease in the number and 
staining intensity o f lymphocytes in the white pulp of SLS-infected laboratory rabbits 
(Figure 5.19A) compared to other infections (Figure 5.19B). Secondly, by 10dpi there 
was a decrease in the number of macophages containing apoptotic bodies in the splenic 
red pulp o f SLS-infected laboratory rabbits (Figure 5.19C) compared to other groups of 
infected rabbits (Figure 5.19D).
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Figure 5.17: TUNEL staining of the spleen from an uninfected rabbit. (A) TUNEL+ 
cells in the red and white pulp of the spleen. The majority of TUNEL signal in the red 
pulp localised to macrophages. Bar represents 150p.m. (B) TUNEL+ lymphocytes and 
macrophages in the red pulp of the spleen. The macrophage cytoplasm contains 
TUNEL+ apoptotic bodies. Bar represents 15pm. RP, red pulp; WP, white pulp; L, 
lymphocyte; M, macrophage.
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Figure 5.18: Numbers of TUNEL+ cells in the (A) red pulp and (B) white pulp of 
spleens from SLS and Uriarra infected laboratory and wild rabbits (cells/100pm2 ± SE). 
Using fixed tissue sections, the nucleus of cells containing fragmented DNA was 
labeled using the TUNEL reaction. A grid was superimposed over the field of view (5 
fields were used per section, three tissue sections per tissue, see Table 4.1 for the 
number of rabbits at each time point) and up to 20 individual units of the grid counted. 
Day 0 has not been shown as this was not different to 2dpi.
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Figure 5.19: TUNEL+ cells in the spleen of SLS and Uriarra-infected laboratory rabbits 
at 10dpi. Bar represents 400fim. (A) TUNEL+ cells in the white pulp of SLS-infected 
laboratory rabbits. (B) TUNEL+ cells in the white pulp of Uriarra-infected laboratory 
rabbits. Bar represents 400jam. (C) TUNEL+ cells in the red and white pulp of SLS- 
infected laboratory rabbits. Bar represents 400jam. (D) TUNEL+ cells in the red and 
white pulp of Uriarra-infected laboratory rabbits. Bar represents 200jiim RP, red pulp; 
WP, white pulp.
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5.3.4 Infection of rabbits with myxoma virus deletion mutants, vMyxlacMl 1L‘, 
vMyxlacT5', vMyxlacT4‘ or vMyxlacT2‘
To examine if the myxoma virus genes known to function as inhibitors of apoptosis in 
infected cells are important in virus replication and transport from the primary 
inoculation site in the skin to the draining lymph node, laboratory rabbits were 
inoculated with vMyx-lac+, or the vMyxlacMl 1L‘, vMyxlacT5‘, vMyxlacT4' or 
vMyxlacT2' myxoma virus gene-deletion mutants. These viruses were visualised in 
tissue sections of the primary inoculation site and the draining lymph node by 
immunofluorescence at 24 and 48 hpi. To examine the ability of these viruses to 
replicate at the primary inoculation site and the draining lymph node, and to disseminate 
to and replicate in the contralateral lymph node, virus titres were determined in these 
tissues at 6dpi.
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5.3.4.1 Autopsy findings following infection of laboratory rabbits with myxoma virus- 
apoptosis gene deletion mutants or vMyx-lac+
There were no gross changes at the inoculation site or in the draining or contralateral 
lymph nodes of rabbits at 24 or 48 hpi. The gross pathological changes following six 
days of infection of laboratory rabbits with myxoma virus-apoptosis gene deletion 
mutants or vMyx-lac+ are summarised in Table 5.1 and described below.
At 6dpi with the control myxoma virus, vMyx-lac+, the inoculation site was 
approximately 1.5cm in diameter, raised and red. The draining lymph node was 
enlarged to approximately three times normal size, and had localised patches of dark 
purple discolouration. The contralateral lymph node generally did not appear enlarged, 
but was slightly purple in colour.
At 6dpi with the vMyxlacMl 1L', the skin at the primary inoculation site was thickened, 
slightly raised and pink. Both the draining and contralateral lymph nodes were enlarged 
to approximately twice normal size, and the draining lymph node had small areas of 
purple discolouration. The primary inoculation sites of vMyxlacT2\ vMyxlacT4' and 
vMyxlacT5' were raised and red, with the vMyxlacT2' primary lesion being the greatest 
in diameter and the vMyxlacT5" lesion the smallest. The draining lymph node 
following infection with all three viruses was grossly enlarged, at four to five times
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normal size and very haemorrhagic in appearance. However, the contralateral lymph 
node following infection of rabbits with these viruses was generally not enlarged and 
remained ivory in colour.
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Table 5.2: Autopsy findings at 6dpi of laboratory rabbits with myxoma virus deletion 
mutants and vMyxlac+.
Myxoma virus 
deletion mutant
Primary inoculation 
site
Draining lymph 
node
Contralateral lymph 
node
vMyx-lac+ 1.5cm x 1.5cm, 3 x normal size, not enlarged, slighty
raised, red discoloured discoloured
vMyxlacMl 1L' thickened, pink * 2 x normal size, 2 x normal size,
discoloured discoloured
vMyxlacT2~ 3cm x 1.5cm, 4 x normal size, 1.5 x normal size,
raised, red purple not discoloured
vMyxlacT4' 2cm x 1.5cm, 5 x normal size, no change
raised, red purple
vMyxlacT5‘ 1cm x 1cm, slightly 4 x normal size, no change
raised, red purple
* lesion could not be accurately defined
5.3.4.2 Localisation of myxoma virus deletion mutants at 24 and 48hpi by 
immunofluorescence
At 24hpi, all five viruses were present in dendritic cells in the dermis, and in 
mononuclear cells in the paracortex of the draining lymph node. vMyx-lac+, 
vMyxlacT5‘, vMyxlacTA and vMyxlacT2~ were present in the skin from all three 
rabbits inoculated with each virus, whereas vMyxlacMl 1L was only present in the skin 
of two of three infected rabbits. At 48hpi, vMyx-lac+, vMyxlacT5 , vMyxlacT4', 
vMyxlacT2' and vMyxlacMl 1L' were present in dendritic cells of the dermis in all three 
rabbits inoculated with each virus. However, visually, the overall number of infected 
cells in the dermis from two rabbits inoculated with vMyx-Ml 1L‘ was slightly less than 
those inoculated with vMyx-lac+, vMyxlacT5 , vMyxlacT4' or vMyxlacT2' (Figure 
5.20).
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Figure 5.20: Localisation of vMyx-lac+ (A) and vMyxlacMl 1L' (B) in the dermis 
of the primary inoculation site at 48hpi. E, epidermis; D, dermis. Bar represents 
300pm.
vMyx-lac+, vMyxlacT5‘, vMyxlacT4' and vMyxlacT2~ were present in the paracortex of 
the draining lymph node at 24hpi in mononuclear cells resembling lymphocytes and 
macrophages. At 48hpi, all five viruses, including vMyxlacMl 1L~, were present in 
lymphocytes positioned in continuous lines, one to three cells deep, spanning the cortex 
and paracortex of draining lymph nodes. Lymphocytes not contiguous with other 
lymphocytes or in clusters of 3 to 5 lymphocytes were also positive for myxoma virus in 
the draining lymph nodes of all infected rabbits at 48hpi.
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53.4.3 Titres of virus in the primary lesion, draining and contralateral lymph nodes
at 6dpi
Following intradermal inoculation, the titre of the control virus, vMyx-lac+, was greater
o
than 10 pfu/g at 6dpi in the primary lesions. At 6dpi, the titres of vMyxlacMl 1L and 
vMyxlacT5' were 100-1000 fold less than the control virus in the primary inoculation 
site of two of three infected rabbits in each group. vMyxlacT2 and vMyxlacT4~ were 
present in the primary lesion of all three infected rabbits in each group at titres 
approximately 10 fold less than the control virus (Figure 5.21 A). In the draining lymph 
node at 6dpi, vMyx-lac+ titres were greater than 106 pfu/g in all rabbits and reached a 
maximum titre of 1.3 x 108 in one infected rabbit. By 6dpi, vMyxlacMl 1L‘ and 
vMyxlacT5' were present at 10-100 fold lower titres, and vMyxlacT2 and vMyxlacT4~ 
were present at approximately 10 fold lower titres, than the control virus, vMyx-lac" 
(Figure 5.2IB). The control virus and all four gene-deletion mutant viruses 
disseminated to the contralateral lymph node. In this lymph node, vMyx-lac+ titres 
ranged between 103 and 104 pfu/g. vMyxlacMl 1L and vMyxlacT4 viruses were 
present in the contralateral lymph node of all three rabbits inoculated with either virus, 
although in two vMyxlacMl IL'-infected rabbits and in all vMyxlacT4 -infected 
rabbits, the titres were approximately 10 fold lower than following infection with the 
control virus. Virus was not present by 6dpi in the contralateral lymph nodes of one 
laboratory rabbit inoculated with vMyxlacT2 and in two rabbits infected with 
vMyxlacT5\ Titres of virus present in the contralateral lymph nodes of vMyxlacT2' or 
vMyxlacT5 infected rabbits were 103 to 2.5 x 103 pfu/g (Figure 5.21C).
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Figure 5.21: Virus titre at 6dpi in the primary lesion (A), draining lymph node (B) and 
contralateral lymph node (C) of laboratory rabbits infected with myxoma virus gene 
deletion mutants, vMyxlacMl 1L', vMyxlacT5\ vMyxlacT4\ vMyxlacT2‘ or the control 
virus, vMyxlac+. Three rabbits were intradermally inoculated in the dorsum of the hind 
foot with lOOOpfu of virus. Each column represents the titre of virus (pfu/g) for an 
individual rabbit. An asterix indicates virus was not detected by plaque assay. The limit 
of detection was 102 pfu/g tissue.
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53.4.4 Myxoma virus gene-deletion mutant plaque phenotypes on Vero cells
The titre of virus stocks was determined by plaque assay on Vero cells. The 
morphology of the plaques formed following infection of Vero cell monolayers with all 
five viruses as originally obtained following culture in BGMK cells was large and 
round, with vMyxlacMUL' yielding the plaques with the largest diameter after 6 days 
of culture, followed by vMyx-lac+ and vMyx-T4. vMyxlacT2‘ and vMyxlacT5" yielded 
the plaques with the smallest diameter. Following six days of in vivo passage, the 
plaque morphology of vMyx-lac+, vMyxlacT2", vMyxlacTT and vMyxlacT5' did not 
change. However, infection of Vero cells with vMYX-MUL' after rabbit passage 
yielded large round plaques that had much smaller plaques in a tail formation to one 
side of the main plaque. These plaques are termed rocket plaques (data not shown).
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5.4 Discussion
5.4.1 Cell permissivity to infection from wild rabbits
The experimental evidence presented in this thesis suggests that the control of SLS 
replication by wild rabbits demonstrated in Chapter 3 is mediated through the early 
activation of a more efficient immune response to infection compared to that of 
laboratory rabbits. However, the early restriction of virus replication in the draining 
lymph nodes of wild rabbits compared to laboratory rabbits could also have resulted 
from resistance at the level of cell permissivity to virus infection or replication, such as 
occurs in flavivirus resistant mice (reviewed in Shellam et al., 1998). SLS replicated 
efficiently in primary cells from the spleen and lymph nodes of both resistant and 
susceptible rabbits and similar results were obtained in primary fibroblasts. In both 
cases, similar proportions of cells were infected. This suggests that the permissivity of 
rabbit cells to virus infection is not a crucial factor in genetic resistance to myxoma 
virus, and supports the hypothesis that control of myxoma virus replication in wild 
rabbits is mediated by the immune response.
5.4.2 The induction of apoptosis in the lymph nodes and spleen of myxoma virus- 
infected rabbits
The depletion of lymphocytes from the lymph nodes and spleen of laboratory rabbits
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infected with virulent myxoma virus has been a constant histological finding in both this 
and previous studies (Hurst, 1937a). However, lymphocyte depletion was much more 
extensive in SLS-infected laboratory rabbits compared to Uriarra infection. Apoptosis 
was a major mechanism of cell death of lymphocytes in lymph nodes in both laboratory 
and wild rabbits infected with either SLS or Uriarra. In all rabbits, apoptosis occurred 
only in lymphocytes that did not contain virus antigen. However, the timing and 
distribution of apoptosis throughout the lymph nodes of SLS-infected laboratory rabbits 
was substantially different to all other infections.
Lymphocyte depletion was most obvious in SLS infections. That is, it was a function of 
virus virulence. Histologically, lymphocytes in infected lymph nodes were apoptotic. It 
was hypothesised that the cell depletion was due to apoptosis. However, staining of 
lymph nodes from all the infections showed that extensive apoptosis was a feature in 
lymph nodes whether or not cell depletion was occurring. Thus, apoptosis of 
lymphocytes, while a major feature of myxoma virus infection, was not sufficient to 
explain the extensive loss of lymphocytes from SLS-infected lymph nodes. Despite 
this, there was a correlation between lethal infection and earlier induction of apoptosis 
in lymph nodes. Thus, SLS-infected laboratory rabbits had extensive apoptosis at 4dpi 
whereas all other infections only showed background apoptosis at this time point. This 
is despite relatively similar titres of virus in Uriarra and SLS-infected laboratory rabbits 
(Chapter 3). It is possible that the early induction of apoptosis removes a critical 
population(s) of lymphocytes for the subsequent control of virus replication and that the 
later apoptosis is associated with an ongoing activation of lymphocytes during an 
immune response.
The mechanisms of induction of apoptosis following infection with myxoma virus have 
not been determined. Apoptosis did not occur in lymphocytes in which viral antigen 
could be detected. In SLS-infected laboratory rabbits it was occurring in lymphocytes 
adjacent to these cells. However, in all other infections, lymphocytes undergoing 
apoptosis were not closely associated with lymphocytes infected with virus. This 
supports the idea that in SLS-infection of laboratory rabbits, the mechanism of 
induction of apoptosis may be different than during other infections and may be a direct 
viral effect, perhaps by triggering apoptosis on virus-binding to adjacent cells, or an 
indirect effect due to activation of adjacent cells. The role, if any, of infected 
interdigitating dendritic cells in this remains to be determined.
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Binding of vaccinia virus to non-permissive cells has been shown to induce apoptosis 
(Ramsey-Ewing and Moss, 1998). Following myxoma virus infection in vitro, around 
50% of lymph node primary cells did not become infected. Apoptosis of these cells has 
not been reported (Barry et al., 1997; Macen et al., 1996b; Mossman et al., 1996a; 
Schreiber et al., 1997) and was not examined in my study. It is possible that in the 
environment of the lymph node, these cells do undergo apoptosis on non-permissive 
infection with SLS. This explanation is not completely satisfactory unless there is a 
significant difference between SLS infection in wild rabbit lymphocytes and laboratory 
rabbits, which was not apparent in vitro. One possible explanation is a difference in the 
proportion of extracellular enveloped versus intracellular mature virus (EEV and IEV, 
repectively) particles produced in each case, and possibly in Uriarra versus SLS 
infection, and the relative importance of the different surface proteins of these virus 
phenotypes in the interactions between virus and cell-surface proteins. Apoptosis of 
non-permissive cells would prevent virus infection and therefore be a defence 
mechanism. Without ruling this out, the lack of proximity to infected cells in SLS- 
infected wild rabbits or Uriarra-infected laboratory rabbits, and the fact that apoptosis 
continues in lymph nodes after virus is no longer detectable further suggests that 
apoptosis is not a defence mechanism against virus infection of lymphocytes in these 
animals, but is a part of the activation of the immune response.
Apoptosis is an important regulatory mechanism in immune activation, involved in the 
selection of lymphocytes capable of specifically interacting with antigen, the regulated 
cell death of lymphocytes that are partially activated by signaling with cytokines or 
ligands but are not capable of specifically recognising viral antigen, and the eventual 
reduction of clonally expanded, antigen-reactive, lymphocyte populations (Rudin and 
Thompson, 1997). Apoptosis is also an important killing mechanism of virus-infected 
cells by CTLs (through Fas and serine proteinase mediated mechanisms) or via 
signaling through the TNF receptors (Atkinson and Bleackley, 1995; Henkart, 1994). 
Myxoma virus produces multiple inhibitors of apoptosis in infected lymphocytes, 
including the intracellular form of the T2 protein which inhibits TNF/Fas-mediated 
apoptosis (Schreiber et al., 1997; Sedger and McFadden, 1996), and the Serp2 protein, 
which inhibits interleukin-1 ß-converting enzyme (ICE) (Messud-Petit et al., 1998; Petit 
et al., 1996), a serine protease involved in Fas, TNF and granzyme B mediated 
pathways of apoptosis (reviewed in McFadden and Barry, 1998; Turner and Moyer, 
1998). In myxoma virus-infected rabbits, apoptosis of cells positive for virus was not
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observed suggesting that anti-viral CTL-mediated cell death was not the major 
contributor to apoptosis of lymphocytes in infected lymph nodes.
A possible model for the lymphocyte pathology in myxomatosis is provided by African 
swine fever virus (ASFV) in pigs. Significant apoptosis occurs in lymphocytes in 
infected lymph nodes but these lymphocytes are not infected with virus (Oura et al., 
1998a). The lymphocyte cell death has been attributed to virus infection of monocytes 
which then stimulate inappropriate cell death in lymphocytes. Interestingly, wild bush 
pigs which are resistant to ASFV control virus replication in lymph nodes and this is 
associated with reduced numbers of apoptotic lymphocytes (Oura et al., 1998b).
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5.4.3 The role of M11L, MT-2, MT-4 and MT-5 in virus replication and 
dissemination in vivo.
A model was proposed in Chapter 4 in which myxoma virus replicates initially in 
dermal dendritic cells and disseminates in these cells to the draining lymph node. 
Replication in the lymph node then occurs in T-lymphocytes and these cells are critical 
for further dissemination. The importance of virus replication in dendritic cells and 
lymphocytes for dissemination was investigated by examining the in vivo replication of 
gene-deletion mutants which are partially defective for replication in lymphocytes in 
vitro, and are attenuated in rabbits (Barry et al., 1997; Graham et al., 1992; Macen et 
al., 1996b; Mossman et al., 1996a; Opgenorth et al., 1992; Schreiber et al., 1997). 
These genes are M11L, T2, T4 and T5, which are each involved in the inhibition of 
apoptosis in infected lymphocytes via different pathways.
Deletion of Ml 1L was associated with fewer infected dendritic cells in the skin of the 
primary inoculation site than with the other viruses, which were not different from the 
control virus. The control virus vMyxlac+ grew to 1000 fold greater titres in the skin of 
rabbits than in two of three rabbits infected with either vMyxlacMl 1L or vMyxlacT5~, 
and to 10 fold greater titres than vMyxlacT2' and vMyxlacT4\ All viruses reached the 
draining lymph node in all infected rabbits by 48hpi. The transport of vMyxlacMl 1L~ 
to the draining lymph node was possibly delayed as all other viruses were detected at 
24hpi. Titres of gene-deletion mutants in the draining lymph node were not particularly 
different from each other at 6dpi, although they were considerably lower than the 
control virus, vMyx-lac+. Antigen was detected in lymphocytes in the draining lymph
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node in all virus infections. Thus, in infected rabbits, virus was able to replicate in 
lymphocytes. However, far more lymphocytes were infected in the lymph nodes of 
rabbits infected with vMyx-lac+, which was also present in cells of the lymph node 
capsule.
The main differences between replication of the control virus and the gene-deletion 
mutants was in the contralateral lymph node. At 6dpi, titres were lower for all viruses 
compared to the draining lymph node. Two animals infected with vMyxlacT5 and one 
animal infected with vMyxlacT2‘ had no detectable virus in the contralateral lymph 
node and the titres of vMyxlacMl 1L' and vMyxlacT4 were generally lower than vMyx- 
lac+. At 48hpi, virus was present in the contralateral lymph node of two of three rabbits 
infected with vMyx-lac+, but was not present in the contralateral lymph nodes of any 
other virus-infected rabbits.
Virus replication was limited in the gene-deletion mutants compared to the control 
virus, with reduced titres in the skin and lymph nodes. However, all viruses replicated 
in dendritic cells and reached the draining lymph node, and in some animals, virus 
reached the contralateral lymph node. It is interesting that replication in dendritic cells 
and lymphocytes occurred in vivo and that virus was able to reach distal lymph nodes. 
Obviously the presence of virus in a lymph node was not enough to ensure efficient 
replication of that virus. This is similar to results obtained with SLS and Uriarra in 
resistant rabbits and suggests that the host response to the virus will determine if the 
virus replicates to high titres. In this study it was not possible to dissect out whether 
low virus titres of the gene-deletion mutants were due to enhanced inflammatory and 
immune responses of the rabbits or poor replication of virus in critical cells. Thus, 
infection of rabbits with the gene-deletion mutants did not provide a good model for 
examining the importance of viral replication in particular cell types in virus 
dissemination.
The growth and dissemination of myxoma virus and the control of virus replication by 
the host will undoubtedly involve very complex signaling between the virus and the 
host cell, as well as signaling between host cells in the context of an immune response. 
The deletion of individual viral genes is essential to investigate gene and protein 
function, as well as providing indications as to what type of selection pressures have 
been important in the evolution of the virus. However, infection of rabbits with these
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viruses shows that the individual functions of viral genes are not well defined in vivo, 
and that the attenuation of these viruses is more complex than can be explained by 
impaired replication in lymphocytes. The study of in vivo models of virus pathogenesis 
is thus highly important in the understanding of virulence and genetic resistance.
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Chapter 6: Final Discussion
6. Final Discussion
The coevolution of myxoma virus and the European rabbit is one of the best described 
examples of host-pathogen coadaptation (Fenner and Ratcliffe, 1965). However, while 
the development of genetic resistance in the rabbit and the consequences for biological 
control have been well described, there was remarkably little information on the 
pathogenesis of myxoma virus, particularly in resistant rabbits. This thesis has 
presented a detailed study of the pathogenesis of two strains of myxoma virus, the 
highly virulent SLS and the naturally attenuated Uriarra. By using wild rabbits 
naturally selected for genetic resistance, I have focussed on the interactions of myxoma 
virus with the rabbit immune system and the role of particular cell types in virus 
replication and dissemination.
6.1 Myxoma virus pathogenesis
In Chapter 2, I examined the differences in the immune responses of rabbits to virulent 
and attenuated strains of myxoma virus and showed that the virulent virus suppressed T- 
cell responses to mitogens. In addition, virulent virus caused the almost total loss of 
lymphocytes from the lymph nodes and suppressed the rabbits’ ability to mount an 
antibody response to a coexpressed antigen.
The lymphoid tissues and skin are critical for myxoma virus pathogenesis. In Chapter 3 
I compared the titres of virulent and attenuated strains of myxoma virus in these tissues 
and for the first time, examined the titres in resistant wild rabbits. This demonstrated 
that wild rabbits were able to control virus replication very early in infection at the 
lymph node draining the skin inoculation site and also controlled replication in distal 
sites to which the virus disseminated. In contrast, laboratory rabbits infected with 
attenuated virus mostly controlled replication at distal sites following dissemination.
Using immunofluorescence to localise viral antigen, in Chapter 4, the initial cells in 
which myxoma virus replication occurred were MHC II positive cells in the dermis. 
Virus replication subsequently occurred in cells of the epidermis and the draining lymph 
node. The predominantly lymphocytic inflammatory response to virus infection by 
SLS-infected wild rabbits and Uriarra-infected rabbits indicated a difference between
the ability of SLS and Uriarra to modulate the inflammatory response and that wild 
rabbits could overcome the modulation caused by SLS. Massive depletion of 
lymphocytes occurred in SLS-infected lymph nodes in laboratory rabbits. This was a 
direct effect of virus infections because although apoptosis was a major feature of all 
infected nodes, this occurred in both SLS and Uriarra infected rabbits and continued 
after virus was largely cleared from the nodes (Chapter 5). Apoptosis did not occur in 
lymphocytes productively infected with virus. Importantly, SLS infected laboratory 
rabbits had earlier apoptosis and the cell death was adjacent to virus infected cells. In 
vitro, fibroblasts and lymphoid cells from wild rabbits supported myxoma virus 
replication equivalently to the same cells from laboratory rabbits. This showed that cell 
permissivity was not the cause of resistance and confirmed the immunofluorescence 
results from Chapter 4 where virus was present in the same cell types in wild and 
laboratory rabbits.
The molecular basis of attenuation of Uriarra compared to SLS is not understood. The 
viruses have similar replication rates in tissue culture and a similar cell host range in 
vitro [P.Kerr, unpublished]. As far as is known, both SLS and Uriarra produce the same 
functional proteins involved in modulation of the immune response. These include the 
proteins known to inhibit apoptosis of infected lymphocytes in vitro, as well as the IFNy 
receptor homolog [P.Kerr, unpublished results]. In addition, both SLS and Uriarra 
downregulate MHC I on the surface of infected cells [P.Kerr, unpublished], suggesting 
that CTL responses are potentially limited during infection with either virus. Hence, at 
present, there is no molecular basis for the difference between the ability of the two 
viruses to modulate the immune response. Using Uriarra as the attenuated model virus 
does not provide the detail concerning individual genes and their functions that single 
gene knock-out viruses do. However, Uriarra provides a model of a naturally attenuated 
virus and allows the examination of the phenotypic events occurring in infection of 
laboratory and wild rabbits, and the events associated with replication, dissemination 
and control of an attenuated virus. Similar survival rates of Uriarra-infected laboratory 
rabbits and SLS-infected wild rabbits also suggested that this was a very useful model to 
compare pathogenesis and resistance. Obviously it is not possible to make the sort of 
molecular conclusions in outbred animals that can be made in models using inbred, 
knock-out or transgenic mice. However, while these systems are very powerful for 
examining immunological mechanism, they may not provide a good model for what 
happens in an outbred population of animals naturally infected in the field.
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6.2 Models of myxoma virus pathogenesis in laboratory and wild rabbits
The models of myxoma virus pathogenesis for laboratory and wild rabbits infected with 
either SLS or Uriarra are presented in Figure 6.1, and highlight a series of important 
points concerning virus replication and the control of this replication. Firstly, both SLS 
and Uriarra replicated in dendritic cells in the dermis at the primary inoculation site, 
followed by replication in the epidermis. At this site, both viruses reached titres greater
*7
than 10 pfu/g suggesting that both viruses could be transmitted by mosquitoes from the 
primary lesion of either laboratory or wild rabbits (Day et a l, 1956; Fenner, Day, and 
Woodroofe, 1956). Resistance to infection and control of virus replication was not 
mediated by a block in the transport of virus to the draining lymph node, although in 
Uriarra-infected wild rabbits, the spread of virus to this node was delayed compared to 
the other infections.
Events in the draining lymph node were critical in determining whether virus replication 
was uncontrolled and virus rapidly disseminated to tissues including other lymph 
nodes, the spleen, lung and secondary sites in the skin, as occurred during SLS-infection 
of laboratory rabbits (Figure 6.1 A), or if virus replication and dissemination were 
constrained. Titres of Uriarra in the draining lymph node of laboratory rabbits were 
similar to those in SLS-infected laboratory rabbits until 6dpi, after which time virus 
replication was controlled, leading to the eventual clearance of virus from this tissue 
(Figure 6.IB). Uriarra reached distal tissues later than SLS and replicated to lower titres 
in these tissues. Thus both dissemination to distal tissues and replication were 
controlled, except for the spleen where similar titres were reached. Uriarra titres in the 
distal skin did not reach 107 pfu/g, suggesting that this virus could not be transmitted 
from this sample of skin. However, transmission of Uriarra may occur from secondary 
lesions that formed over the nose and eyelids of infected laboratory rabbits (Day et al., 
1956; Fenner, Day, andWoodroofe, 1956; Fenner and Woodroofe, 1953). Anti-viral 
antibody was produced by these rabbits. However, laboratory-rabbits infected with SLS 
produced earlier and higher titres of virus-specific antibody than Uriarra-infected 
rabbits, suggesting that antibody was not critical in the control of virus replication. 
Rather, the observation that Uriarra replication was restricted from 6dpi suggests a role 
for CTL responses in virus clearance from laboratory rabbits.
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Figure 6.1: Models o f the replication and control of virulent and attenuated myxoma 
virus in infected laboratory and wild rabbits. Following intradermal inoculation at the 
skin, both Uriarra and SLS replicated in dermal dendritic cells and the epidermis, and all 
viruses were transported to the draining lymph node. In SLS-infected laboratory rabbits, 
virus replicated to high titres in the draining lymph node, rapidly disseminated to distal 
tissues and secondary sites in the skin, where it grew to high titres. The dissemination of 
Uriarra to distal tissues was reduced compared to SLS in infected laboratory rabbits. 
The draining lymph node may be important in the control of this dissemination and 
subsequent replication of Uriarra in distal tissues. Control of both SLS or Uriarra by 
wild rabbits occurred at the draining lymph node. All rabbits produced anti-viral 
antibody. Based on the timing, control of virus replication by laboratory rabbits is 
hypothesised to involve CTL responses; in wild rabbits, both NK cells and CTLs may be 
involved. Arrows represent virus dissemination. Uncontrolled virus replication in tissues 
or uncontrolled dissemination are both indicated in red. Control of virus replication or 
dissemination is indicated in green. Hypothesised (indicated by ? )  and known immune 
responses are indicated in blue. Transmission indicates measurement of 107 pfii/g of skin 
at the primary inoculation site and distal skin.
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The draining lymph node was important for the control of myxoma virus replication in 
wild rabbits (Figure 6.1C). This control occurred earlier in SLS-infected wild rabbits 
than in Uriarra-infected laboratory rabbits based on the lower titres of virus. Similarly 
to Uriarra-infected laboratory rabbits, SLS dissemination from the draining lymph node 
to other tissues was constrained as it reached distal tissues later than SLS in infected 
laboratory rabbits, except for the spleen. SLS reached the distal skin site of wild 
rabbits, but did not replicate in the epidermis as efficiently as SLS in laboratory rabbits, 
and reached titres no greater than approximately 103 pfu/g. Hence, virus still reached 
distal tissues but was locally controlled. This control was associated with a rapid and 
concentrated lymphocytic inflammatory response at the distal skin. I hypothesise that 
early control at the draining lymph node may be due to enhanced NK cell activity and 
probably more effective INF ot/ß activity. This is then followed or accompanied by an 
early CTL response. High titres of virus-specific antibody were produced by wild 
rabbits in response to infection with SLS, and this may also be important in the 
restriction of virus spread (Vanderplasschen et al., 1997), such as that in the distal skin. 
Despite this control, SLS may have been transmitted from the distal skin of the one wild 
rabbit in which secondary lesions containing greater than 107 pfu/g of virus formed, and 
from the secondary lesions on the face. However, these lesions rapidly scabbed over, 
which would limit the time virus was accessible to mosquitoes, and thus reduce the 
probability of transmission (Day et al., 1956).
Wild rabbits infected with Uriarra limited virus dissemination and replication to the 
draining lymph node and to other lymph nodes, the lung and distal skin (Figure 6.ID). 
Transmission of Uriarra from the skin of infected wild rabbits is unlikely to occur as 
virus did not grow to high titres and did not cause secondary lesion formation on the 
face. It is interesting that despite the generalised limitation of dissemination and 
replication, Uriarra was able to initially replicate just as efficiently in the primary 
inoculation site and the spleen of wild rabbits as SLS or as Uriarra in infected laboratory 
rabbits. However, the actual primary lesion was smaller in Uriarra-infected wild 
rabbits, suggesting control of virus replication does occur in the skin, but may be 
dependent on effector cells generated elsewhere.
The orchestration of immune responses to viral pathogens depends on the efficient 
delivery of stimulatory signals, such as cytokines and antigen, to appropriate effector 
cells such as NK cells, CD4+ and CD8+ T-cells, and B-cells. Cytokines, such as IFNs
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and TNF, can also have direct antiviral affects (Ramshaw et al., 1997). The most potent 
cells involved in the delivery and organisation of this response are dendritic cells 
(Banchereau and Steinman, 1998). Following viral infection, the activation of dendritic 
cells by viral antigen and the appropriate growth factors such as IL-1, TNF and/or GM- 
CSF (granular macrophage-colony stimulating factor), begins a cascade of stimulatory 
signals which activate effector cells involved in the clearance of virus infection (Caux et 
al., 1992). A very early response of dendritic cells is to produce IL-12. IL-12 activates 
NK cells which recognise and kill virus-infected cells. NK cell recognition of target 
cells is enhanced by low levels of MHC I expression (Trinchieri, 1995). NK cells are 
also an early source of high levels of IFNy that, along with IL-12 produced by dendritic 
cells, stimulates CD4+ T-cell precursors to secrete TNF and IFNy, and hence become 
Th I T-cell clones. The co-stimulation of CD4+ T-cells with antigen in association with 
MHC II by dendritic cells results in further communication between these two cell types 
through CD40/CD40 ligand (Schoenberger et al., 1998). This enables or ‘conditions’ 
dendritic cells to stimulate CD8+ T-cells to become antigen-specific killer cells (or 
cytotoxic T-lymphocytes; CTL) through the continued production of IL-12, and through 
direct signaling with antigen associated with MHC I (Banchereau and Steinman, 1998). 
IFNy produced by both NK cells and CD4+ T-cells also stimulates CD8+ T-cells.
Dendritic cells are the first cells to become infected with myxoma virus in the skin, and 
probably transport virus to initiate virus infection in the draining lymph node. Infection 
of dendritic cells could interfere with cellular gene transcription and protein synthesis, 
thus disrupting cell function. In addition, myxoma virus is known to downregulate the 
cell surface proteins, MHC I and CD4+ (Barry et al., 1995; Boshkov et al., 1992). This 
has the potential to prevent the recognition and stimulation of effector cells. Myxoma 
virus also encodes proteins that may interfere directly with the responses of dendritic 
cells and associated effector cells. In particular, myxoma virus-produced proteins 
interfere with the action of TNF ct/ß, INFy, IL-1 and chemokines (Graham et al., 1997; 
Lalani et al., 1998; McFadden and Graham, 1994; Mossman et al.„ 1995a; Schreiber 
and McFadden, 1994; Schreiber et al., 1997; Upton et al., 1992). Myxoma virus also 
modulates immune responses through proteins with as yet undefined functions, such as 
M11L and the serpins, serpl and serp2 (Macen et al., 1993; Opgenorth et al., 1992, 
Graham, 1992; Petit et al., 1996; Upton et al., 1990). In addition, the entire sequence of 
myxoma virus has not been determined and it is likely that additional immune- 
regulatory proteins remain to be discovered. Based on strategies of immune modulation
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by other poxviruses, myxoma virus has the potential to affect IFN ot/ß and complement 
mediated responses. Infection of dendritic cells with myxoma virus thus has the 
potential to affect immune responses on many different levels and create a milieu in 
which immune function is severely compromised, both in the skin and the draining 
lymph node.
A specific potential example of this following myxoma virus infection of dendritic cells 
is the modulation of immune responses through chemokines. Following stimulation, 
dendritic cells produce chemokines to attract effector cells and increase the probability 
of contact with, and stimulation of, lymphocytes capable of reacting specifically to 
antigen (Banchereau and Steinman, 1998). Myxoma virus produced chemokine binding 
proteins inhibit the CC chemokine-mediated chemotaxis of mononuclear lymphoid cells 
in vitro (Lalani et al., 1998). These myxoma virus-produced binding proteins do not 
inhibit CXC-mediated neutrophil chemotaxis in vitro. If this translates directly to the 
infection of dendritic cells in vivo, the local environment at sites of infection will be 
dominated by stimulatory signals associated with neutrophil granule release. This is 
consistent with the inflammatory response of laboratory rabbits to SLS infection in the 
skin. Although neutrophils have been shown to have an anti-viral function (Lidbury et 
al., 1995; Tumpey et al., 1996; West et al., 1987), the generation of signals in this 
response will not be balanced through cytokine production by mononuclear cells 
involved in the promotion of specific anti-viral immune responses, and will result in 
continued inappropriate signaling of cell responses. Thus, infection of dendritic cells by 
myxoma virus need only initiate an inappropriate response; the cascade of signals 
between cells will serve to amplify it.
In a model of myxoma virus pathogenesis, I propose that infected dendritic cells are 
crucial in determining the interactions of the immune response both in the skin and in 
the draining lymph node. Further, that infection of dendritic cells with SLS results in 
inappropriate signaling between cells and the severe modulation of anti-viral immune 
responses. In the lymph nodes, SLS-infected of dendritic cells (interdigitating dendritic 
cells) may partially activate CD4+ T-cells via the presentation of antigen but fail in the 
delivery of appropriate soluble signals to T-cells through their inhibition by viral 
proteins. Partially activated T-cells may be in a state of anergy and thus unable to 
respond to the in vitro stimulation with mitogens. This would render them highly 
susceptible to activation-induced cell death (AICD). The early death of these cells
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would greatly restrict the T-cell help available for the generation of anti-viral CD8+ 
CTL, and contribute to the failure of the rabbit to control virus replication. Indeed, 
murine Th I clones have been shown to preferentially undergo AICD via the Fas 
pathway of activation (Varadhachary et al., 1997).
T-cell responses to mitogen were not significantly altered in Uriarra-infected rabbits 
(see Chapter 2), and thus T-cells are potentially available to supply help for the 
stimulation of anti-viral CTL in these rabbits. Uriarra infected similar numbers of 
dermal dendritic cells as SLS. Nevertheless, Uriarra reached distal tissues of laboratory 
rabbits later than SLS, and it may be that this control of virus dissemination occurred at 
the level of the draining lymph node. Within this model of myxoma virus pathogenesis, 
it is possible that Uriarra-infected dendritic cells present antigen in association with the 
crucial co-stimulatory signals, resulting in the efficient generation of anti-viral CD8+ 
CTL. This is consistent with the timing of the control of virus replication, and the 
lymphocytic inflammatory response to Uriarra-infection in the skin.
6.3 A model of genetic resistance to myxoma virus infection
The mechanisms of immune modulation employed by SLS and Uriarra strains of 
myxoma virus in infected laboratory rabbits will still be operational in infected wild 
rabbits. However, the wild rabbits are able to overcome this modulation, control virus 
replication and recover from infection. Similarly to Uriarra-infection of laboratory 
rabbits, the control of SLS-infection of wild rabbits is mediated at the draining lymph 
node, and is associated with a lymphocytic inflammatory response in the skin. 
However, titres of SLS in the draining lymph node of wild rabbits were somewhat lower 
than Uriarra in laborator rabbits. This suggests that the control of SLS replication in 
wild rabbits occurs earlier than control of Uriarra in laboratory rabbits. The earliest 
anti-viral effector cells are likely to be NK cells as these do not require the adaptive arm 
of the immune response. In the figures of virus pathogenesis (Figure 6.1), I have 
suggested that two levels of resistance are operating. Firstly, unselected rabbits infected 
with attenuated virus are able to mount an effective CTL response and limit virus 
replication in distal tissues, possibly by INF a/ß action making cells resistant to 
infection as well as by direct killing of virus infected cells. Secondly, in resistant 
rabbits, control of SLS replication occurs earlier in the draining lymph node and here I 
postulate an effective NK cell response together with by INF a/ß and an earlier CTL
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response. However, this does not completely clear the virus from this tissue in one 
rabbit at each late time point. This is probably a reflection of two things; drainage of 
virus from the skin and the outbred nature of the rabbits leading to variation in 
resistance.
This model is supported by the model of resistance to ectromelia virus infection of 
mice. Ectromelia virus resistance is dependent on INFy as well as INF a/ß (Karupiah et 
al., 1990a; Karupiah et al., 1993a), NK cells (Delano and Brownstein, 1995), the early 
generation of anti-viral CTL (ONeill and Brenan, 1987; Ramshaw et al., 1997), and the 
presence of high levels of TH1 -associated cytokines, IL-2, IL-12 and TNFa (in 
Ramshaw et al., 1997). Genetic resistance to ectromelia virus infection is 
predominantly controlled by one locus, a member of the NK gene complex (Rmpl or 
resistance to mousepox) (Delano and Brownstein, 1995; Wallace et al., 1985), but 
several other unlinked, autosomal dominant genes also contribute to resistance 
(Brownstein et al., 1989; Brownstein et al., 1992).
In myxoma virus-infected wild rabbits, NK cells have two potential roles in controlling 
virus infection. Firstly, a strong and early NK cell response to infection in wild rabbits 
may act as an early and concentrated source of IFN7, capable of saturating the IFN7 
binding protein of myxoma virus. Influenza virus-infected murine dendritic cells are 
capable of stimulating CD8+ T-cells in the absence of CD4+ T-cells (Ridge, Di Rosa, 
and Matzinger, 1998). The early production of IFN7 by NK cells, in concert with 
myxoma virus-infected dendritic cells, may be sufficient for the stimulation of CD8+ 
CTL responses to infection, and the control of virus replication. However, SLS does 
deplete lymphocytes from the draining lymph node, implying that some disruption of 
the wild rabbits immune responses is occurring. The second role for NK cells in wild 
rabbits is potentially the recognition and killing of virus-infected dendritic cells.
The role of CD4+ T-cells in these models of virus-induced immune modulation and 
genetic resistance is potentially in the development of a strong cellular immune 
response through the production of TH1 -associated cytokines. Suppression of the 
mitogen-induced proliferative response and/or the early apoptosis of these cells in SLS- 
infected laboratory rabbits may be sufficient to suppress the ensuing CTL response 
hypothesised to be important in the control of Uriarra by laboratory rabbits. 
Alternatively, the modulation of early stimulation of CD4+ T-cells by SLS-infected
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dendritic cells may activate a presominantly Th2 response, resulting in anti-viral 
antibody production, but downregulating the activation of CTL responses. However, 
virus was generally cleared from internal tissues of Uriarra-infected laboratory rabbits 
and SLS-infected wild rabbits, but was not cleared from the skin. Clearance of 
ectromelia or herpes simplex viruses from the skin of mice has been shown to require 
CD4+ T-cells (Karupiah et al., 1996; Nash et ai, 1987). Hence, it may be that strong 
CD4+ T-cell-mediated responses are not generated in response to myxoma virus 
infection.
The models of myxoma virus-induced immune suppression and genetic resistance make 
two predictions. These are firstly that laboratory rabbits infected with Uriarra mount a 
stronger CTL response to infection than SLS-infected laboratory rabbits. Secondly, 
SLS-infected wild rabbits mount both a stronger NK cell response than SLS-infected 
laboratory rabbits and an earlier CTL response. These predictions are testable in 
outbred rabbits, through an examination of effector cell function in laboratory and wild 
rabbits. It might be expected that genetically resistant rabbits may produce higher levels 
of proinflammatory cytokines involved in the mobilisation of NK cell responses. 
Potential candidate cytokines include INFy, TNFa or IL-12. Reverse transcriptase- 
polymerase chain reaction (RT-PCR) assays for cytokine production by cells from 
laboratory and wild rabbits are currently being developed in our laboratory. Reliable 
commercial reagents to investigate subpopulations of rabbit T-cells involved in the 
immune response to myxoma virus infection are limited. However, the development of 
NK cell and virus-specific CTL responses can be examined by investigating the killing 
of non-autologous and autologous (MHC non-restricted and restricted) target cells by 
lymph node cells from resistant and susceptible rabbits infected with virulent and 
attenuated strains of myxoma virus at various times after infection.
6.4 Virus transmission and the selection for virus virulence and host 
resistance
The development of genetic resistance in the wild rabbit population was probably 
dependent on existing polymorphisms at one or more critical loci, as the occurrence of a 
mutational event over such a short time as observed at the Lake Urana field site 
(Marshall and Douglas, 1961; Marshall and Fenner, 1958) is unlikely (Kerr and Best, 
1998). Resistance can be explained by selection for rabbit survival by several genetic 
models. The first is selection on a single locus with a single allele that mediates
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resistance. A second possibility is selection on a single locus with multiple resistance 
alleles that encode for different levels of resistance. In this case, combinations of alleles 
may mediate different levels of resistance. Alternatively, resistance may be selected on 
multiple loci, which individually confer weak resistance, but when inherited together, 
confer strong resistance. A final possibility is the inheritance of combinations of 
resistance loci, with a single locus conferring major resistance and other loci 
contributing (Kerr and Best, 1998) as occurs in genetic resistance in mice to both 
ectromelia virus and cytomegalovirus (Brownstein, Bhatt, andJacoby, 1989; Brownstein 
et al., 1992; Scalzo et al., 1992). Obviously dominance and heterozygosity would also 
be involved at any resistance locus.
Myxoma virus is endemic in Australia causing frequent epidemics in wild rabbit 
populations. Rabbits from these populations usually show a range of resistance 
phenotypes following infection with a standard virus. A small proportion of infected 
rabbits may show no clinical signs, another larger proportion may die and the main 
group will develop clinical myxomatosis and recover [Kerr, Merchant and Robinson, 
unpublished]. It is interesting to speculate that rabbits having high genetic resistance to 
myxomatosis may be selected against in terms of survival from other disease or for 
other causes, and that this leads to populations with only a small proportion of highly 
resistant rabbits.
Selection of successful myxoma virus strains in the field depends on the transmission of 
virus from infected to uninfected animals. On average, if each infected animal fails to 
transmit to at least one susceptible animal, the virus will become extinct. Transmission 
of myxoma virus in natural hosts, the Sylvilagus species of rabbit, depends exclusively 
on high virus titres in the primary skin site as the virus does not disseminate to 
secondary sites of replication in the skin (Marshall and Regnery, 1960; Marshall, 
Regnery, and Grodhaus, 1963). In European rabbits in the absence of a reseviour 
Sylvilagus host, myxoma virus could evolve or be selected in two ways as genetic 
resistance develops. The first is selection of strains that are predominantly transmitted 
from the primary inoculation site, but do not disseminate substantially to other tissues. 
This strategy essentially breaks the strong relationship between success of transmission 
and virus dissemination and requires persistence of virus at high titres at the primary 
inoculation site (Anderson and May, 1982; Fenner and Ross, 1994).
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The second strategy is selection towards highly virulent strains of virus that have a 
greater chance to produce a disseminated disease and replicate to high titres in 
secondary sites in the skin, causing the development of secondary lesions from where 
transmission would occur. These viruses would thus be likely to have a high mortality 
rate, at least in a proportion of infected rabbits. Strains of myxoma virus recently 
isolated in Australia cause a range of clinical signs. Some viruses do not cause primary 
lesions at the inoculation site, but virus can be transmitted from secondary lesions on 
the face (Kerr, Merchant and Robinson, unpublished). These viruses are thus capable of 
systemic dissemination and substantial replication at secondary sites in the skin of 
genetically resistant wild rabbits. Hence, the evidence from the field suggests that host- 
virus coevolution has selected for a virulent, disseminated disease rather than for 
persistence of virus in the skin.
6.5 Final summary
This study has provided the baseline description of pathogenesis of virulent and 
attenuated strains of myxoma virus in both laboratory (unselected for resistance) and 
wild rabbits which have undergone intense selection for resistance to myxoma virus. 
The genetic and molecular basis for this resistance remain to be investigated, but clearly 
involves an effective immune response. However, using the models presented in this 
thesis, we can now focus on likely mechanisms of resistance such as effector cells and 
the generation of effector cells in the innate and adaptive immune response.
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